{
  "meta": {
    "title": "Mission_Neet_Pg-Inicet_Grand_Test-32",
    "url": "https://brainandscalpel.vercel.app/mission-neet-pg-inicet-grand-test-32-83429e45.html",
    "scrapedAt": "2025-11-29T18:21:50.434Z"
  },
  "questions": [
    {
      "id": 98609,
      "choices": [
        {
          "id": 392456,
          "text": "<p><span style=\"font-size:14.0pt;\">1–2</span></p>"
        },
        {
          "id": 392457,
          "text": "<p><span style=\"font-size:14.0pt;\">3–4</span></p>"
        },
        {
          "id": 392458,
          "text": "<p><span style=\"font-size:14.0pt;\">5–6</span></p>"
        },
        {
          "id": 392459,
          "text": "<p><span style=\"font-size:14.0pt;\">7–10</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A preterm infant has the following findings: upper chest lag present, minimal lower chest retractions, prominent xiphoid retractions, marked nasal flaring, and no grunting. What is the likely Silverman-Anderson Respiratory Score (SAS)?</span></p>",
      "unique_key": "Q8628304",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) 5–6</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Silverman-Anderson Score (SAS)</strong> is used to assess the severity of respiratory distress in neonates.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Each of the five components (upper chest movement, lower chest retraction, xiphoid retraction, nasal flaring, and grunting) is scored from 0 to 2.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Upper chest lag = 1</span></li><li><span style=\"font-size:14.0pt;\">Minimal lower chest retraction = 1</span></li><li><span style=\"font-size:14.0pt;\">Marked xiphoid retraction = 2</span></li><li><span style=\"font-size:14.0pt;\">Nasal flaring = 2</span></li><li><span style=\"font-size:14.0pt;\">No Grunting = 0</span><br><span style=\"font-size:14.0pt;\">Total = 6</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>SAS quantifies neonatal respiratory distress (0 = none, 10 = severe).</strong> Moderate scores (5–6) indicate significant distress requiring CPAP and close monitoring.</span></p>",
      "correct_choice_id": 392458,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98609/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98609/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98401,
      "choices": [
        {
          "id": 391636,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-B, 3-A, 4-D</span></p>"
        },
        {
          "id": 391637,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-D, 3-C, 4-A</span></p>"
        },
        {
          "id": 391638,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-C, 4-D</span></p>"
        },
        {
          "id": 391639,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-A, 3-B, 4-D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following healthcare schemes with their target populations in India:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6DAFUI9.png\" width=\"730\" height=\"235\"></span></p>",
      "unique_key": "Q7142617",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1-C, 2-B, 3-A, 4-D</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1-C.</strong> <strong>Pradhan Mantri Jan Arogya Yojana (PM-JAY)- Economically weaker sections:&nbsp;</strong>PM-JAY provides health insurance coverage to economically weaker sections (bottom 40% families).</span></li><li><span style=\"font-size:14.0pt;\"><strong>2-B. Rashtriya Bal Swasthya Karyakram (RBSK)- Children from birth to 18 years:</strong> RBSK focuses on early identification and management of diseases in children from birth to 18 years.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3-A. Janani Suraksha Yojana (JSY)- Pregnant women and newborns:</strong> JSY promotes institutional deliveries by providing cash assistance to pregnant women.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4-D.</strong> <strong>Mission Indradhanush- Infants and children for immunization:&nbsp;</strong>Mission Indradhanush aims to achieve full immunization coverage for children and pregnant women.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PM-JAY is the world's largest government-funded healthcare scheme targeting economically disadvantaged families</span></li><li><span style=\"font-size:14.0pt;\">RBSK provides comprehensive healthcare services to children from birth to 18 years through dedicated teams</span></li></ul>",
      "correct_choice_id": 391636,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98401/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98401/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98774,
      "choices": [
        {
          "id": 393108,
          "text": "<p><span style=\"font-size:14.0pt;\">Arrhythmogenic</span></p>"
        },
        {
          "id": 393109,
          "text": "<p><span style=\"font-size:14.0pt;\">Neurocardiogenic</span></p>"
        },
        {
          "id": 393110,
          "text": "<p><span style=\"font-size:14.0pt;\">Neurologic</span></p>"
        },
        {
          "id": 393111,
          "text": "<p><span style=\"font-size:14.0pt;\">Orthostatic hypotension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 74-year-old woman with no medical history presents with syncope during urination. The event was witnessed, with no evidence of seizure activity. Orthostatic vitals reveal a 5-mmHg systolic drop and a 20 bpm rise in HR. Physical exam and ECG are normal, and she is currently asymptomatic. What is the most likely etiology?</span></p>",
      "unique_key": "Q4493734",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Neurocardiogenic</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Micturition syncope is a classic example of neurocardiogenic (reflex) syncope, triggered by a transient increase in vagal tone during urination.</span></li><li><span style=\"font-size:14.0pt;\">This produces bradycardia and/or hypotension, causing short-term cerebral hypoperfusion and loss of consciousness.</span></li><li><span style=\"font-size:14.0pt;\">Typical triggers for neurocardiogenic syncope include urination, defecation, coughing, standing after prolonged sitting or lying, and emotional stress.</span></li><li><span style=\"font-size:14.0pt;\">This form of syncope is common in older adults and usually benign, with management focused on avoiding triggers and maintaining good hydration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Arrhythmogenic:</strong> Arrhythmogenic syncope often occurs with underlying cardiac disease, is sudden (often without warning), and would show ECG or structural abnormality; not the case here.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Neurologic:</strong> Neurologic causes (e.g., seizure, TIA) usually have additional neurologic features, abnormal postictal state, or focal deficits - none are reported.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Orthostatic hypotension:</strong> Orthostatic hypotension requires a drop in systolic BP ≥20 mmHg; her 5 mmHg drop is not significant, and symptoms were specifically associated with micturition, not posture alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Neurocardiogenic (vasovagal) syncope occurs in response to characteristic triggers like urination and is due to vagal overactivity; a benign condition best managed by education and avoidance of the precipitating stimulus.</span></p>",
      "correct_choice_id": 393109,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98774/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98774/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98795,
      "choices": [
        {
          "id": 393192,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of dihydrofolic acid reductase</span></p>"
        },
        {
          "id": 393193,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of AICAR transformylase</span></p>"
        },
        {
          "id": 393194,
          "text": "<p><span style=\"font-size:14.0pt;\">Blocking Janus Kinase (JAK)</span></p>"
        },
        {
          "id": 393195,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of pyrimidine synthesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old female presents with a 5-year history of joint pain, stiffness, and swelling, primarily involving the small joints of the hands and wrists. Laboratory tests reveal a positive rheumatoid factor and elevated ESR. She is initiated on methotrexate therapy. Which of the following is the mechanism of action of this drug in the treatment of rheumatoid arthritis?</span></p>",
      "unique_key": "Q8897327",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Inhibition of AICAR transformylase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Methotrexate is the first-line DMARD used for rheumatoid arthritis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">At low weekly doses used in rheumatoid arthritis, methotrexate primarily inhibits&nbsp;<strong>AICAR transformylase</strong>, causing accumulation of&nbsp;<strong>adenosine</strong>, a powerful anti-inflammatory mediator.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Methotrexate's immunomodulatory properties help reduce disease progression.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Inhibition of dihydrofolic acid reductase:&nbsp;</strong>Incorrect (mechanism at higher anticancer doses).&nbsp;Methotrexate inhibits&nbsp;<strong>DHFR</strong>&nbsp;in cancer therapy, blocking thymidylate synthesis. In RA, the doses are much lower, and DHFR inhibition is&nbsp;not&nbsp;the primary anti-inflammatory mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Blocking Janus Kinase (JAK):&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>This is the mechanism of&nbsp;<strong>tofacitinib</strong>,&nbsp;<strong>baricitinib</strong>, and other JAK inhibitors (used when MTX fails).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Inhibition of pyrimidine synthesis: </strong>Incorrect.&nbsp;This is the mechanism of&nbsp;<strong>leflunomide</strong>, which inhibits&nbsp;<strong>dihydroorotate dehydrogenase</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Low-dose methotrexate inhibits&nbsp;<strong>AICAR transformylase</strong>, causing accumulation of&nbsp;<strong>AICAR → increased extracellular adenosine</strong>, which:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Decreases neutrophil adhesion</span></li><li><span style=\"font-size:14.0pt;\">Inhibits inflammatory cytokines</span></li><li><span style=\"font-size:14.0pt;\">Suppresses immune cell activation</span></li><li><span style=\"font-size:14.0pt;\">Leading to decreased synovial inflammation.</span></li></ul></li></ul>",
      "correct_choice_id": 393193,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98795/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98795/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98800,
      "choices": [
        {
          "id": 393212,
          "text": "<p><span style=\"font-size:14.0pt;\">It acutely relieves anginal attacks by rapid coronary vasodilation</span></p>"
        },
        {
          "id": 393213,
          "text": "<p><span style=\"font-size:14.0pt;\">It increases exercise tolerance without affecting heart rate or blood pressure</span></p>"
        },
        {
          "id": 393214,
          "text": "<p><span style=\"font-size:14.0pt;\">It acts through direct β-adrenergic receptor antagonism</span></p>"
        },
        {
          "id": 393215,
          "text": "<p><span style=\"font-size:14.0pt;\">It significantly reduces the incidence of myocardial infarction in unstable angina</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man with chronic stable angina is unable to tolerate beta blockers due to bradycardia. His physician initiates ranolazine. Which of the following statements about ranolazine is most accurate?</span></p>",
      "unique_key": "Q1437807",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) It increases exercise tolerance without affecting heart rate or blood pressure</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ranolazine</strong> is a unique antianginal medication approved for <strong>chronic stable angina</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Unlike traditional antianginal agents (e.g., beta-blockers, nitrates, calcium channel blockers), it <strong>does not significantly alter heart rate or blood pressure</strong>. Its <strong>mechanism of action</strong> involves inhibition of the <strong>late sodium current (late INa)</strong> in ischemic myocardial cells.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This leads to a <strong>reduction in intracellular calcium via the Na⁺/Ca²⁺ exchanger (NCX)</strong>, improving diastolic relaxation and reducing myocardial wall tension and oxygen demand.</span></li><li><span style=\"font-size:14.0pt;\">This allows patients to <strong>exercise longer and experience fewer angina episodes</strong>, both as monotherapy and in combination with standard antianginals.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It acutely relieves anginal attacks by rapid coronary vasodilation:</strong> Incorrect. Ranolazine is <strong>not effective for acute angina</strong>. It does not cause coronary vasodilation like nitrates, and is <strong>not used for immediate symptom relief</strong>. It is rather used to prevent angina.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It acts through direct β-adrenergic receptor antagonism:</strong> Incorrect. Ranolazine does <strong>not act on adrenergic receptors</strong>. Beta-blockers (e.g., metoprolol) reduce heart rate and contractility through this pathway, unlike ranolazine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It significantly reduces the incidence of myocardial infarction in unstable angina:</strong> Incorrect. While ranolazine improves <strong>exercise tolerance and symptom burden</strong>, it has <strong>not been shown to significantly reduce MI rates</strong>, especially in <strong>acute coronary syndromes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Ranolazine</strong> improves anginal symptoms by <strong>inhibiting late sodium current</strong>, reducing calcium overload, and improving myocardial relaxation — without affecting hemodynamic parameters like <strong>heart rate or blood pressure</strong>.</span></p>",
      "correct_choice_id": 393213,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98800/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98800/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98589,
      "choices": [
        {
          "id": 392380,
          "text": "<p><span style=\"font-size:14.0pt;\">Failure of class-switch recombination in B cells</span></p>"
        },
        {
          "id": 392381,
          "text": "<p><span style=\"font-size:14.0pt;\">Defective differentiation of pre-B cells into mature B cells</span></p>"
        },
        {
          "id": 392382,
          "text": "<p><span style=\"font-size:14.0pt;\">Failure of somatic hypermutation in germinal centers</span></p>"
        },
        {
          "id": 392383,
          "text": "<p><span style=\"font-size:14.0pt;\">Defective T-cell activation due to absent CD40L expression</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old woman presents with recurrent episodes of sinusitis, otitis media, and pneumonia since childhood. She also reports chronic diarrhea. Laboratory investigations reveal markedly decreased serum levels of IgG, IgA, and IgM. Flow cytometric analysis shows a marked reduction in the number of mature B cells (CD19⁺), while T-cell numbers (CD3⁺) are normal. Genetic analysis shows a mutation in the Bruton tyrosine kinase (BTK) gene located on the X chromosome. Which of the following immune mechanisms is primarily affected in this patient?</span></p>",
      "unique_key": "Q7038910",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Defective differentiation of pre-B cells into mature B cells</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This clinical presentation - recurrent bacterial infections, diarrhea, and absent immunoglobulins with low B cells in a male child - is characteristic of <strong>X-linked (Bruton) agammaglobulinemia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It results from a mutation in the BTK gene (on Xq21.3–Xq22), which is essential for maturation of pre-B cells into mature B cells in the bone marrow.</span></li><li><span style=\"font-size:14.0pt;\">Hence, B-cell development is arrested at the pre-B cell stage, leading to absent mature B cells (CD19⁺) and very low immunoglobulins (IgG, IgA, IgM).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Failure of class-switch recombination in B cells:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Seen in Hyper-IgM syndrome, due to CD40L (on T cells) or CD40 (on B cells) defect.</span></li><li><span style=\"font-size:14.0pt;\">In that case, IgM is high while IgG, IgA, IgE are low, but B-cell numbers are normal.</span></li><li><span style=\"font-size:14.0pt;\">Not consistent with the present case.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Failure of somatic hypermutation in germinal centers:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Also occurs in Hyper-IgM syndrome and some common variable immunodeficiencies.</span></li><li><span style=\"font-size:14.0pt;\">Here, B-cell differentiation occurs but antibody affinity maturation is impaired.</span></li><li><span style=\"font-size:14.0pt;\">This patient has no mature B cells, so somatic hypermutation cannot even occur.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Defective T-cell activation due to absent CD40L expression:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Describes X-linked Hyper-IgM syndrome.</span></li><li><span style=\"font-size:14.0pt;\">Patients have recurrent opportunistic infections (Pneumocystis, Cryptosporidium) due to impaired macrophage activation.</span></li><li><span style=\"font-size:14.0pt;\">Immunoglobulin pattern: ↑ IgM, ↓ IgG, IgA, IgE.</span></li><li><span style=\"font-size:14.0pt;\">Not seen here (all Ig low, not just switched classes).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_HpUMWje.png\" width=\"682\" height=\"359\"></strong></span></p>",
      "correct_choice_id": 392381,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98589/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98589/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 86982,
      "choices": [
        {
          "id": 346412,
          "text": "<p><span style=\"font-size:14.0pt;\">T, T, F</span></p>"
        },
        {
          "id": 346413,
          "text": "<p><span style=\"font-size:14.0pt;\">F, T, F</span></p>"
        },
        {
          "id": 346414,
          "text": "<p><span style=\"font-size:14.0pt;\">T, F, F</span></p>"
        },
        {
          "id": 346415,
          "text": "<p><span style=\"font-size:14.0pt;\">F, T, T</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Categorize the statements below regarding trauma patients as true (T) or false (F):<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Arterial blood gas is a useful indicator of shock in patients of trauma, and trending these values can reflect improvements with resuscitation.</span></li><li><span style=\"font-size:14.0pt;\">In patients with suspected fracture of the cribriform plate, a Ryles tube is inserted nasally.</span></li><li><span style=\"font-size:14.0pt;\">It is essential to catheterize the patient transurethrally before you can proceed to examine the perineum and genitalia.</span></li></ol>",
      "unique_key": "Q1086704",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) T, F, F</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Statement 1. True.&nbsp;</strong>Arterial blood gas (ABG) is indeed a useful indicator of shock in trauma patients and can reflect changes in response to resuscitation efforts.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 2. False.&nbsp;</strong>If a cribriform plate fracture is suspected, inserting a gastric tube nasally is contraindicated due to the risk of entering the cranial vault.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 3. False.</strong> Catheterization should not be done trans-urethrally before examining the perineum and genitalia, particularly if there is evidence of potential urethral injury.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Arterial blood gases are valuable for assessing shock and response to resuscitation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Gastric tubes should be inserted orally in the context of potential cribriform plate fractures to avoid intracranial passage.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Lastly, a careful examination of the perineum and genitalia is necessary before catheterization to avoid exacerbating any potential urethral injuries.</span></li></ul>",
      "correct_choice_id": 346414,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86982/FMGE_SURGERY_MOCK_2_Q_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86982/FMGE_SURGERY_MOCK_2_Q_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 86997,
      "choices": [
        {
          "id": 346472,
          "text": "<p><span style=\"font-size:14.0pt;\">Aorto-iliac block</span></p>"
        },
        {
          "id": 346473,
          "text": "<p><span style=\"font-size:14.0pt;\">Superficial femoral arterial block</span></p>"
        },
        {
          "id": 346474,
          "text": "<p><span style=\"font-size:14.0pt;\">Deep vein thrombosis</span></p>"
        },
        {
          "id": 346475,
          "text": "<p><span style=\"font-size:14.0pt;\">Hip osteoarthritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A chronic smoker gets cramping pain in his calf after walking about 500 m. What is the likely pathology?</span></p>",
      "unique_key": "Q4177363",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Superficial femoral arterial block</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The symptoms described, especially calf pain after walking a specific distance (claudication), suggest peripheral arterial disease (PAD).</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;In PAD, atherosclerotic blockages in arteries cause reduced blood flow to the lower extremities, leading to pain in the muscles during exertion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A superficial femoral arterial block specifically causes calf claudication, as this artery supplies the muscles in the calf region.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Aorto-iliac block:</strong> While an aorto-iliac blockage can also cause claudication, the pain from this blockage typically manifests in the thigh, buttocks, or hip region rather than the calf.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Deep vein thrombosis (DVT):</strong> DVT usually presents with swelling, warmth, and pain that is constant, rather than claudication-like pain that occurs after a certain distance of walking. DVT pain does not typically have a \"distance threshold\" as described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hip osteoarthritis:</strong> Hip osteoarthritis can cause pain with walking, but the pain is generally located in the hip or groin, not specifically in the calf. It is also not typically cramping in nature.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Intermittent claudication, characterized by cramping pain in the leg muscles during exercise, is a hallmark symptom of peripheral arterial disease (PAD).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The location of pain can help localize the site of arterial blockage.</span></li><li><span style=\"font-size:14.0pt;\">Calf pain suggests a blockage in the superficial femoral artery, while thigh or buttock pain suggests a more proximal blockage such as an aorto-iliac obstruction.</span></li></ul>",
      "correct_choice_id": 346473,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86997/FMGE_SURGERY_MOCK_2_Q_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86997/FMGE_SURGERY_MOCK_2_Q_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98394,
      "choices": [
        {
          "id": 391608,
          "text": "<p><span style=\"font-size:14.0pt;\">Maintaining neutral postures during work</span></p>"
        },
        {
          "id": 391609,
          "text": "<p><span style=\"font-size:14.0pt;\">Reducing repetitive motions and force requirements</span></p>"
        },
        {
          "id": 391610,
          "text": "<p><span style=\"font-size:14.0pt;\">Increasing productivity by avoiding breaks during work</span></p>"
        },
        {
          "id": 391611,
          "text": "<p><span style=\"font-size:14.0pt;\">Designing workstations to fit individual worker dimensions</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following are ergonomic principles for preventing work-related musculoskeletal disorders except:</span></p>",
      "unique_key": "Q7276184",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Increasing productivity by avoiding breaks during work</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ergonomic principles focus on designing work environments and practices that reduce physical stress and prevent musculoskeletal disorders.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Key principles include maintaining neutral postures, minimizing repetitive motions and excessive force, and ensuring proper workstation design.</span></li><li><span style=\"font-size:14.0pt;\">However, increasing work duration without breaks contradicts ergonomic principles as it increases fatigue and risk of injury.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Regular breaks are essential for muscle recovery and preventing overuse injuries.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Maintaining neutral postures during work:</strong> Maintaining neutral postures is a fundamental ergonomic principle that reduces stress on joints and muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Reducing repetitive motions and force requirements:</strong> Reducing repetitive motions and force requirements is a core ergonomic strategy to prevent musculoskeletal disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Designing workstations to fit individual worker dimensions:</strong> Proper workstation design that fits worker dimensions is essential for maintaining good posture and preventing injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ergonomic principles aim to reduce physical stress and prevent work-related musculoskeletal disorders</span></li><li><span style=\"font-size:14.0pt;\">Regular breaks and rest periods are crucial components of ergonomic workplace design</span></li><li><span style=\"font-size:14.0pt;\">Proper workstation design should accommodate individual worker characteristics and promote neutral postures</span></li></ul>",
      "correct_choice_id": 391610,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98394/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98394/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98796,
      "choices": [
        {
          "id": 393196,
          "text": "<p><span style=\"font-size:14.0pt;\">Orphan drug</span></p>"
        },
        {
          "id": 393197,
          "text": "<p><span style=\"font-size:14.0pt;\">Me-too drug</span></p>"
        },
        {
          "id": 393198,
          "text": "<p><span style=\"font-size:14.0pt;\">Essential drug</span></p>"
        },
        {
          "id": 393199,
          "text": "<p><span style=\"font-size:14.0pt;\">Adulterated drug</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A drug company is developing a medication similar in structure and mechanism of action to an existing drug, with slight differences in pharmacokinetics like volume of distribution (Vd) and half-life (t½). What type of drug is this classified as?</span></p>",
      "unique_key": "Q1975103",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Me-too drug</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Me-too drugs are structurally similar to existing drugs with minor differences, primarily in pharmacokinetics like volume of distribution (Vd) and half-life (t½). Examples include ACE inhibitors like enalapril and ramipril.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Orphan drug:</strong> Incorrect. Orphan drugs treat rare conditions and are developed under specific laws.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Essential drug:</strong> Incorrect. Essential drugs address priority healthcare needs based on safety, efficacy, and cost-effectiveness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Adulterated drug:</strong> Incorrect. Adulterated drugs are compromised in quality due to harmful substances.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Me-too drugs are structurally and mechanistically similar to existing drugs but may differ slightly in pharmacokinetics.</span></p>",
      "correct_choice_id": 393197,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98796/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98796/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 87023,
      "choices": [
        {
          "id": 346576,
          "text": "<p><span style=\"font-size:14.0pt;\">Outer Diameter of 16 mm</span></p>"
        },
        {
          "id": 346577,
          "text": "<p><span style=\"font-size:14.0pt;\">Outer diameter of 5.3 mm</span></p>"
        },
        {
          "id": 346578,
          "text": "<p><span style=\"font-size:14.0pt;\">Inner diameter of 16 mm</span></p>"
        },
        {
          "id": 346579,
          "text": "<p><span style=\"font-size:14.0pt;\">Radius of 5.3 mm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 16 French size of Foley's catheter refers to:</span></p>",
      "unique_key": "Q5399099",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)</strong> <strong>Outer diameter of 5.3 mm</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">French is a unit of measurement used for the outer diameter of a Foley catheter.</span></li><li><span style=\"font-size:14.0pt;\">It is a common way to denote the size of the catheter, especially in medical and healthcare settings.</span></li><li><span style=\"font-size:14.0pt;\">The French scale is based on a 3:1 ratio, where one French unit (Fr) is approximately equal to 0.33 millimeters in outer diameter.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;For example, a Foley catheter with a size of 16 Fr has an outer diameter of approximately 5.3 millimeters.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The diameter of a catheter in millimeters can be determined by dividing the French size by 3.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_5gfvpVm.png\" width=\"734\" height=\"586\"></span></p>",
      "correct_choice_id": 346577,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87023/FMGE_SURGERY_MOCK_2_Q_29.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87023/FMGE_SURGERY_MOCK_2_Q_29.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98392,
      "choices": [
        {
          "id": 391600,
          "text": "<p><span style=\"font-size:14.0pt;\">Indoor residual spraying with insecticides</span></p>"
        },
        {
          "id": 391601,
          "text": "<p><span style=\"font-size:14.0pt;\">Use of bed nets during daytime</span></p>"
        },
        {
          "id": 391602,
          "text": "<p><span style=\"font-size:14.0pt;\">Elimination of stagnant water collections</span></p>"
        },
        {
          "id": 391603,
          "text": "<p><span style=\"font-size:14.0pt;\">Mass administration of prophylactic antibiotics</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The image shows the life cycle of a vector responsible for transmission of chikungunya. What is the most effective method to control this vector based on its breeding pattern shown?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_AyELCIT.png\" width=\"738\" height=\"415\"></span></p>",
      "unique_key": "Q8298227",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Elimination of stagnant water collections</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows the life cycle of Aedes aegypti mosquito, which requires stagnant water for breeding.</span></li><li><span style=\"font-size:14.0pt;\">The most effective control measure is source reduction by eliminating stagnant water collections where the mosquito lays eggs and larvae develop.</span></li><li><span style=\"font-size:14.0pt;\">This targets the aquatic stages of the vector's life cycle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Indoor residual spraying with insecticides:</strong> Indoor residual spraying is less effective for Aedes as they are primarily outdoor breeders and day-biters</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Use of bed nets during daytime:</strong> Bed nets are ineffective as Aedes mosquitoes bite during daytime hours</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mass administration of prophylactic antibiotics:</strong> Antibiotics have no role in viral disease prevention or vector control</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Aedes aegypti breeds in clean stagnant water collections around human habitations</span></li><li><span style=\"font-size:14.0pt;\">Source reduction (eliminating breeding sites) is the most effective control strategy</span></li><li><span style=\"font-size:14.0pt;\">Community participation in removing water storage sites is crucial for vector control</span></li></ul>",
      "correct_choice_id": 391602,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98392/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98392/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98491,
      "choices": [
        {
          "id": 391992,
          "text": "<p><span style=\"font-size:14.0pt;\">Histidine</span></p>"
        },
        {
          "id": 391993,
          "text": "<p><span style=\"font-size:14.0pt;\">Arginine</span></p>"
        },
        {
          "id": 391994,
          "text": "<p><span style=\"font-size:14.0pt;\">Aspartic acid</span></p>"
        },
        {
          "id": 391995,
          "text": "<p><span style=\"font-size:14.0pt;\">Glutamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman presents with flushing, headaches, and occasional dizziness. Laboratory studies reveal elevated levels of a vasodilatory compound in his blood. This compound is known to be produced by the decarboxylation of an amino acid. Which of the following amino acids is the precursor for this compound?</span></p>",
      "unique_key": "Q7786583",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Histidine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The vasodilatory compound described in this question is <strong>histamine</strong>, which is derived from the decarboxylation of the amino acid <strong>histidine</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Histidine is converted into histamine through the action of the enzyme histidine decarboxylase.</span></li><li><span style=\"font-size:14.0pt;\">Histamine is a biogenic amine that plays multiple roles in the body, including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Vasodilation</strong>: By acting on H1 and H2 receptors, histamine causes smooth muscle relaxation in blood vessels, leading to increased blood flow and redness (flushing).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Immune response</strong>: Released by mast cells and basophils during allergic reactions.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Regulation of gastric acid</strong>: Stimulates acid secretion in the stomach.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The clinical presentation of flushing, dizziness, and elevated levels of a vasodilatory compound are consistent with excess histamine activity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Arginine:</strong> Arginine is a precursor for nitric oxide (NO), another vasodilator. However, nitric oxide production involves the enzyme nitric oxide synthase and does not involve decarboxylation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Aspartic acid:&nbsp;</strong>Aspartic acid is involved in the urea cycle and neurotransmitter synthesis but does not lead to the production of vasodilatory compounds through decarboxylation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Glutamine:</strong> Glutamine serves as a nitrogen donor in various metabolic processes, including nucleotide synthesis, but it does not directly produce vasodilatory compounds via decarboxylation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Histamine is a vasodilatory compound derived from the decarboxylation of the amino acid <strong>histidine</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This reaction is catalyzed by histidine decarboxylase and is crucial in mediating processes such as allergic reactions, gastric acid secretion, and vascular regulation.</span></li></ul>",
      "correct_choice_id": 391992,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98491/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98491/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98591,
      "choices": [
        {
          "id": 392384,
          "text": "<p><span style=\"font-size:14.0pt;\">Histamine</span></p>"
        },
        {
          "id": 392385,
          "text": "<p><span style=\"font-size:14.0pt;\">Interleukin-1 (IL-1)</span></p>"
        },
        {
          "id": 392386,
          "text": "<p><span style=\"font-size:14.0pt;\">Leukotriene B4 (LTB4)</span></p>"
        },
        {
          "id": 392387,
          "text": "<p><span style=\"font-size:14.0pt;\">Platelet-activating factor (PAF)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 22-year-old man develops pain, swelling, and redness at the site of an intramuscular injection after 24 hours. Examination shows warmth and tenderness with no pus formation. A biopsy from the site reveals dilated blood vessels, edema, and a predominant infiltration of neutrophils in the interstitial tissue. Which of the following mediators is primarily responsible for the neutrophil chemotaxis observed in this lesion?</span></p>",
      "unique_key": "Q1970645",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Leukotriene B4 (LTB4)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This case describes an acute inflammatory response (onset within 24 hours, neutrophil predominant).</span></li><li><span style=\"font-size:14.0pt;\">Key steps in acute inflammation include vasodilation, increased permeability, and leukocyte recruitment (chemotaxis).</span></li><li><span style=\"font-size:14.0pt;\">LTB4, derived from arachidonic acid via the 5-lipoxygenase pathway, is one of the most potent chemo attractants for neutrophils.</span></li><li><span style=\"font-size:14.0pt;\">It enhances adhesion to endothelium, chemotaxis, and activation of neutrophils (increasing ROS and lysosomal enzyme release).</span></li><li><span style=\"font-size:14.0pt;\">Hence, LTB4 is the principal mediator responsible for the neutrophil infiltration in early acute inflammation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Histamine:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Released by mast cells, basophils, platelets.</span></li><li><span style=\"font-size:14.0pt;\">Causes vasodilation and increased vascular permeability, but does not attract neutrophils.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Interleukin-1 (IL-1):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Produced by macrophages; acts as a pyrogen and endothelial activator (increases adhesion molecules).</span></li><li><span style=\"font-size:14.0pt;\">Promotes fever and systemic inflammation, but not direct chemotaxis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Platelet-activating factor (PAF):&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Causes platelet aggregation, vasodilation, bronchoconstriction, and increased permeability.</span></li><li><span style=\"font-size:14.0pt;\">It may enhance leukocyte adhesion, but LTB4 is far more specific and potent for chemotaxis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key inflammatory mediators:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_dmkajhV.png\" width=\"758\" height=\"484\"></strong></span></p>",
      "correct_choice_id": 392386,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98591/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98591/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98388,
      "choices": [
        {
          "id": 391584,
          "text": "<p><span style=\"font-size:14.0pt;\">VHND sessions are conducted monthly on a mutually decided date targeting children (0-6 years) and pregnant women only.</span></p>"
        },
        {
          "id": 391585,
          "text": "<p><span style=\"font-size:14.0pt;\">VHND sessions are conducted weekly targeting all children under 5 years, pregnant and lactating mothers, and adolescent girls.</span></p>"
        },
        {
          "id": 391586,
          "text": "<p><span style=\"font-size:14.0pt;\">VHND sessions are conducted monthly on a mutually decided date by the village health team, targeting children 0-6 years, pregnant and lactating mothers, and eligible couples for family planning.</span></p>"
        },
        {
          "id": 391587,
          "text": "<p><span style=\"font-size:14.0pt;\">VHND sessions are conducted twice a month with mandatory medical officer supervision, targeting only malnourished children and high-risk pregnant women.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding the timing and target beneficiaries of Village Health and Nutrition Day (VHND) is most accurate?</span></p>",
      "unique_key": "Q6865355",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) VHND sessions are conducted monthly on a mutually decided date by the village health team, targeting children 0-6 years, pregnant and lactating mothers, and eligible couples for family planning</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Village Health and Nutrition Day (VHND) is conducted monthly preferably on Wednesdays or on a date mutually decided by ANM, ASHA, and Anganwadi Worker based on local convenience.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The target beneficiaries include children 0-6 years for immunization and nutrition services, pregnant and lactating mothers for antenatal/postnatal care, and eligible couples for family planning counseling and services.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The flexibility in scheduling and comprehensive target population coverage are key features of VHND implementation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-25%20130739.jpg\" width=\"664\" height=\"804\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. VHND sessions are conducted monthly on a mutually decided date targeting children (0-6 years) and pregnant women only:</strong> VHND does not have a mandatory fixed date, and target beneficiaries include more than just children 0-6 years and pregnant women. This is a distractor option, if the word “target” is missed in the question, Option A would most likely be chosen as the answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. VHND sessions are conducted weekly targeting all children under 5 years, pregnant and lactating mothers, and adolescent girls:</strong> VHND is not conducted weekly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. VHND sessions are conducted twice a month with mandatory medical officer supervision, targeting only malnourished children and high-risk pregnant women:</strong> VHND is conducted monthly, not twice a month, and targets all eligible beneficiaries, not just malnourished children and high-risk cases</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">VHND provides integrated health and nutrition services through sessions conducted monthly on mutually convenient dates with flexible scheduling</span></li><li><span style=\"font-size:14.0pt;\">Target beneficiaries include children 0-6 years, pregnant/lactating mothers, and eligible couples for comprehensive care</span></li></ul>",
      "correct_choice_id": 391586,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98388/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98388/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98799,
      "choices": [
        {
          "id": 393208,
          "text": "<p><span style=\"font-size:14.0pt;\">Risperidone</span></p>"
        },
        {
          "id": 393209,
          "text": "<p><span style=\"font-size:14.0pt;\">Chlorpromazine</span></p>"
        },
        {
          "id": 393210,
          "text": "<p><span style=\"font-size:14.0pt;\">Quetiapine</span></p>"
        },
        {
          "id": 393211,
          "text": "<p><span style=\"font-size:14.0pt;\">Haloperidol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following antipsychotic medications has been associated with the development of lens opacities requiring periodic eye examinations during long-term therapy?</span></p>",
      "unique_key": "Q9228756",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Quetiapine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Quetiapine</strong>, an atypical antipsychotic, has been linked in animal studies and early human reports to <strong>cataract formation</strong> with chronic use.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This prompted recommendations for patients on prolonged therapy to undergo <strong>baseline and routine ophthalmologic monitoring</strong>, although conclusive human data remains limited.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This adverse effect is <strong>unique among second-generation antipsychotics</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Risperidone:</strong> While it may cause extrapyramidal symptoms and hyperprolactinemia, it is not associated with cataract development.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Chlorpromazine:</strong> Known to cause <strong>pigment deposits in the cornea</strong>, but not cataracts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Haloperidol:</strong> No known link to cataract formation; its adverse effects are mainly neurologic (EPS, tardive dyskinesia).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Quetiapine</strong> is the only atypical antipsychotic associated with <strong>lens changes</strong> in animal models, prompting <strong>eye exams during long-term use</strong>.</span></p>",
      "correct_choice_id": 393210,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98799/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98799/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98390,
      "choices": [
        {
          "id": 391592,
          "text": "<p><span style=\"font-size:14.0pt;\">Confidentiality must be maintained between the healthcare provider and the adolescent</span></p>"
        },
        {
          "id": 391593,
          "text": "<p><span style=\"font-size:14.0pt;\">Parental consent is mandatory for providing contraceptive counseling to unmarried minors below 18 years</span></p>"
        },
        {
          "id": 391594,
          "text": "<p><span style=\"font-size:14.0pt;\">Healthcare providers should assess the adolescent's capacity for informed decision-making</span></p>"
        },
        {
          "id": 391595,
          "text": "<p><span style=\"font-size:14.0pt;\">Emergency contraception can be provided to adolescents without parental involvement in cases of sexual assault</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 16-year-old unmarried girl approaches a community health center seeking contraceptive advice without parental consent. According to the Medical Termination of Pregnancy (Amendment) Act 2021 and current Indian medical ethics guidelines, all of the following are correct principles regarding adolescent reproductive health services except:</span></p>",
      "unique_key": "Q1027304",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Parental consent is mandatory for providing contraceptive counseling to unmarried minors below 18 years</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to current Indian medical ethics and the MTP Amendment Act 2021, parental consent is <strong>not</strong> mandatory for providing contraceptive counseling to unmarried minors.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The principle of adolescent autonomy in reproductive health decisions recognizes that mature minors can make informed decisions about their reproductive health.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;Healthcare providers should prioritize the adolescent's best interests, maintain confidentiality, and assess their decision-making capacity rather than requiring automatic parental consent for contraceptive services.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Confidentiality must be maintained between the healthcare provider and the adolescent:</strong> Confidentiality is a fundamental principle in adolescent reproductive health services to encourage help-seeking behavior</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Healthcare providers should assess the adolescent's capacity for informed decision-making:</strong> Assessment of decision-making capacity is essential to ensure informed consent in adolescent healthcare</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Emergency contraception can be provided to adolescents without parental involvement in cases of sexual assault:</strong> Emergency contraception provision without parental involvement is ethically justified in sexual assault cases to protect the victim's immediate health needs</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Adolescent reproductive health services prioritize the minor's autonomy and best interests over automatic parental consent requirements</span></li><li><span style=\"font-size:14.0pt;\">Confidentiality is crucial for encouraging adolescents to seek reproductive health services</span></li></ul>",
      "correct_choice_id": 391593,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98390/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98390/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98775,
      "choices": [
        {
          "id": 393112,
          "text": "<p><span style=\"font-size:14.0pt;\">Disconnect the ventilator</span></p>"
        },
        {
          "id": 393113,
          "text": "<p><span style=\"font-size:14.0pt;\">Decrease positive end-expiratory pressure (PEEP)</span></p>"
        },
        {
          "id": 393114,
          "text": "<p><span style=\"font-size:14.0pt;\">Increase FiO₂</span></p>"
        },
        {
          "id": 393115,
          "text": "<p><span style=\"font-size:14.0pt;\">Increase respiratory rate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient with severe asthma was intubated and ventilated. The same night he has a ventilator alarm for high airway pressures. Ventilator readings show a Peak inspiratory pressure of 50 mmHg and a Plateau pressure of 35 mmHg. Ventilator tubing is intact, and the patient is already on appropriate bronchodilators and steroids. What is the next best step in management?</span></p>",
      "unique_key": "Q8237550",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Disconnect the ventilator</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>simultaneous rise in peak (50 mmHg)</strong> and <strong>plateau (35 mmHg) pressures</strong> suggests <strong>dynamic hyperinflation (auto-PEEP)</strong> or <strong>alveolar overdistention</strong> rather than isolated airway resistance.</span></li><li><span style=\"font-size:14.0pt;\">This can occur in severe asthma due to air-trapping from incomplete exhalation, leading to dangerously high intrathoracic pressures and risk of <strong>barotrauma</strong> or <strong>hemodynamic compromise</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>immediate step</strong> is to <strong>disconnect the ventilator circuit</strong> and <strong>manually ventilate</strong> the patient with slow, controlled breaths, allowing sufficient time for exhalation.</span></li><li><span style=\"font-size:14.0pt;\">This releases trapped gas and helps confirm whether the problem lies in the ventilator circuit or within the patient (air-trapping, bronchospasm, or tension pneumothorax).</span></li><li><span style=\"font-size:14.0pt;\">Once stabilized, adjust ventilator settings to prevent recurrence:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Low respiratory rate (8–10/min)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Low tidal volume (4–6 mL/kg ideal body weight)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>High inspiratory flow</strong> (short inspiratory time → prolonged expiratory time)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Permissive hypercapnia</strong> (acceptable pH &gt; 7.15)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Minimal or zero PEEP</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Decrease positive end-expiratory pressure (PEEP):&nbsp;</strong>While excessive PEEP can raise pressures, this patient’s problem is <strong>auto-PEEP</strong> from air-trapping, not excessive applied PEEP. Decreasing PEEP does not immediately correct the issue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Increase FiO₂:&nbsp;</strong>Addresses oxygenation but not the life-threatening cause of high pressures (air-trapping/overdistention).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increase RR:&nbsp;</strong>Would <strong>worsen air-trapping</strong> by further shortening expiratory time.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In mechanically ventilated asthma, <strong>concurrent elevation of peak and plateau pressures</strong> signifies <strong>dynamic hyperinflation (auto-PEEP)</strong> and risk of barotrauma.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Immediate disconnection of the ventilator</strong> allows trapped air to escape and helps assess the airway before ventilator adjustments are made.</span></li></ul>",
      "correct_choice_id": 393112,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98775/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98775/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98286,
      "choices": [
        {
          "id": 391176,
          "text": "<p><span style=\"font-size:14.0pt;\">Brachytherapy</span></p>"
        },
        {
          "id": 391177,
          "text": "<p><span style=\"font-size:14.0pt;\">Chemotherapy</span></p>"
        },
        {
          "id": 391178,
          "text": "<p><span style=\"font-size:14.0pt;\">Surgery</span></p>"
        },
        {
          "id": 391179,
          "text": "<p><span style=\"font-size:14.0pt;\">Chemoradiation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 54-year-old woman presents with foul-smelling, bloody vaginal discharge mixed with mucus. On examination, there is a necrotic cervical growth with lateral parametrium involvement. What is the most appropriate management for this patient?</span></p>",
      "unique_key": "Q6130650",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Chemoradiation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has findings consistent with <strong>locally advanced cervical cancer</strong> — characterized by:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Necrotic, ulcerative cervical mass</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Parametrial involvement</strong> (extension to the connective tissue around the cervix)</span></li><li><span style=\"font-size:14.0pt;\">Absence of distant metastasis</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>FIGO Staging Correlation:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Parametrial involvement without extension to pelvic wall → Stage IIB</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Extension to the pelvic wall → Stage IIIB</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">For <strong>Stage IIB–IVA (locally advanced)</strong> cervical cancer, <strong>surgery is no longer feasible</strong> due to extensive local spread.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Standard of Care:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>treatment of choice</strong> for <strong>locally advanced cervical cancer (Stage IIB–IVA)</strong> is: <strong>Concurrent chemoradiation therapy (CCRT)</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>External Beam Radiotherapy (EBRT)</strong>: To the pelvis (for primary and nodal disease)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Concurrent weekly Cisplatin chemotherapy</strong> (40 mg/m²): Acts as a radiosensitizer</span></li><li><span style=\"font-size:14.0pt;\"><strong>Intracavitary brachytherapy</strong>: Delivers a high local dose to the cervix</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This combined approach improves <strong>local control</strong> and <strong>overall survival</strong> compared to radiation alone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Brachytherapy:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Used as a <strong>part of chemoradiation</strong>, not as a standalone therapy in advanced disease.</span></li><li><span style=\"font-size:14.0pt;\">Alone, it is insufficient for parametrial involvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Chemotherapy:&nbsp;</strong>Incorrect. Chemotherapy alone is <strong>not curative</strong> in cervical cancer; it is used for <strong>palliative or metastatic disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Surgery:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Radical hysterectomy is indicated <strong>only in early stages (IA–IB1)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Parametrial involvement makes the disease <strong>inoperable</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>locally advanced cervical cancer (Stage IIB–IVA)</strong> with <strong>parametrial involvement</strong>, the <strong>treatment of choice</strong> is <strong>concurrent chemoradiation</strong> — combining <strong>external beam radiotherapy</strong>, <strong>cisplatin-based chemotherapy</strong>, and <strong>brachytherapy</strong> for optimal disease control.</span></p>",
      "correct_choice_id": 391179,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98286/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98286/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98499,
      "choices": [
        {
          "id": 392024,
          "text": "<p><span style=\"font-size:14.0pt;\">Contains sphingosine as the backbone alcohol</span></p>"
        },
        {
          "id": 392025,
          "text": "<p><span style=\"font-size:14.0pt;\">Has four fatty acid chains attached to three glycerol molecules</span></p>"
        },
        {
          "id": 392026,
          "text": "<p><span style=\"font-size:14.0pt;\">Contains a choline head group</span></p>"
        },
        {
          "id": 392027,
          "text": "<p><span style=\"font-size:14.0pt;\">Is composed of ceramide and glucose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman with recurrent pregnancy losses tests positive for anticardiolipin antibodies. Her laboratory results also show a false-positive VDRL test. What is the unique structural feature of cardiolipin?</span></p>",
      "unique_key": "Q6705005",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Has four fatty acid chains attached to three glycerol molecules</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cardiolipin</strong> (also called <strong>diphosphatidylglycerol</strong>) is a <strong>unique phospholipid</strong> found almost exclusively in the <strong>inner mitochondrial membrane</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It plays a crucial role in maintaining the structural integrity and optimal function of the <strong>electron transport chain</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Structural Features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cardiolipin consists of:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Three glycerol molecules</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Four fatty acid chains</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Two phosphate groups</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">It can be described as two <strong>phosphatidic acid molecules</strong> linked by a <strong>glycerol bridge</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This unusual structure (four fatty acid tails and three glycerol backbones) distinguishes cardiolipin from all other membrane phospholipids.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical Significance:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Anticardiolipin antibodies</strong> are a type of <strong>antiphospholipid antibody</strong>, seen in <strong>Antiphospholipid Syndrome (APS)</strong>, which causes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Recurrent pregnancy loss</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Thrombosis (arterial or venous)</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">These antibodies also <strong>cross-react with antigens used in syphilis tests</strong>, resulting in <strong>false-positive VDRL/RPR tests</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Contains sphingosine as the backbone alcohol:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This describes <strong>sphingolipids</strong>, not cardiolipin.</span></li><li><span style=\"font-size:14.0pt;\">Example: <strong>Sphingomyelin</strong>, which has <strong>sphingosine + fatty acid = ceramide backbone.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Contains a choline head group:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This describes <strong>phosphatidylcholine (lecithin)</strong>, not cardiolipin.</span></li><li><span style=\"font-size:14.0pt;\">Found abundantly in cell membranes and lung surfactant.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Is composed of ceramide and glucose:</strong> This describes <strong>cerebrosides</strong>, a type of <strong>glycosphingolipid</strong> found in the <strong>myelin sheath of neurons.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cardiolipin</strong> is a unique <strong>mitochondrial phospholipid</strong> composed of <strong>three glycerol molecules and four fatty acid chains</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It serves as an important component of the <strong>inner mitochondrial membrane</strong>, and antibodies against it (anticardiolipin antibodies) are associated with <strong>Antiphospholipid Syndrome</strong> and <strong>false-positive VDRL tests</strong>.</span></li></ul>",
      "correct_choice_id": 392025,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98499/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98499/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 87011,
      "choices": [
        {
          "id": 346528,
          "text": "<p><span style=\"font-size:14.0pt;\">Supine with neck flexion</span></p>"
        },
        {
          "id": 346529,
          "text": "<p><span style=\"font-size:14.0pt;\">Supine with neck extension</span></p>"
        },
        {
          "id": 346530,
          "text": "<p><span style=\"font-size:14.0pt;\">Sitting with neck flexion</span></p>"
        },
        {
          "id": 346531,
          "text": "<p><span style=\"font-size:14.0pt;\">Sitting with neck extension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During the insertion of a Ryle’s tube, what is the best position for a conscious patient to be in?</span></p>",
      "unique_key": "Q5304585",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Sitting with neck flexion&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is the <strong>best position for a conscious patient during Ryle's tube insertion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;Sitting allows for better alignment of the upper gastrointestinal tract, making it easier to guide the tube through the esophagus and into the stomach.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Neck flexion helps align the crico-pharynx with the Ryle’s tube, reducing faulty tracheal insertion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The best position for a conscious patient to be in during the insertion of Ryle's tube is sitting with neck flexion.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Confirmation of the correct position of RT is done by:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Auscultation in the epigastric area while injecting a bolus of air</span></li><li><span style=\"font-size:14.0pt;\">Aspiration of gastric contents</span></li><li><span style=\"font-size:14.0pt;\">X-ray chest + upper abdomen</span></li></ul></li></ul>",
      "correct_choice_id": 346530,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87011/FMGE_SURGERY_MOCK_2_Q_26_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87011/FMGE_SURGERY_MOCK_2_Q_26_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98611,
      "choices": [
        {
          "id": 392464,
          "text": "<p><span style=\"font-size:14.0pt;\">Rubella</span></p>"
        },
        {
          "id": 392465,
          "text": "<p><span style=\"font-size:14.0pt;\">Toxoplasmosis</span></p>"
        },
        {
          "id": 392466,
          "text": "<p><span style=\"font-size:14.0pt;\">Cytomegalovirus</span></p>"
        },
        {
          "id": 392467,
          "text": "<p><span style=\"font-size:14.0pt;\">Herpes simplex virus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3-week-old infant presents with unresolving fever and associated hepatosplenomegaly, with&nbsp; microcephaly. Blood investigations and neuroimaging was done which is shown below. After detailed observation, the pediatrician advised urine examination.</span></p><p><span style=\"font-size:14.0pt;\">Complete blood report</span></p><p><span style=\"font-size:14.0pt;\">Patient Name: Master Aarav</span></p><p><span style=\"font-size:14.0pt;\">Age / Sex: 3 years / Male</span></p><p><span style=\"font-size:14.0pt;\">Date: 01-Apr-2024</span></p><p><span style=\"font-size:14.0pt;\">Hemoglobin: 11.2 g/dL</span></p><p><span style=\"font-size:14.0pt;\">WBC (TLC): 2,100 /mm³</span></p><p><span style=\"font-size:14.0pt;\">Neutrophils: 42%</span></p><p><span style=\"font-size:14.0pt;\">Lymphocytes: 50%</span></p><p><span style=\"font-size:14.0pt;\">Platelet Count: 2.3 lakh /mm³</span></p><p><span style=\"font-size:14.0pt;\">Peripheral Smear: Normocytic normochromic RBCs</span></p><p><span style=\"font-size:14.0pt;\">What is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Fh1NITn.png\" width=\"388\" height=\"375\"></span></p>",
      "unique_key": "Q6829438",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Cytomegalovirus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This infant presents with the classic triad of congenital cytomegalovirus (CMV) infection: hepatosplenomegaly, thrombocytopenia, and microcephaly.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">CMV is the <strong>most common congenital infection</strong> worldwide, affecting approximately 0.5-2% of all live births.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Urine PCR is the gold standard diagnostic test for CMV, offering high sensitivity (&gt;90%) and specificity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The virus is shed in large quantities in the urine for months to years after congenital infection, making urine PCR an ideal non-invasive diagnostic method.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Rubella:</strong> Is diagnosed primarily through detection of rubella-specific IgM antibodies in the infant's serum, not through urine PCR. Congenital rubella typically presents with cataracts, congenital heart defects (particularly PDA), and sensorineural hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Toxoplasmosis:</strong> Diagnosis relies on detection of Toxoplasma-specific IgM in serum or demonstration of the organism in body fluids or tissues. Urine PCR is not the test of choice. Congenital toxoplasmosis classically presents with chorioretinitis, intracranial calcifications, and hydrocephalus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Herpes simplex virus (HSV):</strong> Is best diagnosed through PCR or viral culture from vesicular lesions, CSF, or blood, depending on the clinical presentation. Urine PCR is not routinely used for HSV diagnosis. Congenital HSV typically presents with vesicular skin lesions, seizures, and CNS involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When evaluating a neonate with suspected congenital infection, the diagnostic approach varies by pathogen.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">For CMV (the most common congenital infection), urine PCR is the preferred diagnostic test due to high viral shedding in urine.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The most common long-term sequelae of congenital CMV is sensorineural hearing loss, which may be progressive and not apparent at birth.</span></li></ul>",
      "correct_choice_id": 392466,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98611/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98611/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98115,
      "choices": [
        {
          "id": 390500,
          "text": "<p><span style=\"font-size:14.0pt;\">6-9 months</span></p>"
        },
        {
          "id": 390501,
          "text": "<p><span style=\"font-size:14.0pt;\">9-12 months</span></p>"
        },
        {
          "id": 390502,
          "text": "<p><span style=\"font-size:14.0pt;\">12-16 months</span></p>"
        },
        {
          "id": 390503,
          "text": "<p><span style=\"font-size:14.0pt;\">20-25 months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A forensic investigator examines the dentition of decomposed remains in which the following temporary tooth are present- 1st Molars, central incisors, and lateral incisors. The upper canines and 2nd molar have not yet erupted. There is no permanent teeth. Based on this dental development, what is the most likely age range of the deceased individual?</span></p>",
      "unique_key": "Q5870739",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) 12-16 months</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Since the 1st molars have erupted (requiring at least ~12 months) but the canines have not yet erupted (less than ~18months), the most accurate age bracket is <strong>12-16 months</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This represents the developmental window after incisors and 1st molars have emerged but before canine eruption begins.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Age Estimation from Dentition:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-19%20170045.jpg\" width=\"1026\" height=\"646\"></p>",
      "correct_choice_id": 390502,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98115/INI-NEET_-_GT__27th_Nov_2025_FMT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98115/INI-NEET_-_GT__27th_Nov_2025_FMT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98772,
      "choices": [
        {
          "id": 393100,
          "text": "<p><span style=\"font-size:14.0pt;\">Finerenone</span></p>"
        },
        {
          "id": 393101,
          "text": "<p><span style=\"font-size:14.0pt;\">Enalapril</span></p>"
        },
        {
          "id": 393102,
          "text": "<p><span style=\"font-size:14.0pt;\">Tirzepatide</span></p>"
        },
        {
          "id": 393103,
          "text": "<p><span style=\"font-size:14.0pt;\">Empagliflozin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 66-year-old woman with hypertension, obesity, and sleep apnea presents with exertional dyspnea, high blood pressure, elevated JVP, crackles, lower extremity edema. Her echo shows an LVEF of 60%. She improves with diuresis and antihypertensive therapy. Which medication does not reduce the risk of rehospitalization for heart failure?</span></p>",
      "unique_key": "Q5004463",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Enalapril</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In HFpEF (heart failure with preserved ejection fraction), the cornerstone of therapy to reduce hospitalization is an SGLT2 inhibitor, such as empagliflozin.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These have demonstrated a modest reduction in the risk of heart failure hospitalization and improvement in quality of life, and are supported as first-line therapy by both American and European guidelines.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Finerenone (a nonsteroidal mineralocorticoid antagonist) also reduces the risk of heart failure hospitalization in HFpEF and is beneficial as secondary therapy, while GLP-1 agonists such as tirzepatide can reduce HF hospitalizations and improve outcomes in patients with HFpEF and obesity, supported by recent trials and meta-analyses.</span></li><li><span style=\"font-size:14.0pt;\">ACE inhibitors (such as enalapril), once considered mainstays,&nbsp;<strong>do not reduce rehospitalization risk</strong>&nbsp;for HFpEF, although they may be used for other comorbidities (diabetes, hypertension, CKD).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Multiple randomized trials have not shown a reduction in all-cause mortality or HF hospitalizations for ACE inhibitors in this population, though there may be mild improvement in functional status.</span></li><li><span style=\"font-size:14.0pt;\">As a result, among these options, only enalapril does not have evidence to reduce risk of rehospitalization in HFpEF, while SGLT2 inhibitors, MRAs, and GLP-1 agonists are all effective in lowering this risk through distinct mechanisms.​</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Finerenone:</strong> Has demonstrated benefit in reducing HF hospitalization rates in clinical trials for HFpEF and in those with CKD.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C. Tirzepatide:</strong> A GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, has shown to lower risk of HF hospitalization (especially in those with obesity and diabetes).</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D. Empagliflozin:</strong> Is an SGLT2 inhibitor and is guideline-recommended to reduce risk of HF hospitalization in HFpEF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In HFpEF, therapies with clear evidence for reducing heart failure rehospitalization include SGLT2 inhibitors, certain MRAs, and GLP-1 agonists.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">ACE inhibitors, including enalapril, have not shown similar benefit for this endpoint and are not preferred solely for this indication.</span></li></ul>",
      "correct_choice_id": 393101,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98772/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98772/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98776,
      "choices": [
        {
          "id": 393116,
          "text": "<p><span style=\"font-size:14.0pt;\">Roflumilast</span></p>"
        },
        {
          "id": 393117,
          "text": "<p><span style=\"font-size:14.0pt;\">Ipratropium</span></p>"
        },
        {
          "id": 393118,
          "text": "<p><span style=\"font-size:14.0pt;\">Fluticasone</span></p>"
        },
        {
          "id": 393119,
          "text": "<p><span style=\"font-size:14.0pt;\">Ensifentrine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 70-year-old man with a 10-year history of chronic obstructive pulmonary disease presents with progressive exertional dyspnea and reduced exercise tolerance over the past few months. He is a former smoker and has been compliant with dual bronchodilator therapy consisting of tiotropium and formoterol. On evaluation, his post-bronchodilator FEV₁ is 71% of predicted, and his blood eosinophil count is 74 cells/µL. There is no history of frequent exacerbations. Which of the following is the most appropriate next step in pharmacologic management?</span></p>",
      "unique_key": "Q9571676",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Ensifentrine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient remains <strong>symptomatic despite optimized LAMA + LABA therapy</strong>. His <strong>low eosinophil count (&lt; 100 cells/µL)</strong> and absence of frequent exacerbations make the addition of <strong>inhaled corticosteroids</strong> inappropriate.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ensifentrine</strong> is a novel <strong>dual phosphodiesterase-3 and phosphodiesterase-4 inhibitor</strong> that provides <strong>both bronchodilation and anti-inflammatory activity</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It has shown improvement in <strong>FEV₁, dyspnea scores, and exacerbation rates</strong> when added to standard bronchodilator therapy, <strong>without an increased pneumonia risk</strong>, and its benefit is <strong>independent of eosinophil count</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Roflumilast:</strong> Indicated for <strong>severe COPD with recurrent exacerbations due to chronic bronchitis and FEV₁ &lt; 50%</strong>, not for this patient with mild obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ipratropium:</strong> A short-acting muscarinic antagonist; redundant when the patient is already on <strong>tiotropium (LAMA)</strong>.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Fluticasone:</strong> It is an inhaled corticosteroid (ICS) which is reserved for patients with <strong>eosinophils ≥ 300 cells/µL</strong> or <strong>≥ 2 exacerbations/year&nbsp;</strong>– criteria not met here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In COPD patients with <strong>persistent dyspnea on LAMA + LABA and low eosinophil counts</strong>, consider adding <strong>ensifentrine</strong>, a dual PDE-3/4 inhibitor that enhances bronchodilation and reduces exacerbations <strong>without the risks associated with inhaled corticosteroids</strong>.</span></p>",
      "correct_choice_id": 393119,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98776/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98776/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98777,
      "choices": [
        {
          "id": 393120,
          "text": "<p><span style=\"font-size:14.0pt;\">EMG</span></p>"
        },
        {
          "id": 393121,
          "text": "<p><span style=\"font-size:14.0pt;\">SPEP</span></p>"
        },
        {
          "id": 393122,
          "text": "<p><span style=\"font-size:14.0pt;\">Hepatitis B testing</span></p>"
        },
        {
          "id": 393123,
          "text": "<p><span style=\"font-size:14.0pt;\">Liver biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old woman presents with carpal tunnel syndrome. She also suffers from urinary incontinence and neuropathic pain for the last 2 months. On examination, she has hepatosplenomegaly and bruises near the eyes. Lab tests reveal proteinuria. Which is the next best step in diagnosis? (Key: EMG – Electromyography, SPEP – Serum Protein Electrophoresis)</span></p>",
      "unique_key": "Q5229115",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) SPEP</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Amyloidosis often presents with multisystem involvement:</strong> proteinuria (renal), neuropathy (peripheral), carpal tunnel syndrome, hepatosplenomegaly, autonomic dysfunction (orthostasis, bladder and bowel disorders), restrictive cardiomyopathy, and easy bruising.</span></li><li><span style=\"font-size:14.0pt;\">Serum protein electrophoresis (SPEP) and urine protein electrophoresis (UPEP) with immunofixation are initial tests to detect abnormal monoclonal proteins or light chains (M-proteins), which are seen in AL (light-chain) amyloidosis and other monoclonal gammopathies.​</span></li><li><span style=\"font-size:14.0pt;\">These tests are sensitive for diagnosing systemic amyloidosis and identifying candidates for further targeted biopsy or therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. EMG:</strong> EMG is useful for neuropathy characterization, but does not detect or confirm systemic monoclonal protein disorders.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp; C. Hepatitis B testing:</strong> Hepatitis B testing may be indicated in some cases of abnormal liver or renal function, but does not fit the multisystem, proteinuria-focused symptoms seen in amyloidosis.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp; D. Liver biopsy:</strong> Liver biopsy may be helpful for organ-specific diagnosis but is higher risk and not first-line; SPEP/UPEP are less invasive and more appropriate for systemic workup.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">For possible amyloidosis with proteinuria and multisystem findings, initial diagnostic work-up should include serum and urine protein electrophoresis with immunofixation to screen for monoclonal proteins and direct further investigation.</span></p>",
      "correct_choice_id": 393121,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98777/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98777/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98231,
      "choices": [
        {
          "id": 390956,
          "text": "<p><span style=\"font-size:14.0pt;\">Cerebellar peduncle</span></p>"
        },
        {
          "id": 390957,
          "text": "<p><span style=\"font-size:14.0pt;\">Cerebral peduncle</span></p>"
        },
        {
          "id": 390958,
          "text": "<p><span style=\"font-size:14.0pt;\">Medullary pyramids</span></p>"
        },
        {
          "id": 390959,
          "text": "<p><span style=\"font-size:14.0pt;\">Inferior colliculus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the structures highlighted in green in the image shown below?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-18%20111150.jpg\" width=\"410\" height=\"459\"></strong></span></p>",
      "unique_key": "Q7235814",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cerebral peduncle</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The structures highlighted in <strong>green</strong> are the <strong>cerebral peduncles</strong>, which are large bundles of descending white matter tracts located on the <strong>ventral surface of the midbrain</strong>.</span></li><li><span style=\"font-size:14.0pt;\">They contain fibers of the <strong>corticospinal</strong>, <strong>corticobulbar</strong>, and <strong>corticopontine tracts</strong>, which carry motor information from the <strong>cerebral cortex</strong> to the <strong>brainstem and spinal cord</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>cerebral peduncles</strong> connect the <strong>cerebrum to the pons</strong>, forming an essential pathway for <strong>voluntary motor control</strong>.</span></li><li><span style=\"font-size:14.0pt;\">They lie anterior to the <strong>tegmentum</strong> and posterior to the <strong>optic tracts</strong> and <strong>crus cerebri</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-18%20111213.jpg\" width=\"784\" height=\"788\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cerebellar peduncle:&nbsp;</strong>Incorrect. These are three pairs of tracts (superior, middle, and inferior) connecting the <strong>cerebellum</strong> to the brainstem, located <strong>posteriorly</strong>, not anteriorly as in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Medullary pyramids:&nbsp;</strong>Incorrect. These are located on the <strong>ventral medulla</strong>, containing descending <strong>corticospinal tracts</strong>, and are not part of the midbrain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Inferior colliculus:&nbsp;</strong>Incorrect. These are <strong>dorsal midbrain</strong> structures involved in the <strong>auditory pathway</strong>, not seen in the ventral view shown here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>cerebral peduncles</strong> are paired structures on the <strong>ventral midbrain</strong> that contain <strong>descending motor tracts</strong> (corticospinal, corticobulbar and corticopontine fibers) connecting the <strong>cerebral cortex</strong> to the <strong>brainstem and spinal cord</strong>.</span></p>",
      "correct_choice_id": 390957,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98231/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98231/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98294,
      "choices": [
        {
          "id": 391208,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine inertia</span></p>"
        },
        {
          "id": 391209,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine tachysystole</span></p>"
        },
        {
          "id": 391210,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine hyperstimulation</span></p>"
        },
        {
          "id": 391211,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine tetany</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman at 38 weeks of gestation is undergoing induction of labor with oxytocin. After 4 hours of infusion, she develops 7 contractions in 10 minutes, accompanied by fetal heart rate decelerations. What is this condition called?</span></p>",
      "unique_key": "Q2309701",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Uterine hyperstimulation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This scenario describes <strong>excessive uterine activity</strong> resulting from <strong>oxytocin infusion</strong>, leading to <strong>fetal distress</strong> (decelerations on FHR tracing).</span></li><li><span style=\"font-size:14.0pt;\">The term <strong>uterine hyperstimulation</strong> (also known as <strong>uterine hypertonus</strong>) is used when <strong>increased contraction frequency or intensity</strong> is associated with <strong>abnormal fetal heart rate patterns</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Oxytocin overdose</strong> can cause uterine contractions to become <strong>too frequent or prolonged</strong>, leading to <strong>reduced uteroplacental blood flow</strong> and <strong>fetal hypoxia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The combination of <strong>tachysystole + FHR decelerations&nbsp;</strong>defines <strong>uterine hyperstimulation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Stop oxytocin infusion immediately.</strong></span></li><li><span style=\"font-size:14.0pt;\">Place the patient in <strong>left lateral position</strong> to improve uteroplacental perfusion.</span></li><li><span style=\"font-size:14.0pt;\">Administer <strong>oxygen</strong> via face mask.</span></li><li><span style=\"font-size:14.0pt;\">If contractions persist, give a <strong>tocolytic agent</strong> (e.g., <strong>terbutaline 0.25 mg SC</strong>) to relax the uterus.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Uterine inertia:&nbsp;</strong>Incorrect. Refers to <strong>ineffective contractions</strong> causing <strong>prolonged labor</strong>, not excessive ones.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Uterine tachysystole:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Refers to &gt;5 contractions in 10 minutes <strong>without </strong>fetal heart rate changes.</span></li><li><span style=\"font-size:14.0pt;\">In this case, <strong>FHR decelerations</strong> are present → <strong>hyperstimulation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Uterine tetany:&nbsp;</strong>Incorrect. Continuous, <strong>sustained contraction without relaxation</strong> (no rhythmic pattern), often leading to <strong>fetal hypoxia or uterine rupture</strong> — not seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Uterine hyperstimulation</strong> is defined as <strong>excessive uterine contractions associated with fetal heart rate decelerations</strong>, typically due to <strong>oxytocin overuse</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Immediate management involves <strong>stopping oxytocin</strong>, <strong>maternal repositioning</strong>, <strong>oxygen</strong>, and if necessary, <strong>tocolysis</strong> to restore adequate uteroplacental perfusion.</span></li></ul>",
      "correct_choice_id": 391210,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98294/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98294/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98355,
      "choices": [
        {
          "id": 391452,
          "text": "<p><span style=\"font-size:14.0pt;\">Tinea corporis</span></p>"
        },
        {
          "id": 391453,
          "text": "<p><span style=\"font-size:14.0pt;\">Erythema multiforme</span></p>"
        },
        {
          "id": 391454,
          "text": "<p><span style=\"font-size:14.0pt;\">Pityriasis versicolor</span></p>"
        },
        {
          "id": 391455,
          "text": "<p><span style=\"font-size:14.0pt;\">Psoriasis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old man presents with an itchy, circular lesion on his thigh. The lesion has central clearing and a raised, erythematous, scaly margin. A KOH mount of skin scrapings reveals a picture as shown below. What is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KPn3HSR.png\" width=\"300\" height=\"183\"></span></p>",
      "unique_key": "Q7769052",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Tinea corporis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tinea corporis</strong> (ringworm of the body) is a <strong>superficial dermatophyte infection</strong> caused by Trichophyton, Microsporum, or Epidermophyton species.</span></li><li><span style=\"font-size:14.0pt;\">The infection typically presents as an <strong>annular (ring-shaped) lesion</strong> with <strong>central clearing</strong> and an <strong>active scaly, erythematous border</strong> that spreads peripherally.</span></li><li><span style=\"font-size:14.0pt;\"><strong>KOH mount</strong> of scrapings confirms the diagnosis by showing <strong>branching, septate fungal hyphae</strong> in the stratum corneum.</span></li><li><span style=\"font-size:14.0pt;\">The term “ringworm” is a misnomer since the causative organism is a <strong>fungus</strong>, not a worm.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Erythema multiforme:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Targetoid lesions with concentric color zones; no fungal hyphae on KOH.</span></li><li><span style=\"font-size:14.0pt;\">Typically associated with HSV infection or drugs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pityriasis versicolor:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Caused by Malassezia furfur; presents with <strong>hypo- or hyperpigmented scaly macules</strong> on trunk.</span></li><li><span style=\"font-size:14.0pt;\">KOH shows “<strong>spaghetti and meatballs</strong>” appearance (hyphae and spores), not just septate hyphae.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Psoriasis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chronic papulosquamous disorder with <strong>silvery white scales</strong> on extensor surfaces.</span></li><li><span style=\"font-size:14.0pt;\">KOH negative and lacks annular pattern or central clearing.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Tinea corporis</strong> is a <strong>dermatophyte infection</strong> of the body presenting with <strong>annular scaly lesions having central clearing and raised margins</strong>, confirmed by <strong>branching septate hyphae on KOH mount</strong>.</span></p>",
      "correct_choice_id": 391452,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98355/INI-NEET_-_GT__27th_Nov_2025_Derma_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98355/INI-NEET_-_GT__27th_Nov_2025_Derma_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98612,
      "choices": [
        {
          "id": 392468,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypotonic cerebral palsy</span></p>"
        },
        {
          "id": 392469,
          "text": "<p><span style=\"font-size:14.0pt;\">Spastic quadriplegic cerebral palsy</span></p>"
        },
        {
          "id": 392470,
          "text": "<p><span style=\"font-size:14.0pt;\">Ataxic cerebral palsy</span></p>"
        },
        {
          "id": 392471,
          "text": "<p><span style=\"font-size:14.0pt;\">Dyskinetic cerebral palsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 2-year-old boy is brought to your clinic with concerns about delayed motor development. His mother had pregnancy-induced hypertension and the baby required stimulation at birth. He has difficulty sitting without support and shows an unusual presentation of legs. On examination, he has increased tone in all limbs with upper limbs and lower limbs affected equally with hyperreflexia. Which of the following best describes his condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_GLUsN3t.png\" width=\"320\" height=\"602\"></span></p>",
      "unique_key": "Q3571740",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Spastic quadriplegic cerebral palsy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical presentation strongly suggests spastic quadriplegic cerebral palsy based on several characteristic features.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">First, there are clear <strong>risk factors</strong> in the history, including pregnancy-induced hypertension in the mother and birth asphyxia requiring stimulation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Spastic quadriplegia is the most severe form of cerebral palsy and is often associated with perinatal hypoxic-ischemic injury.</span></li><li><span style=\"font-size:14.0pt;\">The physical examination findings are classic for spastic quadriplegia, including <strong>increased tone in all four limbs</strong> (both upper and lower extremities), <strong>hyperreflexia</strong>, and <strong>scissoring of the legs</strong> when held upright (indicative of lower limb spasticity).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The developmental delay with inability to sit independently at age 2 years indicates severe motor impairment affecting the whole body.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A. Hypotonic cerebral palsy:</strong> This presentation would involve decreased muscle tone (floppiness) rather than the increased tone and hyperreflexia described in the case. While hypotonia can be an early presentation of cerebral palsy in some infants, by age 2, this child clearly demonstrates spasticity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ataxic cerebral palsy:</strong> This type is characterized by problems with balance, coordination, and depth perception. Tremors and intentional movements would be disrupted, but there would not be the significant spasticity, scissoring, and hyperreflexia described in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D. Dyskinetic cerebral palsy:</strong> This form is characterized by involuntary, uncontrolled, recurring, occasionally stereotyped movements. The child would demonstrate slow, writhing movements (athetosis) or rapid, jerky movements (chorea) rather than the sustained increased tone described in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Spastic quadriplegic cerebral palsy presents with increased tone in all four limbs, hyperreflexia, and severe motor delays.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Key risk factors include perinatal asphyxia and maternal conditions like pregnancy-induced hypertension that compromise fetal blood flow</span></li></ul>",
      "correct_choice_id": 392469,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98612/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98612/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98768,
      "choices": [
        {
          "id": 393088,
          "text": "<p><span style=\"font-size:14.0pt;\">Admission to the hospital for IV heparin</span></p>"
        },
        {
          "id": 393089,
          "text": "<p><span style=\"font-size:14.0pt;\">Admission to the hospital for monitoring of clot progression and pain</span></p>"
        },
        {
          "id": 393090,
          "text": "<p><span style=\"font-size:14.0pt;\">Discharge home with repeat CT of the abdomen in 1 month</span></p>"
        },
        {
          "id": 393091,
          "text": "<p><span style=\"font-size:14.0pt;\">EGD screening for varices and initiation of anticoagulation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old male veteran with HCV-related cirrhosis, hypertension, and diabetes presents with 5 days of abdominal pain. He is stable and CT reveals a heterogeneous liver, moderate ascites, no focal liver lesions, and acute portal vein thrombosis. Labs are unchanged from baseline. He feels well and requests discharge. What is the most appropriate management plan?</span></p>",
      "unique_key": "Q1148489",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) EGD screening for varices and initiation of anticoagulation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In cirrhotic patients found to have acute portal vein thrombosis (PVT), the risk of portal hypertension and variceal bleeding must be addressed before starting anticoagulation.</span></li><li><span style=\"font-size:14.0pt;\">EGD (</span><span style=\"color:#444444;font-size:14.0pt;\">Esophagogastroduodenoscopy</span><span style=\"font-size:14.0pt;\">) should be performed to screen for esophageal varices.</span></li><li><span style=\"font-size:14.0pt;\">If varices are present, steps to reduce bleeding risk (e.g., banding, nonselective beta-blockers) are indicated prior to anticoagulation.</span></li><li><span style=\"font-size:14.0pt;\">Once varices are ruled out or treated, anticoagulation is recommended for acute PVT to prevent clot propagation and worsening portal hypertension.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Admission to the hospital for IV heparin:</strong> Admission solely for IV heparin is inappropriate before variceal assessment; bleeding risk must be evaluated first.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Admission to the hospital for monitoring of clot progression and pain:</strong> Admission for monitoring is not needed in stable patients with no signs of worsening pain or systemic instability.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Discharge home with repeat CT of the abdomen in 1 month:&nbsp;</strong>Repeat CT without addressing portal hypertension misses the need for variceal evaluation and definitive management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For cirrhosis with acute portal vein thrombosis, initial management requires EGD screening for varices, with anticoagulation only after bleeding risk is evaluated and mitigated.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Outpatient follow-up is suitable in stable patients after completing urgent variceal assessment.</span></li></ul>",
      "correct_choice_id": 393091,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98768/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98768/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98790,
      "choices": [
        {
          "id": 393172,
          "text": "<p><span style=\"font-size:14.0pt;\">Phenytoin</span></p>"
        },
        {
          "id": 393173,
          "text": "<p><span style=\"font-size:14.0pt;\">Carbamazepine</span></p>"
        },
        {
          "id": 393174,
          "text": "<p><span style=\"font-size:14.0pt;\">Sodium valproate</span></p>"
        },
        {
          "id": 393175,
          "text": "<p><span style=\"font-size:14.0pt;\">Phenobarbital</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following drugs is most commonly associated with pseudolymphoma syndrome on long-term use?</span></p>",
      "unique_key": "Q4559563",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Phenytoin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pseudolymphoma syndrome</strong> is a rare but notable hypersensitivity reaction that mimics <strong>malignant lymphoma</strong> both <strong>clinically</strong> and <strong>histologically</strong>, but is <strong>benign and reversible</strong> upon withdrawal of the offending drug.</span></li><li><span style=\"font-size:14.0pt;\">Among antiepileptics, <strong>phenytoin</strong> is the most commonly implicated drug. The syndrome is characterized by:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Fever</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Lymphadenopathy</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hepatosplenomegaly</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Rash</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Eosinophilia</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Histologically, it may resemble <strong>T-cell lymphoma</strong>, hence the term “pseudo-lymphoma.”</span></li><li><span style=\"font-size:14.0pt;\">It is part of the broader <strong>anticonvulsant hypersensitivity syndrome</strong>, and may also include <strong>elevated liver enzymes</strong> and <strong>multiorgan involvement</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Carbamazepine</strong>: Though it can also cause drug rash and systemic symptoms (DRESS), <strong>pseudolymphoma is not its classical adverse effect</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Sodium valproate</strong>: It has <strong>hepatotoxicity</strong> and <strong>weight gain</strong>, but not associated with pseudolymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Phenobarbital</strong>: Can cause rash and sedation, but <strong>pseudolymphoma is not a typical side effect</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Phenytoin</strong> is the drug most classically associated with <strong>pseudolymphoma syndrome</strong>, a benign condition that mimics lymphoma and reverses upon drug withdrawal.</span></p>",
      "correct_choice_id": 393172,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98790/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98790/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98782,
      "choices": [
        {
          "id": 393140,
          "text": "<p><span style=\"font-size:14.0pt;\">Fosfomycin</span></p>"
        },
        {
          "id": 393141,
          "text": "<p><span style=\"font-size:14.0pt;\">Nitrofurantoin</span></p>"
        },
        {
          "id": 393142,
          "text": "<p><span style=\"font-size:14.0pt;\">TMP-SMX</span></p>"
        },
        {
          "id": 393143,
          "text": "<p><span style=\"font-size:14.0pt;\">Norfloxacin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A young, otherwise&nbsp;healthy woman&nbsp;presents with&nbsp;acute uncomplicated&nbsp;cystitis and&nbsp;requires empiric antibiotic&nbsp;therapy. Which&nbsp;of the following&nbsp;agents is not&nbsp;considered appropriate&nbsp;for empiric treatment?</span></p>",
      "unique_key": "Q4338742",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Norfloxacin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fosfomycin, nitrofurantoin, and trimethoprim-sulfamethoxazole&nbsp;(TMP-SMX) are&nbsp;all considered&nbsp;first-line empiric agents for&nbsp;acute uncomplicated&nbsp;cystitis in otherwise&nbsp;healthy women.​</span></li><li><span style=\"font-size:14.0pt;\">Each offers&nbsp;effective coverage&nbsp;for common uropathogens, especially&nbsp;Escherichia coli.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fosfomycin:</strong> 3 gm single-dose&nbsp;agent, broad&nbsp;coverage, limited&nbsp;resistance.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nitrofurantoin:</strong> Well tolerated, given in a dose of 100 mg BD for 5 to 7 days, safe unless&nbsp;advanced renal&nbsp;disease.</span></li><li><span style=\"font-size:14.0pt;\"><strong>TMP-SMX:</strong> Preferred&nbsp;where E. coli&nbsp;resistance rates&nbsp;are &lt;20%, avoided&nbsp;in sulfa-allergic patients, 1 double-strength tablet given twice a day for 3 days</span></li><li><span style=\"font-size:14.0pt;\">Norfloxacin&nbsp;is a fluoroquinolone.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While once&nbsp;used for lower&nbsp;urinary tract&nbsp;infections, current&nbsp;guidelines do&nbsp;not recommend&nbsp;fluoroquinolones (including&nbsp;norfloxacin)&nbsp;as first-line&nbsp;empiric therapy&nbsp;for uncomplicated&nbsp;cystitis due&nbsp;to rising resistance, adverse effects, and concerns&nbsp;about collateral&nbsp;damage.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They are reserved&nbsp;for more complicated&nbsp;or resistant&nbsp;cases when other&nbsp;options are contraindicated.​</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Fosfomycin:</strong> Is a recommended&nbsp;first-line agent.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Nitrofurantoin:</strong> Is a recommended&nbsp;first-line agent&nbsp;for acute cystitis.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. TMP-SMX:</strong> Is a first-line agent when&nbsp;local resistance&nbsp;rates are low.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">First-line&nbsp;empiric treatment&nbsp;for uncomplicated&nbsp;cystitis includes&nbsp;fosfomycin, nitrofurantoin, and&nbsp;TMP-SMX, but&nbsp;fluoroquinolones like norfloxacin should&nbsp;be avoided as&nbsp;initial therapy&nbsp;due to resistance&nbsp;and safety concerns.</span></p>",
      "correct_choice_id": 393143,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98782/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98782/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98228,
      "choices": [
        {
          "id": 390944,
          "text": "<p><span style=\"font-size:14.0pt;\">Endocardial cushions derived from endoderm&nbsp;</span></p>"
        },
        {
          "id": 390945,
          "text": "<p><span style=\"font-size:14.0pt;\">Septum primum derived from atrial mesoderm&nbsp;</span></p>"
        },
        {
          "id": 390946,
          "text": "<p><span style=\"font-size:14.0pt;\">Conotruncal ridges derived from neural crest cells&nbsp;</span></p>"
        },
        {
          "id": 390947,
          "text": "<p><span style=\"font-size:14.0pt;\">Interventricular septum derived from ventricular myocardium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A newborn presents with central cyanosis, a harsh systolic murmur, and a boot-shaped heart on chest X-ray. Abnormal development of which embryologic structure is most likely responsible for this condition?&nbsp;</span></p>",
      "unique_key": "Q9751700",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Conotruncal ridges derived from neural crest cells</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The infant has Tetralogy of Fallot, evidenced by cyanosis (right-to-left shunt) and boot-shaped heart (Coeur en Sabot).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This condition results from abnormal development of the conotruncal ridges, which are derived from neural crest cells (NCCs).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">When the spiral septum fails to develop properly in the midline and shifts, it causes: pulmonary stenosis (narrowed pulmonary valve), overriding aorta (aorta covering both ventricles), ventricular septal defect, and right ventricular hypertrophy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The NCCs are crucial for proper partitioning of the outflow tract.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-18%20111116.jpg\" width=\"1348\" height=\"687\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Endocardial cushions derived from endoderm:</strong> Endocardial cushions are not derived from endoderm but from mesenchyme, and they primarily form the atrioventricular valves and portions of the atrial and ventricular septa. Their defects cause atrioventricular septal defects, not TOF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Septum primum derived from atrial mesoderm:</strong> Septum primum forms part of the interatrial septum. Its defects lead to atrial septal defects (ASD), which cause left-to-right shunts and acyanotic heart disease, not the cyanotic presentation seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Interventricular septum derived from ventricular myocardium:</strong> While the interventricular septum is involved in TOF with a VSD, the primary problem is the malalignment of the conotruncal septum, not the muscular interventricular septum itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Tetralogy of Fallot results from abnormal neural crest cell-derived conotruncal septum development, causing four defects that produce cyanotic congenital heart disease with a characteristic boot-shaped cardiac silhouette.</span></p>",
      "correct_choice_id": 390946,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98228/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98228/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98496,
      "choices": [
        {
          "id": 392012,
          "text": "<p><span style=\"font-size:14.0pt;\">NADH dehydrogenase</span></p>"
        },
        {
          "id": 392013,
          "text": "<p><span style=\"font-size:14.0pt;\">Cytochrome c oxidase</span></p>"
        },
        {
          "id": 392014,
          "text": "<p><span style=\"font-size:14.0pt;\">Succinate dehydrogenase</span></p>"
        },
        {
          "id": 392015,
          "text": "<p><span style=\"font-size:14.0pt;\">ATP synthase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 67-year-old man with long-standing hypertension is admitted with acute shortness of breath. An arterial blood gas shows a mildly elevated lactate level. The ICU team explains to a medical student that during oxidative phosphorylation, one key mitochondrial enzyme is responsible for reducing molecular oxygen to water as the final step of the electron transport chain. Which enzyme performs this function?</span></p>",
      "unique_key": "Q7876940",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cytochrome c oxidase&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is <strong>Complex IV</strong> of the electron transport chain.</span></li><li><span style=\"font-size:14.0pt;\"><strong>It performs the final step of oxidative phosphorylation:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Accepts electrons from cytochrome c</span></li><li><span style=\"font-size:14.0pt;\">Transfers them to <strong>molecular oxygen (O₂)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Reduces O₂ to water (H₂O)</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">This enzyme is essential for aerobic metabolism and is inhibited by toxins like <strong>cyanide</strong> and <strong>carbon monoxide</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. NADH dehydrogenase (Complex I):&nbsp;</strong>Transfers electrons from NADH to ubiquinone. It <strong>does not directly act on O₂</strong> and <strong>does not produce water</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Succinate dehydrogenase (Complex II):&nbsp;</strong>Involved in both the TCA cycle and ETC. Transfers electrons from FADH₂ to ubiquinone. Again, <strong>does not reduce oxygen.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. ATP synthase:&nbsp;</strong>Uses the proton gradient to produce ATP from ADP + Pi. It plays <strong>no role in handling molecular oxygen.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cytochrome c oxidase (Complex IV)</strong> is the <strong>terminal enzyme of the electron transport chain</strong>, responsible for <strong>reducing molecular oxygen to water</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Inhibition of this enzyme (e.g., by cyanide or carbon monoxide) leads to <strong>cellular hypoxia, impaired oxidative phosphorylation, and lactate accumulation</strong>.</span></li></ul>",
      "correct_choice_id": 392013,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98496/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98496/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98773,
      "choices": [
        {
          "id": 393104,
          "text": "<p><span style=\"font-size:14.0pt;\">3-6 months</span></p>"
        },
        {
          "id": 393105,
          "text": "<p><span style=\"font-size:14.0pt;\">6-12 months</span></p>"
        },
        {
          "id": 393106,
          "text": "<p><span style=\"font-size:14.0pt;\">12-18 months</span></p>"
        },
        {
          "id": 393107,
          "text": "<p><span style=\"font-size:14.0pt;\">24-36 months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 63-year-old man with hypertension, hyperlipidemia, and a smoking history is incidentally found to have a thoracic aortic aneurysm measuring 4 cm on chest CT. When should the next imaging assessment of aneurysm size be performed?</span></p>",
      "unique_key": "Q9931456",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) 6 - 12 months</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Thoracic aortic aneurysms measuring 3.5-4.4 cm fall into a surveillance category recommending repeat imaging every 12 months to monitor for growth or progression, but first imaging should be done in 6 months and later every 12 months.​</span></li><li><span style=\"font-size:14.0pt;\">Aneurysms 4.5–5.4 cm require more frequent monitoring, typically every 6 months, and ≥5.5 cm or rapid expansion (≥0.5 cm/year) prompt surgical consideration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For thoracic aortic aneurysms measuring 3.5–4.4 cm, current guidelines recommend follow-up imaging at 6-12 months to ensure stability, with intervals adjusted based on growth rate and aneurysm size to optimize timing of surgical referral.</span></p>",
      "correct_choice_id": 393105,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98773/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98773/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98522,
      "choices": [
        {
          "id": 392116,
          "text": "<p><span style=\"font-size:14.0pt;\">1–B, 2–A, 3–C</span></p>"
        },
        {
          "id": 392117,
          "text": "<p><span style=\"font-size:14.0pt;\">1–A, 2–B, 3–C</span></p>"
        },
        {
          "id": 392118,
          "text": "<p><span style=\"font-size:14.0pt;\">1–A, 2–C, 3–B</span></p>"
        },
        {
          "id": 392119,
          "text": "<p><span style=\"font-size:14.0pt;\">1–B, 2–C, 3–A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following correctly matches the type of antigenic determinant of immunoglobulins with its defining feature?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_3jTFv3D.png\" width=\"730\" height=\"263\"></span></p>",
      "unique_key": "Q6976005",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1–B, 2–A, 3–C</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>1–B. Isotypes</strong> refer to the major classes and subclasses of immunoglobulins—<strong>IgG, IgA, IgM, IgD, and IgE</strong>—which differ in the <strong>constant regions of their heavy chains</strong>. These constant-region differences define each antibody’s <strong>biological role and effector function</strong> (e.g., complement activation, placental transfer). All members of a species share the same set of isotypes. Hence, <strong>isotypic variation</strong> distinguishes antibody classes, not individuals.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2–A. Allotypes</strong> represent <strong>allelic variations within the constant region</strong> of immunoglobulin genes among individuals of the same species. These genetic differences do not alter antibody function but can elicit immune reactions if transferred between individuals (e.g., after transfusion or pregnancy).</span></li><li><span style=\"font-size:14.0pt;\"><strong>3–C</strong>. <strong>Idiotypes</strong> are the <strong>unique antigenic determinants</strong> located in the <strong>variable region (VH and VL)</strong>, particularly in or near the <strong>paratope</strong>. Each idiotype reflects a specific antigen-binding structure generated through <strong>somatic recombination and hypermutation</strong>, making every antibody molecule distinct.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Isotypes</strong> differ between antibody classes (IgG, IgA, etc.), <strong>Allotypes</strong> differ between individuals within the same species due to allelic variation in the constant region, and <strong>Idiotypes</strong> differ between antibodies within an individual, defined by the unique amino acid sequences of their variable regions.</span></p>",
      "correct_choice_id": 392116,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98522/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98522/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98277,
      "choices": [
        {
          "id": 391140,
          "text": "<p><span style=\"font-size:14.0pt;\">Cyst aspiration for cytologic examination</span></p>"
        },
        {
          "id": 391141,
          "text": "<p><span style=\"font-size:14.0pt;\">Conservative management with ultrasound follow-up every 4 months</span></p>"
        },
        {
          "id": 391142,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate staging laparotomy with total abdominal hysterectomy and bilateral salpingo-oophorectomy</span></p>"
        },
        {
          "id": 391143,
          "text": "<p><span style=\"font-size:14.0pt;\">Laparoscopic oophorectomy with frozen section</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old postmenopausal woman undergoes a routine pelvic ultrasound that reveals a 4 cm unilateral, unilocular ovarian cyst with no solid areas or septations. Her CA-125 level is 18 U/mL (normal &lt;35 U/mL), and her Risk of Malignancy Index (RMI) is 20. She is asymptomatic. What is the most appropriate management?</span></p>",
      "unique_key": "Q5241847",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Conservative management with ultrasound follow-up every 4 months</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>postmenopausal women</strong>, the management of an <strong>ovarian cyst</strong> depends on several key factors — cyst morphology (simple vs complex), <strong>tumor marker levels</strong> (CA-125), and <strong>Risk of Malignancy Index (RMI)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 1: Understanding the RMI (Risk of Malignancy Index)</strong></span></p><p><span style=\"font-size:14.0pt;\">The <strong>RMI = U × M × CA-125</strong>, where:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>U (Ultrasound score)</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">0 = no suspicious features</span></li><li><span style=\"font-size:14.0pt;\">1 = one feature (e.g., multilocular cyst, solid areas, metastases, ascites, bilateral lesions)</span></li><li><span style=\"font-size:14.0pt;\">3 = two or more features</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>M (Menopausal status)</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">1 = premenopausal</span></li><li><span style=\"font-size:14.0pt;\">3 = postmenopausal</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>CA-125</strong> = measured value (U/mL)</span></li></ul><p><span style=\"font-size:14.0pt;\">For this patient:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">U = 1 (simple cyst, unilocular, no solid components)</span></li><li><span style=\"font-size:14.0pt;\">M = 3 (postmenopausal)</span></li><li><span style=\"font-size:14.0pt;\">CA-125 = 18</span></li></ul><p><span style=\"font-size:14.0pt;\"><strong>RMI = 1 × 3 × 18 = 54</strong>, but as per the question, RMI = <strong>20</strong>, still <strong>&lt;200</strong>, which is <strong>low risk for malignancy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 2: Management of a Low-Risk Ovarian Cyst in Postmenopausal Women</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Simple cyst</strong>, <strong>&lt;5 cm</strong>,<strong>normal CA-125</strong>, and <strong>low RMI (&lt;200)</strong> can be managed <strong>conservatively</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Such women should undergo <strong>repeat ultrasound every 4–6 months</strong> to monitor cyst size and morphology.</span></li><li><span style=\"font-size:14.0pt;\">If the cyst remains stable or regresses, the interval can be increased to <strong>annual follow-up</strong> or discontinued after 1 year of stability.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Surgery is not indicated</strong> unless the cyst grows, develops solid components, or the CA-125 rises.</span></li><li><span style=\"font-size:14.0pt;\">Thus, this patient—<strong>asymptomatic, unilocular cyst, normal CA-125, RMI 20</strong>—should be managed conservatively with <strong>ultrasound surveillance</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cyst aspiration for cytologic examination:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Aspiration is <strong>contraindicated</strong> due to the risk of <strong>tumor spillage</strong> if malignant.</span></li><li><span style=\"font-size:14.0pt;\">Cytology has <strong>low sensitivity</strong> and cannot reliably exclude malignancy.</span></li><li><span style=\"font-size:14.0pt;\">It is only used for <strong>palliative purposes</strong> in inoperable malignancies causing ascites.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Immediate staging laparotomy with total abdominal hysterectomy and bilateral salpingo-oophorectomy:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Indicated when <strong>RMI &gt;200</strong> or when the cyst is <strong>complex</strong> or <strong>CA-125 is elevated</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This patient is <strong>low risk</strong>, so major surgery is unnecessary.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Laparoscopic oophorectomy with frozen section:</strong> Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Considered for <strong>intermediate-risk lesions</strong> (RMI 25–200) or <strong>symptomatic cysts</strong>&gt;7 cm.</span></li><li><span style=\"font-size:14.0pt;\">Not indicated here, as the cyst is small, simple, and the patient is asymptomatic.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>postmenopausal women</strong>, a <strong>simple ovarian cyst &lt;7 cm</strong>, with <strong>normal CA-125</strong> and <strong>low RMI (&lt;200)</strong>, should be managed <strong>conservatively</strong> with <strong>repeat ultrasound monitoring</strong> every 4–6 months.</span></li><li><span style=\"font-size:14.0pt;\">Surgical intervention is reserved for <strong>complex, enlarging, or high-risk cysts</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_MHhpomv.png\" width=\"1006\" height=\"975\"></span></p>",
      "correct_choice_id": 391141,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98277/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98277/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98604,
      "choices": [
        {
          "id": 392436,
          "text": "<p><span style=\"font-size:14.0pt;\">Give oxygen and morphine</span></p>"
        },
        {
          "id": 392437,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer IV fluids and digitalis</span></p>"
        },
        {
          "id": 392438,
          "text": "<p><span style=\"font-size:14.0pt;\">Start furosemide</span></p>"
        },
        {
          "id": 392439,
          "text": "<p><span style=\"font-size:14.0pt;\">Place the child supine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3-year-old child with known Tetralogy of Fallot develops sudden cyanosis and breathlessness after crying. What is the immediate next step?</span></p>",
      "unique_key": "Q5124979",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Give oxygen and morphine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">“Tet spell” (hypercyanotic spell) management includes <strong>oxygen, knee-chest position, morphine, and beta-blockers</strong> to reduce infundibular spasm and increase SVR.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Administer IV fluids and digitalis:</strong> Digitalis worsens obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Start furosemide:</strong> Furosemide reduces preload, worsening spell.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Place the child supine:</strong> Supine position decreases venous return.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>hypercyanotic spells (Tet spells)</strong>, treatment aims to <strong>reduce right-to-left shunting</strong> with oxygen, morphine, and postural modification (knee-chest).</span></p>",
      "correct_choice_id": 392436,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98604/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98604/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98791,
      "choices": [
        {
          "id": 393176,
          "text": "<p><span style=\"font-size:14.0pt;\">Azathioprine</span></p>"
        },
        {
          "id": 393177,
          "text": "<p><span style=\"font-size:14.0pt;\">Cladribine</span></p>"
        },
        {
          "id": 393178,
          "text": "<p><span style=\"font-size:14.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 393179,
          "text": "<p><span style=\"font-size:14.0pt;\">Fludarabine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old man presents with pancytopenia and splenomegaly. Bone marrow biopsy confirms hairy cell leukemia. Which of the following is the most appropriate first-line treatment?</span></p>",
      "unique_key": "Q5640437",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Cladribine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hairy cell leukemia (HCL)</strong> is a rare B-cell lymphoproliferative disorder that typically presents with <strong>splenomegaly</strong> and <strong>pancytopenia</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The disease is characterized morphologically by <strong>\"hairy\" projections</strong> on leukemic cells seen under microscopy.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cladribine</strong> is the <strong>drug of choice</strong> for HCL.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is a <strong>purine analog</strong> (adenosine analog) that is <strong>resistant to degradation by adenosine deaminase</strong>, allowing it to accumulate in cells and cause DNA strand breaks.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is highly effective, leading to prolonged remission in most patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Azathioprine:&nbsp;</strong>Azathioprine is an <strong>immunosuppressant</strong> used in autoimmune conditions and organ transplantation. It has <strong>no role in the treatment of hairy cell leukemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Methotrexate:&nbsp;</strong>Methotrexate is an <strong>antifolate agent</strong> used in cancers (e.g., ALL, lymphoma) and autoimmune diseases (e.g., RA, psoriasis). It is <strong>not effective for HCL</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fludarabine:&nbsp;</strong>Fludarabine is a <strong>purine analog</strong> used in the treatment of <strong>chronic lymphocytic leukemia (CLL)</strong>, not hairy cell leukemia. While it is effective in B-cell malignancies, <strong>cladribine is superior</strong> and specifically indicated for HCL.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cladribine is the first-line treatment for hairy cell leukemia due to its potent activity and resistance to adenosine deaminase degradation.</span></p>",
      "correct_choice_id": 393177,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98791/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98791/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98314,
      "choices": [
        {
          "id": 391288,
          "text": "<p><span style=\"font-size:14.0pt;\">Cholesteatoma</span></p>"
        },
        {
          "id": 391289,
          "text": "<p><span style=\"font-size:14.0pt;\">Acoustic neuroma</span></p>"
        },
        {
          "id": 391290,
          "text": "<p><span style=\"font-size:14.0pt;\">Glomus tumor</span></p>"
        },
        {
          "id": 391291,
          "text": "<p><span style=\"font-size:14.0pt;\">Otosclerosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old woman presents with a history of hearing loss and pulsatile tinnitus. Otoscopic examination shows in the following image. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_hffvHYK.png\" width=\"237\" height=\"231\"></span></p>",
      "unique_key": "Q8108458",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Glomus tumor</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>glomus tumor</strong> (also called paraganglioma) is the most common vascular tumor of the middle ear. It typically presents with <strong>pulsatile tinnitus</strong> due to the tumor's vascular nature and hearing loss, often conductive in type.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of a <strong>red reflex behind an intact tympanic membrane</strong> (referred to as the \"rising sun\" sign) is characteristic and suggests a highly vascular lesion in the middle ear.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pulsatile tinnitus suggests a vascular origin.</span></li><li><span style=\"font-size:14.0pt;\">Hearing loss is due to interference with the ossicular chain or middle ear function.</span></li><li><span style=\"font-size:14.0pt;\">Red reflex indicates the vascularity of the tumor visible through the tympanic membrane.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cholesteatoma:&nbsp;</strong>Cholesteatoma presents with foul-smelling ear discharge, conductive hearing loss, and a retraction pocket or whitish mass in the middle ear on examination. It is not associated with pulsatile tinnitus or a red reflex.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-25%20140253.jpg\" width=\"586\" height=\"577\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acoustic neuroma:&nbsp;</strong>Acoustic neuroma is a vestibular schwannoma that causes sensorineural hearing loss, tinnitus (non-pulsatile), and balance issues. It does not present with a red reflex or pulsatile tinnitus.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-25%20140354.jpg\" width=\"609\" height=\"433\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Otosclerosis:&nbsp;</strong>Otosclerosis causes progressive conductive hearing loss due to stapes fixation. It does not cause pulsatile tinnitus or a red reflex behind the tympanic membrane.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-25%20140429.jpg\" width=\"920\" height=\"715\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A glomus tumor is a vascular middle ear tumor that presents with pulsatile tinnitus, conductive hearing loss, and a red reflex behind an intact tympanic membrane.</span></p>",
      "correct_choice_id": 391290,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98314/INI-NEET_-_GT__27th_Nov_2025_NET_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98314/INI-NEET_-_GT__27th_Nov_2025_NET_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98271,
      "choices": [
        {
          "id": 391116,
          "text": "<p><span style=\"font-size:14.0pt;\">Bicarbonate</span></p>"
        },
        {
          "id": 391117,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucose</span></p>"
        },
        {
          "id": 391118,
          "text": "<p><span style=\"font-size:14.0pt;\">Chloride</span></p>"
        },
        {
          "id": 391119,
          "text": "<p><span style=\"font-size:14.0pt;\">Amino acids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man is evaluated for recurrent nephrolithiasis. Laboratory studies reveal increased urinary solute excretion. As filtrate passes through the PCT, the concentrations of most solutes decrease due to reabsorption. Which of the following solutes does not decrease in concentration within the proximal tubule?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6136140",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Chloride</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In the <strong>proximal convoluted tubule (PCT)</strong>, solutes such as <strong>glucose, amino acids, and bicarbonate</strong> are reabsorbed very efficiently in the early segment.</span></li><li><span style=\"font-size:14.0pt;\">Chloride will be absorbed 60-70% in PCT</span></li><li><span style=\"font-size:14.0pt;\">As a result, their <strong>concentration in tubular fluid decreases</strong> rapidly.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chloride</strong>, however, is reabsorbed less rapidly in the early PCT compared with water.</span></li><li><span style=\"font-size:14.0pt;\">Since water is reabsorbed in proportion to sodium, chloride becomes <strong>relatively concentrated</strong> in the tubular fluid as it progresses down the PCT.</span></li><li><span style=\"font-size:14.0pt;\">Later in the PCT, chloride is reabsorbed along with sodium, but <strong>its concentration does not decrease initially</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Thus, the solute that does not decrease in concentration within the proximal tubule is <strong>chloride</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Bicarbonate:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bicarbonate is reabsorbed in the early PCT through <strong>Na⁺/H⁺ exchange and carbonic anhydrase activity</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This reduces its concentration in tubular fluid as it moves along the PCT.</span></li><li><span style=\"font-size:14.0pt;\">Bicarbonate will be absorbed 80-85% in PCT&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, this option is incorrect.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Glucose:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Glucose is almost completely reabsorbed in the <strong>early PCT</strong> via sodium-glucose cotransporters (SGLT).</span></li><li><span style=\"font-size:14.0pt;\">Its concentration in tubular fluid falls quickly and significantly.</span></li><li><span style=\"font-size:14.0pt;\">Glucose will be absorbed 100% in PCT&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thus, this option is incorrect.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Amino acids:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Amino acids are also actively reabsorbed in the <strong>early PCT</strong> along with sodium.</span></li><li><span style=\"font-size:14.0pt;\">Their concentration in tubular fluid decreases rapidly.</span></li><li><span style=\"font-size:14.0pt;\">Amino acid will be absorbed 100% in PCT</span></li><li><span style=\"font-size:14.0pt;\">Hence, this option is incorrect.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In the proximal convoluted tubule, glucose, amino acids, and bicarbonate are rapidly reabsorbed, leading to decreased concentrations in tubular fluid.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Chloride is reabsorbed more slowly, so its relative concentration does not decrease initially.</span></li></ul>",
      "correct_choice_id": 391118,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98271/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98271/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98109,
      "choices": [
        {
          "id": 390476,
          "text": "<p><span style=\"font-size:14.0pt;\">Ollier Disease</span></p>"
        },
        {
          "id": 390477,
          "text": "<p><span style=\"font-size:14.0pt;\">Neurofibromatosis Type 1 (NF1)</span></p>"
        },
        {
          "id": 390478,
          "text": "<p><span style=\"font-size:14.0pt;\">Klippel-Trenaunay Syndrome</span></p>"
        },
        {
          "id": 390479,
          "text": "<p><span style=\"font-size:14.0pt;\">Maffucci Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old girl is brought for orthopedic evaluation due to progressive shortening and bowing of her left leg, along with multiple pathological fractures since the age of 5. She has noticeable lumps under the skin of her hands, chest, and arms that feel like soft, compressible, dark bluish-red masses. The bony lesions with unilateral distribution are seen. X-ray is shown below. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_WrKmGTu.png\" width=\"453\" height=\"302\"></span></p>",
      "unique_key": "Q7179967",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Maffucci Syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">&nbsp;This rare, non-hereditary condition is defined by the triad of multiple enchondromas (benign cartilage tumors) and multiple soft tissue hemangiomas (vascular malformations), often with a predominantly unilateral distribution.</span></li><li><span style=\"font-size:14.0pt;\">Clinical Correlation:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Progressive shortening, bowing, pathological fractures, and unilateral bony lesions are caused by the enchondromas.</span></li><li><span style=\"font-size:14.0pt;\">Soft, compressible, dark bluish-red masses under the skin are the hemangiomas.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Patients are at a high risk (up to 50%) for malignant transformation of the enchondromas into chondrosarcoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ollier Disease:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Characterized by the presence of multiple enchondromas, like Maffucci syndrome, resulting in skeletal deformities and pathological fractures.</span></li><li><span style=\"font-size:14.0pt;\">Ollier disease lacks the associated hemangiomas (vascular lesions).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of both bony and soft-tissue vascular tumors in the case rules out pure Ollier disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Neurofibromatosis Type 1 (NF1):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A common neurocutaneous disorder involving the skin, nervous system, and bones.</span></li><li><span style=\"font-size:14.0pt;\">NF1 is defined by café-au-lait macules, cutaneous and plexiform neurofibromas, Lisch nodules (iris hamartomas), and frequently causes skeletal abnormalities like pseudarthrosis of the tibia or scoliosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It does not typically cause the combination of multiple widespread enchondromas and hemangiomas described.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Klippel-Trenaunay Syndrome:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A congenital condition characterized by a triad of port-wine stain (capillary malformation), venous malformations (often varicose veins), and limb hypertrophy (overgrowth of the limb).</span></li><li><span style=\"font-size:14.0pt;\">While it involves vascular lesions, it presents primarily as limb overgrowth and a distinct skin stain and does not involve multiple enchondromas or lead to the severe skeletal bowing and fractures characteristic of the enchondromatosis syndromes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The primary educational objective is to differentiate between the enchondromatosis syndromes, specifically by recognizing that Maffucci Syndrome is defined by the unique combination of multiple enchondromas (bony lesions) and multiple hemangiomas (vascular lesions), a combination not found in the other common differential diagnoses like Ollier disease.</span></p>",
      "correct_choice_id": 390479,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98109/INI-NEET_-_GT__27th_Nov_2025_Orthopedics_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98109/INI-NEET_-_GT__27th_Nov_2025_Orthopedics_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98318,
      "choices": [
        {
          "id": 391304,
          "text": "<p><span style=\"font-size:14.0pt;\">Epiglottitis</span></p>"
        },
        {
          "id": 391305,
          "text": "<p><span style=\"font-size:14.0pt;\">Croup</span></p>"
        },
        {
          "id": 391306,
          "text": "<p><span style=\"font-size:14.0pt;\">Foreign body aspiration</span></p>"
        },
        {
          "id": 391307,
          "text": "<p><span style=\"font-size:14.0pt;\">Retropharyngeal abscess</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 2-year-old child presents with a barking cough, stridor and hoarseness. A neck X-ray is shown below. What is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_FVq8UBc.png\" width=\"352\" height=\"360\"></span></p>",
      "unique_key": "Q9638908",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Croup&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical presentation of <strong>barking cough, stridor, and hoarseness</strong>, along with the X-ray finding of the <strong>steeple sign</strong> (narrowing of the subglottic trachea), is highly characteristic of <strong>croup</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Croup</strong>, or laryngotracheobronchitis, is a viral infection (commonly caused by the parainfluenza virus) that leads to inflammation and edema of the upper airway, particularly in the subglottic region.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>steeple sign</strong> on X-ray represents the narrowing of the subglottic airway due to inflammation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Epiglottitis:&nbsp;</strong>Epiglottitis presents with a sudden onset of high fever, drooling, severe distress, and a \"tripod position.\" The lateral neck X-ray shows a <strong>thumbprint sign</strong>, not the steeple sign.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-26%20102340.jpg\" width=\"418\" height=\"378\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Foreign body aspiration:&nbsp;</strong>Foreign body aspiration can cause stridor but typically presents with sudden onset and focal airway obstruction. Radiographs may show a visible foreign body or air trapping, but the steeple sign is not seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Retropharyngeal abscess: </strong>Retropharyngeal abscess is characterized by fever, dysphagia, and neck stiffness. The lateral neck X-ray shows <strong>widening of the prevertebral space</strong>, not the steeple sign.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-26%20102408.jpg\" width=\"424\" height=\"503\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The steeple sign on an X-ray, along with barking cough, stridor, and hoarseness, is diagnostic of croup, a viral infection causing subglottic airway inflammation.</span></p>",
      "correct_choice_id": 391305,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98318/INI-NEET_-_GT__27th_Nov_2025_NET_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98318/INI-NEET_-_GT__27th_Nov_2025_NET_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98530,
      "choices": [
        {
          "id": 392148,
          "text": "<p><span style=\"font-size:14.0pt;\">Floats on the surface</span></p>"
        },
        {
          "id": 392149,
          "text": "<p><span style=\"font-size:14.0pt;\">Sinks to the bottom</span></p>"
        },
        {
          "id": 392150,
          "text": "<p><span style=\"font-size:14.0pt;\">Hatches into a larva</span></p>"
        },
        {
          "id": 392151,
          "text": "<p><span style=\"font-size:14.0pt;\">Loses its bile staining</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">When placed in a saturated salt solution, the egg shown in the image below behaves in which of the following ways?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_nWRhMK2.png\" width=\"489\" height=\"393\"></span></p>",
      "unique_key": "Q5230227",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Sinks to the bottom</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows an <strong>unfertilized egg of Ascaris lumbricoides</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Key identifying features include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Elongated shape</strong> (approx. 90 µm × 45 µm)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Thin or absent albuminous coat</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Bile-stained brown color</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Irregular refractile granules</strong> filling the interior</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Diagnostic Property:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Unlike <strong>fertilized eggs</strong>, the <strong>unfertilized eggs are heavier</strong> and <strong>do not float</strong> in saturated salt or zinc sulfate solutions used in stool concentration techniques.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-26%20104815.jpg\" width=\"572\" height=\"388\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hence, in a <strong>flotation test</strong>, unfertilized eggs <strong>sink to the bottom</strong> of the solution.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Floats on the surface:</strong> Seen with fertilized Ascaris eggs, which are lighter due to the thick mammillated coat.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hatches into a larva:</strong> Unfertilized eggs contain disorganized cytoplasmic material and <strong>cannot develop</strong> into larvae.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Loses its bile staining:</strong> Bile staining persists; it does not fade upon suspension in salt solution.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Unfertilized eggs of Ascaris lumbricoides</strong> are <strong>elongated, bile-stained</strong>, and contain <strong>refractile granules</strong> with a <strong>thin or absent albuminous coat</strong>.</span></li><li><span style=\"font-size:14.0pt;\">They are <strong>non-infective</strong> and <strong>sink</strong> in saturated salt solution — a key laboratory differentiator from fertilized eggs.</span></li></ul>",
      "correct_choice_id": 392149,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98530/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98530/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98573,
      "choices": [
        {
          "id": 392316,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 3, 4 and 5 are correct</span></p>"
        },
        {
          "id": 392317,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 2 and 5 are correct</span></p>"
        },
        {
          "id": 392318,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 2, 3 and 4 are correct</span></p>"
        },
        {
          "id": 392319,
          "text": "<p><span style=\"font-size:14.0pt;\">All five statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Chronic Myeloid Leukemia are correct?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">CML is characterized by a reciprocal translocation between chromosomes 9 and 22 leading to formation of the BCR-ABL fusion gene.</span></li><li><span style=\"font-size:14.0pt;\">The BCR-ABL tyrosine kinase increases apoptosis and decreases proliferation of myeloid cells.</span></li><li><span style=\"font-size:14.0pt;\">The accelerated phase is defined by increasing basophils, rising WBC counts, and 10–19% blasts in bone marrow or blood.</span></li><li><span style=\"font-size:14.0pt;\">The blast crisis resembles acute leukemia and is diagnosed when blasts exceed 20%.</span></li><li><span style=\"font-size:14.0pt;\">Imatinib and other tyrosine kinase inhibitors target the ATP-binding site of the BCR-ABL fusion protein.</span></li></ol>",
      "unique_key": "Q9943654",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Only 1, 3, 4 and 5 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>CML is characterized by a reciprocal translocation between chromosomes 9 and 22 leading to formation of the BCR-ABL fusion gene: </strong>Correct. CML is caused by a <strong>reciprocal translocation between chromosomes 9 and 22</strong>, known as the <strong>Philadelphia chromosome (t(9;22)(q34;q11))</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This translocation fuses the <strong>BCR gene (on chromosome 22)</strong> with the <strong>ABL gene (on chromosome 9)</strong>, forming the <strong>BCR-ABL fusion gene</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The resulting <strong>BCR-ABL tyrosine kinase</strong> promotes uncontrolled myeloid proliferation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>The accelerated phase is defined by increasing basophils, rising WBC counts, and 10–19% blasts in bone marrow or blood:</strong> Correct. The <strong>accelerated phase</strong> of CML is characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>10–19% blasts</strong> in blood or bone marrow,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Increasing basophils</strong>, and</span></li><li><span style=\"font-size:14.0pt;\"><strong>Rising WBC counts</strong> despite therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>The blast crisis resembles acute leukemia and is diagnosed when blasts exceed 20%:&nbsp;</strong>Correct. The <strong>blast crisis</strong> phase represents transformation to an <strong>acute leukemia-like state</strong>, defined by <strong>≥20% blasts</strong> in blood or bone marrow. This marks the terminal stage of the disease with poor prognosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5</strong>.<strong>Imatinib and other tyrosine kinase inhibitors target the ATP-binding site of the BCR-ABL fusion protein → no phosphorylation → no downstream signaling:&nbsp;</strong>Correct.<strong> Imatinib (a tyrosine kinase inhibitor)</strong> specifically binds to the <strong>ATP-binding site</strong> of the <strong>BCR-ABL fusion protein</strong>, preventing <strong>phosphorylation and downstream signaling</strong>. This inhibits uncontrolled myeloid proliferation and induces apoptosis in leukemic cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect</strong> <strong>Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>The BCR-ABL tyrosine kinase increases apoptosis and decreases proliferation of myeloid cells:</strong> Incorrect. The <strong>BCR-ABL tyrosine kinase</strong> causes <strong>increased proliferation</strong>, <strong>reduced apoptosis</strong>, and <strong>enhanced survival</strong> of myeloid cells. It does <strong>not</strong> increase apoptosis; rather, it inhibits normal cell death mechanisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Chronic Myeloid Leukemia (CML)</strong> is characterized by a <strong>BCR-ABL fusion gene</strong> resulting from a <strong>t(9;22) translocation</strong>, producing a <strong>constitutively active tyrosine kinase</strong> that <strong>increases myeloid proliferation and inhibits apoptosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>blast crisis</strong> phase occurs when <strong>blasts exceed 20%</strong>, and <strong>Imatinib</strong> acts by <strong>blocking the ATP-binding site</strong> of the BCR-ABL protein to inhibit downstream signaling.</span></li></ul>",
      "correct_choice_id": 392316,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98573/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98573/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98554,
      "choices": [
        {
          "id": 392244,
          "text": "<p><span style=\"font-size:14.0pt;\">Grossly enlarged kidney</span></p>"
        },
        {
          "id": 392245,
          "text": "<p><span style=\"font-size:14.0pt;\">Focal area of hypoechogenicity</span></p>"
        },
        {
          "id": 392246,
          "text": "<p><span style=\"font-size:14.0pt;\">Perinephric collection (pus in the perinephric space)</span></p>"
        },
        {
          "id": 392247,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased vascularity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old woman presents with high-grade fever, chills, right flank pain, and dysuria for the past two days. Urinalysis shows pyuria and positive leukocyte esterase. Ultrasound of the abdomen is performed to assess for renal involvement. Which of the following findings is least likely to be observed on renal ultrasound in this patient?</span></p>",
      "unique_key": "Q9103429",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Increased vascularity</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>acute pyelonephritis</strong>, ultrasound findings primarily reflect <strong>inflammation and edema</strong> of the renal parenchyma rather than increased blood flow.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The typical sonographic features include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Enlarged kidney</strong> due to edema and inflammation</span></li><li><span style=\"font-size:14.0pt;\"><strong>Focal areas of hypoechogenicity</strong> representing focal inflammation or abscess formation</span></li><li><span style=\"font-size:14.0pt;\"><strong>Perinephric fluid collections</strong> may be seen if infection extends beyond the renal capsule</span></li></ul></li><li><span style=\"font-size:14.0pt;\">However, <strong>increased vascularity is not a typical feature</strong>, as infection and edema actually <strong>decrease perfusion</strong>, often leading to areas of reduced or absent vascular flow on Doppler imaging.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Grossly enlarged kidney:&nbsp;</strong>Seen due to acute inflammatory swelling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Focal area of hypoechogenicity:&nbsp;</strong>Common finding caused by focal inflammation or edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Perinephric collection&nbsp;(pus in the perinephric space):&nbsp;</strong>Indicates extension of infection outside the renal capsule.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ultrasound in <strong>acute pyelonephritis</strong> helps identify renal enlargement, focal inflammation, and perinephric extension.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Key point:&nbsp;</strong>Reduced — not increased — <strong>vascularity</strong> is typical, helping differentiate infection from hypervascular tumors.</span></li></ul>",
      "correct_choice_id": 392247,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98554/INI-NEET_-_GT__27th_Nov_2025_Radiology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98554/INI-NEET_-_GT__27th_Nov_2025_Radiology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98359,
      "choices": [
        {
          "id": 391468,
          "text": "<p><span style=\"font-size:14.0pt;\">Chlamydia trachomatis</span></p>"
        },
        {
          "id": 391469,
          "text": "<p><span style=\"font-size:14.0pt;\">Mycoplasma genitalium</span></p>"
        },
        {
          "id": 391470,
          "text": "<p><span style=\"font-size:14.0pt;\">Trichomonas vaginalis</span></p>"
        },
        {
          "id": 391471,
          "text": "<p><span style=\"font-size:14.0pt;\">Neisseria gonorrhoeae</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old man complains of burning pain during urination. He reluctantly admits that he had unprotected sexual intercourse four days ago. Which of the following organisms is most likely responsible for this presentation?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_vspkJFn.png\" width=\"689\" height=\"637\"></span></p>",
      "unique_key": "Q1022269",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Neisseria gonorrhoeae</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Neisseria gonorrhoeae is a gram-negative diplococcus causing gonococcal urethritis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It typically presents with burning micturition and thick, purulent urethral discharge 2–7 days after unprotected sexual contact.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Gram stain of urethral discharge reveals gram-negative diplococci inside polymorphonuclear leukocytes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is a highly contagious sexually transmitted infection, often coexisting with Chlamydia trachomatis infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Chlamydia trachomatis:</strong> Causes nongonococcal urethritis with a thinner, mucoid discharge and longer incubation period (1–3 weeks). It does not show diplococci on Gram stain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mycoplasma genitalium:</strong> Also causes nongonococcal urethritis but produces milder symptoms and is less purulent. It lacks a cell wall, so Gram staining is ineffective.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Trichomonas vaginalis:</strong> A protozoal infection leading to frothy, greenish discharge in women and may cause mild urethritis in men, but not a thick purulent discharge.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Gonococcal urethritis presents with an acute onset of painful urination and thick purulent discharge after unprotected sexual exposure, typically caused by Neisseria gonorrhoeae.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Gram-negative diplococci seen on smear confirm the diagnosis.</span></li></ul>",
      "correct_choice_id": 391471,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98359/INI-NEET_-_GT__27th_Nov_2025_Derma_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98359/INI-NEET_-_GT__27th_Nov_2025_Derma_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98780,
      "choices": [
        {
          "id": 393132,
          "text": "<p><span style=\"font-size:14.0pt;\">Add acetazolamide</span></p>"
        },
        {
          "id": 393133,
          "text": "<p><span style=\"font-size:14.0pt;\">Add amiloride</span></p>"
        },
        {
          "id": 393134,
          "text": "<p><span style=\"font-size:14.0pt;\">Add spironolactone</span></p>"
        },
        {
          "id": 393135,
          "text": "<p><span style=\"font-size:14.0pt;\">Infuse normal saline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man with decompensated congestive heart failure is admitted after failed outpatient diuresis, rapid weight gain, and persistent dyspnea. Despite significant diuresis with high-dose IV loop diuretics, he remains volume overloaded and his ABG shows the following - pH 7.51, PaCO2 52 mmHg and HCO3 45 mEq/L. What is the most appropriate treatment?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4917793",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Add acetazolamide</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient developed metabolic alkalosis due to prolonged, high-dose loop diuretic therapy, which promotes sodium, chloride, and water loss, increased distal sodium delivery, and H⁺ secretion.</span></li><li><span style=\"font-size:14.0pt;\">Acetazolamide, a carbonic anhydrase inhibitor, increases urinary bicarbonate excretion and can correct alkalosis while continuing diuresis—a key goal in patients who remain fluid overloaded.</span></li><li><span style=\"font-size:14.0pt;\">Acetazolamide is particularly useful for correcting metabolic alkalosis while maintaining effective volume control, and is appropriate for patients who cannot tolerate volume repletion with saline.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Add amiloride:</strong> A potassium-sparing diuretic, helpful for preventing hypokalemia, but not for correcting diuretic-induced alkalosis.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Add spironolactone:</strong> Useful for heart failure management, but does not directly correct metabolic alkalosis.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Infuse normal saline:</strong> This can reverse diuretic-induced alkalosis by restoring sodium/chloride and volume, but is inappropriate here due to ongoing hypervolemia (persistent volume overload and supplemental oxygen requirement); fluid would worsen his heart failure status.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Acetazolamide is the preferred therapy for diuretic-induced metabolic alkalosis when fluid overload precludes volume repletion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It enables correction of alkalosis while maintaining diuretic effect and limiting additional fluid accumulation.</span></li></ul>",
      "correct_choice_id": 393132,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98780/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98780/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98400,
      "choices": [
        {
          "id": 391632,
          "text": "<p><span style=\"font-size:14.0pt;\">-2 to +8 degrees</span></p>"
        },
        {
          "id": 391633,
          "text": "<p><span style=\"font-size:14.0pt;\">0 to +4 degrees</span></p>"
        },
        {
          "id": 391634,
          "text": "<p><span style=\"font-size:14.0pt;\">-2 to -8 degrees</span></p>"
        },
        {
          "id": 391635,
          "text": "<p><span style=\"font-size:14.0pt;\">+2 to +8 degrees</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the operating temperature of the cold chain equipment shown in the picture?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tezQrX8.png\" width=\"496\" height=\"382\"></span></p>",
      "unique_key": "Q5667367",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) +2 to +8 degrees</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image above is of an Ice-Lined-Refrigerator which is the primary cold chain equipment used at PHCs.</span></li><li><span style=\"font-size:14.0pt;\">An ILR maintains the temperature between +2°C and +8°C. An ILR is used to store all Universal Immunization Program vaccines at the Public Health Centre (PHC) level.</span></li><li><span style=\"font-size:14.0pt;\">An ILR can maintain a temperature from +2°C to +8°C with as little as 8 hours of power supply in 24 hours.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ice-Lined Refrigerators (ILR) are used for storing the majority of routine vaccines (e.g., DPT, Measles). The mandatory operating range is +2 to +8 degrees</span></li><li><span style=\"font-size:14.0pt;\">Maintaining the correct, narrow temperature range is essential to prevent vaccine or product degradation due to freezing (damage to most vaccines) or overheating (loss of potency).</span></li></ul>",
      "correct_choice_id": 391635,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98400/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98400/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98519,
      "choices": [
        {
          "id": 392104,
          "text": "<p><span style=\"font-size:14.0pt;\">Polymerase chain reaction (PCR)</span></p>"
        },
        {
          "id": 392105,
          "text": "<p><span style=\"font-size:14.0pt;\">Cloning</span></p>"
        },
        {
          "id": 392106,
          "text": "<p><span style=\"font-size:14.0pt;\">Southern blotting</span></p>"
        },
        {
          "id": 392107,
          "text": "<p><span style=\"font-size:14.0pt;\">Hybridization</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A molecular biologist compares gene activity in normal and cancerous cells using a DNA microarray. Labeled complementary DNA (cDNA) from both samples is applied to a chip containing thousands of DNA probes, and the resulting fluorescence pattern is analyzed. Which fundamental molecular principle enables this technique?</span></p>",
      "unique_key": "Q4217780",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Hybridization</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>DNA microarrays (gene chips)</strong> work on the principle of <strong>nucleic acid hybridization</strong>—the ability of complementary DNA strands to base-pair with each other.</span></li><li><span style=\"font-size:14.0pt;\">In this method, DNA probes corresponding to thousands of genes are fixed on a solid surface.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Labeled cDNA (derived from the mRNA of the sample) is applied to the chip.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If a gene in the sample is expressed, its cDNA will <strong>hybridize (bind)</strong> to its complementary probe on the chip.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The amount of hybridization is measured by detecting the fluorescence intensity at each spot, reflecting the level of gene expression.</span></li><li><span style=\"font-size:14.0pt;\">Hybridization allows <strong>parallel detection of thousands of gene sequences</strong> simultaneously, enabling comparison between normal and diseased tissues, identification of mutations, or assessment of gene expression profiles.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-24%20181514.jpg\" width=\"927\" height=\"675\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Polymerase chain reaction (PCR):&nbsp;</strong>PCR amplifies DNA sequences exponentially using primers and DNA polymerase. It is highly sensitive for detecting and quantifying specific genes but does not involve large-scale, parallel hybridization as in microarrays.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cloning:&nbsp;</strong>Cloning involves inserting DNA fragments into vectors to propagate identical copies within host cells. It is used for gene manipulation and protein expression, not for high-throughput detection of gene mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Southern blotting:&nbsp;</strong>Southern blotting is used to detect specific DNA fragments after electrophoresis via hybridization with a labeled probe. Although it also uses hybridization, it analyzes <strong>one or few genes at a time</strong>, unlike microarrays which assess thousands simultaneously.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">DNA microarrays detect gene mutations and expression changes through nucleic acid hybridization between sample cDNA and complementary DNA probes fixed on a chip.</span></p>",
      "correct_choice_id": 392107,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98519/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98519/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98526,
      "choices": [
        {
          "id": 392132,
          "text": "<p><span style=\"font-size:14.0pt;\">PAS stain showing hyphae within hair follicles and dermis</span></p>"
        },
        {
          "id": 392133,
          "text": "<p><span style=\"font-size:14.0pt;\">Acid-fast bacilli in Ziehl–Neelsen stain</span></p>"
        },
        {
          "id": 392134,
          "text": "<p><span style=\"font-size:14.0pt;\">Broad aseptate hyphae in necrotic tissue</span></p>"
        },
        {
          "id": 392135,
          "text": "<p><span style=\"font-size:14.0pt;\">Sclerotic bodies on KOH mount</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following diagnostic findings best confirms the condition shown in the image below?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_VwXVVfP.png\" width=\"436\" height=\"325\"></span></p>",
      "unique_key": "Q7653991",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) PAS stain showing hyphae within hair follicles and dermis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image depicts <strong>Majocchi’s granuloma</strong>, a <strong>deep follicular dermatophytosis</strong> caused most commonly by <strong>Trichophyton rubrum</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The infection occurs when <strong>dermatophytes invade the dermis through damaged hair follicles</strong>, often following <strong>shaving or misuse of potent topical corticosteroids</strong> on tinea lesions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Diagnostic finding:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">On <strong>histopathology</strong>, <strong>Periodic acid–Schiff (PAS)</strong> or <strong>Grocott’s methenamine silver (GMS)</strong> stain demonstrates <strong>fungal hyphae within hair follicles and extending into the dermis</strong>, confirming the diagnosis.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>granulomatous inflammatory response</strong> with lymphocytes, macrophages, and giant cells is characteristic.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acid-fast bacilli in Ziehl–Neelsen stain:</strong> Seen in Mycobacterium infections (e.g., lupus vulgaris, scrofuloderma), not in dermatophyte infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Broad aseptate hyphae in necrotic tissue:</strong> Characteristic of <strong>mucormycosis</strong>, not Majocchi’s granuloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Sclerotic bodies on KOH mount:</strong> Diagnostic of <strong>chromoblastomycosis</strong>, where brown, thick-walled “Medlar bodies” are seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Majocchi’s granuloma</strong> is a <strong>deep folliculitis caused by dermatophytes</strong>, typically <strong>Trichophyton rubrum</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is confirmed histologically by <strong>PAS or GMS stains showing fungal hyphae within hair follicles and dermis</strong>, especially in patients with <strong>steroid-modified or recurrent tinea infections</strong>.</span></li></ul>",
      "correct_choice_id": 392132,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98526/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98526/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98315,
      "choices": [
        {
          "id": 391292,
          "text": "<p><span style=\"font-size:14.0pt;\">Excessive production of perilymph</span></p>"
        },
        {
          "id": 391293,
          "text": "<p><span style=\"font-size:14.0pt;\">Atrophy of the cochlear nerve</span></p>"
        },
        {
          "id": 391294,
          "text": "<p><span style=\"font-size:14.0pt;\">Excessive endolymph in the inner ear</span></p>"
        },
        {
          "id": 391295,
          "text": "<p><span style=\"font-size:14.0pt;\">Blockage of the Eustachian tube</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 49-year-old woman presents with recurrent episodes of vertigo, aural fullness, fluctuating sensorineural hearing loss, and tinnitus. She is diagnosed with Meniere's disease. Which of the following is the most likely underlying pathophysiological mechanism?</span></p>",
      "unique_key": "Q3353184",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Excessive endolymph in the inner ear</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Meniere's disease is characterized by <strong>endolymphatic hydrops</strong>, a condition where excessive endolymph accumulates in the membranous labyrinth of the inner ear.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This increased volume and pressure within the inner ear disrupt normal cochlear and vestibular function, leading to the classic triad of symptoms:</span><ol><li><span style=\"font-size:14.0pt;\">Recurrent episodes of vertigo.</span></li><li><span style=\"font-size:14.0pt;\">Fluctuating <strong>sensorineural hearing loss</strong> (initially unilateral).</span></li><li><span style=\"font-size:14.0pt;\">Tinnitus and/or aural fullness.</span></li></ol></li><li><span style=\"font-size:14.0pt;\">The excessive endolymph affects both auditory (cochlear) and vestibular structures, causing the described symptoms.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-25%20140732.jpg\" width=\"1079\" height=\"523\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Excessive production of perilymph:&nbsp;</strong>Perilymph is the fluid located in the bony labyrinth, surrounding the membranous labyrinth. Excess perilymph is not associated with the pathogenesis of Meniere’s disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Atrophy of the cochlear nerve:&nbsp;</strong>Atrophy of the cochlear nerve could lead to sensorineural hearing loss but does not explain the episodic vertigo or the fluctuating nature of the hearing loss seen in Meniere’s disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Blockage of the Eustachian tube:&nbsp;</strong>Blockage of the Eustachian tube is associated with middle ear pathologies, such as otitis media or barotrauma. It does not cause the inner ear dysfunction seen in Meniere’s disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Meniere's disease is caused by endolymphatic hydrops, where excessive endolymph in the inner ear disrupts auditory and vestibular function, resulting in vertigo, tinnitus, fluctuating sensorineural hearing loss, and aural fullness.</span></p>",
      "correct_choice_id": 391294,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98315/INI-NEET_-_GT__27th_Nov_2025_NET_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98315/INI-NEET_-_GT__27th_Nov_2025_NET_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98786,
      "choices": [
        {
          "id": 393156,
          "text": "<p><span style=\"font-size:14.0pt;\">Ceftriaxone + Azithromycin</span></p>"
        },
        {
          "id": 393157,
          "text": "<p><span style=\"font-size:14.0pt;\">Piperacillin–tazobactam + Doxycycline</span></p>"
        },
        {
          "id": 393158,
          "text": "<p><span style=\"font-size:14.0pt;\">Ceftriaxone + Vancomycin + Levofloxacin</span></p>"
        },
        {
          "id": 393159,
          "text": "<p><span style=\"font-size:14.0pt;\">Linezolid alone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 64-year-old man with a history of COPD and well-controlled type 2 diabetes mellitus presents with a 2-day history of fever, productive cough, and progressive dyspnea. He recently recovered from an influenza-like illness treated with oseltamivir. On examination, he is tachypneic, BP = 92/56 mmHg, HR = 118/min, and SpO₂ = 86% on room air. Chest X-ray reveals bilateral multilobar infiltrates. ABG shows - pH 7.29, PaCO₂ 48 mmHg, PaO₂ 56 mmHg on 6 L O₂. Labs: WBC 19,000/µL, BUN 32 mg/dL, Na⁺ 129 mEq/L. What is the most appropriate empiric antibiotic regimen for this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9897146",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Ceftriaxone + Vancomycin + Levofloxacin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient meets <strong>major criteria for severe community-acquired pneumonia (CAP):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Hypotension (SBP &lt; 90 mmHg)</span></li><li><span style=\"font-size:14.0pt;\">Hypoxemia (PaO₂ &lt; 60 mmHg)</span></li><li><span style=\"font-size:14.0pt;\">Multilobar infiltrates</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The <strong>recent influenza infection</strong> is a key clue — post-influenza severe pneumonia is classically associated with <strong>Staphylococcus aureus</strong>, including <strong>MRSA</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Hence, empiric coverage must include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>A β-lactam</strong> (e.g., <strong>ceftriaxone</strong>) for Streptococcus pneumoniae and H. influenzae</span></li><li><span style=\"font-size:14.0pt;\"><strong>A fluoroquinolone (levofloxacin)</strong> or macrolide for atypical pathogens (Legionella, Mycoplasma, Chlamydia)</span></li><li><span style=\"font-size:14.0pt;\"><strong>An anti-MRSA agent (vancomycin or linezolid)</strong> to cover post-influenza S. aureus infection</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, the optimal empiric regimen is <strong>Ceftriaxone + Levofloxacin + Vancomycin.</strong></span></li><li><span style=\"font-size:14.0pt;\">Once cultures and nasal PCR are negative for MRSA, vancomycin can be de-escalated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ceftriaxone + Azithromycin:&nbsp;</strong>Suitable for non-severe inpatient CAP, but <strong>lacks MRSA coverage</strong> in post-influenza pneumonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Piperacillin–tazobactam + Doxycycline:&nbsp;</strong>Pseudomonal coverage is unnecessary here (no structural lung disease or recent hospitalization). <strong>Misses MRSA as well.&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Linezolid alone:&nbsp;</strong>Provides MRSA coverage but <strong>no activity against Gram-negatives or atypicals</strong>; inadequate as monotherapy for CAP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Post-influenza <strong>severe community-acquired pneumonia</strong> is strongly associated with <strong>MRSA.</strong></span></li><li><span style=\"font-size:14.0pt;\">Empiric therapy should include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>β-lactam (ceftriaxone/ampicillin-sulbactam)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Fluoroquinolone or macrolide</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>MRSA coverage (vancomycin or linezolid)</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Broad antipseudomonal therapy is reserved for patients with specific risk factors such as prior colonization, recent hospitalization, or structural lung disease.</span></li></ul>",
      "correct_choice_id": 393158,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98786/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98786/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98382,
      "choices": [
        {
          "id": 391560,
          "text": "<p><span style=\"font-size:14.0pt;\">Central government expenditure</span></p>"
        },
        {
          "id": 391561,
          "text": "<p><span style=\"font-size:14.0pt;\">State government expenditure</span></p>"
        },
        {
          "id": 391562,
          "text": "<p><span style=\"font-size:14.0pt;\">Out-of-pocket expenditure by households</span></p>"
        },
        {
          "id": 391563,
          "text": "<p><span style=\"font-size:14.0pt;\">International aid and donor funding</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In India, the largest share of current health expenditure comes from which of the following?</span></p>",
      "unique_key": "Q9002151",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Out-of-pocket expenditure by households</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In India, out-of-pocket expenditure by households constitutes approximately 50% of current health expenditure, making it the largest source.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This high proportion of direct payments by families creates significant financial barriers, often leading to catastrophic health expenditure and impoverishment.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Central government expenditure:</strong> Central government expenditure contributes only about 15% of current health expenditure in India.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. State government expenditure:</strong> State government expenditure accounts for approximately 22% of current health expenditure, less than out-of-pocket payments.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. International aid and donor funding:</strong> International aid and donor funding constitute less than 5% of total healthcare financing in India.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Out-of-pocket expenditure is the predominant source of healthcare financing in India (50%)</span></li><li><span style=\"font-size:14.0pt;\">High out-of-pocket payments lead to financial hardship and limited access to healthcare services</span></li></ul>",
      "correct_choice_id": 391562,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98382/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98382/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98769,
      "choices": [
        {
          "id": 393092,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiate β-blocker and statin</span></p>"
        },
        {
          "id": 393093,
          "text": "<p><span style=\"font-size:14.0pt;\">Perform a transthoracic echocardiogram (TTE)</span></p>"
        },
        {
          "id": 393094,
          "text": "<p><span style=\"font-size:14.0pt;\">Reassure patient with no change in medical therapy</span></p>"
        },
        {
          "id": 393095,
          "text": "<p><span style=\"font-size:14.0pt;\">Refer for coronary angiography</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old man with hypertension presents with exertional chest pain relieved by rest. He is on aspirin and lisinopril. His exercise treadmill test shows he reached 90% of max HR, had chest pain at peak exercise, and nonspecific ECG changes. Perfusion imaging reveals mild lateral wall ischemia and a preserved LVEF (65%). What is the next best management?</span></p>",
      "unique_key": "Q5604061",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Initiate β-blocker and statin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has stable angina confirmed by exercise-induced ischemia in a single coronary territory with preserved LV function.</span></li><li><span style=\"font-size:14.0pt;\"><strong>The recommended next step is to start optimal medical therapy (OMT):</strong> β-blocker (reduces heart rate and myocardial oxygen demand), statin (reduces LDL and stabilizes plaques), continuation of aspirin (antiplatelet), and as-needed nitroglycerin for symptom relief.</span></li><li><span style=\"font-size:14.0pt;\">Coronary angiography is reserved for high-risk stress findings (extensive ischemia, reduced EF, hypotensive response), refractory symptoms, or failed OMT.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. Perform a transthoracic echocardiogram (TTE):</strong> TTE is not needed when LVEF is already documented as normal and there’s no sign of heart failure.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C. Reassure patient with no change in medical therapy:</strong> Reassurance alone is inadequate; stress testing confirmed ischemia, necessitating intensification of therapy to prevent CAD progression.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D. Refer for coronary angiography:</strong> Coronary angiography is unnecessary unless symptoms persist despite OMT, or if stress testing demonstrates multiple high-risk features.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Patients with stable angina and mild ischemia should be started on a β-blocker and statin as part of OMT before considering invasive evaluation.</span></li><li><span style=\"font-size:14.0pt;\">Symptom and risk-factor control are key for long-term outcomes.</span></li></ul>",
      "correct_choice_id": 393092,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98769/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98769/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98527,
      "choices": [
        {
          "id": 392136,
          "text": "<p><span style=\"font-size:14.0pt;\">Naegleria fowleri</span></p>"
        },
        {
          "id": 392137,
          "text": "<p><span style=\"font-size:14.0pt;\">Acanthamoeba spp.</span></p>"
        },
        {
          "id": 392138,
          "text": "<p><span style=\"font-size:14.0pt;\">Balamuthia mandrillaris</span></p>"
        },
        {
          "id": 392139,
          "text": "<p><span style=\"font-size:14.0pt;\">Entamoeba histolytica</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A microbiologist inoculates a CSF sample on non-nutrient agar seeded with E. coli and observes a trail sign. The causative organism fails to grow when NaCl concentration exceeds 0.4%. Which organism is most likely?</span></p>",
      "unique_key": "Q7378567",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Naegleria fowleri</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The described culture findings — <strong>growth on non-nutrient agar with E. coli lawn</strong>, formation of a <strong>trail sign</strong>, and <strong>failure to grow in &gt;0.4% NaCl</strong> — are diagnostic of <strong>Naegleria fowleri</strong>, the <strong>causative agent of Primary Amoebic Meningoencephalitis (PAM)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Culture feature:</strong> Naegleria trophozoites move along the E. coli lawn, producing a <strong>clear trail</strong> (path of feeding).</span></li><li><span style=\"font-size:14.0pt;\"><strong>NaCl sensitivity:</strong> It cannot tolerate saline concentration above 0.4%, helping to differentiate it from Acanthamoeba spp.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Infective form:</strong> The <strong>trophozoite (amoeboid form)</strong> is the infective stage, entering via <strong>nasal mucosa</strong> during swimming in <strong>warm freshwater</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Clinical course:</strong> Rapidly progressive, <strong>acute and fatal meningoencephalitis</strong>, with <strong>neutrophilic CSF</strong> resembling bacterial meningitis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acanthamoeba spp:&nbsp;</strong>Causes <strong>Granulomatous Amoebic Encephalitis (GAE)</strong> and <strong>Amoebic keratitis</strong>; more <strong>chronic course</strong>, grows <strong>despite high NaCl</strong>, and contains both <strong>cyst and trophozoite</strong> stages.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Balamuthia mandrillaris:&nbsp;</strong>Causes GAE similar to Acanthamoeba but <strong>does not grow on E. coli-seeded agar</strong> and requires <strong>cell culture</strong> for isolation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Entamoeba histolytica:&nbsp;</strong>Pathogenic amoeba causing <strong>intestinal amebiasis</strong> and <strong>liver abscess</strong>, not CNS infection; grows on <strong>Robinson’s or Locke–Egg medium</strong>, not non-nutrient agar.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Naegleria fowleri</strong> causes <strong>Primary Amoebic Meningoencephalitis</strong>, typically in healthy individuals exposed to <strong>warm freshwater</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It grows on <strong>non-nutrient agar with E. coli lawn</strong>, produces a <strong>trail sign</strong>, and is inhibited by <strong>&gt;0.4% NaCl</strong>, distinguishing it from Acanthamoeba.</span></li></ul>",
      "correct_choice_id": 392136,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98527/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98527/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98803,
      "choices": [
        {
          "id": 393224,
          "text": "<p><span style=\"font-size:14.0pt;\">Primaquine</span></p>"
        },
        {
          "id": 393225,
          "text": "<p><span style=\"font-size:14.0pt;\">Chloroquine</span></p>"
        },
        {
          "id": 393226,
          "text": "<p><span style=\"font-size:14.0pt;\">Quinine</span></p>"
        },
        {
          "id": 393227,
          "text": "<p><span style=\"font-size:14.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following medications exhibits gametocidal activity against all species of Plasmodium?</span></p>",
      "unique_key": "Q4011398",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Primaquine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Primaquine</strong> is unique among antimalarial drugs because it targets the <strong>sexual stages (gametocytes)</strong> of <strong>all Plasmodium species</strong>, including P. falciparum, P. vivax, P. ovale, and P. malariae.</span></li><li><span style=\"font-size:14.0pt;\">Additionally, primaquine is the only drug that can eradicate <strong>hypnozoites</strong> (dormant liver forms) of P. vivax and P. ovale, making it essential for preventing relapses.</span></li><li><span style=\"font-size:14.0pt;\">This dual action—against both liver forms and gametocytes—makes primaquine especially valuable in interrupting <strong>malaria transmission</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Chloroquine:&nbsp;</strong>Acts on <strong>erythrocytic schizonts</strong>, not gametocytes of P. falciparum. It does not have gametocidal action against all species. It acts only against the&nbsp;gametocytes of P. vivax species.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Quinine:&nbsp;</strong>Primarily targets <strong>blood schizonts</strong>, and has <strong>limited or no gametocidal activity</strong>. Not effective in clearing gametocytes across all species. It acts only against the&nbsp;gametocytes of P. vivax species.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Primaquine is the only antimalarial with gametocidal activity across all Plasmodium species and is used to prevent relapse in infections caused by P. vivax and P. ovale.</span></p>",
      "correct_choice_id": 393224,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98803/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98803/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98402,
      "choices": [
        {
          "id": 391640,
          "text": "<p><span style=\"font-size:14.0pt;\">Eosin - causes liver toxicity and is carcinogenic</span></p>"
        },
        {
          "id": 391641,
          "text": "<p><span style=\"font-size:14.0pt;\">Metanil yellow - causes gastric irritation and is potentially carcinogenic</span></p>"
        },
        {
          "id": 391642,
          "text": "<p><span style=\"font-size:14.0pt;\">Rhodamine B - causes thyroid dysfunction and reproductive toxicity</span></p>"
        },
        {
          "id": 391643,
          "text": "<p><span style=\"font-size:14.0pt;\">Malachite green - causes respiratory irritation and skin sensitization</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The image shows a laboratory test result for detecting adulteration in a commonly used lentil. The pink coloration observed indicates the presence of a specific adulterant. What is the most likely adulterant detected and the health hazard it poses?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_UrmZLk9.png\" width=\"408\" height=\"372\"></span></p>",
      "unique_key": "Q4953154",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Metanil yellow - causes gastric irritation and is potentially carcinogenic</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The pink coloration in the chemical test indicates the presence of metanil yellow, a commonly used adulterant in lentils.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Metanil yellow is an industrial dye that is added to enhance the yellow color of lentils.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The concentrated HCl test produces a characteristic pink color when metanil yellow is present.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This adulterant can cause gastric irritation, diarrhea, and has potential carcinogenic properties, making it a significant public health concern.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Eosin - causes liver toxicity and is carcinogenic:</strong> Eosin is a fluorescent red dye used in histology, most notably as a counterstain with hematoxylin. This is a distractor option, if the “adulterant” word is missed, Eosin might be selected because of the pink color.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Rhodamine B - causes thyroid dysfunction and reproductive toxicity:</strong> Rhodamine B detection involves different testing methods and shows fluorescent properties under UV light.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Malachite green - causes respiratory irritation and skin sensitization:</strong> Malachite green is typically found in fish and poultry products and requires different detection methods.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Metanil yellow is a common adulterant in lentils and turmeric that can be detected by the characteristic pink color reaction with concentrated HCl</span></li><li><span style=\"font-size:14.0pt;\">Food adulteration poses significant health risks including gastric irritation and potential carcinogenic effects</span></li></ul>",
      "correct_choice_id": 391641,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98402/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98402/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98384,
      "choices": [
        {
          "id": 391568,
          "text": "<p><span style=\"font-size:14.0pt;\">Situation analysis</span></p>"
        },
        {
          "id": 391569,
          "text": "<p><span style=\"font-size:14.0pt;\">Priority setting</span></p>"
        },
        {
          "id": 391570,
          "text": "<p><span style=\"font-size:14.0pt;\">Resource allocation</span></p>"
        },
        {
          "id": 391571,
          "text": "<p><span style=\"font-size:14.0pt;\">Implementation planning</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In health planning, the step that involves determining the order of precedence for various health problems based on magnitude, severity, and available resources is known as:</span></p>",
      "unique_key": "Q6944957",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Priority setting</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Priority setting is a crucial step in health planning that involves determining which health problems should be addressed first based on specific criteria such as magnitude of the problem, severity, feasibility of intervention, and availability of resources.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This systematic approach ensures optimal utilization of limited resources and maximum health impact.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Priority setting typically follows situation analysis and precedes resource allocation in the health planning cycle.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-25%20135325_CPu2c1m.jpg\" width=\"880\" height=\"750\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Situation analysis:</strong> Situation analysis is the initial step that involves assessing the current health status and identifying health problems but does not involve prioritizing them.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Resource allocation:&nbsp;</strong>Resource allocation comes after priority setting and involves distributing available resources according to the established priorities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Implementation planning:</strong> Implementation planning is a later step that involves developing specific strategies and timelines for executing the planned interventions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Health planning follows a systematic sequence: situation analysis → priority setting → resource allocation → implementation</span></li><li><span style=\"font-size:14.0pt;\">Priority setting uses criteria like magnitude, severity, feasibility, and resource availability</span></li><li><span style=\"font-size:14.0pt;\">Proper priority setting ensures efficient use of limited healthcare resources for maximum population benefit</span></li></ul>",
      "correct_choice_id": 391569,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98384/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98384/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98550,
      "choices": [
        {
          "id": 392228,
          "text": "<p><span style=\"font-size:14.0pt;\">Elsching’s spots</span></p>"
        },
        {
          "id": 392229,
          "text": "<p><span style=\"font-size:14.0pt;\">Bonnet sign</span></p>"
        },
        {
          "id": 392230,
          "text": "<p><span style=\"font-size:14.0pt;\">Siegrist streaks</span></p>"
        },
        {
          "id": 392231,
          "text": "<p><span style=\"font-size:14.0pt;\">Salu’s sign</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 36-year-old woman with malignant hypertension is found to have linear hyperpigmented streaks along the choroidal vessels on fundoscopic examination. What is the name of this sign?</span></p>",
      "unique_key": "Q3414362",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Siegrist streaks</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Siegrist streaks</strong> are <strong>linear hyperpigmentation along the choroidal vessels</strong> seen in <strong>malignant hypertension</strong> due to <strong>fibrinoid necrosis of the choroidal arterioles</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This occurs due to <strong>severe, uncontrolled hypertension</strong>, which leads to ischemic damage in the choroid, followed by hyperpigmentation along the affected vessels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology of Siegrist Streaks:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Hypertension-induced vascular damage</strong> → Choroidal arteriole fibrinoid necrosis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ischemia and subsequent RPE damage</strong> → Hyperpigmentation along the choroidal vessels.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fundoscopic appearance</strong>: Linear streaks following the course of the choroidal vessels.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-26%20105440.jpg\" width=\"368\" height=\"319\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Elsching’s spots:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">These are <strong>focal infarcts of the retinal pigment epithelium (RPE)</strong> due to <strong>choroidal ischemia</strong> in malignant hypertension.</span></li><li><span style=\"font-size:14.0pt;\">They appear as <strong>discrete, small, white lesions</strong> in the <strong>posterior pole</strong> of the fundus.</span></li><li><span style=\"font-size:14.0pt;\">Unlike <strong>Siegrist streaks</strong>, which are <strong>linear</strong>, Elsching’s spots are <strong>round and focal</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-26%20105454.jpg\" width=\"501\" height=\"391\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Bonnet sign:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Seen in Grade III hypertensive retinopathy</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It refers to <strong>banking of veins distal to the arteriovenous (AV) crossing</strong> due to <strong>arteriolar narrowing and compression of the vein</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>not associated with choroidal damage</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Salu’s sign:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Seen in Grade II hypertensive retinopathy</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It describes <strong>the deflection of veins at AV crossings</strong> due to arteriosclerosis.</span></li><li><span style=\"font-size:14.0pt;\">Unlike Siegrist streaks, it does not indicate <strong>choroidal ischemia</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-26%20105523.jpg\" width=\"619\" height=\"451\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Siegrist streaks are a characteristic feature of malignant hypertension, representing hyperpigmented linear streaks along the choroidal vessels due to fibrinoid necrosis of the choroidal arterioles.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This differentiates them from Elsching’s spots, which are focal RPE infarcts, and Bonnet and Salu’s signs, which are features of hypertensive retinopathy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note: Hypertensive Retinopathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_PHIDIko.png\" width=\"673\" height=\"335\"></strong></span></p>",
      "correct_choice_id": 392230,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98550/INI-NEET_-_GT__27th_Nov_2025_Ophthalmology_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98550/INI-NEET_-_GT__27th_Nov_2025_Ophthalmology_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98293,
      "choices": [
        {
          "id": 391204,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal for first trimester</span></p>"
        },
        {
          "id": 391205,
          "text": "<p><span style=\"font-size:14.0pt;\">Subclinical hypothyroidism</span></p>"
        },
        {
          "id": 391206,
          "text": "<p><span style=\"font-size:14.0pt;\">Overt hypothyroidism</span></p>"
        },
        {
          "id": 391207,
          "text": "<p><span style=\"font-size:14.0pt;\">Gestational thyrotoxicosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old G2P1 woman presents at 28 weeks gestation. Her first-trimester TSH level was 3.2 mIU/L. Based on pregnancy-specific reference ranges, how should this result be interpreted?</span></p>",
      "unique_key": "Q2764030",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Subclinical hypothyroidism</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During pregnancy, <strong>thyroid physiology changes</strong> due to the effects of <strong>human chorionic gonadotropin (hCG)</strong> and <strong>estrogen</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>hCG</strong> has a <strong>TSH-like effect</strong>, leading to a <strong>physiologic decrease in TSH</strong>, especially in the <strong>first trimester</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, <strong>pregnancy-specific reference ranges</strong> for TSH are <strong>lower</strong> than those for non-pregnant women.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Trimester-Specific TSH Reference Ranges (approximate WHO/ATA values):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>First trimester:</strong> 0.1 – 2.5 mIU/L</span></li><li><span style=\"font-size:14.0pt;\"><strong>Second trimester:</strong> 0.2 – 3.0 mIU/L</span></li><li><span style=\"font-size:14.0pt;\"><strong>Third trimester:</strong> 0.3 – 3.0 mIU/L</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Since this woman’s <strong>first-trimester TSH is 3.2 mIU/L</strong>, it is <strong>above the upper limit (2.5 mIU/L)</strong> for that trimester.</span></li><li><span style=\"font-size:14.0pt;\">If her <strong>free T4 (FT4)</strong> levels are <strong>normal</strong>, this represents <strong>subclinical hypothyroidism</strong> (elevated TSH with normal FT4).</span></li><li><span style=\"font-size:14.0pt;\">If <strong>FT4 were low</strong>, it would indicate <strong>overt hypothyroidism</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Normal for first trimester:&nbsp;</strong>Incorrect. The upper limit of normal for TSH in the first trimester is <strong>2.5 mIU/L</strong>; 3.2 is <strong>above</strong> that.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Overt hypothyroidism:&nbsp;</strong>Incorrect. Would require <strong>elevated TSH with low free T4</strong>, which is not described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Gestational thyrotoxicosis:&nbsp;</strong>Incorrect. Characterized by <strong>low TSH</strong> due to high <strong>hCG</strong>, not elevated TSH.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During the <strong>first trimester</strong>, normal TSH levels are <strong>lower</strong> due to the stimulatory effect of hCG on the thyroid.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>TSH &gt;2.5 mIU/L</strong> with <strong>normal free T4</strong> during early pregnancy indicates <strong>subclinical hypothyroidism</strong>, which should be monitored and treated if persistent, especially in women with <strong>anti-TPO antibodies</strong> or a <strong>history of infertility or miscarriage</strong>.</span></li></ul>",
      "correct_choice_id": 391205,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98293/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98293/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98114,
      "choices": [
        {
          "id": 390496,
          "text": "<p><span style=\"font-size:14.0pt;\">Sertraline</span></p>"
        },
        {
          "id": 390497,
          "text": "<p><span style=\"font-size:14.0pt;\">Cognitive Behavioral Therapy (CBT)</span></p>"
        },
        {
          "id": 390498,
          "text": "<p><span style=\"font-size:14.0pt;\">Sertraline plus CBT</span></p>"
        },
        {
          "id": 390499,
          "text": "<p><span style=\"font-size:14.0pt;\">Venlafaxine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old female who is breastfeeding her child presents with symptoms of mild depression. What is the management of choice in this case?</span></p>",
      "unique_key": "Q5205666",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cognitive Behavioral Therapy (CBT)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>mild depression</strong>, both <strong>SSRIs</strong> and <strong>Cognitive Behavioral Therapy (CBT)</strong> have been found to be <strong>equally effective</strong>.</span></li><li><span style=\"font-size:14.0pt;\">However, in a <strong>breastfeeding patient</strong>, where there is a need to <strong>avoid pharmacological exposure to the infant</strong>, <strong>CBT</strong> is preferred as the first-line management option.</span></li><li><span style=\"font-size:14.0pt;\">If the symptoms do not improve or worsen, pharmacotherapy (preferably <strong>Sertraline</strong>, due to its safety in lactation) can be considered later.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Sertraline:</strong> Safest SSRI in lactating women; preferred if symptoms are <strong>moderate or persistent</strong>, but not first choice in <strong>mild depression</strong> when therapy can suffice.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Sertraline plus CBT:</strong> Indicated when depression is <strong>moderate to severe</strong> or when a single modality fails.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Venlafaxine:</strong> SNRI with higher excretion in breast milk; <strong>not preferred</strong> during lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>mild depression</strong>, <strong>SSRIs and CBT are equally effective</strong>, but in a <strong>breastfeeding woman</strong>, <strong>CBT</strong> is preferred initially to avoid infant drug exposure.</span></li><li><span style=\"font-size:14.0pt;\">If pharmacotherapy becomes necessary, <strong>Sertraline</strong> is the safest antidepressant option during lactation.</span></li></ul>",
      "correct_choice_id": 390497,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98114/New_GT_Psychiatry_Question_35.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98114/New_GT_Psychiatry_Question_35.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98778,
      "choices": [
        {
          "id": 393124,
          "text": "<p><span style=\"font-size:14.0pt;\">Add low-dose dopamine infusion</span></p>"
        },
        {
          "id": 393125,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiate Metolazone</span></p>"
        },
        {
          "id": 393126,
          "text": "<p><span style=\"font-size:14.0pt;\">Stop sacubitril/valsartan and give IV fluids</span></p>"
        },
        {
          "id": 393127,
          "text": "<p><span style=\"font-size:14.0pt;\">Begin continuous renal replacement therapy immediately</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old man with ischemic cardiomyopathy (LVEF 25%) and stage 3b chronic kidney disease (baseline creatinine 1.8 mg/dL) is admitted with worsening dyspnea, orthopnea, and peripheral edema. His BP = 94/60 mmHg, JVP = 14 cm H₂O, and chest radiograph shows pulmonary congestion. After IV furosemide 80 mg twice daily, his urine output remains 20ml per hour. S. Na is 130 mEq/L and S. K is 4.2 mEq/L. He is already on carvedilol 12.5 mg BID, sacubitril/valsartan 49/51 mg BID, and empagliflozin 10 mg daily. Which of the following is the most appropriate next step in management?</span></p>",
      "unique_key": "Q4467494",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Initiate Metolazone&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has <strong>acute decompensated heart failure with cardiorenal syndrome (type 1) </strong>- acute kidney injury precipitated by venous congestion and reduced renal perfusion.</span></li><li><span style=\"font-size:14.0pt;\">Despite adequate IV loop diuretics, he remains <strong>oliguric with volume overload</strong>, suggesting <strong>diuretic resistance</strong> due to distal nephron sodium reabsorption.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Next step:</strong> Add a <strong>thiazide-type diuretic (metolazone or chlorothiazide)</strong> for sequential nephron blockade.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Enhances natriuresis, overcomes loop diuretic resistance.</span></li><li><span style=\"font-size:14.0pt;\">Must monitor closely for <strong>hyponatremia and hypokalemia</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Continue guideline-directed medical therapy</strong> (ARNI, β-blocker, SGLT2 inhibitor) unless there is <strong>symptomatic hypotension</strong> or <strong>severe renal dysfunction (eGFR &lt; 20)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Low-dose dopamine</strong> <strong>infusion:</strong> No proven renal or mortality benefit (ROSE-AHF, DAD-HF trials); increases arrhythmia risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Stop sacubitril/valsartan and give IV fluids:</strong> Contraindicated patient is volume overloaded; worsening congestion would further reduce renal function.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Begin continuous renal replacement therapy immediately:</strong> Reserved for refractory volume overload, severe hyperkalemia, metabolic acidosis, or uremic symptoms; not indicated before trying combination diuretic therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>cardiorenal syndrome (type 1)</strong>, when loop diuretics alone are ineffective, <strong>sequential nephron blockade</strong> with a thiazide-type diuretic (e.g., metolazone) is the evidence-based next step before considering ultrafiltration or CRRT.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Avoid dopamine or fluid loading</strong>, which worsen outcomes in congestive cardiorenal states.</span></li></ul>",
      "correct_choice_id": 393125,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98778/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98778/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98549,
      "choices": [
        {
          "id": 392224,
          "text": "<p><span style=\"font-size:14.0pt;\">Afferent pupillary defect (Marcus Gunn pupil)</span></p>"
        },
        {
          "id": 392225,
          "text": "<p><span style=\"font-size:14.0pt;\">Oculomotor nerve palsy</span></p>"
        },
        {
          "id": 392226,
          "text": "<p><span style=\"font-size:14.0pt;\">Complete optic nerve lesion</span></p>"
        },
        {
          "id": 392227,
          "text": "<p><span style=\"font-size:14.0pt;\">Adie’s tonic pupil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient with complete unilateral blindness is examined in a dark room. When a light is directed into the blind eye, no response is observed in either eye. However, when light is directed into the normal eye, both pupils constrict. Which of the following best explains these findings?</span></p>",
      "unique_key": "Q4322416",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Complete optic nerve lesion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>complete optic nerve lesion</strong> causes <strong>unilateral blindness</strong> and eliminates the afferent limb of the pupillary light reflex, known as Total Afferent Pupillary Defect (TAPD).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Light in the blind eye produces no response</strong>, but light in the normal eye <strong>elicits a normal direct and consensual response</strong> because the efferent pathway remains intact.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Afferent pupillary defect (Marcus Gunn pupil):</strong> Causes <strong>paradoxical dilation</strong> of both pupils when light is swung to the affected eye, but <strong>not complete loss of response</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Oculomotor nerve palsy:</strong> Causes a <strong>dilated, non-reactive pupil</strong> but does not explain the findings in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Adie’s tonic pupil:</strong> Causes <strong>a sluggish pupil reaction</strong>, but not complete loss of response in one eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In unilateral blindness, light directed into the blind eye produces no response, but light directed into the normal eye elicits normal pupillary constriction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This indicates a complete optic nerve lesion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pupillary Abnormalities:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8mTiXw5.png\" width=\"674\" height=\"406\"></strong></span></p>",
      "correct_choice_id": 392226,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98549/INI-NEET_-_GT__27th_Nov_2025_Ophthalmology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98549/INI-NEET_-_GT__27th_Nov_2025_Ophthalmology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98492,
      "choices": [
        {
          "id": 391996,
          "text": "<p><span style=\"font-size:14.0pt;\">Isoleucine</span></p>"
        },
        {
          "id": 391997,
          "text": "<p><span style=\"font-size:14.0pt;\">Valine</span></p>"
        },
        {
          "id": 391998,
          "text": "<p><span style=\"font-size:14.0pt;\">Histidine</span></p>"
        },
        {
          "id": 391999,
          "text": "<p><span style=\"font-size:14.0pt;\">Lysine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 16-year-old girl is evaluated for fatigue and muscle wasting during a prolonged illness. During periods of fasting, some amino acids can generate intermediates for the TCA cycle (supporting glucose production) while also forming acetyl-CoA or acetoacetate (supporting ketone formation). Which of the following amino acids is both glucogenic and ketogenic?</span></p>",
      "unique_key": "Q1261303",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Isoleucine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Isoleucine is one of the few amino acids that is <strong>both glucogenic and ketogenic</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It forms <strong>succinyl-CoA</strong> → supports <strong>gluconeogenesis</strong></span></li><li><span style=\"font-size:14.0pt;\">It forms <strong>acetyl-CoA</strong> → supports <strong>ketogenesis</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Valine:&nbsp;</strong>Incorrect. Valine is <strong>purely glucogenic</strong>, forming succinyl-CoA. No role in ketone production.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Histidine:&nbsp;</strong>Incorrect. Histidine is <strong>purely glucogenic</strong>, forming α-ketoglutarate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lysine:&nbsp;</strong>Incorrect. Lysine is <strong>purely ketogenic</strong>. It produces acetoacetyl-CoA but cannot be converted to glucose.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Isoleucine</strong> is one of the amino acids that is <strong>both glucogenic and ketogenic</strong>, producing <strong>succinyl-CoA</strong> (for glucose synthesis) and <strong>acetyl-CoA</strong> (for ketone synthesis) during catabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pure Ketogenic AA: Leucine and Lysine&nbsp;</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Both Ketogenic and Glucogenic AA: Tyrosine, Tryptophan, Isoleucine and Phenylalanine &nbsp;</strong></span></li></ul>",
      "correct_choice_id": 391996,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98492/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98492/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98788,
      "choices": [
        {
          "id": 393164,
          "text": "<p><span style=\"font-size:14.0pt;\">Alendronate</span></p>"
        },
        {
          "id": 393165,
          "text": "<p><span style=\"font-size:14.0pt;\">Denosumab</span></p>"
        },
        {
          "id": 393166,
          "text": "<p><span style=\"font-size:14.0pt;\">Teriparatide</span></p>"
        },
        {
          "id": 393167,
          "text": "<p><span style=\"font-size:14.0pt;\">Raloxifene</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old woman with osteoporosis is prescribed a drug that decreases bone resorption by inhibiting RANKL activity. Which of the following drugs corresponds to this mechanism of action?</span></p>",
      "unique_key": "Q6756228",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Denosumab</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Denosumab is a monoclonal antibody targeting RANKL (Receptor Activator of Nuclear Factor Kappa-Β Ligand), a key inhibitor of osteoclast formation and activity. &nbsp;</span></li><li><span style=\"font-size:14.0pt;\">By inhibiting RANKL, denosumab reduces bone resorption and is commonly used to treat osteoporosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:320/359;width:37.42%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_VfTzKGY.png\" width=\"320\" height=\"359\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Alendronate:</strong> A bisphosphonate that reduces bone resorption by binding hydroxyapatite in bone and inhibiting osteoclast activity. It inhibits the osteoclast activity by inhibiting the phospholipid pathway.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Teriparatide:</strong> A recombinant parathyroid hormone analog that stimulates bone formation (osteoblasts) rather than inhibiting resorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Raloxifene:</strong> A selective estrogen receptor modulator (SERM) that reduces bone turnover by mimicking estrogen's effects on bone and inhibiting osteoclasts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Denosumab inhibits RANKL activity, reducing osteoclast-mediated bone resorption and is used in osteoporosis management.</span></p>",
      "correct_choice_id": 393165,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98788/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98788/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98802,
      "choices": [
        {
          "id": 393220,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
        },
        {
          "id": 393221,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 only</span></p>"
        },
        {
          "id": 393222,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 393223,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old man with type 2 diabetes mellitus is being reviewed for adjustment of his medications. Which of the following statements are correct?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Metformin acts by increasing hepatic gluconeogenesis.</span></li><li><span style=\"font-size:14.0pt;\">Pramlintide is approved for type 1 diabetes mellitus</span></li><li><span style=\"font-size:14.0pt;\">Thiazolidinediones are contraindicated in heart failure.</span></li><li><span style=\"font-size:14.0pt;\">Bromocriptine acts via dopamine receptor agonism to reduce blood glucose.</span></li></ol>",
      "unique_key": "Q2255274",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) 2, 3 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.&nbsp;Pramlintide is approved for type 1 diabetes mellitus: </strong>Correct.&nbsp;Pramlintide is a synthetic analog of <strong>amylin</strong>, a hormone co-secreted with insulin. It <strong>delays gastric emptying, suppresses glucagon</strong>, and <strong>enhances satiety</strong>, leading to <strong>reduction in postprandial glucose levels</strong>. It's FDA-approved for <strong>adjunct use with mealtime insulin</strong> in type 1 and type 2 diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.&nbsp;Thiazolidinediones are contraindicated in heart failure:&nbsp;</strong>Correct.&nbsp;Thiazolidinediones like <strong>pioglitazone and rosiglitazone</strong> activate PPAR-γ, improving insulin sensitivity. However, they can cause <strong>fluid retention</strong>, leading to <strong>worsening of congestive heart failure</strong>. Hence, they are contraindicated in <strong>NYHA Class III-IV HF</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.&nbsp;Bromocriptine acts via dopamine receptor agonism to reduce blood glucose:&nbsp;</strong>Correct.&nbsp;Bromocriptine is a <strong>D₂-receptor agonist</strong>, and its antidiabetic effect is believed to stem from <strong>resetting circadian dopamine activity</strong>, which improves insulin sensitivity and lowers blood glucose. It's approved for <strong>type 2 diabetes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.&nbsp;Metformin acts by increasing hepatic gluconeogenesis:&nbsp;</strong>This is <strong>incorrect</strong>. Metformin <strong>decreases</strong> hepatic gluconeogenesis (glucose production by the liver), which is one of its <strong>primary mechanisms</strong>. It also improves peripheral glucose uptake and insulin sensitivity, without increasing insulin secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Metformin inhibits</strong> hepatic gluconeogenesis — not stimulates it.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pramlintide</strong> is an amylin analog used with insulin to reduce <strong>post-meal glucose spikes</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>TZDs are contraindicated in patients with heart failure</strong> due to risk of fluid retention.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bromocriptine</strong>, a <strong>dopamine agonist</strong>, has a novel role in <strong>glycemic control</strong> in T2DM.</span></li></ul>",
      "correct_choice_id": 393220,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98802/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98802/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98113,
      "choices": [
        {
          "id": 390492,
          "text": "<p><span style=\"font-size:14.0pt;\">Delusional Disorder</span></p>"
        },
        {
          "id": 390493,
          "text": "<p><span style=\"font-size:14.0pt;\">Schizophrenia</span></p>"
        },
        {
          "id": 390494,
          "text": "<p><span style=\"font-size:14.0pt;\">Schizoaffective Disorder</span></p>"
        },
        {
          "id": 390495,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute and Transient Psychotic Disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old man believes that his wife is having an affair with one of the neighbours. He has installed extensive surveillance equipment to confirm his suspicion. Despite having no evidence to support his belief, he continues to repeatedly question his wife about the alleged affair. There are no hallucinations, and he remains well adjusted in his professional life. What is the likely diagnosis?</span></p>",
      "unique_key": "Q6199225",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Delusional Disorder</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Delusional Disorder is characterized by the presence of one or more non-bizarre delusions lasting at least one month, without other prominent psychotic features such as hallucinations, disorganized speech, or behavior.</span></li><li><span style=\"font-size:14.0pt;\">Apart from the delusion, the individual’s functioning remains relatively preserved.</span></li><li><span style=\"font-size:14.0pt;\">In this case, the patient’s fixed false belief of infidelity without supporting evidence and preserved occupational functioning is characteristic of a delusional disorder, jealous type (Othello syndrome)<strong>.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Schizophrenia:&nbsp;</strong>Incorrect. Schizophrenia involves multiple psychotic symptoms (delusions, hallucinations, disorganization, negative symptoms) with social and occupational dysfunction, which are absent here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Schizoaffective Disorder:&nbsp;</strong>Incorrect. Requires the presence of mood symptoms (mania or depression) concurrent with schizophrenia-like symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Acute and Transient Psychotic Disorder:&nbsp;</strong>Incorrect. This psychotic disorder has an acute onset (within 2 weeks) and a brief duration (&lt;1 month).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Delusional Disorder involves persistent, systematized delusions with otherwise normal functioning and no prominent hallucinations or disorganization; the jealous type (Othello syndrome) features delusions of a partner’s infidelity.</span></p>",
      "correct_choice_id": 390492,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98113/New_GT_Psychiatry_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98113/New_GT_Psychiatry_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98521,
      "choices": [
        {
          "id": 392112,
          "text": "<p><span style=\"font-size:14.0pt;\">Deoxyribonucleotides (dNTPs)</span></p>"
        },
        {
          "id": 392113,
          "text": "<p><span style=\"font-size:14.0pt;\">Thermostable DNA polymerase</span></p>"
        },
        {
          "id": 392114,
          "text": "<p><span style=\"font-size:14.0pt;\">Dideoxyribonucleotides (ddNTPs)</span></p>"
        },
        {
          "id": 392115,
          "text": "<p><span style=\"font-size:14.0pt;\">Magnesium ions and template DNA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following components are required for a Polymerase Chain<strong>&nbsp;</strong>Reaction (PCR) except:</span></p>",
      "unique_key": "Q9015397",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Dideoxyribonucleotides (ddNTPs)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>PCR requires:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Template DNA</strong> – to provide the sequence to be amplified.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Primers</strong> – short DNA sequences that flank the region of interest.</span></li><li><span style=\"font-size:14.0pt;\"><strong>dNTPs</strong> – building blocks for new DNA strand synthesis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Thermostable DNA polymerase</strong> (e.g., Taq polymerase) – to withstand repeated heating and cooling cycles.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Magnesium ions (Mg²⁺)</strong> – act as cofactors for the polymerase enzyme.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Dideoxyribonucleotides (ddNTPs)</strong> are <strong>not</strong> used in PCR.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They <strong>lack a 3'-OH group</strong>, which terminates DNA chain elongation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These are used instead in <strong>Sanger DNA sequencing</strong>, not in PCR amplification.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">PCR uses dNTPs for DNA synthesis, while ddNTPs are specific to Sanger sequencing because they terminate DNA chain elongation.</span></p>",
      "correct_choice_id": 392114,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98521/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98521/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 87008,
      "choices": [
        {
          "id": 346516,
          "text": "<p><span style=\"font-size:14.0pt;\">Ileum</span></p>"
        },
        {
          "id": 346517,
          "text": "<p><span style=\"font-size:14.0pt;\">Caecum</span></p>"
        },
        {
          "id": 346518,
          "text": "<p><span style=\"font-size:14.0pt;\">Jejunum</span></p>"
        },
        {
          "id": 346519,
          "text": "<p><span style=\"font-size:14.0pt;\">Sigmoid colon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old patient presents with acute abdominal distension and bilious vomiting. He had an open appendectomy 2 years back via the Rutherford Morrison incision. After evaluating and performing imaging, a decision for exploratory laparotomy is made, suspecting intestinal obstruction. Which organ will be first visualized to know if this is a case of small bowel or large bowel obstruction?</span></p>",
      "unique_key": "Q2567071",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Caecum</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The caecum is a pouch-like structure at the beginning of the colon.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Visualizing the caecum first would indicate that the obstruction likely involves the large bowel if it is distended, helping to differentiate it from a small bowel obstruction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The caecum is the first organ to be visualized to differentiate between small and large bowel obstruction in cases of intestinal obstruction.</span></li><li><span style=\"font-size:14.0pt;\">Distension of the caecum will confirm large bowel involvement, while collapsed caecum implies small bowel obstruction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Identifying a collapsed distal segment of the large bowel and its sequential proximal assessment leads to the identification of the cause.</span></li></ul>",
      "correct_choice_id": 346517,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87008/FMGE_SURGERY_MOCK_2_Q_25.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87008/FMGE_SURGERY_MOCK_2_Q_25.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98793,
      "choices": [
        {
          "id": 393184,
          "text": "<p><span style=\"font-size:14.0pt;\">Esmolol &lt; Adenosine &lt; Omeprazole &lt; Amiodarone</span></p>"
        },
        {
          "id": 393185,
          "text": "<p><span style=\"font-size:14.0pt;\">Adenosine &lt; Esmolol &lt; Omeprazole &lt; Amiodarone</span></p>"
        },
        {
          "id": 393186,
          "text": "<p><span style=\"font-size:14.0pt;\">Adenosine &lt; Omeprazole &lt; Esmolol &lt; Amiodarone</span></p>"
        },
        {
          "id": 393187,
          "text": "<p><span style=\"font-size:14.0pt;\">Esmolol &lt; Omeprazole &lt; Adenosine &lt; Amiodarone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following correctly lists the drugs in ascending order of their biological half-life?</span></p>",
      "unique_key": "Q3676727",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Adenosine &lt; Esmolol &lt; Omeprazole &lt; Amiodarone</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The correct sequence from <strong>shortest to longest half-life</strong> is:</span></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Adenosine (&lt;10 seconds)</strong> → <strong>Esmolol (&lt;5 minutes)</strong> → <strong>Omeprazole (1–2 hours)</strong> → <strong>Amiodarone (&gt;3 weeks)</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Adenosine</strong>: The shortest-acting antiarrhythmic drug. It has a plasma half-life of &lt;10 seconds due to rapid uptake by erythrocytes and endothelial cells.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Esmolol</strong>: An ultra-short-acting β₁-blocker, metabolized by <strong>plasma pseudocholinesterase</strong>, giving it a half-life of about 5-10 minutes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Omeprazole</strong>: Despite a short plasma half-life (30 mins), its <strong>irreversible inhibition</strong> of the H⁺/K⁺-ATPase gives a <strong>24-hour effect</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Amiodarone</strong>: The <strong>longest-acting antiarrhythmic</strong>, with a half-life of <strong>over 3 weeks</strong> due to high lipid solubility and tissue accumulation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The correct sequence of <strong>half-life </strong>in ascending order:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Adenosine (&lt;10 seconds)</strong> → <strong>Esmolol (&lt;5 minutes)</strong> → <strong>Omeprazole (1–2 hours)</strong> → <strong>Amiodarone (&gt;3 weeks)</strong></span></p>",
      "correct_choice_id": 393185,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98793/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98793/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98386,
      "choices": [
        {
          "id": 391576,
          "text": "<p><span style=\"font-size:14.0pt;\">Coverage extends to pre-existing conditions from day one of policy inception</span></p>"
        },
        {
          "id": 391577,
          "text": "<p><span style=\"font-size:14.0pt;\">Beneficiaries can avail cashless treatment at both public and private empaneled hospitals</span></p>"
        },
        {
          "id": 391578,
          "text": "<p><span style=\"font-size:14.0pt;\">The scheme provides coverage for major surgeries, critical illnesses, and medical procedures that require inpatient admission</span></p>"
        },
        {
          "id": 391579,
          "text": "<p><span style=\"font-size:14.0pt;\">Routine out-patient consultations are fully covered under the scheme</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Under the Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), all the following are features of the scheme except:</span></p>",
      "unique_key": "Q8183687",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Routine out-patient consultations are fully covered under the scheme</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">AB-PMJAY does not cover routine Outpatient Department (OPD) consultations and services.</span></li><li><span style=\"font-size:14.0pt;\">However, the scheme does cover medical examination, treatment, and consultation expenses incurred during the covered pre-hospitalization (up to 3 days) and post-hospitalization (up to 15 days) periods.</span></li><li><span style=\"font-size:14.0pt;\">The scheme automatically covers eligible families based on Socio-Economic Caste Census (SECC) 2011 data and state-specific criteria.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Coverage extends to pre-existing conditions from day one of policy inception:</strong> This is correct - AB-PMJAY covers pre-existing conditions from day one without any waiting period</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Beneficiaries can avail cashless treatment at both public and private empaneled hospitals:</strong> This is correct - beneficiaries can access cashless treatment at both government and private empaneled hospitals</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The scheme provides coverage for major surgeries, critical illnesses, and medical procedures that require inpatient admission:</strong> This is correct - the scheme includes coverage for major surgeries, critical illnesses, and medical procedures that require inpatient admission</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The scheme provides comprehensive coverage including pre-existing conditions and mental health services</span></li><li><span style=\"font-size:14.0pt;\">Treatment is available on cashless basis at both public and private empaneled healthcare facilities</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note –&nbsp;</strong></span></p><p>&nbsp;</p><p style=\"margin-left:0in;\"><span style=\"color:black;font-size:14.0pt;\">Ayushman Bharat adopts a continuum of care approach, comprising of two inter-related components, which are -</span></p><p style=\"margin-left:0in;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Health and Wellness Centres (HWCs)</span></li><li><span style=\"font-size:14.0pt;\">Pradhan Mantri Jan Arogya Yojana (PM-JAY): It provides a cover of Rs. 5 lakhs per family per year for secondary and tertiary care hospitalization across public and private empanelled hospitals in India. It covers up to 3 days of pre-hospitalization and 15 days post-hospitalization expenses such as diagnostics and medicines. There is no restriction on the family size, age or gender. All pre–existing conditions are covered from day one. Benefits of the scheme are portable across the country i.e. a beneficiary can visit any empanelled public or private hospital in India to avail cashless treatment.</span></li></ul>",
      "correct_choice_id": 391579,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98386/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98386/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98532,
      "choices": [
        {
          "id": 392156,
          "text": "<p><span style=\"font-size:14.0pt;\">Acinetobacter baumannii</span></p>"
        },
        {
          "id": 392157,
          "text": "<p><span style=\"font-size:14.0pt;\">Klebsiella pneumoniae</span></p>"
        },
        {
          "id": 392158,
          "text": "<p><span style=\"font-size:14.0pt;\">Clostridium perfringens</span></p>"
        },
        {
          "id": 392159,
          "text": "<p><span style=\"font-size:14.0pt;\">Mycobacterium tuberculosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient on prolonged mechanical ventilation develops fever and purulent endotracheal secretions after 6 days of intubation. Which of the following organisms is most commonly associated with ventilator-associated pneumonia (VAP)?</span></p>",
      "unique_key": "Q2425805",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Acinetobacter baumannii</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Acinetobacter baumannii</strong> is a <strong>major cause of ventilator-associated pneumonia (VAP)</strong>, particularly in <strong>ICU patients</strong> receiving prolonged mechanical ventilation.</span></li><li><span style=\"font-size:14.0pt;\">It is a <strong>non-fermenting, aerobic, Gram-negative coccobacillus</strong> that thrives in moist environments, such as <strong>ventilator circuits, catheters, and hospital surfaces</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Acinetobacter species are <strong>notorious for multidrug resistance (MDR)</strong>, including resistance to <strong>carbapenems</strong>.</span></li><li><span style=\"font-size:14.0pt;\">VAP caused by Acinetobacter typically presents with <strong>fever, purulent tracheal secretions, leukocytosis, and new infiltrates</strong> on chest imaging.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Risk factors include:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Prolonged intubation or ICU stay</span></li><li><span style=\"font-size:14.0pt;\">Prior broad-spectrum antibiotic use</span></li><li><span style=\"font-size:14.0pt;\">Mechanical ventilation &gt;48 hours</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Klebsiella pneumoniae:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Also a known cause of hospital-acquired pneumonia but <strong>less commonly associated with VAP</strong> compared to Acinetobacter or Pseudomonas.</span></li><li><span style=\"font-size:14.0pt;\">Classically causes <strong>lobar pneumonia</strong> with “currant jelly” sputum, especially in alcoholics and diabetics.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Clostridium perfringens:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">An <strong>anaerobic, spore-forming, Gram-positive bacillus</strong> causing <strong>gas gangrene</strong> and <strong>food poisoning</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It does <strong>not colonize ventilator circuits</strong> or cause pneumonia in ventilated patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mycobacterium tuberculosis:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Causes <strong>chronic, community-acquired pulmonary infection</strong>, not VAP.</span></li><li><span style=\"font-size:14.0pt;\">VAP is typically due to <strong>nosocomial, fast-growing, Gram-negative bacteria</strong>, not slow-growing mycobacteria.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ventilator-associated pneumonia (VAP)</strong> most often involves <strong>multidrug-resistant, aerobic Gram-negative bacilli</strong>, particularly <strong>Acinetobacter baumannii</strong> and Pseudomonas aeruginosa.</span></li><li><span style=\"font-size:14.0pt;\">These pathogens colonize the <strong>endotracheal tube and respiratory equipment</strong>, leading to infection after <strong>≥48 hours of mechanical ventilation</strong>.</span></li></ul>",
      "correct_choice_id": 392156,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98532/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98532/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98234,
      "choices": [
        {
          "id": 390968,
          "text": "<p><span style=\"font-size:14.0pt;\">Tibialis posterior tendon</span></p>"
        },
        {
          "id": 390969,
          "text": "<p><span style=\"font-size:14.0pt;\">Flexor hallucis longus tendon</span></p>"
        },
        {
          "id": 390970,
          "text": "<p><span style=\"font-size:14.0pt;\">Tendo calcaneus</span></p>"
        },
        {
          "id": 390971,
          "text": "<p><span style=\"font-size:14.0pt;\">Plantaris tendon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old marathon runner experiences a sudden “pop” sound in the posterior ankle during a sprint, followed by severe pain and inability to plantar flex the foot. On examination, the Thompson test is positive. Which structure is most likely injured?</span></p>",
      "unique_key": "Q7278516",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Tendo calcaneus&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Achilles tendon (tendo calcaneus)</strong> is the <strong>strongest tendon in the body</strong>, connecting the <strong>gastrocnemius and soleus muscles</strong> to the <strong>posterior aspect of the calcaneus</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It enables <strong>plantar flexion</strong> of the foot and <strong>propulsion during running or jumping</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rupture</strong> typically occurs during <strong>sudden, forceful dorsiflexion</strong> (e.g., sprinting, jumping).</span></li><li><span style=\"font-size:14.0pt;\">Risk factors include <strong>overuse</strong>, <strong>fluoroquinolone or corticosteroid use</strong>, and <strong>age-related tendon degeneration</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-18%20111255.jpg\" width=\"411\" height=\"715\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical Features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Audible “pop”</strong> or “snap” at the time of injury.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Severe posterior ankle pain.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Loss of plantar flexion</strong> (cannot stand on toes).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Palpable gap</strong> over the tendon.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Positive Thompson test:</strong> When the calf is squeezed, <strong>no plantar flexion</strong> occurs → diagnostic of Achilles tendon rupture.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Tibialis posterior tendon:&nbsp;</strong>Incorrect. Injury causes <strong>loss of medial arch support</strong> and <strong>valgus deformity</strong>, not loss of plantar flexion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Flexor hallucis longus tendon:&nbsp;</strong>Incorrect. Flexes the <strong>great toe</strong>; its rupture affects toe movement, not ankle plantar flexion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Plantaris tendon:&nbsp;</strong>Incorrect. A small, vestigial muscle; rupture may cause pain but <strong>does not impair plantar flexion</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>positive Thompson test</strong> following a <strong>sudden posterior ankle injury</strong> is diagnostic of <strong>Achilles tendon rupture</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It results in <strong>loss of plantar flexion</strong> and requires <strong>prompt surgical or conservative repair</strong> depending on the patient’s activity level.</span></li></ul>",
      "correct_choice_id": 390970,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98234/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98234/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98398,
      "choices": [
        {
          "id": 391624,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal distribution</span></p>"
        },
        {
          "id": 391625,
          "text": "<p><span style=\"font-size:14.0pt;\">Positively skewed distribution</span></p>"
        },
        {
          "id": 391626,
          "text": "<p><span style=\"font-size:14.0pt;\">Negatively skewed distribution</span></p>"
        },
        {
          "id": 391627,
          "text": "<p><span style=\"font-size:14.0pt;\">Bimodal distribution</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a community health survey, the ages of 100 participants were recorded. The mean age was 45 years, median age was 42 years, and mode was 40 years. What type of distribution does this data represent?</span></p>",
      "unique_key": "Q8965081",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Positively skewed distribution</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When mean &gt; median &gt; mode (45 &gt; 42 &gt; 40), the distribution is positively skewed (right-skewed).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In a positively skewed distribution, the tail extends toward higher values, pulling the mean toward the right of the median and mode.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is commonly seen in age distributions, income data, and many health-related variables in community surveys.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-24%20181408.jpg\" width=\"511\" height=\"485\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Normal distribution:</strong> In a normal distribution, mean = median = mode, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-24%20181421.jpg\" width=\"417\" height=\"350\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Negatively skewed distribution:</strong> In negatively skewed distribution, mean &lt; median &lt; mode, which is opposite to the given scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-24%20181434.jpg\" width=\"509\" height=\"464\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Bimodal distribution:</strong> Bimodal distribution has two modes, but only one mode (40 years) is mentioned in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-24%20181453.jpg\" width=\"619\" height=\"356\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When mean &gt; median &gt; mode, the distribution is positively skewed</span></li><li><span style=\"font-size:14.0pt;\">Positively skewed distributions are common in community health data</span></li></ul>",
      "correct_choice_id": 391625,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98398/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98398/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98279,
      "choices": [
        {
          "id": 391148,
          "text": "<p><span style=\"font-size:14.0pt;\">Radical hysterectomy with pelvic lymphadenectomy</span></p>"
        },
        {
          "id": 391149,
          "text": "<p><span style=\"font-size:14.0pt;\">Primary radiation therapy with concurrent cisplatin chemotherapy</span></p>"
        },
        {
          "id": 391150,
          "text": "<p><span style=\"font-size:14.0pt;\">Neoadjuvant chemotherapy followed by radical surgery</span></p>"
        },
        {
          "id": 391151,
          "text": "<p><span style=\"font-size:14.0pt;\">Palliative radiation therapy only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old woman is diagnosed with Stage IIIB cervical cancer. Imaging reveals bilateral parametrial involvement extending to the pelvic sidewall, but no distant metastasis. What is the most appropriate primary treatment approach for this patient?</span></p>",
      "unique_key": "Q9637413",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Primary radiation therapy with concurrent cisplatin chemotherapy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to <strong>FIGO staging</strong>, <strong>Stage IIIB cervical cancer</strong> indicates:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Tumor extension to the pelvic sidewall</strong> and/or</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hydronephrosis or non-functioning kidney</strong> due to tumor obstruction.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In this stage, the disease has spread <strong>beyond the cervix and parametria</strong>, making <strong>surgical management (hysterectomy)</strong> technically unfeasible and non-curative.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Standard Treatment:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>gold-standard primary treatment</strong> for <strong>locally advanced cervical cancer (Stage IIB–IVA)</strong> is <strong>concurrent chemoradiation therapy (CCRT)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This involves:</span><ol><li><span style=\"font-size:14.0pt;\"><strong>External beam radiotherapy (EBRT)</strong> to the pelvis</span></li><li><span style=\"font-size:14.0pt;\"><strong>Intracavitary brachytherapy</strong> to deliver targeted radiation to the cervix</span></li><li><span style=\"font-size:14.0pt;\"><strong>Weekly cisplatin chemotherapy (40 mg/m²)</strong> as a radiosensitizer</span></li></ol></li><li><span style=\"font-size:14.0pt;\">This combined approach offers the best <strong>local control and survival rates</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Radical hysterectomy with pelvic lymphadenectomy:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Surgical treatment is reserved for <strong>early-stage disease (IA–IB1)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In Stage IIIB, <strong>parametrial extension and pelvic sidewall involvement</strong> make the tumor <strong>non-resectable</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Neoadjuvant chemotherapy followed by radical surgery:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Neoadjuvant therapy has limited benefit in advanced cervical cancer and is not superior to concurrent chemoradiation.</span></li><li><span style=\"font-size:14.0pt;\">Surgery post-chemotherapy is technically difficult due to tissue fibrosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Palliative radiation therapy only:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Palliative radiation is used for <strong>metastatic (Stage IVB)</strong> or <strong>symptom control</strong> (e.g., bleeding, pain).</span></li><li><span style=\"font-size:14.0pt;\">This patient has <strong>potentially curable, locally advanced disease</strong>, requiring <strong>definitive concurrent chemoradiation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For <strong>Stage IIIB cervical cancer</strong>, the <strong>treatment of choice</strong> is <strong>primary concurrent chemoradiation</strong> using <strong>external beam radiation</strong>, <strong>brachytherapy</strong>, and <strong>cisplatin-based chemotherapy</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Surgery is contraindicated due to <strong>parametrial and pelvic sidewall involvement</strong>.</span></li></ul>",
      "correct_choice_id": 391149,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98279/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98279/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 86981,
      "choices": [
        {
          "id": 346408,
          "text": "<p><span style=\"font-size:14.0pt;\">Liver abscess</span></p>"
        },
        {
          "id": 346409,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute pancreatitis</span></p>"
        },
        {
          "id": 346410,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute pyelonephritis</span></p>"
        },
        {
          "id": 346411,
          "text": "<p><span style=\"font-size:14.0pt;\">Severe acute pancreatitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old man with a history of alcohol use is brought to the emergency department by his family after being found confused and in distress. He had a recent episode of binge drinking. On examination, his BP is 72/48 mmHg, HR is 120/min, RR is 28/min, and SpO₂ is 88% on room air. He complains of severe epigastric pain radiating to the back. Serum amylase, lipase, and BUN levels are markedly elevated. A CT scan of the abdomen is shown below. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-07%20165022.jpg\" width=\"705\" height=\"515\"></p>",
      "unique_key": "Q5782352",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Severe acute pancreatitis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Severe acute pancreatitis is characterized by persistent organ failure lasting more than 48 hours.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this case, the patient has multi-organ dysfunction: renal impairment (elevated creatinine), respiratory compromise (hypoxia), and hypotension.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The CT scan shows non-enhancing areas of the pancreas, indicating necrosis. These findings fulfil the criteria for severe acute pancreatitis per the Modified Atlanta Classification.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">His BISAP score (raised BUN, impaired GCS, SIRS, age &gt; 60 years) is at least 4/5.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Liver abscess:</strong> Presents with right upper quadrant pain, fever, and liver imaging abnormalities. The CT here shows pancreatic involvement, not liver pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acute pancreatitis:</strong> Though likely initially, the presence of persistent organ failure and necrosis shifts the diagnosis to <strong>severe</strong> acute pancreatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Acute pyelonephritis:</strong> Typically presents with flank pain, fever, and urinary symptoms. Renal imaging would show renal enlargement or wedge-shaped hypodensities, not pancreatic necrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Severe acute pancreatitis is diagnosed when acute pancreatitis is accompanied by persistent (&gt;48 hours) organ failure, and imaging often reveals pancreatic necrosis or non-enhancing areas on contrast-enhanced CT.</span></p>",
      "correct_choice_id": 346411,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86981/FMGE_SURGERY_MOCK_2_Q_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86981/FMGE_SURGERY_MOCK_2_Q_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98117,
      "choices": [
        {
          "id": 390508,
          "text": "<p><span style=\"font-size:14.0pt;\">The presence of multiple fracture lines</span></p>"
        },
        {
          "id": 390509,
          "text": "<p><span style=\"font-size:14.0pt;\">A clean, curved line without radiating fractures</span></p>"
        },
        {
          "id": 390510,
          "text": "<p><span style=\"font-size:14.0pt;\">A linear groove with beveled edges</span></p>"
        },
        {
          "id": 390511,
          "text": "<p><span style=\"font-size:14.0pt;\">Compression fractures at the base of the skull</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In the evaluation of a skull fracture depicted in an image, what characteristic feature differentiates a gutter fracture caused by a bullet from other types of skull fractures?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_bcUZY0I.png\" width=\"425\" height=\"320\"></span></p>",
      "unique_key": "Q1790614",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) A linear groove with beveled edges</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A gutter fracture, typically caused by a bullet grazing the skull, is characterized by a linear groove with beveled edges.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This unique feature arises as the bullet skims along the surface of the skull, displacing bone in its trajectory.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The beveling occurs on the side where the bullet enters, sloping inwards, and is an indication of the bullet's direction.</span></li><li><span style=\"font-size:14.0pt;\">This characteristic helps forensic experts to differentiate it from other types of skull fractures that might not exhibit such specific directional features.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The presence of multiple fracture lines:</strong> This option generally relates to comminuted fractures where the bone is broken into several pieces, often due to high-impact trauma from a blunt object. It does not specifically indicate a grazing bullet.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. A clean, curved line without radiating fractures:</strong> While this might describe some non-penetrating blunt force trauma or even a parietal skull fracture from a curved object, it does not feature the beveled edges typical of a gutter fracture.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Compression fractures at the base of the skull:</strong> These fractures are associated with high-energy trauma that compresses the skull vertically, commonly seen in falls or blows to the head where the force is transmitted to the base of the skull. They do not involve linear grooves or beveling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The specific morphological features of gutter fractures, notably the linear groove with beveled edges, which help in forensic contexts to ascertain the direction and nature of the force involved, specifically identifying gunshot wounds to the head.</span></p>",
      "correct_choice_id": 390510,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98117/INI-NEET_-_GT__27th_Nov_2025_FMT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98117/INI-NEET_-_GT__27th_Nov_2025_FMT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98613,
      "choices": [
        {
          "id": 392472,
          "text": "<p><span style=\"font-size:14.0pt;\">Needle aspiration and pressure dressing</span></p>"
        },
        {
          "id": 392473,
          "text": "<p><span style=\"font-size:14.0pt;\">Reassurance; observe for spontaneous resolution over weeks</span></p>"
        },
        {
          "id": 392474,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate CT head to exclude skull fracture</span></p>"
        },
        {
          "id": 392475,
          "text": "<p><span style=\"font-size:14.0pt;\">Start prophylactic antibiotics</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A term newborn with a prolonged second stage of labor develops a fluctuant swelling over the right parietal bone that does not cross sutures. The skin is intact, and hemoglobin is normal. What is the best management?</span></p>",
      "unique_key": "Q6923955",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Reassurance; observe for spontaneous resolution over weeks</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cephalhematoma is a <strong>subperiosteal hemorrhage</strong> confined by cranial sutures, typically over a parietal bone.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is benign and resolves spontaneously within weeks.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Monitoring for jaundice is recommended due to bilirubin load from resorption.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Needle aspiration and pressure dressing:</strong> Aspiration is contraindicated due to risk of infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Immediate CT head to exclude skull fracture:</strong> Skull fractures are rare and usually clinically insignificant unless neurological signs appear; imaging is not routinely needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Start prophylactic antibiotics:</strong> Antibiotics are not indicated unless infection develops (rare).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Cephalhematomas</strong> are subperiosteal hemorrhages that do not cross sutures and usually <strong>resolve spontaneously</strong>; observation and monitoring for jaundice are the mainstays of care.</span></p>",
      "correct_choice_id": 392473,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98613/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98613/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98270,
      "choices": [
        {
          "id": 391112,
          "text": "<p><span style=\"font-size:14.0pt;\">Aortic regurgitation</span></p>"
        },
        {
          "id": 391113,
          "text": "<p><span style=\"font-size:14.0pt;\">Mitral regurgitation</span></p>"
        },
        {
          "id": 391114,
          "text": "<p><span style=\"font-size:14.0pt;\">Aortic stenosis</span></p>"
        },
        {
          "id": 391115,
          "text": "<p><span style=\"font-size:14.0pt;\">Congestive cardiac failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following conditions is most likely associated with the leftward shift of the pressure-volume loop?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-26%20101325.jpg\" width=\"606\" height=\"583\"></p>",
      "unique_key": "Q2175441",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Aortic stenosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>leftward shift</strong> of the pressure-volume loop indicates that the heart is working at a <strong>lower end-diastolic volume</strong> and higher pressures, consistent with <strong>aortic stenosis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In aortic stenosis, the left ventricle must generate significantly higher pressures to overcome the narrowed aortic valve, resulting in a taller and narrower loop.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The ventricle's ability to fill may also be reduced, leading to a smaller end-diastolic volume, causing the loop to shift leftward.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The narrowed aortic valve increases afterload, which is the hallmark of aortic stenosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Aortic regurgitation:</strong> Incorrect. Aortic regurgitation results in an increase in left ventricular volume due to the backflow of blood into the ventricle during diastole, leading to a <strong>rightward</strong> and <strong>widened</strong> loop, not a leftward shift. The loop also shows increased stroke volume due to the extra volume regurgitated back into the ventricle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mitral regurgitation:</strong> Incorrect. Mitral regurgitation is characterized by an increase in left ventricular volume due to backflow of blood from the ventricle into the left atrium during systole, causing a <strong>rightward shift</strong> in the loop. The loop becomes wider due to the increased volume in the ventricle, but there is no leftward shift.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Congestive cardiac failure:</strong> Incorrect. Congestive cardiac failure typically leads to a <strong>downward and rightward shift</strong> of the loop due to reduced contractility and higher end-diastolic volumes, not a leftward shift. The loop reflects impaired systolic function and reduced ejection fraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>leftward shift</strong> of the pressure-volume loop is indicative of <strong>aortic stenosis</strong>, where the heart generates higher pressures at lower volumes due to increased afterload from the stenotic aortic valve.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The ventricle must work harder to pump blood through the narrowed valve, leading to this characteristic change in the loop.</span></li></ul>",
      "correct_choice_id": 391114,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98270/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98270/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98555,
      "choices": [
        {
          "id": 392248,
          "text": "<p><span style=\"font-size:14.0pt;\">Hydropneumothorax</span></p>"
        },
        {
          "id": 392249,
          "text": "<p><span style=\"font-size:14.0pt;\">Simple pneumothorax</span></p>"
        },
        {
          "id": 392250,
          "text": "<p><span style=\"font-size:14.0pt;\">Tension pneumothorax</span></p>"
        },
        {
          "id": 392251,
          "text": "<p><span style=\"font-size:14.0pt;\">Lung collapse with compensatory hyperinflation of the opposite lung</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 4‑year‑old child is brought to the emergency department with acute onset of severe respiratory distress and cyanosis following a bout of coughing. The chest X‑ray is given below. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_O97Z4gZ.png\" width=\"277\" height=\"323\"></span></p>",
      "unique_key": "Q8350846",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Tension pneumothorax</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The X‑ray demonstrates a <strong>hyperlucent left hemithorax</strong> with <strong>absence of lung markings</strong> and <strong>mediastinal shift to the right</strong>, classic for a <strong>tension pneumothorax</strong> — a life‑threatening emergency requiring immediate decompression.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hydropneumothorax:</strong> Would show both <strong>air–fluid levels</strong> and <strong>horizontal fluid line</strong>, which are absent here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Simple pneumothorax:</strong> Shows lung collapse without mediastinal shift — hence less severe.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lung collapse with contralateral hyperinflation</strong> <strong>of the opposite lung:</strong> Mediastinum shifts toward the affected side (not away), opposite of what’s seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Tension pneumothorax occurs when intrapleural pressure exceeds atmospheric pressure, collapsing the ipsilateral lung and shifting mediastinal structures — leading to <strong>impaired venous return and cardiac output</strong>.</span></p>",
      "correct_choice_id": 392250,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98555/INI-NEET_-_GT__27th_Nov_2025_Radiology_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98555/INI-NEET_-_GT__27th_Nov_2025_Radiology_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98378,
      "choices": [
        {
          "id": 391544,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer oral amoxicillin and advise follow-up in 2 days</span></p>"
        },
        {
          "id": 391545,
          "text": "<p><span style=\"font-size:14.0pt;\">Refer immediately for injectable antibiotics and prompt vaccination for missed dose</span></p>"
        },
        {
          "id": 391546,
          "text": "<p><span style=\"font-size:14.0pt;\">Give supportive care with paracetamol and advise home management</span></p>"
        },
        {
          "id": 391547,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer oral cotrimoxazole and schedule follow-up in 3 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 15-month-old child presents with fever, cough, and fast breathing. The mother reports that the child received all vaccines as per schedule but missed the recent booster dose. According to IMNCI guidelines, what is the most appropriate immediate intervention for this child presenting with pneumonia?</span></p>",
      "unique_key": "Q7409310",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Administer oral amoxicillin and advise follow-up in 2 days</strong></span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to IMNCI (Integrated Management of Neonatal and Childhood Illness) guidelines, pneumonia in children aged 2-59 months should be treated with oral amoxicillin as first-line therapy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The child shows signs of pneumonia (fever, cough, fast breathing) but no danger signs requiring immediate referral.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Oral amoxicillin 90mg/kg/day divided into two doses for 5 days is the standard treatment, with follow-up in 2 days to assess improvement.</span></li></ul><p><span style=\"font-size:14.0pt;\">&nbsp;&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Refer immediately for injectable antibiotics and prompt vaccination for missed dose:</strong> Immediate hospital referral is indicated only when danger signs are present (unable to drink/breastfeed, vomits everything, convulsions, lethargic or unconscious). This is a distractor option as the mention of missed booster vaccination might mislead candidates to think about prevention rather than treatment, or that the child might be more susceptible and require hospital referral. However, vaccination status doesn't change the immediate management of pneumonia according to IMNCI protocols.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Give supportive care with paracetamol and advise home management:</strong> Supportive care alone is inadequate for pneumonia; specific antibiotic treatment is required</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Administer oral cotrimoxazole and schedule follow-up in 3 days:</strong> Cotrimoxazole is second-line therapy and follow-up should be in 2 days, not 3 days</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">IMNCI guidelines recommend oral amoxicillin as first-line treatment for pneumonia in children 2-59 months with follow-up should be scheduled in 2 days to assess treatment response</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-25%20130638.jpg\" width=\"1096\" height=\"691\"></span></p>",
      "correct_choice_id": 391544,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98378/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98378/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98283,
      "choices": [
        {
          "id": 391164,
          "text": "<p><span style=\"font-size:14.0pt;\">To examine the condition of the uterine endometrium</span></p>"
        },
        {
          "id": 391165,
          "text": "<p><span style=\"font-size:14.0pt;\">To assess sperm motility and interaction with cervical mucus</span></p>"
        },
        {
          "id": 391166,
          "text": "<p><span style=\"font-size:14.0pt;\">To confirm ovulation has taken place</span></p>"
        },
        {
          "id": 391167,
          "text": "<p><span style=\"font-size:14.0pt;\">To analyze the consistency and viscosity of cervical mucus alone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A couple undergoing evaluation for infertility is advised to undergo a postcoital test (PCT) as part of their diagnostic workup. What is the primary purpose of this test?</span></p>",
      "unique_key": "Q4948746",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) To assess sperm motility and interaction with cervical mucus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>postcoital test (PCT)</strong>, also known as the <strong>Sims-Huhner test</strong>, is performed during infertility evaluation to assess the <strong>interaction between sperm and cervical mucus</strong> in the peri-ovulatory period.</span></li><li><span style=\"font-size:14.0pt;\">The cervical mucus, under the influence of estrogen, becomes thin and receptive to sperm penetration around ovulation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The test is conducted within <strong>8–12 hours after intercourse</strong>, and a sample of cervical mucus is examined microscopically for:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Presence of motile sperm</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Number of motile sperm per high-power field</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Sperm motility pattern (progressive vs. sluggish)</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">The <strong>purpose of this test is to assess whether the sperm can survive and migrate through the cervical mucus</strong>, which is critical for natural conception.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. To examine the condition of the uterine endometrium</strong>: Incorrect. The <strong>uterine lining</strong> is assessed by <strong>endometrial biopsy</strong>, not the postcoital test. The PCT does not provide information about endometrial health.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. To confirm ovulation has taken place:&nbsp;</strong>Incorrect. The occurrence of <strong>ovulation</strong> is typically confirmed through methods such as <strong>mid-luteal serum progesterone measurement</strong>, <strong>ultrasound follicular monitoring</strong>, or <strong>basal body temperature tracking</strong>, not via the postcoital test.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. To analyze the consistency and viscosity of cervical mucus alone:&nbsp;</strong>Incorrect. Although the postcoital test includes an assessment of <strong>cervical mucus properties</strong>, its <strong>primary aim is to evaluate sperm survival and motility within the mucus</strong> after intercourse, not just the mucus characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The postcoital test is performed during infertility evaluation to assess sperm motility and survival within the cervical mucus, providing information on the sperm-cervical mucus interaction critical for natural conception.</span></p>",
      "correct_choice_id": 391165,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98283/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98283/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98801,
      "choices": [
        {
          "id": 393216,
          "text": "<p><span style=\"font-size:14.0pt;\">Bosentan</span></p>"
        },
        {
          "id": 393217,
          "text": "<p><span style=\"font-size:14.0pt;\">Ambrisentan</span></p>"
        },
        {
          "id": 393218,
          "text": "<p><span style=\"font-size:14.0pt;\">Macitentan</span></p>"
        },
        {
          "id": 393219,
          "text": "<p><span style=\"font-size:14.0pt;\">Epoprostenol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old woman with WHO Group 1 pulmonary arterial hypertension is started on an oral endothelin receptor antagonist that selectively blocks the endothelin-A (ETA) receptor, minimizing hepatotoxicity. Which of the following agents was most likely prescribed?</span></p>",
      "unique_key": "Q5015082",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Ambrisentan</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ambrisentan</strong> is a selective <strong>endothelin-A receptor antagonist (ERA)</strong> approved for <strong>pulmonary arterial hypertension (PAH)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">By blocking the ETA receptor, it <strong>reduces vasoconstriction and smooth muscle proliferation</strong> in pulmonary vessels, improving symptoms and exercise capacity.</span></li><li><span style=\"font-size:14.0pt;\">Importantly, unlike <strong>bosentan</strong> (which blocks both ETA and ETB), <strong>ambrisentan has a lower risk of hepatotoxicity</strong> and does <strong>not require monthly liver function monitoring</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Bosentan:</strong> A <strong>dual ETA/ETB antagonist</strong> associated with <strong>significant risk of hepatotoxicity</strong> via inhibition of the bile salt export pump (BSEP). Requires <strong>monthly LFTs</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Macitentan:</strong> A <strong>dual ERA</strong>, but with improved tissue selectivity and pharmacokinetics. Though better tolerated than bosentan, it still blocks <strong>both ETA and ETB receptors</strong>, unlike ambrisentan’s ETA selectivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Epoprostenol:</strong> A <strong>prostacyclin analog</strong>, not an endothelin receptor antagonist. Administered via continuous IV infusion for severe PAH. It <strong>acts by vasodilation and inhibition of platelet aggregation</strong>, not endothelin antagonism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ambrisentan</strong> selectively antagonizes <strong>ETA receptors</strong> and is used in <strong>WHO Group 1 pulmonary arterial hypertension</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its <strong>selectivity spares the ETB receptor</strong>, minimizing hepatotoxicity risk compared to non-selective ERAs like bosentan.</span></li></ul>",
      "correct_choice_id": 393217,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98801/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98801/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98272,
      "choices": [
        {
          "id": 391120,
          "text": "<p><span style=\"font-size:14.0pt;\">+6 mm Hg, net absorption</span></p>"
        },
        {
          "id": 391121,
          "text": "<p><span style=\"font-size:14.0pt;\">−6 mm Hg, net filtration</span></p>"
        },
        {
          "id": 391122,
          "text": "<p><span style=\"font-size:14.0pt;\">+6 mm Hg, net filtration</span></p>"
        },
        {
          "id": 391123,
          "text": "<p><span style=\"font-size:14.0pt;\">−6 mm Hg, net absorption</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old man with long-standing hypertension is being evaluated for mild ankle swelling at the end of the day. On assessment of his capillary dynamics at the arteriolar end of a systemic capillary bed, the following pressures are measured:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Capillary hydrostatic pressure = 30 mm Hg</span></li><li><span style=\"font-size:14.0pt;\">Capillary oncotic pressure = 28 mm Hg</span></li><li><span style=\"font-size:14.0pt;\">Interstitial hydrostatic pressure = 0 mm Hg</span></li><li><span style=\"font-size:14.0pt;\">Interstitial oncotic pressure = 4 mm Hg</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Based on the Starling forces, what is the net filtration pressure, and will filtration or absorption occur?</span></p>",
      "unique_key": "Q8392435",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) +6 mm Hg, net filtration</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The movement of fluid across a capillary wall is governed by the <strong>Starling equation</strong>, which compares hydrostatic and oncotic pressures in both capillary and interstitial compartments:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Net filtration pressure = (P<sub>c</sub> – P<sub>i</sub>) – (π<sub>c</sub> -&nbsp;π<sub>i</sub>)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Where:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pc</strong>= capillary hydrostatic pressure</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pi</strong>= interstitial hydrostatic pressure</span></li><li><span style=\"font-size:14.0pt;\"><strong>πc</strong> = capillary oncotic pressure</span></li><li><span style=\"font-size:14.0pt;\"><strong>πi</strong> = interstitial oncotic pressure</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 1: Substitute the given values</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">(30 - 0) - (28 - 4) = 30 – 24 = + 6 mm Hg</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>positive value</strong> indicates <strong>filtration</strong>, meaning fluid is moving <strong>out of the capillary</strong> into the interstitial space.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At the <strong>arteriolar end</strong> of capillaries, <strong>hydrostatic pressure exceeds oncotic pressure</strong>, resulting in <strong>net filtration of fluid into the interstitial space</strong>.</span></li><li><span style=\"font-size:14.0pt;\">At the <strong>venular end</strong>, capillary hydrostatic pressure falls, oncotic pressure dominates, and <strong>reabsorption</strong> occurs.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Formula to remember:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Net filtration pressure = (P<sub>c</sub> – P<sub>i</sub>) – (π<sub>c</sub> -&nbsp;π<sub>i</sub>)</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Positive value → filtration</strong>, <strong>Negative value → absorption</strong></span></li></ul>",
      "correct_choice_id": 391122,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98272/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98272/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 87016,
      "choices": [
        {
          "id": 346548,
          "text": "<p><span style=\"font-size:14.0pt;\">Gallstone ileus</span></p>"
        },
        {
          "id": 346549,
          "text": "<p><span style=\"font-size:14.0pt;\">Mirizzi syndrome</span></p>"
        },
        {
          "id": 346550,
          "text": "<p><span style=\"font-size:14.0pt;\">Gallbladder perforation</span></p>"
        },
        {
          "id": 346551,
          "text": "<p><span style=\"font-size:14.0pt;\">Biliary pancreatitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old woman with acute cholecystitis develops a sudden increase in pain. The Abdomen shows cardboard rigidity on palpation. Imaging reveals free fluid around the liver. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q7710811",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Gallbladder perforation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Gallbladder perforation is a complication of acute cholecystitis and presents with peritonitis and free fluid on imaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Gallstone ileus:</strong> Gallstone ileus presents with small bowel obstruction, not peritonitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mirizzi syndrome:</strong> Mirizzi syndrome involves obstruction of the bile duct by a gallstone without free fluid, presents with Jaundice.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Biliary pancreatitis:</strong></span><span style=\"font-size:11.0pt;\">&nbsp;</span><span style=\"font-size:14.0pt;\">While it causes abdominal pain, it does not present with peritonitis or free perihepatic fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Gallbladder perforation is a surgical emergency in patients with acute cholecystitis and peritonitis, requiring immediate intervention.</span></p>",
      "correct_choice_id": 346550,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87016/FMGE_SURGERY_MOCK_2_Q_28.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87016/FMGE_SURGERY_MOCK_2_Q_28.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98266,
      "choices": [
        {
          "id": 391096,
          "text": "<p><span style=\"font-size:14.0pt;\">A, B, C, D</span></p>"
        },
        {
          "id": 391097,
          "text": "<p><span style=\"font-size:14.0pt;\">A, C, D</span></p>"
        },
        {
          "id": 391098,
          "text": "<p><span style=\"font-size:14.0pt;\">A, B, C</span></p>"
        },
        {
          "id": 391099,
          "text": "<p><span style=\"font-size:14.0pt;\">B, D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old man is admitted with worsening dyspnea and leg swelling. His clinicians want to measure his cardiac output to assess cardiac performance. Which of the following methods can be used for cardiac output calculation?</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:14.0pt;\">Thermodilution</span></li><li><span style=\"font-size:14.0pt;\">Fick’s principle</span></li><li><span style=\"font-size:14.0pt;\">Echocardiography (ECHO)</span></li><li><span style=\"font-size:14.0pt;\">Ventilation-perfusion (V/Q) scan</span></li></ol>",
      "unique_key": "Q8188874",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) A, B, C</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cardiac output (CO)</strong> is the volume of blood pumped by the heart per minute. Several validated techniques exist for its calculation:</span></li><li><span style=\"font-size:14.0pt;\"><strong>A. Thermodilution:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Measured using a <strong>pulmonary artery catheter (Swan-Ganz catheter)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Cold saline is injected into the right atrium, and the change in blood temperature at the pulmonary artery is measured.</span></li><li><span style=\"font-size:14.0pt;\">This is a standard invasive method to calculate CO.</span></li></ul></li></ul><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>B. Fick’s principle:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Based on <strong>oxygen consumption (VO₂) and arteriovenous O₂ difference</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Formula:</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:14.0pt;\"><strong>CO=O₂&nbsp;consumption/ (Arterial&nbsp;O₂&nbsp;content&nbsp;–&nbsp;Venous&nbsp;O₂&nbsp;content)</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Considered a gold standard in physiology.</span></li></ul></li></ul><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>C. Echocardiography:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Doppler echocardiography can calculate stroke volume by measuring <strong>left ventricular outflow tract diameter and velocity-time integral (VTI)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Multiplying stroke volume by heart rate gives cardiac output.</span></li></ul></li><li><p><span style=\"font-size:14.0pt;\">Thus, the correct methods are <strong>A (Thermodilution), B (Fick’s principle), and C (ECHO)</strong>.</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D. Ventilation-perfusion (V/Q) scan:&nbsp;</strong>This is a diagnostic test for <strong>pulmonary embolism</strong> and does not measure cardiac output.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cardiac output can be measured using thermodilution, Fick’s principle, or echocardiography. Ventilation-perfusion scanning is not used to measure cardiac output.</span></p>",
      "correct_choice_id": 391098,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98266/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98266/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98548,
      "choices": [
        {
          "id": 392220,
          "text": "<p><span style=\"font-size:14.0pt;\">Edrophonium (Tensilon) test</span></p>"
        },
        {
          "id": 392221,
          "text": "<p><span style=\"font-size:14.0pt;\">Ice pack test</span></p>"
        },
        {
          "id": 392222,
          "text": "<p><span style=\"font-size:14.0pt;\">Acetylcholine receptor antibody test</span></p>"
        },
        {
          "id": 392223,
          "text": "<p><span style=\"font-size:14.0pt;\">Orbital MRI with contrast</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man presents with fluctuating ptosis and diplopia, which worsen by the evening. His symptoms improve transiently after administering an IV medication. The image shows the patient's eye movements before and after drug administration. Which of the following is the best diagnostic test for confirming the suspected condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zhjm09f.png\" width=\"617\" height=\"187\"></span></p>",
      "unique_key": "Q9454502",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Acetylcholine receptor antibody test</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Myasthenia gravis is an autoimmune disorder affecting the neuromuscular junction, often presenting with fluctuating ptosis and diplopia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>edrophonium (Tensilon) test</strong> and <strong>ice pack test</strong> can provide a rapid diagnosis, but the <strong>definitive diagnostic test is the detection of acetylcholine receptor antibodies</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Edrophonium (Tensilon) test:</strong> A short-acting acetylcholinesterase inhibitor that temporarily improves symptoms but has fallen out of favour due to risks of bradycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ice pack test:</strong> Cooling the eyelid improves ptosis in MG, but it is not confirmatory.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-26%20105304.jpg\" width=\"602\" height=\"203\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Orbital MRI with contrast:</strong> Useful in cases where a <strong>thymoma or compressive lesion</strong> is suspected, but not required for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The acetylcholine receptor antibody test is the gold standard for diagnosing myasthenia gravis, while the edrophonium test and ice pack test provide rapid but less definitive diagnostic confirmation.</span></p>",
      "correct_choice_id": 392222,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98548/INI-NEET_-_GT__27th_Nov_2025_Ophthalmology_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98548/INI-NEET_-_GT__27th_Nov_2025_Ophthalmology_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98520,
      "choices": [
        {
          "id": 392108,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 392109,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 only</span></p>"
        },
        {
          "id": 392110,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
        },
        {
          "id": 392111,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements correctly describe non-nutritional environmental factors influencing bacterial growth?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Ultraviolet radiation damages bacterial DNA and inhibits replication.</span></li><li><span style=\"font-size:14.0pt;\">High osmotic pressure favors the growth of most non-halophilic pathogens.</span></li><li><span style=\"font-size:14.0pt;\">Moisture is essential for bacterial survival and metabolic activity.</span></li><li><span style=\"font-size:14.0pt;\">Mechanical stress and desiccation can damage or destroy bacterial cell walls.</span></li></ol>",
      "unique_key": "Q1391098",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 3 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Ultraviolet radiation damages bacterial DNA and inhibits replication:&nbsp;</strong>Correct. Ultraviolet radiation induces <strong>thymine dimers</strong> in bacterial DNA, inhibiting replication and transcription, thereby killing or inactivating the bacteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Moisture is essential for bacterial survival and metabolic activity:&nbsp;</strong>Correct.<strong>&nbsp;</strong>Water is vital for enzyme activity, nutrient transport, and metabolism. Bacteria require adequate <strong>moisture</strong> to grow.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Mechanical stress and desiccation can damage or destroy bacterial cell walls: </strong>Correct. <strong>Mechanical stress</strong> (e.g., ultrasonic vibration) and <strong>desiccation</strong> (drying) can disrupt bacterial membranes and cell walls, leading to loss of viability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>High osmotic pressure favors the growth of most non-halophilic pathogens:&nbsp;</strong>Incorrect. High osmotic pressure <strong>inhibits</strong> the growth of non-halophilic (salt-sensitive) pathogens by causing plasmolysis. Only halophilic bacteria thrive in such environments.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bacterial growth is strongly influenced by non-nutritional environmental factors such as UV radiation, osmotic pressure, moisture, and mechanical stress. Most non-halophilic pathogens require moist, isotonic, dark environments and are inhibited by dryness, high salt concentration, or radiation exposure.</span></p>",
      "correct_choice_id": 392108,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98520/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98520/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 86985,
      "choices": [
        {
          "id": 346424,
          "text": "<p><span style=\"font-size:14.0pt;\">It is caused by multiple organisms</span></p>"
        },
        {
          "id": 346425,
          "text": "<p><span style=\"font-size:14.0pt;\">The testis remains unaffected</span></p>"
        },
        {
          "id": 346426,
          "text": "<p><span style=\"font-size:14.0pt;\">Surgical treatment is required in most cases</span></p>"
        },
        {
          "id": 346427,
          "text": "<p><span style=\"font-size:14.0pt;\">Mortality is low</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old Type 2 diabetic patient presents with fever and hypotension to the casualty. He reports a history of a boil in the perianal area that developed two weeks ago. On examination, the perianal area is as shown in the image below. Identify the incorrect statement about this condition.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-07%20164436.jpg\" width=\"642\" height=\"433\"></p>",
      "unique_key": "Q5319212",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D)</strong> <strong>Mortality is low</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This statement is incorrect. The condition shown in the image is likely Fournier’s gangrene, a life-threatening necrotizing fasciitis of the perineum and genital region.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Fournier’s gangrene has a <strong>high mortality</strong> rate (around 50%), especially in diabetic and immunocompromised patients, due to rapid spread of infection and sepsis if not treated promptly.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is caused by multiple organisms:</strong> Fournier’s gangrene is typically caused by polymicrobial infection, involving both aerobic and anaerobic bacteria. Common pathogens include E. coli, Klebsiella, Streptococci, and anaerobes like Bacteroides.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. The testis remains unaffected:</strong> The testis may often remain unaffected because its blood supply comes from the testicular artery, which is separate from the perineal tissues. This anatomical feature can protect the testes from necrosis even when the surrounding tissues are severely affected.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Surgical treatment is required in most cases:</strong> Surgical debridement is essential in most cases of Fournier’s gangrene to remove necrotic tissue and control the spread of infection. This treatment, along with broad-spectrum antibiotics, is critical for improving survival.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fournier’s gangrene is a rapidly progressing necrotizing infection of the perineal and genital area with high mortality.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It requires urgent surgical debridement and broad-spectrum antibiotics.</span></li><li><span style=\"font-size:14.0pt;\">Delay in treatment can result in a poor prognosis, particularly in diabetic and immunocompromised individuals.</span></li></ul>",
      "correct_choice_id": 346427,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86985/FMGE_SURGERY_MOCK_2_Q_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86985/FMGE_SURGERY_MOCK_2_Q_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98523,
      "choices": [
        {
          "id": 392120,
          "text": "<p><span style=\"font-size:14.0pt;\">Localized Type I reaction with eosinophilic inflammation</span></p>"
        },
        {
          "id": 392121,
          "text": "<p><span style=\"font-size:14.0pt;\">Localized Type III reaction due to deposition of immune complexes in alveoli</span></p>"
        },
        {
          "id": 392122,
          "text": "<p><span style=\"font-size:14.0pt;\">Systemic Type II reaction with complement-mediated lysis</span></p>"
        },
        {
          "id": 392123,
          "text": "<p><span style=\"font-size:14.0pt;\">Type IV delayed-type reaction involving Th1 lymphocytes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old bird breeder develops cough, dyspnea, and malaise several hours after cleaning bird cages. Chest imaging reveals diffuse infiltrates. This condition represents which type and mechanism of hypersensitivity reaction?</span></p>",
      "unique_key": "Q6085959",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Localized Type III reaction due to deposition of immune complexes in alveoli</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient’s presentation is characteristic of <strong>Bird Fancier’s Lung (Hypersensitivity Pneumonitis)</strong>, a <strong>localized Type III hypersensitivity reaction</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The pathogenesis involves <strong>inhalation of avian antigens</strong>, which combine with preformed <strong>IgG antibodies</strong> in the alveolar walls.</span></li><li><span style=\"font-size:14.0pt;\">These antigen–antibody complexes trigger <strong>complement activation</strong>, leading to the recruitment of <strong>neutrophils</strong> and release of inflammatory mediators.</span></li><li><span style=\"font-size:14.0pt;\">The result is <strong>immune complex–mediated alveolitis</strong>, manifesting as cough, dyspnea, fever, and diffuse infiltrates on imaging.</span></li><li><span style=\"font-size:14.0pt;\">This condition represents a <strong>localized (Arthus-type) Type III reaction</strong>, as immune complexes form and deposit directly at the site of antigen exposure (lungs).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Localized Type I reaction with eosinophilic inflammation:&nbsp;</strong>Incorrect. Type I hypersensitivity is <strong>IgE-mediated</strong> and involves <strong>mast cell degranulation</strong>, producing immediate allergic responses such as asthma, urticaria, or anaphylaxis. Bird Fancier’s lung develops <strong>hours after exposure</strong>, consistent with immune complex deposition, not IgE-mediated inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Systemic Type II reaction with complement-mediated lysis:&nbsp;</strong>Incorrect. Type II hypersensitivity involves <strong>antibody binding to cell-surface antigens</strong> and subsequent <strong>cell lysis or phagocytosis</strong> (e.g., autoimmune hemolytic anemia). Bird Fancier’s lung involves soluble antigen–antibody complexes, not antibody-mediated cytotoxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Type IV delayed-type reaction involving Th1 lymphocytes:&nbsp;</strong>Incorrect. Type IV reactions are <strong>cell-mediated</strong> and typically occur <strong>48–72 hours post-exposure</strong>, as seen in <strong>tuberculin skin test or contact dermatitis</strong>. Bird Fancier’s lung occurs within <strong>hours</strong> and is mediated by immune complexes, not T cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Bird Fancier’s Lung (Hypersensitivity Pneumonitis)</strong> is a <strong>localized Type III hypersensitivity reaction</strong> caused by deposition of <strong>antigen–antibody immune complexes</strong> in alveolar walls following inhalation of organic antigens.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This leads to complement activation, neutrophilic inflammation, and subsequent tissue injury.</span></li></ul>",
      "correct_choice_id": 392121,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98523/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98523/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98552,
      "choices": [
        {
          "id": 392236,
          "text": "<p><span style=\"font-size:14.0pt;\">Neurocysticercosis</span></p>"
        },
        {
          "id": 392237,
          "text": "<p><span style=\"font-size:14.0pt;\">Tuberculoma</span></p>"
        },
        {
          "id": 392238,
          "text": "<p><span style=\"font-size:14.0pt;\">Glioblastoma multiforme</span></p>"
        },
        {
          "id": 392239,
          "text": "<p><span style=\"font-size:14.0pt;\">Brain abscess</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32‑year‑old man presents with new‑onset seizures. MRI shows a ring‑enhancing lesion in the parietal lobe. MR spectroscopy reveals a prominent lipid‑lactate peak with reduced N‑acetylaspartate (NAA), as shown in the image. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_BQu7D6b.png\" width=\"291\" height=\"277\"></span></p>",
      "unique_key": "Q7786681",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Tuberculoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Magnetic Resonance Spectroscopy (MRS)</strong> evaluates brain metabolites before structural changes become apparent.</span></li><li><span style=\"font-size:14.0pt;\">Key metabolites include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>N‑acetylaspartate (NAA)</strong> → neuronal marker (↓ in neuronal loss)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Choline (Cho)</strong> → cell membrane turnover (↑ in neoplasms)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Creatine (Cr)</strong> → energy metabolism (relatively stable)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Lipid–lactate peaks</strong> → indicate necrosis or anaerobic metabolism</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In <strong>tuberculoma</strong>, caseous necrosis produces <strong>prominent lipid peaks</strong> (due to breakdown of mycobacterial and host lipids), accompanied by <strong>decreased NAA</strong> (neuronal destruction).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This MRS pattern differentiates tuberculoma from other ring‑enhancing lesions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Neurocysticercosis:&nbsp;</strong>Lipid peaks are absent in neurocysticercosis since there’s no caseous necrosis; spectroscopy findings are usually normal or nonspecific.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Glioblastoma Multiforme:&nbsp;</strong>Shows high choline from active cell proliferation but lacks the prominent lipid-lactate peak seen with necrotic infections like tuberculoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Brain Abscess:&nbsp;</strong>Displays amino acid and lactate peaks from bacterial metabolism rather than the lipid peaks typical of caseous necrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Lipid peaks</strong> on MRS are a hallmark of <strong>tuberculoma</strong> due to caseous necrosis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>NAA decrease</strong> = neuronal loss; <strong>choline increase</strong> = cellular proliferation.</span></li><li><span style=\"font-size:14.0pt;\">MR spectroscopy helps differentiate <strong>infective lesions</strong> (tuberculoma, abscess) from <strong>neoplastic</strong> or <strong>parasitic</strong> causes.</span></li></ul>",
      "correct_choice_id": 392237,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98552/INI-NEET_-_GT__27th_Nov_2025_Radiology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98552/INI-NEET_-_GT__27th_Nov_2025_Radiology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98804,
      "choices": [
        {
          "id": 393228,
          "text": "<p><span style=\"font-size:14.0pt;\">Raloxifene</span></p>"
        },
        {
          "id": 393229,
          "text": "<p><span style=\"font-size:14.0pt;\">Tamoxifen</span></p>"
        },
        {
          "id": 393230,
          "text": "<p><span style=\"font-size:14.0pt;\">Fulvestrant</span></p>"
        },
        {
          "id": 393231,
          "text": "<p><span style=\"font-size:14.0pt;\">Tibolone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old woman with hormone receptor-positive metastatic breast cancer has progressed despite prior tamoxifen therapy. Her oncologist initiates a new IM therapy that acts by downregulation of estrogen receptors. Which drug is most appropriate?</span></p>",
      "unique_key": "Q4623836",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Fulvestrant</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Fulvestrant</strong> is a <strong>Selective Estrogen Receptor Downregulator (SERD)</strong> and the drug of choice in <strong>tamoxifen-resistant hormone receptor-positive metastatic breast cancer</strong> in postmenopausal women.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Unlike SERMs, which can have mixed agonist/antagonist actions, fulvestrant is a <strong>pure estrogen receptor antagonist</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mechanism of action:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Binds estrogen receptors (ER) with <strong>&gt;100x affinity than tamoxifen</strong></span></li><li><span style=\"font-size:14.0pt;\">Prevents ER dimerization</span></li><li><span style=\"font-size:14.0pt;\">Promotes <strong>receptor degradation</strong></span></li><li><span style=\"font-size:14.0pt;\">Leads to <strong>complete suppression</strong> of estrogen-driven transcription</span></li></ul></li><li><span style=\"font-size:14.0pt;\">It is administered as a <strong>monthly intramuscular injection</strong>, with a relatively favorable safety profile.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Raloxifene</strong>: A SERM used for <strong>osteoporosis prevention</strong> and <strong>breast cancer prophylaxis</strong> in high-risk women, but not effective for treating <strong>metastatic breast cancer</strong>, especially after tamoxifen failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Tamoxifen</strong>: Already failed in this patient. While it is a mainstay SERM for ER+ breast cancer, resistance can develop, making it <strong>ineffective in progressive disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Tibolone</strong>: A <strong>Selective Tissue Estrogen Activity Regulator (STEAR)</strong> used in <strong>menopausal symptom relief</strong> and <strong>osteoporosis</strong>, but has <strong>no role in breast cancer therapy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Fulvestrant</strong> is a <strong>pure estrogen receptor antagonist</strong> (SERD) used in <strong>postmenopausal women with tamoxifen-resistant, hormone receptor-positive metastatic breast cancer</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It works by <strong>downregulating and degrading ERs</strong>, offering efficacy where SERMs fail.</span></li></ul>",
      "correct_choice_id": 393230,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98804/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98804/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98393,
      "choices": [
        {
          "id": 391604,
          "text": "<p><span style=\"font-size:14.0pt;\">High protein diet with 4-5 gm/kg/day protein immediately</span></p>"
        },
        {
          "id": 391605,
          "text": "<p><span style=\"font-size:14.0pt;\">F-75 formula followed by F-100 formula in stabilization phase</span></p>"
        },
        {
          "id": 391606,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravenous albumin infusion to correct hypoproteinemia</span></p>"
        },
        {
          "id": 391607,
          "text": "<p><span style=\"font-size:14.0pt;\">Iron and folic acid supplementation as primary intervention</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3-year-old child admitted to Nutrition Rehabilitation Centre with severe acute malnutrition shows bilateral pitting edema, apathy, and growth retardation. What is the most appropriate initial therapeutic approach?</span></p>",
      "unique_key": "Q3466665",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) F-75 formula followed by F-100 formula in stabilization phase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to WHO guidelines for management of severe acute malnutrition, the initial stabilization phase requires careful nutritional rehabilitation using F-75 formula (75 kcal/100ml) which provides controlled energy and protein intake.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This prevents refeeding syndrome and allows gradual metabolic adaptation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">F-100 formula is introduced later in the rehabilitation phase once the child is stabilized.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. High protein diet with 4-5 gm/kg/day protein immediately:</strong> High protein diet immediately can precipitate refeeding syndrome and worsen the condition due to metabolic complications</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Intravenous albumin infusion to correct hypoproteinemia:</strong> IV albumin is contraindicated in SAM as it can cause fluid overload and heart failure in these vulnerable children</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Iron and folic acid supplementation as primary intervention:</strong> While micronutrient supplementation is important, it is not the primary initial intervention; nutritional rehabilitation takes precedence</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">F-75 formula is the standard initial treatment for severe acute malnutrition in Nutrition Rehabilitation Centres</span></li><li><span style=\"font-size:14.0pt;\">Gradual nutritional rehabilitation prevents refeeding syndrome complications</span></li><li><span style=\"font-size:14.0pt;\">High protein intake should be avoided initially in severely malnourished children</span></li></ul>",
      "correct_choice_id": 391605,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98393/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98393/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98358,
      "choices": [
        {
          "id": 391464,
          "text": "<p><span style=\"font-size:14.0pt;\">Nail pitting commonly seen</span></p>"
        },
        {
          "id": 391465,
          "text": "<p><span style=\"font-size:14.0pt;\">Pterygium of nails</span></p>"
        },
        {
          "id": 391466,
          "text": "<p><span style=\"font-size:14.0pt;\">Islands of sparing over the body</span></p>"
        },
        {
          "id": 391467,
          "text": "<p><span style=\"font-size:14.0pt;\">Herald patch</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man presents to the dermatology outpatient department with gradual thickening of palms and soles and dry scaly plaques over his trunk. Based on these findings, which of the following features is most likely to be found in this patient?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XJQLISl.png\" width=\"448\" height=\"295\"></p>",
      "unique_key": "Q5440723",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Islands of sparing over the body</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pityriasis rubra pilaris (PRP)</strong> is a <strong>chronic papulosquamous disorder</strong> characterized by:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Salmon-red or orange-red scaly plaques</strong>, often beginning on the <strong>trunk</strong> and spreading to involve the extremities.</span></li><li><span style=\"font-size:14.0pt;\">The plaques often <strong>coalesce</strong>, but <strong>patches of normal skin (islands of sparing)</strong> remain between affected areas — a <strong>hallmark feature</strong> of PRP.</span></li><li><span style=\"font-size:14.0pt;\">There is frequently <strong>palmoplantar keratoderma</strong> (thickening of palms and soles).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The disease is due to <strong>abnormal keratinization</strong> and typically affects adults in an insidious pattern.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Nail pitting commonly seen:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Typical of <strong>psoriasis</strong>, not PRP.</span></li><li><span style=\"font-size:14.0pt;\">Results from defective keratinization of nail plate matrix.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pterygium of nails:</strong> Seen in <strong>lichen planus</strong>, due to adhesion between the proximal nail fold and nail bed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Herald patch: </strong>Seen in <strong>pityriasis rosea</strong>, presenting as a single large “herald” lesion followed by smaller secondary eruptions in a Christmas-tree pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pityriasis rubra pilaris</strong> presents with <strong>salmon-red scaly plaques</strong>, <strong>palmoplantar keratoderma</strong>, and <strong>“islands of sparing”</strong> — characteristic areas of normal skin amidst diffuse erythema.</span></p>",
      "correct_choice_id": 391466,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98358/INI-NEET_-_GT__27th_Nov_2025_Derma_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98358/INI-NEET_-_GT__27th_Nov_2025_Derma_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 86992,
      "choices": [
        {
          "id": 346452,
          "text": "<p><span style=\"font-size:14.0pt;\">Hemorrhoids</span></p>"
        },
        {
          "id": 346453,
          "text": "<p><span style=\"font-size:14.0pt;\">Fissure in ano</span></p>"
        },
        {
          "id": 346454,
          "text": "<p><span style=\"font-size:14.0pt;\">Fistula in ano</span></p>"
        },
        {
          "id": 346455,
          "text": "<p><span style=\"font-size:14.0pt;\">Anal canal cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presents with painless PR (per rectal) bleed during defecation. The following is seen on proctoscopy. What is the likely diagnosis?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-07%20164044.jpg\" width=\"628\" height=\"448\"></p>",
      "unique_key": "Q1968692",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Hemorrhoids</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The image shown on proctoscopy displays hemorrhoids, which are enlarged vascular structures in the anal canal.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;Hemorrhoids are a common cause of painless rectal bleeding, especially during defecation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hemorrhoids are typically classified by grade:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Grade 1 and 2: </strong>These can often be managed with conservative measures such as sclerotherapy or rubber band ligation (banding).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Grade 3 and 4</strong>: For advanced hemorrhoids, treatment may require stapled hemorrhoidopexy or hemorrhoidectomy (such as the Milligan-Morgan procedure).</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Fissure in ano:</strong> Anal fissures usually cause severe pain during defecation and are associated with bright red blood on toilet paper or stool. They are typically seen as a tear in the anoderm and would not present as painless bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Fistula in ano:</strong> Anal fistulas are abnormal connections between the anal canal and the perianal skin, often presenting with discharge or infection rather than painless bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Anal canal cancer:</strong> Anal canal cancer can cause bleeding, but it is usually associated with other symptoms such as pain, a mass, or changes in bowel habits. The appearance on proctoscopy is different from hemorrhoids and would typically require a biopsy for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hemorrhoids are a common cause of painless rectal bleeding during defecation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They can be managed based on their grade, with lower grades treated by minimally invasive procedures like sclerotherapy or banding, and higher grades requiring surgical options like stapled hemorrhoidopexy or hemorrhoidectomy.</span></li></ul>",
      "correct_choice_id": 346452,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86992/FMGE_SURGERY_MOCK_2_Q_16_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86992/FMGE_SURGERY_MOCK_2_Q_16_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98528,
      "choices": [
        {
          "id": 392140,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 only</span></p>"
        },
        {
          "id": 392141,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 392142,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 392143,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 5 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following organisms are most commonly associated with the development of botryomycosis?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Staphylococcus aureus</span></li><li><span style=\"font-size:14.0pt;\">Staphylococcus albus</span></li><li><span style=\"font-size:14.0pt;\">Pseudomonas aeruginosa</span></li><li><span style=\"font-size:14.0pt;\">Streptococcus pneumoniae</span></li><li><span style=\"font-size:14.0pt;\">Streptococcus pyogenes</span></li></ol>",
      "unique_key": "Q3921082",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1 and 3 only</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Botryomycosis</strong> is a <strong>chronic granulomatous bacterial infection</strong> that clinically and histologically <strong>mimics actinomycosis</strong>, but it is <strong>non-fungal and non-actinomycotic</strong> in origin.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>most common etiologic agent</strong> is <strong>Staphylococcus aureus</strong> (in about 80% of cases).</span></li><li><span style=\"font-size:14.0pt;\">Other bacteria occasionally implicated include <strong>Pseudomonas aeruginosa, Escherichia coli, Proteus, and Streptococcus species.</strong></span></li><li><span style=\"font-size:14.0pt;\">It usually follows <strong>local trauma, surgical procedures, or chronic infection</strong> and can involve <strong>skin, subcutaneous tissue, or viscera (especially lungs and liver).</strong></span></li><li><span style=\"font-size:14.0pt;\">Histologically, it shows <strong>granules composed of bacterial colonies surrounded by eosinophilic material</strong> (Splendore–Hoeppli phenomenon).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Staphylococcus albus:</strong> Older term for Staphylococcus epidermidis; rarely associated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Streptococcus pneumonia:</strong> Causes lobar pneumonia; not linked to botryomycosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5. Streptococcus pyogenes:</strong> May cause soft-tissue infections but not chronic granulomatous lesions of botryomycosis type.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Botryomycosis</strong> is a <strong>granulomatous bacterial infection</strong>, most frequently due to <strong>Staphylococcus aureus</strong>, and less commonly <strong>Pseudomonas aeruginosa</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It can mimic <strong>actinomycosis</strong> but is caused by <strong>true bacteria</strong>, not filamentous organisms.</span></li></ul>",
      "correct_choice_id": 392141,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98528/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98528/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98399,
      "choices": [
        {
          "id": 391628,
          "text": "<p><span style=\"font-size:14.0pt;\">During the susceptibility phase before exposure</span></p>"
        },
        {
          "id": 391629,
          "text": "<p><span style=\"font-size:14.0pt;\">During the subclinical disease phase before symptoms appear</span></p>"
        },
        {
          "id": 391630,
          "text": "<p><span style=\"font-size:14.0pt;\">During the clinical disease phase after symptom onset</span></p>"
        },
        {
          "id": 391631,
          "text": "<p><span style=\"font-size:14.0pt;\">During the outcome phase after disease resolution</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The image shows the natural history of disease model. At which stage shown in the diagram would secondary prevention measures be most effectively implemented?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_nWbt97O.png\" width=\"954\" height=\"401\"></span></p>",
      "unique_key": "Q2040687",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) During the subclinical disease phase before symptoms appear</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Secondary prevention aims to detect and treat disease in its early stages before symptoms develop, thereby preventing progression to clinical disease.</span></li><li><span style=\"font-size:14.0pt;\">This is most effectively implemented during the subclinical disease phase when pathological changes have begun but clinical manifestations have not yet appeared.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. During the susceptibility phase before exposure:</strong> This represents primary prevention, which aims to prevent disease occurrence before the pathological process begins</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. During the clinical disease phase after symptom onset:</strong> This represents early tertiary prevention or treatment phase, when disease is already clinically manifest</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. During the outcome phase after disease resolution:</strong> This represents tertiary prevention or rehabilitation phase, focusing on preventing complications and disability</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Secondary prevention targets the subclinical phase of disease when pathological changes exist but symptoms haven't appeared</span></li><li><span style=\"font-size:14.0pt;\">The natural history model helps identify optimal intervention points for different levels of prevention</span></li></ul>",
      "correct_choice_id": 391629,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98399/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98399/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98606,
      "choices": [
        {
          "id": 392444,
          "text": "<p><span style=\"font-size:14.0pt;\">Urine protein-to-creatinine ratio (UPCR)</span></p>"
        },
        {
          "id": 392445,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum albumin level</span></p>"
        },
        {
          "id": 392446,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum cholesterol level</span></p>"
        },
        {
          "id": 392447,
          "text": "<p><span style=\"font-size:14.0pt;\">Documentation of edema</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3-year-old boy presents with periorbital edema most noticeable in the morning and decreased urine output. Laboratory investigations show frothy urine. His mother mentions that his face appears puffy, especially after waking up. Lab investigations are attached. Which of the following is the most appropriate investigation to confirm the suspected diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TDqidTb.png\" width=\"1050\" height=\"498\"></span></p>",
      "unique_key": "Q1820103",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Urine protein-to-creatinine ratio (UPCR)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Urine protein-to-creatinine ratio (UPCR) is the most appropriate initial investigation for a child presenting with periorbital edema and decreased urine output, which are classic symptoms of nephrotic syndrome.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">UPCR provides a quantitative assessment of proteinuria using a spot urine sample.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In children with suspected nephrotic syndrome, demonstrating significant proteinuria is the first diagnostic step, as it is the primary pathophysiologic abnormality that leads to other manifestations such as hypoalbuminemia, edema.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A UPCR value &gt;2.0 mg/mg indicates nephrotic-range proteinuria, which is sufficient to establish this critical diagnostic criterion without requiring a cumbersome 24-hour urine collection that is difficult to obtain accurately in young children.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Serum albumin level:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While hypoalbuminemia (&lt;3 g/dL) is a hallmark of nephrotic syndrome, it is secondary to urinary protein loss</span></li><li><span style=\"font-size:14.0pt;\">This would typically be ordered after confirming proteinuria</span></li><li><span style=\"font-size:14.0pt;\">It helps confirm the diagnosis but is not the most appropriate initial test</span></li><li><span style=\"font-size:14.0pt;\">Cannot distinguish between nephrotic syndrome and other causes of hypoalbuminemia (like liver disease or malnutrition) without first establishing proteinuria</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Serum cholesterol level:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hyperlipidemia is a secondary finding in nephrotic syndrome, not the primary abnormality</span></li><li><span style=\"font-size:14.0pt;\">Elevated cholesterol develops as a consequence of hypoalbuminemia and altered lipoprotein metabolism</span></li><li><span style=\"font-size:14.0pt;\">Less specific than proteinuria for the diagnosis</span></li><li><span style=\"font-size:14.0pt;\">Would typically be ordered as part of the comprehensive evaluation after proteinuria is confirmed</span></li><li><span style=\"font-size:14.0pt;\">Can be elevated in many other conditions beyond kidney disease</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Documentation of edema:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This represents a clinical finding rather than a laboratory investigation</span></li><li><span style=\"font-size:14.0pt;\">Edema is already evident in the history (periorbital edema)</span></li><li><span style=\"font-size:14.0pt;\">Cannot distinguish between nephrotic syndrome and other causes of edema</span></li><li><span style=\"font-size:14.0pt;\">While important to document, this does not provide objective evidence of kidney dysfunction</span></li><li><span style=\"font-size:14.0pt;\">May be influenced by position and time of day, making it variable</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a child with suspected nephrotic syndrome, always begin the diagnostic evaluation with assessment of proteinuria (UPCR) as it is the primary abnormality.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The classic tetrad of nephrotic syndrome includes:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XuXoRCu.png\" width=\"399\" height=\"253\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">UPCR offers significant advantages over 24-hour urine collection in pediatric patients, providing reliable results with a single spot sample.</span></li></ul>",
      "correct_choice_id": 392444,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98606/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98606/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98397,
      "choices": [
        {
          "id": 391620,
          "text": "<p><span style=\"font-size:14.0pt;\">Collaborating with traditional healers to integrate ORS use alongside their herbal treatments as complementary therapy</span></p>"
        },
        {
          "id": 391621,
          "text": "<p><span style=\"font-size:14.0pt;\">Intensively replacing traditional beliefs with scientific explanations about diarrhea causation through health education campaigns</span></p>"
        },
        {
          "id": 391622,
          "text": "<p><span style=\"font-size:14.0pt;\">Using local dialect and incorporating familiar cultural metaphors to explain how ORS works in the body</span></p>"
        },
        {
          "id": 391623,
          "text": "<p><span style=\"font-size:14.0pt;\">Training community health workers from the same tribe to demonstrate ORS preparation using culturally appropriate teaching methods</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a remote tribal area of Jharkhand where the community believes that diarrheal diseases in children are caused by \"evil eye\" and traditional healers use herbal concoctions a medical officer needs to implement an oral rehydration therapy (ORT) program. All of the following are appropriate health communication strategies that should be employed in this scenario except:</span></p>",
      "unique_key": "Q6085139",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Intensively replacing traditional beliefs with scientific explanations about diarrhea causation through health education campaigns</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Represents a confrontational approach that directly challenges deeply held cultural beliefs, which is counterproductive in health communication.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This approach often leads to resistance, mistrust, and poor program acceptance.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Effective health communication in tribal communities requires cultural competence, collaboration with traditional systems, and gradual integration rather than replacement of beliefs.</span></li><li><span style=\"font-size:14.0pt;\">The incorrect traditional beliefs should be gradually replaced by the correct scientific explanations – should not be replaced intensively/aggressively – the population may not accept it.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Collaborating with traditional healers to integrate ORS use alongside their herbal treatments as complementary therapy:</strong> This collaborative approach respects cultural beliefs while introducing modern treatment, leading to better acceptance and compliance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Using local dialect and incorporating familiar cultural metaphors to explain how ORS works in the body:</strong> Using local language and cultural metaphors enhances understanding and makes health messages more relatable and acceptable.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Training community health workers from the same tribe to demonstrate ORS preparation using culturally appropriate teaching methods:</strong> Training community members as health workers ensures cultural appropriateness and builds trust within the community.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Health communication in tribal areas requires cultural sensitivity and collaborative approaches rather than confrontational replacement of traditional beliefs</span></li><li><span style=\"font-size:14.0pt;\">Integration of traditional and modern medical systems often yields better health outcomes than complete replacement strategies</span></li><li><span style=\"font-size:14.0pt;\">Community participation and use of local resources are essential for successful health communication programs in remote areas</span></li></ul>",
      "correct_choice_id": 391621,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98397/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98397/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98242,
      "choices": [
        {
          "id": 391000,
          "text": "<p><span style=\"font-size:14.0pt;\">Lateral cricoarytenoid&nbsp;</span></p>"
        },
        {
          "id": 391001,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior cricoarytenoid&nbsp;</span></p>"
        },
        {
          "id": 391002,
          "text": "<p><span style=\"font-size:14.0pt;\">Thyroarytenoid&nbsp;</span></p>"
        },
        {
          "id": 391003,
          "text": "<p><span style=\"font-size:14.0pt;\">Cricothyroid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presents with hoarseness following thyroid surgery. Laryngoscopy reveals that the left vocal cord is in the paramedian position and does not abduct during inspiration. Which muscle's paralysis is responsible for the inability to abduct the vocal cord?</span></p>",
      "unique_key": "Q9285045",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Posterior cricoarytenoid</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>posterior cricoarytenoid</strong> is the <strong>only abductor of the vocal cords</strong> and is known as the \"safety muscle of the larynx.\"&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is supplied by the recurrent laryngeal nerve.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">When this muscle is paralyzed due to recurrent laryngeal nerve injury (common during thyroid surgery), the vocal cord cannot abduct and remains in a paramedian position.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This results in hoarseness and potentially respiratory distress if bilateral.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">All other intrinsic laryngeal muscles either adduct, tense, or relax the vocal cords.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-18%20111352.jpg\" width=\"647\" height=\"363\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lateral cricoarytenoid</strong>: This is incorrect. The lateral cricoarytenoid muscle is an adductor of the vocal cords, not an abductor. Its paralysis would affect vocal cord adduction, not the abduction that is impaired in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Thyroarytenoid:</strong> This is incorrect. The thyroarytenoid muscle functions to relax the vocal cords and contributes to adduction. It does not abduct the vocal cords, so its paralysis wouldn't prevent abduction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cricothyroid:</strong> This is incorrect. The cricothyroid muscle tenses the vocal cords and is the only intrinsic laryngeal muscle supplied by the external laryngeal nerve, not the recurrent laryngeal nerve. It doesn't abduct the vocal cords.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The posterior cricoarytenoid is the sole abductor of vocal cords (\"safety muscle of larynx\") and its paralysis from recurrent laryngeal nerve injury causes the vocal cord to remain in paramedian position.</span></p>",
      "correct_choice_id": 391001,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98242/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98242/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98250,
      "choices": [
        {
          "id": 391032,
          "text": "<p><span style=\"font-size:14.0pt;\">Median nerve compression at the carpal tunnel</span></p>"
        },
        {
          "id": 391033,
          "text": "<p><span style=\"font-size:14.0pt;\">Combined median and ulnar nerve injury at the wrist</span></p>"
        },
        {
          "id": 391034,
          "text": "<p><span style=\"font-size:14.0pt;\">Lower trunk injury at the thoracic outlet</span></p>"
        },
        {
          "id": 391035,
          "text": "<p><span style=\"font-size:14.0pt;\">Ulnar nerve compression at Guyon’s canal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman, a pianist, reports progressive weakness and numbness in her right hand for 3 months, with difficulty performing fine finger movements and flattening of the hand. Examination reveals wasting of the hypothenar and interossei muscles, clawing of the ring and little fingers, and sensory loss over the medial one and a half fingers on both palmar and dorsal surfaces, while dorsal hand sensation is preserved. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q5212174",
      "difficulty_level": "intermediate",
      "solution": "<p style=\"margin-left:0in;\"><span style=\"font-size:14.0pt;\"><strong>Ans. D) Ulnar nerve compression at Guyon’s canal</strong></span></p><p style=\"margin-left:0in;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>ulnar nerve</strong> supplies the <strong>hypothenar muscles</strong>, <strong>interossei</strong>, <strong>adductor pollicis</strong>, and the <strong>medial two lumbricals</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It also provides <strong>sensation</strong> to the <strong>medial one and a half fingers</strong> on both the <strong>palmar and dorsal aspects</strong> of the hand.</span></li><li><span style=\"font-size:14.0pt;\">Compression of the <strong>ulnar nerve in Guyon’s canal</strong> (a fibro-osseous tunnel at the wrist between the <strong>pisiform</strong> and <strong>hook of hamate</strong>) leads to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Motor deficits:</strong> Weakness or wasting of <strong>interossei</strong> and <strong>hypothenar muscles</strong>, causing <strong>flattening of the hand</strong> and <strong>clawing of the 4th and 5th fingers</strong> (due to unopposed action of the long finger flexors).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Sensory loss:</strong> Over the <strong>palmar</strong> and <strong>distal dorsal surfaces</strong> of the <strong>little finger and medial half of the ring finger</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Preserved dorsal hand sensation:</strong> Because the <strong>dorsal cutaneous branch</strong> of the ulnar nerve branches <strong>proximal to Guyon’s canal</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This constellation of findings is <strong>characteristic of ulnar nerve compression at Guyon’s canal</strong> (also called <strong>ulnar tunnel syndrome</strong>).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-18%20111519.jpg\" width=\"558\" height=\"704\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Median nerve compression at the carpal tunnel:&nbsp;</strong>Incorrect. Causes <strong>thenar muscle wasting</strong> and <strong>sensory loss over the lateral 3½ digits</strong>, not the medial side.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Combined median and ulnar nerve injury at the wrist:&nbsp;</strong>Incorrect. Would cause <strong>loss of both thenar and hypothenar functions</strong> with <strong>global sensory loss</strong>, not the selective pattern seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lower trunk injury at the thoracic outlet:&nbsp;</strong>Incorrect. Leads to <strong>Klumpke’s palsy</strong> involving both <strong>median and ulnar nerves</strong>, with <strong>sensory loss along the medial arm and forearm</strong>, not limited to the hand.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Ulnar nerve compression at Guyon’s canal</strong> causes <strong>claw hand deformity</strong>, <strong>wasting of hypothenar and interossei muscles</strong>, and <strong>sensory loss over the medial one and a half fingers</strong>, with <strong>preserved dorsal sensation</strong> because the dorsal cutaneous branch arises <strong>proximal to the canal</strong>.</span></p>",
      "correct_choice_id": 391035,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98250/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98250/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98785,
      "choices": [
        {
          "id": 393152,
          "text": "<p><span style=\"font-size:14.0pt;\">Abdominal PET scan</span></p>"
        },
        {
          "id": 393153,
          "text": "<p><span style=\"font-size:14.0pt;\">Liver biopsy</span></p>"
        },
        {
          "id": 393154,
          "text": "<p><span style=\"font-size:14.0pt;\">Liver MRI</span></p>"
        },
        {
          "id": 393155,
          "text": "<p><span style=\"font-size:14.0pt;\">Repeat AFP level in 3 months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 53-year-old man with alcohol-induced cirrhosis undergoing routine ultrasound and AFP screening is found to have a new suspicious liver lesion with no change in AFP. What is the next best diagnostic step?</span></p>",
      "unique_key": "Q8541793",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Liver MRI</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In cirrhotic patients, a new liver lesion detected on surveillance ultrasound should be further evaluated with liver MRI with contrast (or multiphase CT), as this imaging modality is highly sensitive for detecting HCC and is preferred for noninvasive diagnosis.​</span></li><li><span style=\"font-size:14.0pt;\">MRI can identify the arterial enhancement and venous/delayed washout typical of HCC and is diagnostic for most cases without a need for biopsy.</span></li><li><span style=\"font-size:14.0pt;\">AFP levels are neither sensitive nor specific and should not delay definitive imaging work-up when a suspicious lesion is present.</span></li><li><span style=\"font-size:14.0pt;\">PET scan is not standard for initial diagnosis of HCC due to limited sensitivity.</span></li><li><span style=\"font-size:14.0pt;\">Liver biopsy may be reserved for indeterminate imaging findings but is generally not the first step if high-quality MRI or CT can provide a diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2S2dyOF.png\" width=\"730\" height=\"306\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Abdominal PET scan:</strong> Abdominal PET scan is not recommended for initial diagnosis of HCC.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. Liver biopsy:</strong> Liver biopsy is not the initial step; imaging is diagnostic in most cirrhosis cases and avoids biopsy risks.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D. Repeat AFP level in 3 months:&nbsp;</strong>Repeat AFP is not helpful for immediate decision-making; imaging should proceed promptly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">For patients with cirrhosis and a newly detected liver lesion on ultrasound, the preferred next investigation is contrast-enhanced MRI, which has the highest sensitivity and specificity for HCC and minimizes the need for invasive procedures.</span></p>",
      "correct_choice_id": 393154,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98785/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98785/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 87001,
      "choices": [
        {
          "id": 346488,
          "text": "<p><span style=\"font-size:14.0pt;\">More than 40% of blood volume</span></p>"
        },
        {
          "id": 346489,
          "text": "<p><span style=\"font-size:14.0pt;\">Less than 15% of blood volume</span></p>"
        },
        {
          "id": 346490,
          "text": "<p><span style=\"font-size:14.0pt;\">Between 15% to 30% of blood volume</span></p>"
        },
        {
          "id": 346491,
          "text": "<p><span style=\"font-size:14.0pt;\">Between 30% to 40% of blood volume</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 44-year-old female presents to the emergency department after a motor vehicle accident. Her pulse rate is 80/minute, BP 120/84 mm of Hg, and she is hemodynamically stable. What is the approximate blood loss in this patient?</span></p>",
      "unique_key": "Q7118950",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Less than 15% of blood volume</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This patient’s <strong>normal hemodynamics</strong> suggests <strong>Class I hemorrhage (&lt;15% blood loss)</strong>, where compensatory mechanisms maintain hemodynamic stability.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hemorrhagic shock is classified into four classes</strong> based on blood loss percentage and clinical signs:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Class I:</strong> <strong>&lt;15% blood loss</strong>, normal/increased pulse pressure, normal BP.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Class II:</strong> <strong>15-30% blood loss</strong>, mild tachycardia, decreased pulse pressure.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Class III:</strong> <strong>30-40% blood loss</strong>, hypotension, confusion.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Class IV:</strong> <strong>&gt;40% blood loss</strong>, severe hypotension, lethargy.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Only in Class I hemorrhage are the vital parameters normal</strong>, whereas in <strong>other classes, they are deranged</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. More than 40% blood loss:</strong> Would result in <strong>severe hypotension, tachycardia &gt;140, confusion, and minimal urine output</strong>, which are not present here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Between 15-30% blood loss&nbsp;</strong>&amp;<strong> Option D. Between 30-40% blood loss:</strong> These would <strong>decrease pulse pressure</strong> and show signs of <strong>tachycardia, anxiety, or hypotension</strong>, none of which are seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Class I hemorrhage (&lt;15% blood loss) presents with pulse, normal blood pressure, and no significant hemodynamic compromise</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>higher classes of hemorrhagic shock</strong>, pulse increases<strong>, and hypotension develops</strong>.</span></li></ul>",
      "correct_choice_id": 346489,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87001/FMGE_SURGERY_MOCK_2_Q_21.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87001/FMGE_SURGERY_MOCK_2_Q_21.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98316,
      "choices": [
        {
          "id": 391296,
          "text": "<p><span style=\"font-size:14.0pt;\">Otitis externa</span></p>"
        },
        {
          "id": 391297,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute otitis media in the presuppuration stage</span></p>"
        },
        {
          "id": 391298,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic otitis media</span></p>"
        },
        {
          "id": 391299,
          "text": "<p><span style=\"font-size:14.0pt;\">Otitis media with effusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 5-year-old child presents with ear pain, fever, and a feeling of ear fullness. Otoscopic examination reveals a congested tympanic membrane with a specific appearance as shown in the image. What is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Ui6Tedt.png\" width=\"297\" height=\"183\"></span></p>",
      "unique_key": "Q5943329",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Acute otitis media in the presuppuration stage</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Acute otitis media (AOM)</strong> is a common condition in children characterized by bacterial or viral infection of the middle ear.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>presuppuration stage</strong> is the second stage of AOM and is identified by:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">A <strong>congested tympanic membrane</strong> with dilated radial blood vessels, producing the classic \"cartwheel appearance.\"</span></li><li><span style=\"font-size:14.0pt;\">Symptoms such as fever, ear pain, and a sensation of ear fullness.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This stage occurs before the tympanic membrane bulges or pus collects in the middle ear (suppuration stage).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Otitis externa:&nbsp;</strong>Otitis externa, also known as swimmer's ear, involves infection of the external auditory canal. It is associated with pain, tenderness on manipulation of the pinna, and canal swelling but does not produce a congested tympanic membrane or the cartwheel appearance.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-26%20102206.jpg\" width=\"1147\" height=\"584\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Chronic otitis media:&nbsp;</strong>Chronic otitis media typically presents with persistent ear discharge and tympanic membrane perforation. It does not show the acute findings or the cartwheel appearance seen in AOM.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-25%20130602.jpg\" width=\"418\" height=\"368\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Otitis media with effusion:&nbsp;</strong>Otitis media with effusion involves fluid in the middle ear without signs of infection, such as fever or pain. The tympanic membrane is often dull and retracted, without the congestion or cartwheel appearance seen in AOM.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-25%20130616.jpg\" width=\"563\" height=\"473\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The cartwheel appearance of the tympanic membrane is a hallmark of the presuppuration stage of acute otitis media, which presents with fever, ear pain, and a sensation of ear fullness.</span></p>",
      "correct_choice_id": 391297,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98316/INI-NEET_-_GT__27th_Nov_2025_NET_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98316/INI-NEET_-_GT__27th_Nov_2025_NET_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98607,
      "choices": [
        {
          "id": 392448,
          "text": "<p><span style=\"font-size:14.0pt;\">Child should be measured in Frankfurt plane with shoes on</span></p>"
        },
        {
          "id": 392449,
          "text": "<p><span style=\"font-size:14.0pt;\">Head, shoulders, buttocks, and heels should touch the wall with shoes removed</span></p>"
        },
        {
          "id": 392450,
          "text": "<p><span style=\"font-size:14.0pt;\">Child can be measured at any time of the day as height doesn't vary</span></p>"
        },
        {
          "id": 392451,
          "text": "<p><span style=\"font-size:14.0pt;\">Measurement can be taken with child looking down at examiner</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 5-year-old child needs height measurement as part of a comprehensive growth assessment in a pediatric clinic. The nurse is training a new staff member on proper anthropometric techniques. Which of the following describes the correct technique for measuring standing height?</span></p>",
      "unique_key": "Q8633232",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Head, shoulders, buttocks, and heels should touch the wall with shoes removed</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The correct technique for measuring standing height requires that the child stands with shoes and socks removed, with four points of contact against the vertical surface: the occiput (back of head), shoulders, buttocks, and heels.</span></li><li><span style=\"font-size:14.0pt;\">This position ensures proper body alignment for an accurate measurement. Additionally, the child's head should be positioned in the Frankfurt horizontal plane (where the line from the lower margin of the eye orbit to the upper margin of the ear canal is horizontal and parallel to the floor).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The measurement should be taken using a stadiometer, with the horizontal bar lowered to gently touch the crown of the head while maintaining the proper position.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This standardized approach minimizes variation and ensures accurate and reproducible measurements, which are crucial for growth assessment and monitoring.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:381/624;width:46.61%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4Wh7PYi.png\" width=\"381\" height=\"624\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Child should be measured in Frankfurt plane with shoes on:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While the Frankfurt plane is the correct head position, <strong>shoes must be removed</strong></span></li><li><span style=\"font-size:14.0pt;\">Shoes add variable height (1-3 cm) that significantly distorts measurement</span></li><li><span style=\"font-size:14.0pt;\">Different shoe types have different heights, introducing inconsistency</span></li><li><span style=\"font-size:14.0pt;\">Standardized protocols require bare feet to ensure measurement accuracy</span></li><li><span style=\"font-size:14.0pt;\">This violates a fundamental rule of anthropometric measurement</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Child can be measured at any time of the day as height doesn't vary:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is incorrect because <strong>height varies throughout the day</strong></span></li><li><span style=\"font-size:14.0pt;\">Maximum height occurs in the morning after lying supine overnight</span></li><li><span style=\"font-size:14.0pt;\">Height can decrease by 0.5-1 cm by evening due to compression of intervertebral discs</span></li><li><span style=\"font-size:14.0pt;\">For accurate tracking, measurements should ideally be taken at consistent times</span></li><li><span style=\"font-size:14.0pt;\">This diurnal variation is especially important when monitoring growth in children</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Measurement can be taken with child looking down at examiner:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This position violates the Frankfurt horizontal plane requirement</span></li><li><span style=\"font-size:14.0pt;\">Looking down causes <strong>flexion of the cervical spine</strong>, reducing measured height</span></li><li><span style=\"font-size:14.0pt;\">Proper head position is with eyes looking straight ahead</span></li><li><span style=\"font-size:14.0pt;\">Consistent head positioning is essential for reproducible measurements</span></li><li><span style=\"font-size:14.0pt;\">This error could lead to systematic underestimation of height</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Proper height measurement technique is critical for accurate growth assessment.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The \"four-point contact\" method (head, shoulders, buttocks, and heels touching the wall) with shoes removed, head in Frankfurt plane, and using a proper stadiometer represents the gold standard.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Consistency in technique is essential when monitoring a child's growth over time, as small measurement errors can lead to significant misinterpretations of growth patterns.</span></li><li><span style=\"font-size:14.0pt;\">The image illustrates proper height measurement technique with:</span><ol><li><span style=\"font-size:14.0pt;\">Child standing straight against wall/stadiometer</span></li><li><span style=\"font-size:14.0pt;\">Shoes and socks removed</span></li><li><span style=\"font-size:14.0pt;\">Four points of contact with wall</span></li><li><span style=\"font-size:14.0pt;\">Head in Frankfurt horizontal plane</span></li><li><span style=\"font-size:14.0pt;\">Stadiometer headpiece touching crown of head at 90° angle</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:376/703;width:35.83%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_0DBqcAZ.png\" width=\"376\" height=\"703\"></span></p>",
      "correct_choice_id": 392449,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98607/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98607/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98765,
      "choices": [
        {
          "id": 393076,
          "text": "<p><span style=\"font-size:14.0pt;\">Cavernous sinus thrombosis</span></p>"
        },
        {
          "id": 393077,
          "text": "<p><span style=\"font-size:14.0pt;\">Subarachnoid hemorrhage</span></p>"
        },
        {
          "id": 393078,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypertensive intracerebral hemorrhage</span></p>"
        },
        {
          "id": 393079,
          "text": "<p><span style=\"font-size:14.0pt;\">Cortical venous thrombosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 21-year-old woman presents with sudden, severe headache, nausea, vomiting, left-sided limb weakness, and a witnessed seizure two days ago. Contrast CT of the head is shown below. What is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_k34GOmw.png\" width=\"331\" height=\"331\"></span></p>",
      "unique_key": "Q1316068",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Cortical venous thrombosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The “empty delta sign” on contrast-enhanced CT is a classic finding indicating cerebral venous (sinus) thrombosis, reflecting a filling defect (thrombosed sinus) surrounded by enhancement of collateral veins.​</span></li><li><span style=\"font-size:14.0pt;\">Cortical venous thrombosis (also known as cerebral venous sinus thrombosis) can present with headache, seizures, focal neurologic deficits, and can produce hemorrhagic infarction due to impaired venous drainage.</span></li><li><span style=\"font-size:14.0pt;\">This condition is most commonly seen in young women and often misdiagnosed as arterial stroke or other intracranial hemorrhagic events.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Cavernous sinus thrombosis:</strong> Typically involves cranial neuropathies, orbital symptoms (proptosis, ophthalmoplegia), and is not associated with the empty delta sign.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. Subarachnoid hemorrhage:</strong> Presents with thunderclap headache but would not show the empty delta sign or large hemorrhagic infarcts in the temporoparietal region. The CT may show star of death appearance or diffuse presence of blood. The patient may also present with hydrocephalus.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C. Hypertensive intracerebral hemorrhage:&nbsp;</strong>Usually presents in older patients (&gt; 40 years) with long-standing hypertension, involves deep brain structures, and does not lead to the empty delta sign or the pattern described.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">The empty delta sign on CT with clinical features of headache and focal neurologic deficit strongly suggests cortical venous (sinus) thrombosis, a diagnosis that should be suspected in young patients presenting with atypical stroke-like syndromes and seizures.</span></p>",
      "correct_choice_id": 393079,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98765/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98765/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98396,
      "choices": [
        {
          "id": 391616,
          "text": "<p><span style=\"font-size:14.0pt;\">SRS</span></p>"
        },
        {
          "id": 391617,
          "text": "<p><span style=\"font-size:14.0pt;\">CRS</span></p>"
        },
        {
          "id": 391618,
          "text": "<p><span style=\"font-size:14.0pt;\">NFHS</span></p>"
        },
        {
          "id": 391619,
          "text": "<p><span style=\"font-size:14.0pt;\">AHS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which source provides the most reliable data for calculating age-specific fertility rates in India, considering the inherent limitations of routine data collection systems?</span></p>",
      "unique_key": "Q6979770",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) SRS</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Sample Registration System (SRS) provides the most reliable data for calculating age-specific fertility rates in India.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While CRS theoretically should be the gold standard, it suffers from significant under-registration (estimated 70-80% coverage for births).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">SRS uses a dual recording system with built-in verification mechanisms, making it more reliable for demographic parameters.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">NFHS provides periodic data but not continuous monitoring, and AHS has been discontinued.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. CRS:</strong> Civil Registration System (CRS) has massive under-registration issues, particularly in rural areas, making fertility rate calculations unreliable. This is a distractor option as it is more likely to be picked if the word “inherent limitations’ is missed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. NFHS:</strong> National Family Health Survey (NFHS) provides cross-sectional data every 4-5 years, not continuous vital statistics needed for annual fertility rates</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. AHS:</strong> Annual Health Survey (AHS) was discontinued after 2014 and covered only high-focus states, limiting its utility for national estimates&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">SRS uses dual recording system ensuring better data quality than single-source systems</span></li><li><span style=\"font-size:14.0pt;\">CRS under-registration remains a major challenge for vital statistics in India</span></li><li><span style=\"font-size:14.0pt;\">Sample-based systems often provide more reliable estimates than universal registration systems with poor coverage</span></li></ul>",
      "correct_choice_id": 391616,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98396/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98396/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98581,
      "choices": [
        {
          "id": 392348,
          "text": "<p><span style=\"font-size:14.0pt;\">Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</span></p>"
        },
        {
          "id": 392349,
          "text": "<p><span style=\"font-size:14.0pt;\">Ectopic ACTH production leading to Cushing’s syndrome</span></p>"
        },
        {
          "id": 392350,
          "text": "<p><span style=\"font-size:14.0pt;\">Lambert-Eaton myasthenic syndrome</span></p>"
        },
        {
          "id": 392351,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypercalcemia due to PTHrP secretion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man presents with progressive fatigue, unexplained weight loss, and new-onset muscle weakness in his lower limbs. He also reports occasional dizziness and episodes of flushing. On examination, he has a plethoric face and mild proximal muscle weakness. Laboratory investigations reveal: Hematocrit: 60%, Serum sodium: 124 mEq/L (↓), Serum potassium: 3.2 mEq/L (↓) and Serum calcium: 9.2 mg/dL (normal). Chest X-ray shows a central hilar mass. Biopsy image is shown below. Immunohistochemistry is positive for chromogranin A and synaptophysin. Which of the following paraneoplastic syndromes is not associated with this tumor?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_e0fvfH7.png\" width=\"373\" height=\"341\"></span></p>",
      "unique_key": "Q3328474",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Hypercalcemia due to PTHrP secretion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical, radiological, and histopathological features are consistent with Small Cell Carcinoma of the Lung (SCLC) - a highly malignant neuroendocrine tumor.</span></li><li><span style=\"font-size:14.0pt;\">Hypercalcemia due to PTHrP - PTHrP (parathyroid hormone–related peptide) secretion causes hypercalcemia in malignancy.</span></li><li><span style=\"font-size:14.0pt;\">Seen in: Squamous cell carcinoma of lung, breast, renal, and head/neck carcinomas.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Not&nbsp;</strong>typically seen in SCLC, which tends to cause hyponatremia or Cushing’s, not hypercalcemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Syndrome of inappropriate antidiuretic hormone secretion (SIADH):&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">SCLC often secretes ADH ectopically, leading to SIADH.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Manifestations:</strong> hyponatremia, low serum osmolality, and confusion or seizures.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong> inappropriate water retention without volume expansion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Ectopic ACTH production leading to Cushing’s syndrome:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">SCLC may produce ACTH, leading to paraneoplastic Cushing’s syndrome. Lab findings: high cortisol, hypokalemic alkalosis, hyperglycemia.</span></li><li><span style=\"font-size:14.0pt;\">Mechanism: ectopic ACTH → bilateral adrenal hyperplasia→ Explains this patient’s low potassium and weakness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lambert-Eaton myasthenic syndrome:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Caused by autoantibodies against presynaptic voltage-gated calcium channels. Presents with proximal muscle weakness that improves with activity (unlike myasthenia gravis). Strongly associated with SCLC.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Paraneoplastic syndrome in SCLC:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_3l5fCJe.png\" width=\"759\" height=\"522\"></span></p>",
      "correct_choice_id": 392351,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98581/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98581/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98553,
      "choices": [
        {
          "id": 392240,
          "text": "<p><span style=\"font-size:14.0pt;\">Medulloblastoma</span></p>"
        },
        {
          "id": 392241,
          "text": "<p><span style=\"font-size:14.0pt;\">Ependymoma</span></p>"
        },
        {
          "id": 392242,
          "text": "<p><span style=\"font-size:14.0pt;\">Pilocytic Astrocytoma</span></p>"
        },
        {
          "id": 392243,
          "text": "<p><span style=\"font-size:14.0pt;\">Hemangioblastoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10‑year‑old child presents with progressively worsening headaches and vomiting. MRI of the brain, as shown in the image, demonstrates a cystic lesion with an enhancing mural nodule in the cerebellum. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_FcNSCTo.png\" width=\"314\" height=\"369\"></span></p>",
      "unique_key": "Q3099298",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Pilocytic Astrocytoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pilocytic Astrocytoma</strong> is a <strong>WHO Grade I tumor</strong>, commonly seen in children and young adults.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Classic MRI findings</strong>: A <strong>cystic lesion</strong> with an <strong>enhancing mural nodule</strong> (as seen in the image). Importantly, the <strong>cyst wall does not enhance</strong>, distinguishing it from other tumors.</span></li><li><span style=\"font-size:14.0pt;\">Commonly found in the <strong>cerebellum</strong> and often <strong>associated with NF-1</strong> when optic pathway gliomas are seen.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Medulloblastoma</strong>: Typically appears as a <strong>midline cerebellar mass</strong> in children, but is <strong>solid</strong>, not cystic with mural nodules. Often shows <strong>restricted diffusion</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ependymoma</strong>: Arises from the <strong>fourth ventricle</strong>, often shows <strong>calcification</strong> and <strong>extension through foramina of Luschka and Magendie</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hemangioblastoma</strong>: Also cystic with mural nodule but typically occurs in <strong>adults</strong>, often in the <strong>cerebellum</strong>, and may be associated with <strong>von Hippel–Lindau disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pilocytic Astrocytoma</strong> should be suspected in <strong>pediatric posterior fossa cystic lesions</strong> with <strong>enhancing mural nodules</strong> and <strong>non-enhancing cyst walls</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The appearance is pathognomonic on MRI and helps in distinguishing from other posterior fossa tumors.</span></li></ul>",
      "correct_choice_id": 392242,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98553/INI-NEET_-_GT__27th_Nov_2025_Radiology_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98553/INI-NEET_-_GT__27th_Nov_2025_Radiology_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98289,
      "choices": [
        {
          "id": 391188,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral bisphosphonates</span></p>"
        },
        {
          "id": 391189,
          "text": "<p><span style=\"font-size:14.0pt;\">Systemic hormone replacement therapy</span></p>"
        },
        {
          "id": 391190,
          "text": "<p><span style=\"font-size:14.0pt;\">Vaginal estrogen cream</span></p>"
        },
        {
          "id": 391191,
          "text": "<p><span style=\"font-size:14.0pt;\">Calcium and vitamin D supplementation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old postmenopausal woman presents with recurrent urinary tract infections and dyspareunia for the past 3 years. On examination, her vaginal mucosa appears pale and dry. Which of the following is the most appropriate treatment for her urogenital symptoms?</span></p>",
      "unique_key": "Q9118784",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Vaginal estrogen cream</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This woman’s symptoms — <strong>recurrent UTIs</strong>, <strong>vaginal dryness</strong>, <strong>dyspareunia</strong>, and <strong>pale mucosa</strong> — are classic for <strong>genitourinary syndrome of menopause (GSM)</strong>, previously termed <strong>atrophic vaginitis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">After menopause, <strong>estrogen levels fall</strong>, leading to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Thinning of vaginal and urethral epithelium</span></li><li><span style=\"font-size:14.0pt;\">Decreased glycogen content → loss of protective lactobacilli</span></li><li><span style=\"font-size:14.0pt;\">Increased vaginal pH → predisposition to infection</span></li><li><span style=\"font-size:14.0pt;\">Vaginal dryness, irritation, and dyspareunia</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Treatment:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>First-line: Local vaginal estrogen therapy</strong> (cream, tablet, or ring).</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Restores local estrogen levels.</span></li><li><span style=\"font-size:14.0pt;\">Improves <strong>vaginal epithelium</strong>, <strong>blood flow</strong>, and <strong>pH balance</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Reduces <strong>recurrent UTIs</strong> by restoring the normal flora and mucosal barrier.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Systemic absorption is minimal, so it is safe for most women unless contraindicated (e.g., history of estrogen-dependent cancer).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Oral bisphosphonates:&nbsp;</strong>Incorrect. Used for <strong>osteoporosis</strong>, not for urogenital atrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Systemic hormone replacement therapy:&nbsp;</strong>Incorrect. Effective but <strong>not first-line</strong> for localized urogenital symptoms; higher systemic risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Calcium and vitamin D supplementation:&nbsp;</strong>Incorrect. Prevent osteoporosis but <strong>do not relieve vaginal or urinary symptoms</strong> of menopause.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Genitourinary syndrome of menopause</strong> results from <strong>estrogen deficiency</strong> causing <strong>vaginal and urinary tract atrophy</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>treatment of choice</strong> is <strong>local vaginal estrogen therapy</strong>, which directly relieves dryness, dyspareunia, and recurrent infections.</span></li></ul>",
      "correct_choice_id": 391190,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98289/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98289/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98292,
      "choices": [
        {
          "id": 391200,
          "text": "<p><span style=\"font-size:14.0pt;\">Oxytocin infusion alone</span></p>"
        },
        {
          "id": 391201,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate hysterectomy</span></p>"
        },
        {
          "id": 391202,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral methylergonovine only</span></p>"
        },
        {
          "id": 391203,
          "text": "<p><span style=\"font-size:14.0pt;\">Antibiotics and uterine evacuation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old G3P2 woman, 10 days postpartum, presents with heavy vaginal bleeding. She had an uncomplicated vaginal delivery. Her temperature is 38.2°C, and examination reveals a subinvoluted, tender uterus with a patulous cervical os. Ultrasound demonstrates echogenic material in the uterine cavity. What is the most appropriate management?</span></p>",
      "unique_key": "Q5283257",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Antibiotics and uterine evacuation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This presentation is typical of <strong>secondary postpartum hemorrhage (PPH)</strong> — defined as <strong>excessive vaginal bleeding occurring 24 hours to 12 weeks after delivery</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Likely Cause:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient has <strong>retained products of conception (RPOC)</strong> complicated by <strong>endometritis</strong>, as evidenced by:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Fever (38.2°C)</span></li><li><span style=\"font-size:14.0pt;\">Tender, sub involuted uterus</span></li><li><span style=\"font-size:14.0pt;\">Echogenic material on ultrasound</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These findings indicate <strong>infected retained tissue</strong> inside the uterus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management Steps:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Start broad-spectrum antibiotics</strong> (e.g., ampicillin + metronidazole ± gentamicin) to treat endometritis.</span></li><li><span style=\"font-size:14.0pt;\">After adequate antibiotic coverage, perform <strong>uterine evacuation (suction curettage)</strong> to remove retained tissue and stop bleeding.</span></li><li><span style=\"font-size:14.0pt;\">Continue <strong>uterotonics</strong> (like oxytocin) as adjuncts to improve uterine tone.</span></li></ol><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This combined approach addresses both <strong>infection and mechanical cause</strong> of bleeding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Oxytocin infusion alone:&nbsp;</strong>Incorrect. Useful only for uterine atony, not when retained products or infection are present.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Immediate hysterectomy:&nbsp;</strong>Incorrect. Reserved for cases of <strong>uncontrolled hemorrhage</strong> unresponsive to conservative management or <strong>severe uterine sepsis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Oral methylergonovine only:&nbsp;</strong>Incorrect. Appropriate for <strong>subinvolution of the uterus</strong> without infection, but inadequate here due to <strong>infection and retained tissue</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>secondary postpartum hemorrhage</strong>, if ultrasound shows <strong>retained products with signs of infection</strong>, the <strong>correct management</strong> is <strong>broad-spectrum antibiotics followed by uterine evacuation</strong> to control infection and stop bleeding.</span></p>",
      "correct_choice_id": 391203,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98292/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98292/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98285,
      "choices": [
        {
          "id": 391172,
          "text": "<p><span style=\"font-size:14.0pt;\">36 weeks</span></p>"
        },
        {
          "id": 391173,
          "text": "<p><span style=\"font-size:14.0pt;\">34 weeks</span></p>"
        },
        {
          "id": 391174,
          "text": "<p><span style=\"font-size:14.0pt;\">At the onset of labor</span></p>"
        },
        {
          "id": 391175,
          "text": "<p><span style=\"font-size:14.0pt;\">40 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">When should the final switch from warfarin to heparin be made to minimize the risk of fetal complications and maternal bleeding during delivery?</span></p>",
      "unique_key": "Q4898904",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 36 weeks</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Warfarin is a <strong>teratogenic</strong> medication that can cross the placenta and cause <strong>fetal hemorrhage, warfarin embryopathy, and fetal anomalies</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, it is often used in pregnant women with high thromboembolic risk due to mechanical heart valves, as it is more effective than heparin in preventing clot formation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The recommendation is to <strong>switch from warfarin to heparin at 36 weeks</strong> of gestation to reduce the risk of maternal bleeding during delivery and prevent fetal complications.</span></li><li><span style=\"font-size:14.0pt;\">Heparin (unfractionated or low-molecular-weight heparin) does not cross the placenta and is safe for both the mother and the fetus.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Switching at 36 weeks provides time for stabilization on heparin before labor or cesarean delivery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For pregnant women on <strong>warfarin</strong> due to cardiac disease or thromboembolic risk, the final switch to <strong>heparin</strong> is made at <strong>36 weeks</strong> gestation to reduce the risk of bleeding during labor while maintaining effective anticoagulation.</span></p>",
      "correct_choice_id": 391172,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98285/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98285/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98281,
      "choices": [
        {
          "id": 391156,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated FSH and LH levels</span></p>"
        },
        {
          "id": 391157,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated prolactin levels</span></p>"
        },
        {
          "id": 391158,
          "text": "<p><span style=\"font-size:14.0pt;\">Low gonadotropin and cortisol levels</span></p>"
        },
        {
          "id": 391159,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated testosterone levels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman presents with secondary amenorrhea for 8 months following a severe postpartum hemorrhage. She also reports failure of lactation and loss of pubic hair. Laboratory evaluation would most likely show which of the following finding?</span></p>",
      "unique_key": "Q7783348",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Low gonadotropin and cortisol levels</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This clinical scenario is characteristic of <strong>Sheehan’s syndrome (postpartum pituitary necrosis)</strong> — a condition caused by <strong>ischemic necrosis of the anterior pituitary gland</strong> following <strong>massive postpartum hemorrhage (PPH)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During pregnancy, the <strong>pituitary gland enlarges</strong> due to lactotroph hyperplasia, increasing its oxygen demand.</span></li><li><span style=\"font-size:14.0pt;\">Severe <strong>hypovolemic shock</strong> from PPH causes <strong>ischemic damage</strong> to the pituitary.</span></li><li><span style=\"font-size:14.0pt;\">The result is <strong>panhypopituitarism</strong>, leading to <strong>deficiency of anterior pituitary hormones</strong>, including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Gonadotropins (FSH, LH)</strong> → Amenorrhea, loss of libido, pubic/axillary hair loss</span></li><li><span style=\"font-size:14.0pt;\"><strong>Prolactin</strong> → Failure of lactation</span></li><li><span style=\"font-size:14.0pt;\"><strong>ACTH</strong> → Secondary adrenal insufficiency → Low cortisol</span></li><li><span style=\"font-size:14.0pt;\"><strong>TSH</strong> → Secondary hypothyroidism (fatigue, cold intolerance)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Clinical Features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>History of severe postpartum hemorrhage</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Failure to lactate postpartum</strong> (due to ↓ prolactin)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Amenorrhea or oligomenorrhea</strong> (due to ↓ FSH, LH)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Loss of pubic and axillary hair</strong> (due to ↓ androgens from low LH/ACTH)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Symptoms of adrenal insufficiency:</strong> fatigue, hypotension, weight loss</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Elevated FSH and LH levels:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This occurs in <strong>primary ovarian failure (premature menopause)</strong>, not in pituitary failure.</span></li><li><span style=\"font-size:14.0pt;\">In Sheehan’s, <strong>FSH and LH are low</strong> due to pituitary necrosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Elevated prolactin levels:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In Sheehan’s syndrome, <strong>prolactin levels are low</strong> due to <strong>loss of lactotrophs</strong>, leading to <strong>failure of lactation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Elevated prolactin is seen in <strong>prolactinoma</strong> or <strong>dopamine antagonist use</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Elevated testosterone levels:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Androgens are <strong>reduced</strong> due to low LH and ACTH.</span></li><li><span style=\"font-size:14.0pt;\">Elevated testosterone is seen in <strong>PCOS</strong> or <strong>androgen-secreting tumors</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Sheehan’s syndrome</strong> results from <strong>ischemic necrosis of the pituitary gland</strong> following severe postpartum hemorrhage.</span></li><li><span style=\"font-size:14.0pt;\">It presents with <strong>failure of lactation, secondary amenorrhea, and loss of pubic hair</strong>, with laboratory findings showing <strong>low gonadotropins and cortisol levels</strong> due to <strong>anterior pituitary hormone deficiency</strong>.</span></li></ul>",
      "correct_choice_id": 391158,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98281/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98281/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98282,
      "choices": [
        {
          "id": 391160,
          "text": "<p><span style=\"font-size:14.0pt;\">Expectant management with daily NST</span></p>"
        },
        {
          "id": 391161,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate cesarean section</span></p>"
        },
        {
          "id": 391162,
          "text": "<p><span style=\"font-size:14.0pt;\">Cervical priming and Induction of labor</span></p>"
        },
        {
          "id": 391163,
          "text": "<p><span style=\"font-size:14.0pt;\">Amnioinfusion followed by expectant management</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-week pregnant woman presents for evaluation. Ultrasound shows an amniotic fluid index (AFI) of 4 cm, and a non-stress test (NST) shows decreased variability with variable decelerations. The cervix is unfavorable. What is the most appropriate management?</span></p>",
      "unique_key": "Q1418183",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Immediate cesarean section</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This is a case of <strong>post-term pregnancy (42 weeks)</strong> with <strong>fetal distress</strong> features.</span></p><p><br><span style=\"font-size:14.0pt;\">Let’s analyze the findings:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Amniotic Fluid Index (AFI) = 4 cm:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">This indicates <strong>oligohydramnios</strong> (AFI &lt; 5 cm).</span></li><li><span style=\"font-size:14.0pt;\">Oligohydramnios in post-term pregnancy suggests <strong>placental insufficiency</strong> and a <strong>compromised fetus</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Non-Stress Test (NST):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Shows <strong>decreased variability</strong> and <strong>variable decelerations</strong> → both are signs of <strong>fetal hypoxia or distress</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Unfavorable cervix:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Cervical priming and induction would take time, which is unsafe in the presence of <strong>fetal distress</strong>.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hence, <strong>immediate delivery</strong> is needed, and since the cervix is unfavorable, the <strong>safest and quickest method is cesarean section</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Expectant management with daily NST:</strong> Contraindicated in fetal distress and post-term pregnancy with oligohydramnios — delaying delivery may worsen hypoxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cervical priming and induction of labor:</strong> Not advisable because induction in the setting of <strong>fetal distress and poor Bishop’s score</strong> may lead to <strong>fetal compromise or stillbirth</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Amnioinfusion followed by expectant management:</strong> Amnioinfusion is useful in <strong>intrapartum variable decelerations during labor</strong>, not in a <strong>post-term, antepartum</strong> setting with an <strong>unfavorable cervix</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a <strong>post-term pregnancy (≥42 weeks)</strong> with <strong>oligohydramnios (AFI ≤ 5 cm)</strong> and <strong>abnormal NST (decreased variability, decelerations)</strong>, the presence of an <strong>unfavorable cervix</strong> makes <strong>immediate cesarean section</strong> the most appropriate and life-saving management for the fetus.</span></p>",
      "correct_choice_id": 391161,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98282/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98282/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98297,
      "choices": [
        {
          "id": 391220,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid Elimination</span></p>"
        },
        {
          "id": 391221,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid Reabsorption</span></p>"
        },
        {
          "id": 391222,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid Metabolism</span></p>"
        },
        {
          "id": 391223,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid Redistribution</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man was given a single dose of Thiopentone for induction of anesthesia. After 20 minutes he regains consciousness again and is aware of his surroundings. Which property of Thiopentone is responsible for this phenomenon?</span></p>",
      "unique_key": "Q2618284",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Rapid Redistribution</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">\"<strong>Rapid Redistribution</strong>,\" accurately describes the process by which <strong>thiopentone</strong>, after <strong>inducing anesthesia</strong>, is <strong>redistributed</strong> from the <strong>brain</strong> to other, <strong>less well-perfused tissues</strong> like muscle and fat.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This redistribution results in a <strong>decrease</strong> in the <strong>drug's plasma concentration</strong> and its <strong>effect on the brain</strong>, allowing the patient to <strong>regain consciousness</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A</strong>. <strong>Rapid Elimination</strong>: Refers to the <strong>speed</strong> at which a <strong>drug is removed</strong> from the <strong>body</strong>, which typically <strong>involves processes&nbsp;</strong>such as <strong>renal excretion</strong> or <strong>hepatic metabolism</strong>. <strong>Thiopentone</strong> has a <strong>long elimination half-life</strong>, so this is <strong>not the reason</strong> for the <strong>rapid recovery of consciousness</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B</strong>. <strong>Rapid Reabsorption</strong>: Is <strong>not</strong> a term commonly associated with the <strong>pharmacokinetics of anesthesia recovery</strong>. <strong>Reabsorption</strong> typically refers to the <strong>process by which substances</strong> are <strong>transported back</strong> into the <strong>bloodstream from the renal tubules</strong>. This <strong>does not</strong> apply to <strong>thiopentone&nbsp;</strong>and <strong>anesthesia recovery</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong>. <strong>Rapid Metabolism</strong>: Refers to <strong>how quickly a drug</strong> is <strong>chemically altered</strong> by the <strong>body's metabolic processes</strong>. While thiopentone is <strong>metabolized by the liver</strong>, its <strong>rapid recovery</strong> is <strong>not due to its metabolism</strong>, as the <strong>metabolic breakdown of thiopentone</strong> is <strong>relatively slow</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thiopentone <strong>induces rapid anesthesia</strong> but also <strong>allows for quick recovery</strong> due to <strong>its rapid redistribution</strong> from the <strong>brain</strong> to <strong>less perfused tissues</strong>, which <strong>reduces its concentration</strong> in the <strong>central nervous system</strong> and <strong>restores consciousness</strong>.</span></p>",
      "correct_choice_id": 391223,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98297/INI-NEET_-_GT__27th_Nov_2025_Anesthesia_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98297/INI-NEET_-_GT__27th_Nov_2025_Anesthesia_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98245,
      "choices": [
        {
          "id": 391012,
          "text": "<p><span style=\"font-size:14.0pt;\">Germinal center of lymphoid follicles&nbsp;</span></p>"
        },
        {
          "id": 391013,
          "text": "<p><span style=\"font-size:14.0pt;\">Subcapsular sinus&nbsp;</span></p>"
        },
        {
          "id": 391014,
          "text": "<p><span style=\"font-size:14.0pt;\">Paracortex (deep cortex)&nbsp;</span></p>"
        },
        {
          "id": 391015,
          "text": "<p><span style=\"font-size:14.0pt;\">Medullary sinuses</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a lymph node, which region contains high endothelial venules lined by cuboidal endothelium that facilitates lymphocyte migration from blood into lymphoid tissue?</span></p>",
      "unique_key": "Q2077129",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Paracortex (deep cortex)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The paracortex (also called deep cortex or thymus-dependent cortex) is the region between the nodular cortex and medulla.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It contains postcapillary venules that are unusual in being lined by cuboidal endothelium rather than the typical squamous endothelium - hence called high endothelial venules (HEVs).</span></li><li><span style=\"font-size:14.0pt;\">This \"high\" endothelium bears receptors recognized by circulating lymphocytes and readily allows passage of lymphocytes between the bloodstream and surrounding tissue.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The paracortex is mainly populated by T-lymphocytes, which is why it's also called the thymus-dependent zone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-18%20111422.jpg\" width=\"642\" height=\"597\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Germinal centers</strong> <strong>of lymphoid follicles:</strong> These are sites of B-lymphocyte proliferation within lymphoid follicles, containing actively dividing lymphoblasts. They would be correct if asking about antibody production sites.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Subcapsular sinus:</strong> This is the space just beneath the capsule where afferent lymph enters. It's lined by endothelium but not the specialized high endothelial type.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Medullary sinuses:</strong> These are lymphatic channels in the medulla that collect lymph for drainage through efferent vessels. They have regular endothelial lining, not high endothelium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">High endothelial venules in the paracortex of lymph nodes are the specialized sites for lymphocyte trafficking between blood and lymphoid tissue.</span></p>",
      "correct_choice_id": 391014,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98245/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98245/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98770,
      "choices": [
        {
          "id": 393096,
          "text": "<p><span style=\"font-size:14.0pt;\">Emergency coronary arteriography</span></p>"
        },
        {
          "id": 393097,
          "text": "<p><span style=\"font-size:14.0pt;\">V-A ECMO</span></p>"
        },
        {
          "id": 393098,
          "text": "<p><span style=\"font-size:14.0pt;\">Percutaneous LV assist devices</span></p>"
        },
        {
          "id": 393099,
          "text": "<p><span style=\"font-size:14.0pt;\">Insertion of an IABP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 21-year-old&nbsp;man presents&nbsp;with fatigue&nbsp;and dyspnea.&nbsp;He has severe&nbsp;hypotension (SBP - 60 mmHg),&nbsp;cool extremities, and bedside&nbsp;ultrasound shows&nbsp;biventricular&nbsp;failure. His&nbsp;troponin T is&nbsp;markedly elevated&nbsp;(2320 ng/L),&nbsp;and a rapid flu&nbsp;test is positive. He remains&nbsp;in shock despite&nbsp;maximal inotropes and vasopressors. What is the&nbsp;next best step?</span></p>",
      "unique_key": "Q2995476",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) V-A ECMO</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient&nbsp;has fulminant&nbsp;viral myocarditis with severe, refractory cardiogenic shock and&nbsp;biventricular&nbsp;failure.</span></li><li><span style=\"font-size:14.0pt;\">V-A ECMO (Venoarterial Extracorporeal Membrane Oxygenation) provides&nbsp;both cardiac&nbsp;and respiratory&nbsp;support, maintaining&nbsp;systemic perfusion, reducing&nbsp;myocardial work, and allowing&nbsp;time for potential&nbsp;myocardial recovery, which is especially&nbsp;important in&nbsp;acute viral myocarditis.</span></li><li><span style=\"font-size:14.0pt;\">V-A ECMO can serve as&nbsp;a bridge to recovery, further intervention, or transplantation&nbsp;in cases of profound&nbsp;cardiogenic shock&nbsp;unresponsive&nbsp;to medications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Emergency&nbsp;coronary arteriography:</strong> Is not&nbsp;indicated because&nbsp;there are no&nbsp;features of acute&nbsp;coronary syndrome; the global myocardial&nbsp;dysfunction is&nbsp;most consistent&nbsp;with viral myocarditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C. Percutaneous LV assist&nbsp;devices:</strong> Provide&nbsp;only left-sided&nbsp;support, which&nbsp;is inadequate&nbsp;in a patient&nbsp;with biventricular (RV and LV) failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D. Insertion of an&nbsp;IABP:</strong> Intra-aortic balloon pump support is insufficient in cases of severe biventricular dysfunction and does not provide adequate circulatory support for severe shock.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In biventricular failure&nbsp;and refractory&nbsp;shock, V-A ECMO is the most&nbsp;appropriate intervention&nbsp;to provide temporary&nbsp;full cardiopulmonary support, allowing for&nbsp;myocardial recovery&nbsp;and protecting&nbsp;end-organ function</span></p>",
      "correct_choice_id": 393097,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98770/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98770/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 86998,
      "choices": [
        {
          "id": 346476,
          "text": "<p><span style=\"font-size:14.0pt;\">Triangle of doom</span></p>"
        },
        {
          "id": 346477,
          "text": "<p><span style=\"font-size:14.0pt;\">Triangle of pain</span></p>"
        },
        {
          "id": 346478,
          "text": "<p><span style=\"font-size:14.0pt;\">Triangle of Calot</span></p>"
        },
        {
          "id": 346479,
          "text": "<p><span style=\"font-size:14.0pt;\">Corona mortis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the name of this triangle?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_OzqTMcC.png\" width=\"646\" height=\"434\"></span></p>",
      "unique_key": "Q9408262",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Triangle of doom</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>Triangle of Doom</strong> is an important anatomical area in <strong>inguinal and laparoscopic hernia repair</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is bounded by:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Medially:</strong> Ductus deferens (vas deferens)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Laterally:</strong> Gonadal vessels</span></li><li><span style=\"font-size:14.0pt;\"><strong>Posteriorly:</strong> Peritoneal edge</span></li></ul></li><li><span style=\"font-size:14.0pt;\">It contains vital <strong>vascular structures</strong>, including the <strong>external iliac artery and vein</strong>, and manipulation in this area poses a <strong>high risk of major vascular injury</strong>, hence the name \"Triangle of Doom.\"</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Triangle of pain:</strong> This is a separate region <strong>lateral to the gonadal vessels</strong>, containing <strong>cutaneous nerves (e.g., femoral and lateral femoral cutaneous nerves)</strong>. Injury here results in <strong>neuropathy and pain</strong>, not vascular injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Triangle of Calot:</strong> This is encountered in laparoscopic cholecystectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Corona mortis:</strong> The <strong>corona mortis</strong> refers to an <strong>anastomotic vascular connection</strong> between the <strong>obturator artery and the external iliac artery</strong>. It is at risk during <strong>hernia surgery or pelvic procedures</strong> but is not the region shown in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Triangle of Doom</strong> is an area in <strong>inguinal hernia repair</strong> containing <strong>major vessels (external iliac artery and vein)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Injury in this region can lead to <strong>catastrophic hemorrhage</strong>, making careful surgical dissection essential.</span></li></ul>",
      "correct_choice_id": 346476,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86998/FMGE_SURGERY_MOCK_2_Q_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86998/FMGE_SURGERY_MOCK_2_Q_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98291,
      "choices": [
        {
          "id": 391196,
          "text": "<p><span style=\"font-size:14.0pt;\">Maternal mortality ratio</span></p>"
        },
        {
          "id": 391197,
          "text": "<p><span style=\"font-size:14.0pt;\">Maternal near miss</span></p>"
        },
        {
          "id": 391198,
          "text": "<p><span style=\"font-size:14.0pt;\">Maternal morbidity</span></p>"
        },
        {
          "id": 391199,
          "text": "<p><span style=\"font-size:14.0pt;\">Lifetime risk</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A woman experiences severe postpartum hemorrhage but survives after receiving 6 units of blood transfusion and an emergency hysterectomy. This situation best represents which maternal health indicator?</span></p>",
      "unique_key": "Q9711233",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Maternal near miss</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>maternal near miss (MNM)</strong> refers to a woman who <strong>nearly dies but survives</strong> a <strong>life-threatening complication</strong> during <strong>pregnancy, childbirth, or within 42 days of termination of pregnancy</strong>.</span></li><li><span style=\"font-size:14.0pt;\">According to the <strong>World Health Organization (WHO)</strong> definition:</span></li><li><span style=\"font-size:14.0pt;\">“A maternal near miss is a woman who survives life-threatening conditions (such as severe hemorrhage, sepsis, or eclampsia) that occur during pregnancy, childbirth, or within 42 days of termination of pregnancy.”</span></li><li><span style=\"font-size:14.0pt;\"><strong>Key Features of a Maternal Near Miss:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The woman <strong>survives</strong> the complication.</span></li><li><span style=\"font-size:14.0pt;\">The event involves <strong>organ dysfunction</strong> or <strong>intervention</strong> to prevent death (e.g., massive transfusion, hysterectomy, ICU care).</span></li><li><span style=\"font-size:14.0pt;\">The condition is <strong>potentially fatal</strong> — here, massive postpartum hemorrhage requiring 6 units of blood and hysterectomy clearly qualifies.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Maternal mortality ratio:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Refers to the <strong>number of maternal deaths per 100,000 live births </strong>in a given period.</span></li><li><span style=\"font-size:14.0pt;\">This patient survived; hence, it’s not maternal mortality.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Maternal morbidity:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Refers to <strong>any illness or complication</strong> during pregnancy or childbirth, whether mild or severe.</span></li><li><span style=\"font-size:14.0pt;\">“Near miss” is a <strong>specific severe form</strong> of maternal morbidity, where the woman nearly dies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lifetime risk:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Represents the <strong>probability that a 15-year-old girl will eventually die of maternal causes</strong> during her reproductive years.</span></li><li><span style=\"font-size:14.0pt;\">Not applicable to this individual event.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>maternal near miss</strong> occurs when a woman <strong>survives a life-threatening obstetric complication</strong>, such as <strong>severe postpartum hemorrhage requiring massive transfusion or hysterectomy</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is an important indicator of the <strong>quality of obstetric care</strong> and helps identify <strong>gaps in emergency maternal health services</strong>.</span></li></ul>",
      "correct_choice_id": 391197,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98291/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98291/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98248,
      "choices": [
        {
          "id": 391024,
          "text": "<p><span style=\"font-size:14.0pt;\">Sternoclavicular ligament&nbsp;</span></p>"
        },
        {
          "id": 391025,
          "text": "<p><span style=\"font-size:14.0pt;\">Coracoclavicular ligament&nbsp;</span></p>"
        },
        {
          "id": 391026,
          "text": "<p><span style=\"font-size:14.0pt;\">Acromioclavicular ligament&nbsp;</span></p>"
        },
        {
          "id": 391027,
          "text": "<p><span style=\"font-size:14.0pt;\">Coracoacromial ligament</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 22-year-old man sustains a fracture at the junction of middle and lateral thirds of his clavicle. Which ligament primarily maintains the weight transmission from the upper limb to the axial skeleton despite this fracture?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1342036",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Coracoclavicular ligament</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The coracoclavicular ligament, consisting of conoid and trapezoid parts, is the primary structure transmitting weight from the scapula to the clavicle.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The clavicle usually fractures between the attachments of the coracoclavicular ligament (laterally) and the costoclavicular ligament (medially), which corresponds to the junction of the lateral and middle thirds.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Even with a clavicular fracture, the coracoclavicular ligament maintains the connection between the scapula and the lateral fragment of the clavicle, allowing continued weight transmission from the upper limb through this ligament to the clavicle and then to the sternum via the sternoclavicular joint.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-18%20111442.jpg\" width=\"746\" height=\"490\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-18%20111458.jpg\" width=\"730\" height=\"485\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Sternoclavicular ligament:</strong> Stabilizes the sternoclavicular joint but doesn't directly connect the scapula to the clavicle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Acromioclavicular ligament:</strong> Stabilizes the acromioclavicular joint but is weaker than the coracoclavicular ligament for weight transmission.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Coracoacromial ligament:</strong> Forms an arch over the shoulder joint but doesn't participate in weight transmission from the upper limb.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The coracoclavicular ligament is crucial for weight transmission from the scapula to the clavicle, explaining why the clavicle commonly fractures between this ligament and the costoclavicular ligament.</span></p>",
      "correct_choice_id": 391025,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98248/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98248/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98372,
      "choices": [
        {
          "id": 391520,
          "text": "<p><span style=\"font-size:14.0pt;\">COPD is more common in females than males globally</span></p>"
        },
        {
          "id": 391521,
          "text": "<p><span style=\"font-size:14.0pt;\">The leading risk factor for COPD worldwide is outdoor air pollution</span></p>"
        },
        {
          "id": 391522,
          "text": "<p><span style=\"font-size:14.0pt;\">COPD prevalence increases with age and peaks in the 6th-7th decade of life</span></p>"
        },
        {
          "id": 391523,
          "text": "<p><span style=\"font-size:14.0pt;\">Biomass fuel exposure accounts for less than 10% of COPD cases globally</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements is true regarding the epidemiology of Chronic Obstructive Pulmonary Disease (COPD)?</span></p>",
      "unique_key": "Q4089839",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) COPD prevalence increases with age and peaks in the 6th-7th decade of life</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">COPD prevalence demonstrates a clear age-related pattern, with incidence and prevalence rates increasing significantly with advancing age.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The disease typically peaks in the 6th-7th decade of life (50-70 years), which corresponds to the cumulative effects of prolonged exposure to risk factors, particularly tobacco smoke.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This age distribution reflects the chronic progressive nature of the disease and the time required for significant lung function deterioration to manifest clinically.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. COPD is more common in females than males globally:</strong> COPD has traditionally been more common in males due to higher smoking rates, though the gender gap is narrowing in developed countries as female smoking rates have increased.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. The leading risk factor for COPD worldwide is outdoor air pollution:</strong> Tobacco smoking remains the leading risk factor for COPD worldwide, accounting for approximately 80-90% of cases in developed countries.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Biomass fuel exposure accounts for less than 10% of COPD cases globally:</strong> Biomass fuel exposure is a significant risk factor, particularly in developing countries, accounting for approximately 25-30% of COPD cases globally, especially among women and children.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">COPD prevalence increases significantly with age, peaking in the 6th-7th decade</span></li><li><span style=\"font-size:14.0pt;\">Tobacco smoking remains the most important risk factor globally</span></li><li><span style=\"font-size:14.0pt;\">Biomass fuel exposure is a major contributor to COPD burden in developing countries</span></li></ul>",
      "correct_choice_id": 391522,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98372/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98372/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98787,
      "choices": [
        {
          "id": 393160,
          "text": "<p><span style=\"font-size:14.0pt;\">Hepatic metabolism leading to rapid clearance</span></p>"
        },
        {
          "id": 393161,
          "text": "<p><span style=\"font-size:14.0pt;\">Redistribution from the brain to peripheral tissues</span></p>"
        },
        {
          "id": 393162,
          "text": "<p><span style=\"font-size:14.0pt;\">Rapid renal excretion of the unchanged drug</span></p>"
        },
        {
          "id": 393163,
          "text": "<p><span style=\"font-size:14.0pt;\">High lipid solubility preventing sustained CNS concentrations</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old female undergoing a laparoscopic cholecystectomy is induced with thiopentone. The anesthesiologist selects this agent due to its rapid onset and ultra-short duration of action. The patient is then maintained on inhalational anesthetics for the rest of the procedure. Based on the pharmacokinetics of this anesthetic, which of the following is the primary reason for its ultra-short duration of action?</span></p>",
      "unique_key": "Q9382181",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Redistribution from the brain to peripheral tissues</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Thiopental, a barbiturate, has an ultra-short duration of action due to its high lipid solubility.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">After intravenous administration, it rapidly crosses the blood-brain barrier, inducing anesthesia within seconds.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, its effect wanes quickly, not due to metabolism or excretion, but because of redistribution from the brain (a high-perfusion organ) to other tissues like muscle and fat, which act as reservoirs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hepatic metabolism leading to rapid clearance:</strong> Incorrect. While thiopental undergoes hepatic metabolism, this process does not account for its ultra-short duration of action; redistribution is the primary factor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Rapid renal excretion of the unchanged drug:</strong> Incorrect. Thiopental is metabolized in the liver; it is not excreted unchanged by the kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. High lipid solubility preventing sustained CNS concentrations:</strong> Incorrect. Although thiopental is highly lipid-soluble, its rapid redistribution, not sustained lipid solubility, is responsible for its short duration of CNS effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The ultra-short duration of action of thiopental is primarily due to its rapid redistribution from the brain to less vascularized peripheral tissues, not hepatic metabolism or renal excretion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Redistribution is a key pharmacokinetic property of highly lipid-soluble drugs used for anesthesia induction.</span></li></ul>",
      "correct_choice_id": 393161,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98787/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98787/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98797,
      "choices": [
        {
          "id": 393200,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 only</span></p>"
        },
        {
          "id": 393201,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 only</span></p>"
        },
        {
          "id": 393202,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 393203,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about Tedizolid are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">Tedizolid binds to the 30S ribosomal subunit to inhibit protein synthesis.</span></li><li><span style=\"font-size:14.0pt;\">It is active against gram‑positive organisms, including vancomycin‑resistant Staphylococcus aureus (VRSA).</span></li><li><span style=\"font-size:14.0pt;\">Tedizolid is primarily excreted unchanged in the urine.</span></li><li><span style=\"font-size:14.0pt;\">It exhibits excellent oral bioavailability.</span></li></ol>",
      "unique_key": "Q5449294",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) 2 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>It is active against gram‑positive organisms, including</strong></span> <span style=\"font-size:14.0pt;\"><strong>vancomycin resistant Staphylococcus aureus (VRSA): </strong>Tedizolid is a next‑generation <strong>oxazolidinone</strong> effective against <strong>gram‑positive pathogens</strong>, including <strong>MRSA</strong> and <strong>VRSA</strong>. It is particularly valuable when resistance to vancomycin is present.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>It exhibits excellent oral bioavailability: </strong>Tedizolid has <strong>excellent oral bioavailability (~90%)</strong>, allowing convenient <strong>once‑daily oral dosing</strong> comparable in efficacy to IV administration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statements:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Tedizolid binds to the 30S ribosomal subunit to inhibit protein synthesis:&nbsp;</strong>Tedizolid, like linezolid, binds to the <strong>50S</strong> ribosomal subunit—not the 30S—blocking the formation of the initiation complex and thereby inhibiting <strong>bacterial protein synthesis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Tedizolid is primarily excreted unchanged in the urine:&nbsp;</strong>Tedizolid is <strong>metabolized in the liver</strong>, not excreted unchanged. Its hepatic biotransformation reduces the risk of accumulation in renal impairment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tedizolid is an <strong>oxazolidinone antibiotic</strong> that binds the <strong>50S ribosomal subunit</strong>, inhibiting protein synthesis.</span></li><li><span style=\"font-size:14.0pt;\">It demonstrates <strong>excellent oral absorption</strong> and <strong>broad gram‑positive coverage</strong>, including <strong>MRSA and VRSA</strong>, and undergoes <strong>hepatic metabolism</strong> rather than renal excretion.</span></li></ul>",
      "correct_choice_id": 393201,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98797/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98797/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 87014,
      "choices": [
        {
          "id": 346540,
          "text": "<p><span style=\"font-size:14.0pt;\">CT</span></p>"
        },
        {
          "id": 346541,
          "text": "<p><span style=\"font-size:14.0pt;\">PET</span></p>"
        },
        {
          "id": 346542,
          "text": "<p><span style=\"font-size:14.0pt;\">MRI</span></p>"
        },
        {
          "id": 346543,
          "text": "<p><span style=\"font-size:14.0pt;\">Endoscopic USG</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following provides the most accurate information for reporting the 'T stage' of esophageal carcinoma?</span></p>",
      "unique_key": "Q9634846",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Endoscopic USG</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Endoscopic ultrasonography (EUS) is the most accurate modality for determining the T stage (depth of tumor invasion) in esophageal carcinoma.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">EUS provides highly detailed images of the layers of the esophageal wall, allowing precise determination of tumor depth invasion through visualization of the mucosa, submucosa, muscularis propria, and adventitia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. CT:&nbsp;</strong>Incorrect. CT scan is useful for colon cancer, identifying haematogenous metastases and is primarily used to identify distant metastasis (M stage). CT has limited axial resolution which precludes reliable assessment of both depth of wall penetration and early lymph node involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. PET:&nbsp;</strong>Incorrect. PET scanning is valuable for detecting distant metastatic disease not seen on CT alone, focused on identifying metabolically active tumor sites, but lacks the resolution to accurately determine depth of tumor penetration through the esophageal wall layers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. MRI:&nbsp;</strong>Incorrect. MRI doesn't expose the patient to ionizing radiation but is primarily used for rectal cancer, metastasis detection rather than precise T-staging. It lacks the resolution needed for accurate T-staging compared to EUS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For precise T-staging of esophageal carcinoma, endoscopic ultrasonography (EUS) is superior as it visualizes the multi-layered structure of the esophageal wall, allowing accurate determination of tumor depth penetration.</span></p>",
      "correct_choice_id": 346543,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87014/FMGE_SURGERY_MOCK_2_Q_27.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87014/FMGE_SURGERY_MOCK_2_Q_27.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98380,
      "choices": [
        {
          "id": 391552,
          "text": "<p><span style=\"font-size:14.0pt;\">Strengthening tertiary care facilities in urban areas</span></p>"
        },
        {
          "id": 391553,
          "text": "<p><span style=\"font-size:14.0pt;\">Health and Wellness Centers (HWCs) as the foundation of healthcare delivery</span></p>"
        },
        {
          "id": 391554,
          "text": "<p><span style=\"font-size:14.0pt;\">Expansion of private healthcare partnerships exclusively</span></p>"
        },
        {
          "id": 391555,
          "text": "<p><span style=\"font-size:14.0pt;\">Focus on curative and rehabilitative services&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following best describes the primary healthcare approach adopted by India under the National Health Policy 2017 to achieve Universal Health Coverage (UHC)?</span></p>",
      "unique_key": "Q3414115",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Health and Wellness Centers (HWCs) as the foundation of healthcare delivery</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The National Health Policy 2017 emphasizes transforming existing Sub Health Centers and Primary Health Centers into Health and Wellness Centers (HWCs) to provide comprehensive primary healthcare services.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This approach focuses on preventive, promotive, curative, and rehabilitative care closer to the community, forming the foundation for achieving Universal Health Coverage through the Ayushman Bharat initiative.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-25%20130657.jpg\" width=\"1179\" height=\"513\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Strengthening tertiary care facilities in urban areas:</strong> While tertiary care is important, the primary focus is on strengthening primary healthcare infrastructure, not tertiary care facilities</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Expansion of private healthcare partnerships exclusively:</strong> The policy emphasizes public healthcare strengthening as the primary approach, though public-private partnerships are considered complementary</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Focus on curative and rehabilitative services:&nbsp;</strong>The policy specifically emphasizes preventive and promotive care as key components of the comprehensive healthcare approach</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">National Health Policy 2017 prioritizes primary healthcare through Health and Wellness Centers</span></li><li><span style=\"font-size:14.0pt;\">The policy aims to achieve Universal Health Coverage with focus on comprehensive care</span></li><li><span style=\"font-size:14.0pt;\">Preventive and promotive care are emphasized alongside curative services in the new healthcare model</span></li></ul>",
      "correct_choice_id": 391553,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98380/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98380/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 87026,
      "choices": [
        {
          "id": 346588,
          "text": "<p><span style=\"font-size:14.0pt;\">GAVE</span></p>"
        },
        {
          "id": 346589,
          "text": "<p><span style=\"font-size:14.0pt;\">Meckel’s diverticulitis</span></p>"
        },
        {
          "id": 346590,
          "text": "<p><span style=\"font-size:14.0pt;\">Duodenal adenocarcinoma</span></p>"
        },
        {
          "id": 346591,
          "text": "<p><span style=\"font-size:14.0pt;\">Mallory Weiss tear</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man came with complaints of dark-colored stools to the OPD. After undergoing endoscopy, the patient was diagnosed with an upper GI bleed. Which of the following is not included in upper GI bleed?&nbsp;</span></p>",
      "unique_key": "Q1876114",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Meckel’s diverticulitis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Meckel’s diverticulum arises from the distal ileum, making it part of the lower GI tract.</span></li><li><span style=\"font-size:14.0pt;\">While it can cause painless bleeding, especially in children, it's anatomically not part of the upper GI (which ends at the ligament of Treitz).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. GAVE:&nbsp;</strong>GAVE <strong>(Gastric Antral Vascular Ectasia)</strong> is a vascular lesion in the antrum of the stomach, sometimes called \"watermelon stomach.\" It can cause chronic or acute upper GI bleeding, often leading to iron-deficiency anemia<strong>.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Duodenal Adenocarcinoma:</strong> The duodenum is part of the <strong>upper GI tract</strong>, and tumors here may <strong>ulcerate or erode vessels</strong>, causing bleeding. Although rare, duodenal cancers can present with <strong>melena or anemia</strong> due to occult or overt bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mallory-Weiss Tear:</strong> A mucosal laceration at the <strong>gastroesophageal junction</strong>, often caused by forceful vomiting. It leads to <strong>hematemesis</strong> and is a classic cause of acute <strong>upper GI bleed</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Upper GI bleeding sources lie proximal to the ligament of Treitz</strong> — includes esophagus, stomach, and duodenum.</span></p>",
      "correct_choice_id": 346589,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87026/FMGE_SURGERY_MOCK_2_Q_30.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/87026/FMGE_SURGERY_MOCK_2_Q_30.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98501,
      "choices": [
        {
          "id": 392032,
          "text": "<p><span style=\"font-size:14.0pt;\">Superoxide dismutase in mitochondria</span></p>"
        },
        {
          "id": 392033,
          "text": "<p><span style=\"font-size:14.0pt;\">Glutathione peroxidase activity</span></p>"
        },
        {
          "id": 392034,
          "text": "<p><span style=\"font-size:14.0pt;\">Catalase function</span></p>"
        },
        {
          "id": 392035,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin E regeneration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient from a selenium-deficient region in China presents with cardiomyopathy and muscle weakness. This same mineral deficiency would also impair which of the following antioxidant defense mechanisms?</span></p>",
      "unique_key": "Q3776826",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)&nbsp;Glutathione peroxidase activity</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Selenium</strong> is an essential trace mineral that serves as a <strong>cofactor</strong> for several enzymes, most importantly <strong>glutathione peroxidase (GPx)</strong> — a key enzyme in the body’s <strong>antioxidant defense system</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Role of Glutathione Peroxidase:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">GPx protects cells from <strong>oxidative damage</strong> by reducing <strong>hydrogen peroxide (H₂O₂)</strong> and <strong>lipid peroxides</strong> to water and corresponding alcohols.</span></li><li><span style=\"font-size:14.0pt;\">The reaction catalyzed is:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2 GSH + H<sub>2 </sub>O<sub>2</sub> → GSSG + 2 H<sub>2</sub> O</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">(Where GSH = reduced glutathione, GSSG = oxidized glutathione)</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This reaction prevents accumulation of <strong>reactive oxygen species (ROS)</strong> that can damage cellular membranes, lipids, and proteins.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Selenium Deficiency:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Decreases glutathione peroxidase activity → accumulation of ROS → oxidative tissue injury.</span></li><li><span style=\"font-size:14.0pt;\">Associated with <strong>Keshan disease</strong>, an <strong>endemic cardiomyopathy</strong> seen in selenium-deficient regions (especially in parts of China).</span></li><li><span style=\"font-size:14.0pt;\">Also causes <strong>skeletal muscle weakness</strong> due to increased oxidative damage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Superoxide dismutase in mitochondria:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Converts <strong>superoxide radicals (O₂⁻)&nbsp;</strong>to <strong>hydrogen peroxide</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Requires <strong>manganese (Mn)</strong> in mitochondria and <strong>copper/zinc (Cu/Zn)</strong> in the cytosol, <strong>not selenium</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Catalase function:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Converts <strong>hydrogen peroxide (H₂O₂)</strong> to <strong>water and oxygen</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Located mainly in <strong>peroxisomes</strong> and requires <strong>heme (iron)</strong> as a cofactor: <strong>not selenium.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Vitamin E regeneration:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Vitamin E acts as a <strong>lipid-soluble antioxidant</strong> that prevents lipid peroxidation.</span></li><li><span style=\"font-size:14.0pt;\">Selenium deficiency does not directly affect its regeneration, though both have <strong>synergistic roles</strong> in preventing oxidative damage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Selenium</strong> is an essential cofactor for <strong>glutathione peroxidase</strong>, an enzyme that detoxifies <strong>hydrogen peroxide and lipid peroxides</strong>, thereby protecting cells from oxidative injury.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Selenium deficiency impairs this antioxidant defense, leading to <strong>Keshan disease (cardiomyopathy)</strong> and <strong>muscle weakness</strong>.</span></li></ul>",
      "correct_choice_id": 392033,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98501/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98501/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98241,
      "choices": [
        {
          "id": 390996,
          "text": "<p><span style=\"font-size:14.0pt;\">The pyloric region is supplied by the right gastric artery from the common hepatic artery</span></p>"
        },
        {
          "id": 390997,
          "text": "<p><span style=\"font-size:14.0pt;\">The left gastric artery provides the dominant blood supply to the pylorus</span></p>"
        },
        {
          "id": 390998,
          "text": "<p><span style=\"font-size:14.0pt;\">The gastroduodenal artery directly supplies the pyloric sphincter</span></p>"
        },
        {
          "id": 390999,
          "text": "<p><span style=\"font-size:14.0pt;\">The short gastric arteries are the primary supply to this region</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-week-old male infant presents with persistent projectile vomiting after feeding, weight loss, and dehydration. Physical examination reveals a palpable olive-shaped mass in the epigastrium. Ultrasound confirms hypertrophic pyloric stenosis with a thickened pyloric muscle measuring 5mm. During pyloromyotomy, the surgeon must carefully divide the hypertrophied muscle while preserving the underlying mucosa. Understanding the anatomy of this region, which statement correctly describes the blood supply that must be preserved during this procedure?</span></p>",
      "unique_key": "Q9736182",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) The pyloric region is supplied by the right gastric artery from the common hepatic artery</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>pylorus</strong>, located at the distal end of the stomach, receives its main blood supply from <strong>branches of the hepatic artery</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>right gastric artery</strong>, arising from the <strong>common hepatic artery</strong>, supplies the <strong>lesser curvature and pyloric region</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It <strong>anastomoses</strong> with the <strong>left gastric artery</strong> along the lesser curvature, maintaining collateral flow.</span></li><li><span style=\"font-size:14.0pt;\">During <strong>Ramstedt’s pyloromyotomy</strong>, it is crucial to <strong>preserve the mucosa</strong> and <strong>maintain the integrity of the right gastric artery</strong> to ensure adequate perfusion and prevent postoperative complications.4</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-18%20111334.jpg\" width=\"895\" height=\"482\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;The left gastric artery provides the dominant blood supply to the pylorus:&nbsp;</strong>Incorrect. Supplies the <strong>upper part of the lesser curvature</strong>, not the pyloric region.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;The gastroduodenal artery directly supplies the pyloric sphincter:&nbsp;</strong>Incorrect. Supplies the <strong>duodenum and head of the pancreas</strong>, not directly the pylorus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;The short gastric arteries are the primary supply to this region:&nbsp;</strong>Incorrect. Arise from the <strong>splenic artery</strong> and supply the <strong>fundus</strong>, not the pylorus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>pylorus</strong> is primarily supplied by the <strong>right gastric artery (from the common hepatic artery)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Preserving this vessel during <strong>pyloromyotomy</strong> is essential to avoid <strong>ischemia</strong> and ensure <strong>proper healing</strong> of the pyloric region.</span></li></ul>",
      "correct_choice_id": 390996,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98241/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98241/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98794,
      "choices": [
        {
          "id": 393188,
          "text": "<p><span style=\"font-size:14.0pt;\">4 only</span></p>"
        },
        {
          "id": 393189,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4</span></p>"
        },
        {
          "id": 393190,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 393191,
          "text": "<p><span style=\"font-size:14.0pt;\">3 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements is incorrect regarding the new-generation drugs?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Semaglutide is a GLP-1 agonist used orally for type 2 diabetes mellitus.</span></li><li><span style=\"font-size:14.0pt;\">Siponimod modulates sphingosine-1-phosphate receptors and is used in multiple sclerosis.</span></li><li><span style=\"font-size:14.0pt;\">Solriamfetol is a dopamine and noradrenaline reuptake inhibitor used in narcolepsy and OSA-related sleepiness.</span></li><li><span style=\"font-size:14.0pt;\">Selinexor is a VEGF receptor inhibitor used in renal cell carcinoma.</span></li></ol>",
      "unique_key": "Q1737756",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.&nbsp;Selinexor is a VEGF receptor inhibitor used in renal cell carcinoma: </strong>Selinexor is <strong>not</strong> a VEGF receptor inhibitor and is <strong>not</strong> used for renal cell carcinoma. It is a <strong>selective inhibitor of nuclear export (SINE)</strong> that blocks <strong>exportin 1 (XPO1)</strong>, a nuclear export protein. By preventing the export of tumor suppressor proteins from the nucleus, Selinexor promotes apoptosis in malignant cells. It is primarily used in the <strong>treatment of multiple myeloma</strong> and <strong>diffuse large B-cell lymphoma (DLBCL)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Semaglutide is a GLP-1 agonist used orally for type 2 diabetes mellitus:</strong> Correct. Semaglutide is a <strong>GLP-1 receptor agonist</strong> that enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes weight loss. It is available both as a <strong>once-weekly subcutaneous injection</strong> and as an <strong>oral formulation (Rybelsus®)</strong> for <strong>type 2 diabetes mellitus</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Siponimod modulates sphingosine-1-phosphate receptors and is used in multiple sclerosis:&nbsp;</strong>Correct. Siponimod selectively modulates <strong>sphingosine-1-phosphate (S1P) receptors</strong> (subtypes 1 and 5), leading to sequestration of lymphocytes in lymph nodes and reducing neuroinflammation. It is indicated for <strong>secondary progressive multiple sclerosis (SPMS)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Solriamfetol is a dopamine and noradrenaline reuptake inhibitor used in narcolepsy and OSA-related sleepiness:&nbsp;</strong>Correct. Solriamfetol is a <strong>dopamine and norepinephrine reuptake inhibitor</strong> that promotes wakefulness and is approved for <strong>excessive daytime sleepiness</strong> associated with <strong>narcolepsy</strong> and <strong>obstructive sleep apnea (OSA)</strong>. It is <strong>not an amphetamine</strong>, and its mechanism differs from modafinil.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Semaglutide</strong> is an oral and injectable <strong>GLP-1 agonist</strong> used for <strong>type 2 diabetes</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Siponimod</strong> is an <strong>S1P receptor modulator</strong> approved for <strong>secondary progressive MS</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Solriamfetol</strong> is a <strong>DNRI</strong> used to treat <strong>excessive sleepiness</strong> in <strong>narcolepsy and OSA</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Selinexor</strong> is an <strong>XPO1 inhibitor</strong> for <strong>multiple myeloma &amp; DLBCL</strong>, not used in <strong>renal cancer</strong>.</span></li></ul>",
      "correct_choice_id": 393188,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98794/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98794/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98593,
      "choices": [
        {
          "id": 392392,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 3, 4 and 5 are correct</span></p>"
        },
        {
          "id": 392393,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 2 and 4 are correct</span></p>"
        },
        {
          "id": 392394,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 2, 3 and 5 are correct</span></p>"
        },
        {
          "id": 392395,
          "text": "<p><span style=\"font-size:14.0pt;\">All five statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding genomic imprinting are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Genomic imprinting refers to epigenetic silencing of one parental allele through DNA methylation.</span></li><li><span style=\"font-size:14.0pt;\">Prader–Willi syndrome results from loss of maternal gene expression on chromosome 15q11–q13.</span></li><li><span style=\"font-size:14.0pt;\">Angelman syndrome is associated with deletion or inactivation of the maternal UBE3A gene.</span></li><li><span style=\"font-size:14.0pt;\">Uniparental disomy can cause imprinting disorders by duplicating the inactive allele and deleting the active one.</span></li><li><span style=\"font-size:14.0pt;\">Beckwith–Wiedemann syndrome is associated with altered imprinting at 11p15, involving IGF-2 overexpression.</span></li></ol>",
      "unique_key": "Q3332498",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Only 1, 3, 4 and 5 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.&nbsp;Genomic imprinting refers to epigenetic silencing of one parental allele through DNA methylation:&nbsp;</strong>Correct.<strong>&nbsp;</strong>Genomic imprinting = <strong>parent-of-origin–specific expression</strong> due to <strong>methylation</strong> of one allele.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.&nbsp;Angelman syndrome is associated with deletion or inactivation of the maternal UBE3A gene:&nbsp;</strong>Correct.&nbsp;Maternal UBE3A is active; paternal allele is imprinted → loss → <strong>AS</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.&nbsp;Uniparental disomy can cause imprinting disorders by duplicating the inactive allele and deleting the active one:&nbsp;</strong>Correct.<strong>&nbsp;</strong>UPD can cause imprinting diseases by <strong>duplicating the imprinted (silent) allele</strong> → no active gene left.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.&nbsp;Beckwith–Wiedemann syndrome is associated with altered imprinting at 11p15, involving IGF-2 overexpression:&nbsp;</strong>Correct.</span><br><span style=\"font-size:14.0pt;\">Characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>IGF-2 overexpression</strong>,</span></li><li><span style=\"font-size:14.0pt;\">macrosomia</span></li><li><span style=\"font-size:14.0pt;\">organomegaly</span></li><li><span style=\"font-size:14.0pt;\">predisposition to <strong>Wilms tumor</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.&nbsp;Prader–Willi syndrome results from loss of maternal gene expression on chromosome 15q11–q13:&nbsp;</strong>Incorrect.</span><br><span style=\"font-size:14.0pt;\">PWS occurs due to:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Paternal deletion</strong>, or</span></li><li><span style=\"font-size:14.0pt;\">maternal uniparental disomy</span><br><span style=\"font-size:14.0pt;\">Maternal allele of this region is normally <strong>imprinted (silent)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Genomic imprinting</strong> is an <strong>epigenetic mechanism</strong> where one parental allele is silenced by <strong>DNA methylation</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Disorders such as <strong>Prader–Willi</strong>, <strong>Angelman</strong>, and <strong>Beckwith–Wiedemann syndromes</strong> arise from deletions, mutations, or <strong>uniparental disomy</strong> affecting imprinted genes.</span></li></ul>",
      "correct_choice_id": 392392,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98593/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98593/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98805,
      "choices": [
        {
          "id": 393232,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 only</span></p>"
        },
        {
          "id": 393233,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 only</span></p>"
        },
        {
          "id": 393234,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4</span></p>"
        },
        {
          "id": 393235,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about drugs used in CHF are correct?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Nesiritide has a short half-life due to breakdown by neprilysin.</span></li><li><span style=\"font-size:14.0pt;\">Sacubitril may increase risk of angioedema when combined with ACE inhibitors.</span></li><li><span style=\"font-size:14.0pt;\">Nesiritide is used orally for chronic heart failure.</span></li><li><span style=\"font-size:14.0pt;\">Sacubitril improves cardiac function by inhibiting β-receptors.</span></li></ol>",
      "unique_key": "Q2967328",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1 and 2 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Nesiritide has a short half-life due to breakdown by neprilysin:&nbsp;</strong>Correct.Nesiritide, a recombinant BNP, is rapidly degraded by the enzyme <strong>neprilysin (neutral endopeptidase, NEP)</strong>, limiting its duration of action. This breakdown accounts for its <strong>short half-life</strong>, which restricts its use to acute settings only.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Sacubitril may increase the risk of angioedema when combined with ACE inhibitors:&nbsp;</strong>Correct.<strong>&nbsp;</strong>Sacubitril inhibits neprilysin, which degrades <strong>bradykinin</strong>. When combined with ACE inhibitors (which also increase bradykinin), this <strong>raises the risk of angioedema</strong>. Therefore, <strong>sacubitril is used with ARBs</strong> (e.g., valsartan), not ACE inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;Statement 3. Nesiritide is used orally for chronic heart failure:&nbsp;</strong>Incorrect. Nesiritide is administered <strong>intravenously</strong> and is indicated for <strong>acute decompensated heart failure</strong>, not chronic therapy. Its short half-life and rapid degradation make it unsuitable for oral or long-term use.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Sacubitril improves cardiac function by inhibiting β-receptors:&nbsp;</strong>Incorrect. Sacubitril has <strong>no action on β-receptors</strong>. Its mechanism is <strong>neprilysin inhibition</strong>, leading to increased levels of <strong>natriuretic peptides</strong> (e.g., BNP, ANP), which improve heart failure symptoms by promoting vasodilation and natriuresis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Nesiritide</strong> has a short half-life due to <strong>neprilysin-mediated degradation</strong> and is used <strong>only IV for acute CHF</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Sacubitril</strong> must <strong>not</strong> be used with ACE inhibitors due to increased risk of <strong>angioedema</strong>, and <strong>acts by neprilysin inhibition</strong>, <strong>not via β-blockade</strong>.</span></li></ul>",
      "correct_choice_id": 393232,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98805/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98805/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98500,
      "choices": [
        {
          "id": 392028,
          "text": "<p><span style=\"font-size:14.0pt;\">16S rRNA</span></p>"
        },
        {
          "id": 392029,
          "text": "<p><span style=\"font-size:14.0pt;\">23S rRNA</span></p>"
        },
        {
          "id": 392030,
          "text": "<p><span style=\"font-size:14.0pt;\">28S rRNA</span></p>"
        },
        {
          "id": 392031,
          "text": "<p><span style=\"font-size:14.0pt;\">5S rRNA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old man is started on chloramphenicol therapy for treatment of Salmonella typhi infection. After starting the drug, the patient develops bone-marrow suppression. Chloramphenicol acts by inhibiting the enzyme responsible for peptide bond formation during translation. Which RNA component of the ribosome contains peptidyl transferase activity in prokaryotes?</span></p>",
      "unique_key": "Q7742146",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 23S rRNA</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Protein synthesis in <strong>prokaryotes</strong> occurs on the <strong>70S ribosome</strong>, which is made of:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>50S large subunit</strong> → contains <strong>23S rRNA + 5S rRNA</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>30S small subunit</strong> → contains <strong>16S rRNA</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">The <strong>enzyme responsible for peptide bond formation</strong> during translation is called <strong>peptidyl transferase</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This activity is <strong>not a protein enzyme</strong>, but is carried out by <strong>rRNA itself</strong>, making the ribosome a <strong>ribozyme</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Thus, 23S rRNA is the site of peptidyl transferase activity in prokaryotes</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>23S rRNA</strong>, located in the <strong>50S subunit</strong>, contains the <strong>peptidyl transferase center (PTC)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It catalyzes the formation of peptide bonds between amino acids, allowing the growing polypeptide chain to elongate.</span></li><li><span style=\"font-size:14.0pt;\">Drugs such as <strong>chloramphenicol</strong> work by binding to the <strong>50S subunit</strong> and inhibiting this peptidyl transferase activity, stopping protein synthesis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 16S rRNA:</strong> Part of the 30S small subunit; involved in mRNA binding and initiation, not peptide bond formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. 28S rRNA:</strong> Found in eukaryotic 60S ribosomal subunit, not in prokaryotes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. 5S rRNA:</strong> Part of the 50S subunit but does <strong>not</strong> have peptidyl transferase activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>prokaryotes</strong>, the <strong>23S rRNA</strong> component of the <strong>50S ribosomal subunit</strong> possesses <strong>peptidyl transferase activity</strong>, which catalyzes <strong>peptide bond formation</strong> during protein synthesis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Chloramphenicol inhibits this enzyme, leading to <strong>inhibition of bacterial protein synthesis</strong> and possible <strong>bone marrow suppression</strong> as an adverse effect.</span></li></ul>",
      "correct_choice_id": 392029,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98500/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98500/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98498,
      "choices": [
        {
          "id": 392020,
          "text": "<p><span style=\"font-size:14.0pt;\">To neutralize the charge on the protein</span></p>"
        },
        {
          "id": 392021,
          "text": "<p><span style=\"font-size:14.0pt;\">To reduce and break disulfide bonds</span></p>"
        },
        {
          "id": 392022,
          "text": "<p><span style=\"font-size:14.0pt;\">To coat the protein with negative charges</span></p>"
        },
        {
          "id": 392023,
          "text": "<p><span style=\"font-size:14.0pt;\">To denature the protein's secondary structure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During SDS-PAGE analysis, a protein sample is treated with SDS and β-mercaptoethanol before electrophoresis. What is the primary purpose of β-mercaptoethanol in this procedure?</span></p>",
      "unique_key": "Q9829064",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)&nbsp;To reduce and break disulfide bonds</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">β-Mercaptoethanol (or dithiothreitol) is used in SDS-PAGE (Sodium dodecyl sulfate–polyacrylamide gel electrophoresis) to <strong>reduce and break disulfide bonds</strong> between cysteine residues.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is essential for complete denaturation and separation of multimeric proteins into individual polypeptide chains.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The reducing agent contains sulfhydryl groups that cleave disulfide bonds through reduction, converting cystines back to cysteines.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This ensures that proteins are fully linearized and can be separated based solely on molecular mass.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;To neutralize the charge on the protein:</strong> SDS, not β-mercaptoethanol, overwhelms the protein's intrinsic charges by coating it with negative charges.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;To coat the protein with negative charges:</strong> This is the function of SDS, which binds at approximately one molecule per two peptide bonds, providing uniform negative charge density.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;To denature the protein's secondary structure:</strong> While β-mercaptoethanol helps complete denaturation by breaking disulfide bonds, SDS is primarily responsible for disrupting non-covalent interactions and denaturing secondary structure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">β-Mercaptoethanol specifically reduces disulfide bonds in SDS-PAGE, enabling complete separation of polypeptide chains for accurate molecular weight determination.</span></p>",
      "correct_choice_id": 392021,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98498/Ini-Neet_-_Gt__27Th_Nov_2025_Biochemistry_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98498/Ini-Neet_-_Gt__27Th_Nov_2025_Biochemistry_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98529,
      "choices": [
        {
          "id": 392144,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 392145,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 5 only</span></p>"
        },
        {
          "id": 392146,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
        },
        {
          "id": 392147,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following fungi are classified as endemic (systemic dimorphic) fungal pathogens?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Coccidioides immitis</span></li><li><span style=\"font-size:14.0pt;\">Cryptococcus neoformans</span></li><li><span style=\"font-size:14.0pt;\">Histoplasma capsulatum</span></li><li><span style=\"font-size:14.0pt;\">Aspergillus fumigatus</span></li><li><span style=\"font-size:14.0pt;\">Blastomyces dermatitidis</span></li></ol>",
      "unique_key": "Q8115806",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 3 and 5 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Coccidioides immitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Type:</strong> Dimorphic fungus</span></li><li><span style=\"font-size:14.0pt;\"><strong>Endemic area:</strong> Southwestern United States (California, Arizona), Central &amp; South America</span></li><li><span style=\"font-size:14.0pt;\"><strong>Disease:</strong> Coccidioidomycosis (Valley Fever)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pathology:</strong> Produces <strong>spherules with endospores</strong> in tissue (instead of yeast).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Histoplasma capsulatum:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Type:</strong> Dimorphic fungus</span></li><li><span style=\"font-size:14.0pt;\"><strong>Endemic area:</strong> Ohio and Mississippi River valleys; some parts of India</span></li><li><span style=\"font-size:14.0pt;\"><strong>Reservoir:</strong> Soil contaminated with <strong>bat or bird droppings</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Disease:</strong> Histoplasmosis – pulmonary and disseminated forms</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pathology:</strong> Intracellular yeast seen in <strong>macrophages</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5. Blastomyces dermatitidis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Type:</strong> Dimorphic fungus</span></li><li><span style=\"font-size:14.0pt;\"><strong>Endemic area:</strong> Eastern and Central USA; Great Lakes region</span></li><li><span style=\"font-size:14.0pt;\"><strong>Disease:</strong> Blastomycosis – involves lungs, skin, and bone</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pathology:</strong> Broad-based budding yeast on microscopy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Non-Endemic / Opportunistic Fungi:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Cryptococcus neoformans:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Type:</strong> Encapsulated yeast (not dimorphic)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Epidemiology:</strong> Worldwide; opportunistic (esp. in HIV/AIDS)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Source:</strong> Pigeon droppings</span></li><li><span style=\"font-size:14.0pt;\"><strong>Disease:</strong> Cryptococcal meningitis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Aspergillus fumigates:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Type:</strong> Filamentous mold (not dimorphic)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Epidemiology:</strong> Ubiquitous environmental fungus</span></li><li><span style=\"font-size:14.0pt;\"><strong>Disease:</strong> Aspergillosis (allergic, invasive, or colonizing types)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Endemic mycoses</strong> — including Histoplasma capsulatum, Blastomyces dermatitidis, and Coccidioides immitis — are <strong>dimorphic fungi</strong> capable of infecting <strong>healthy individuals</strong> in specific geographic regions.</span></li><li><span style=\"font-size:14.0pt;\">In contrast, <strong>Aspergillus and Cryptococcus</strong> are <strong>opportunistic fungi</strong>, typically affecting <strong>immunocompromised patients</strong> and not geographically restricted.</span></li></ul>",
      "correct_choice_id": 392145,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98529/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98529/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98582,
      "choices": [
        {
          "id": 392352,
          "text": "<p><span style=\"font-size:14.0pt;\">It is associated with TP53 and BRCA1 mutations</span></p>"
        },
        {
          "id": 392353,
          "text": "<p><span style=\"font-size:14.0pt;\">It has the best overall prognosis among invasive breast cancers</span></p>"
        },
        {
          "id": 392354,
          "text": "<p><span style=\"font-size:14.0pt;\">It is also called as basal type of cancer</span></p>"
        },
        {
          "id": 392355,
          "text": "<p><span style=\"font-size:14.0pt;\">It is most likely to respond to trastuzumab therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 48-year-old woman presents with a painless lump in her left breast for 4 months. She has no family history of breast cancer. On examination, the lump is firm, irregular, and fixed to the surrounding tissue. No nipple discharge or skin dimpling is noted. A mammogram reveals a speculated mass with microcalcifications. Core needle biopsy shows infiltrating malignant epithelial cells forming duct-like structures surrounded by desmoplastic stroma. Immunohistochemistry profile is as follows. Which of the following statements regarding this tumor is most accurate?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_U1sP1Aj.png\" width=\"347\" height=\"271\"></span></p>",
      "unique_key": "Q6580345",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) It has the best overall prognosis among invasive breast cancers</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The description fits Invasive Ductal Carcinoma – Luminal A subtype, based on IHC profile:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">ER/PR positive, HER2 negative, low Ki-67 → Luminal A molecular subtype.</span></li><li><span style=\"font-size:14.0pt;\">It has the best overall prognosis among invasive breast cancers&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Luminal A subtype = ER+, PR+, HER2–, low Ki-67</span></li><li><span style=\"font-size:14.0pt;\">Best prognosis due to: Slow growth</span></li><li><span style=\"font-size:14.0pt;\">Hormone receptor positivity → responsive to tamoxifen or aromatase inhibitors</span></li><li><span style=\"font-size:14.0pt;\">Fewer p53 mutations</span></li><li><span style=\"font-size:14.0pt;\">Metastasis tends to occur late, often to bone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is associated with TP53 and BRCA1 mutations:&nbsp;</strong>TP53 and BRCA1 mutations are typically linked with Basal-like (Triple-negative) carcinomas. Those tumors are ER-, PR-, HER2- and often high-grade, aggressive, and common in younger women. The patient here has ER+, PR+, HER2– → not basal-like.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It is also called the basal type of cancer:&nbsp;</strong>The basal type refers to triple-negative breast cancer (ER–, PR–, HER2–), which is aggressive, has a high Ki-67 index, and poor prognosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It is most likely to respond to trastuzumab therapy:&nbsp;</strong>Trastuzumab (Herceptin) targets HER2/neu-positive cancers. HER2-positive subtype = ER–, PR–, HER2+, showing high proliferation. This tumor is HER2-negative, hence won’t respond.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KQSDLzP.png\" width=\"785\" height=\"386\"></strong></span></p>",
      "correct_choice_id": 392353,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98582/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98582/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98290,
      "choices": [
        {
          "id": 391192,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine atony</span></p>"
        },
        {
          "id": 391193,
          "text": "<p><span style=\"font-size:14.0pt;\">Amniotic fluid embolism</span></p>"
        },
        {
          "id": 391194,
          "text": "<p><span style=\"font-size:14.0pt;\">Eclamptic seizure</span></p>"
        },
        {
          "id": 391195,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary thromboembolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old G3P2 woman at 40 weeks gestation undergoes oxytocin augmentation for slow labor. Shortly after placental delivery, she suddenly develops severe dyspnea, hypotension, and seizure-like activity, followed by massive vaginal bleeding. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q3829981",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Amniotic fluid embolism</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This presentation is <strong>classic for amniotic fluid embolism (AFE)</strong>, a <strong>catastrophic obstetric emergency</strong> characterized by <strong>sudden cardiovascular collapse</strong>, <strong>respiratory distress</strong>, <strong>seizure-like activity</strong>, and <strong>coagulopathy (DIC)</strong> occurring <strong>during or shortly after delivery</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Amniotic fluid (containing fetal cells, debris, or trophoblastic tissue) enters the <strong>maternal circulation</strong> through <strong>uterine veins</strong> during:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Labor (especially with strong contractions or oxytocin use)</span></li><li><span style=\"font-size:14.0pt;\">Delivery (vaginal or cesarean)</span></li><li><span style=\"font-size:14.0pt;\">Immediately after placental separation</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This triggers a <strong>massive anaphylactoid reaction</strong> → <strong>pulmonary vasospasm</strong>, <strong>right heart failure</strong>, <strong>hypoxia</strong>, and <strong>DIC</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical Features of Amniotic Fluid Embolism:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Respiratory distress:</strong> Sudden dyspnea, cyanosis</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cardiovascular collapse:</strong> Hypotension, shock, cardiac arrest</span></li><li><span style=\"font-size:14.0pt;\"><strong>Seizure-like activity or coma</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Coagulopathy/DIC:</strong> Massive bleeding from the uterus, IV sites, or wounds</span></li><li><span style=\"font-size:14.0pt;\"><strong>Timing:&nbsp;</strong>Typically <strong>during labor</strong>, <strong>immediately after delivery</strong>, or <strong>after placental separation</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Uterine atony:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Causes <strong>postpartum hemorrhage</strong> but <strong>not respiratory distress, hypotension, or seizures</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The uterus is soft and boggy, but systemic collapse is absent.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Eclamptic seizure:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Occurs <strong>before delivery or during pregnancy</strong>, not immediately <strong>after placental expulsion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Associated with <strong>hypertension and proteinuria</strong>, which are not mentioned here.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pulmonary thromboembolism:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">May cause <strong>dyspnea and hypotension</strong>, but <strong>DIC and massive vaginal bleeding</strong> are not characteristic.</span></li><li><span style=\"font-size:14.0pt;\">Onset is typically <strong>gradual</strong> rather than immediate post-delivery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Amniotic fluid embolism (AFE)</strong> presents <strong>suddenly during or after delivery</strong> with <strong>hypotension, respiratory distress, seizure-like activity, and DIC-related bleeding</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is caused by <strong>amniotic fluid entering maternal circulation</strong>, leading to an <strong>anaphylactoid reaction</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Immediate supportive care</strong> with <strong>oxygenation, hemodynamic stabilization, and correction of coagulopathy</strong> is critical.</span></li></ul>",
      "correct_choice_id": 391193,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98290/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98290/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98587,
      "choices": [
        {
          "id": 392372,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 3 and 5 are correct</span></p>"
        },
        {
          "id": 392373,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 4 and 5 are correct</span></p>"
        },
        {
          "id": 392374,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 2, 3 and 5 are correct</span></p>"
        },
        {
          "id": 392375,
          "text": "<p><span style=\"font-size:14.0pt;\">All five statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Papillary Thyroid Carcinoma (PTC) are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Papillary carcinoma commonly shows Orphan Annie eye nuclei, nuclear grooves, and intranuclear pseudoinclusions.</span></li><li><span style=\"font-size:14.0pt;\">It frequently spreads via the bloodstream to lungs and bones</span></li><li><span style=\"font-size:14.0pt;\">The presence of psammoma bodies is a rare microscopic feature of this tumor.</span></li><li><span style=\"font-size:14.0pt;\">RET/PTC rearrangements and BRAF V600E mutations are commonly associated with papillary carcinoma.</span></li><li><span style=\"font-size:14.0pt;\">Cervical lymph node metastasis is common but generally does not worsen long-term prognosis significantly.</span></li></ol>",
      "unique_key": "Q3037559",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Only 1, 4 and 5 are correct</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Papillary Thyroid Carcinoma (PTC)</strong> is the most common thyroid malignancy (≈80% of cases) and has an excellent prognosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It typically affects younger women and is associated with exposure to <strong>ionizing radiation</strong> and certain <strong>genetic mutations</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Papillary carcinoma commonly shows Orphan Annie eye nuclei, nuclear grooves, and intranuclear pseudoinclusions:</strong>&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">Characteristic nuclei — PTC is identified microscopically by:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Orphan Annie eye nuclei</strong> (cleared nuclei due to dispersed chromatin)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nuclear grooves</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Intranuclear pseudoinclusions</strong></span><br><span style=\"font-size:14.0pt;\">These are hallmark diagnostic features of papillary carcinoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>RET/PTC rearrangements and BRAF V600E mutations are commonly associated with papillary carcinoma:&nbsp;</strong></span></p><p><span style=\"font-size:14.0pt;\">Molecular associations — The most common genetic alterations include:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>RET/PTC rearrangements</strong> (especially in radiation-induced cases)</span></li><li><span style=\"font-size:14.0pt;\"><strong>BRAF V600E mutation</strong> (associated with aggressive variants)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>Cervical lymph node metastasis is common but generally does not worsen long-term prognosis significantly:</strong>&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Lymphatic spread — PTC typically spreads via <strong>lymphatics</strong> to <strong>cervical lymph nodes</strong>.</span></li><li><span style=\"font-size:14.0pt;\">However, despite frequent nodal involvement, <strong>long-term survival remains excellent</strong>, as nodal metastases <strong>do not significantly worsen prognosis</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>It frequently spreads via the bloodstream to lungs and bones: </strong>Blood-borne spread: PTC <strong>spreads via lymphatics</strong>, not bloodstream. <strong>Hematogenous spread</strong> (to lungs or bones) is characteristic of <strong>Follicular Thyroid Carcinoma</strong>, not papillary.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>The presence of psammoma bodies is a rare microscopic feature of this tumor:</strong> Psammoma bodies are <strong>common</strong>, not rare, in PTC. They represent <strong>concentric calcifications</strong> seen in about 50% of cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Papillary Thyroid Carcinoma</strong> is characterized by Orphan Annie eye nuclei, nuclear grooves, psammoma bodies, and RET/PTC or BRAF mutations.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It spreads <strong>lymphatically</strong>, not hematogenously, and despite frequent <strong>cervical lymph node metastasis</strong>, prognosis remains <strong>excellent</strong>.</span></li></ul>",
      "correct_choice_id": 392373,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98587/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98587/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98577,
      "choices": [
        {
          "id": 392332,
          "text": "<p><span style=\"font-size:14.0pt;\">It is associated with usual interstitial pneumonia (UIP) pattern</span></p>"
        },
        {
          "id": 392333,
          "text": "<p><span style=\"font-size:14.0pt;\">It shows temporal heterogeneity on histology</span></p>"
        },
        {
          "id": 392334,
          "text": "<p><span style=\"font-size:14.0pt;\">It responds dramatically to corticosteroid therapy</span></p>"
        },
        {
          "id": 392335,
          "text": "<p><span style=\"font-size:14.0pt;\">Fibroblast foci are a characteristic feature</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old male presents with progressive shortness of breath and dry cough for 1 year. Chest X-ray shows bilateral reticular opacities, and lung biopsy shows honeycomb fibrosis with fibroblast foci. Which of the following statements regarding this condition is not true?</span></p>",
      "unique_key": "Q1312524",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) It responds dramatically to corticosteroid therapy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient’s presentation—<strong>chronic progressive dyspnea</strong>, <strong>dry cough</strong>, <strong>honeycomb fibrosis</strong>, and <strong>fibroblast foci</strong>—is characteristic of <strong>Idiopathic Pulmonary Fibrosis (IPF)</strong>, which shows a <strong>Usual Interstitial Pneumonia (UIP) pattern</strong> on histology.</span></li><li><span style=\"font-size:14.0pt;\">IPF does NOT respond dramatically — or even reliably — to corticosteroids, because the disease is driven by irreversible fibrosis rather than inflammation. Instead, antifibrotic agents such as <strong>pirfenidone and nintedanib&nbsp;</strong>are the mainstay of treatment, functioning to slow the progression of fibrosis.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Features of Idiopathic Pulmonary Fibrosis (UIP pattern):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Gross findings:</strong> Shrunken, firm lungs with subpleural and basal predominance.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Microscopy:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Patchy interstitial fibrosis</strong> (areas of normal lung alternating with fibrotic areas).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Temporal heterogeneity:</strong> coexistence of early fibroblast foci and late-stage honeycombing.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fibroblast foci</strong> — hallmark of ongoing injury and repair.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Clinical course:</strong> Progressive respiratory failure with poor response to corticosteroids or immunosuppressants.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Prognosis:</strong> Poor; median survival 3–5 years.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is associated with usual interstitial pneumonia (UIP) pattern:&nbsp;</strong>True.Idiopathic Pulmonary Fibrosis shows the <strong>UIP pattern</strong>, which is the defining histopathologic feature characterized by <strong>patchy interstitial fibrosis, fibroblast foci, and honeycombing</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. It shows temporal heterogeneity on histology:&nbsp;</strong>True.<strong>&nbsp;</strong>UIP is marked by <strong>temporal heterogeneity</strong>, meaning areas of fibrosis at <strong>different stages of evolution</strong> — some early (fibroblast foci) and some late (dense collagen fibrosis and honeycombing).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fibroblast foci are a characteristic feature:&nbsp;</strong>True. Fibroblast foci represent actively proliferating fibroblasts and are a classic finding in UIP/IPF, indicating ongoing epithelial injury and repair.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Idiopathic Pulmonary Fibrosis (IPF)</strong> is characterized by a <strong>Usual Interstitial Pneumonia (UIP) pattern</strong> with <strong>temporal heterogeneity</strong>, <strong>fibroblast foci</strong>, and <strong>honeycomb fibrosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Unlike inflammatory interstitial lung diseases, IPF <strong>does not respond well to corticosteroid therapy</strong> and has a <strong>progressive, irreversible course</strong>.</span></li></ul>",
      "correct_choice_id": 392334,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98577/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98577/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98108,
      "choices": [
        {
          "id": 390472,
          "text": "<p><span style=\"font-size:14.0pt;\">Carpal Tunnel Syndrome</span></p>"
        },
        {
          "id": 390473,
          "text": "<p><span style=\"font-size:14.0pt;\">Radial Nerve Palsy</span></p>"
        },
        {
          "id": 390474,
          "text": "<p><span style=\"font-size:14.0pt;\">Median Nerve Palsy</span></p>"
        },
        {
          "id": 390475,
          "text": "<p><span style=\"font-size:14.0pt;\">Ulnar Nerve Neuropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 45-year-old male concert violinist presents with a 6-month history of insidious onset numbness and tingling in his left hand. He reports his symptoms worsen after long practice sessions, especially when his elbow is held in a flexed position. On physical examination, atrophy of the hypothenar eminence and a prominent hollowing of the first dorsal interosseous space is noticed. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_RGenNGb.png\" width=\"364\" height=\"241\"></span></p>",
      "unique_key": "Q4057129",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Ulnar Nerve Neuropathy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The ulnar nerve supplies sensation to the little finger and the ulnar half of the ring finger.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While the exact sensory distribution isn't specified, the location of the motor atrophy strongly supports an ulnar nerve issue.</span></li><li><span style=\"font-size:14.0pt;\">The ulnar nerve is the primary motor supply to the intrinsic muscles of the hand, including the:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Hypothenar muscles</span></li><li><span style=\"font-size:14.0pt;\">Interossei muscles&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Adductor Pollicis&nbsp;</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The physical exam findings align perfectly:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Indicates weakness/wasting of the hypothenar muscles (supplied by the ulnar nerve).</span></li><li><span style=\"font-size:14.0pt;\">The first dorsal interosseous muscle is a strong ulnar nerve-supplied muscle. Its atrophy causes hollowing between the thumb and index finger metacarpals.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This sign is a strong indicator of chronic ulnar nerve palsy.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The patient is a violinist and reports symptoms worsening when the elbow is held in a flexed position for long practice sessions.</span></li><li><span style=\"font-size:14.0pt;\">The ulnar nerve passes through the cubital tunnel at the medial aspect of the elbow.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Prolonged elbow flexion significantly increases tension and pressure on the ulnar nerve in this area, making it the most common site of compression neuropathy after the wrist (carpal tunnel).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Carpal Tunnel Syndrome:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Causes numbness and tingling in the thumb, index, and middle fingers.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Motor atrophy, when present, affects the thenar eminence (median nerve supplied muscles), not the hypothenar eminence or interossei.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Radial Nerve Palsy:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Causes wrist drop and finger drop (loss of wrist and finger extension). Sensory loss is typically over the dorsum of the hand.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It does not cause hypothenar or interosseous atrophy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Median Nerve Palsy:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The symptoms are primarily the same as Carpal Tunnel Syndrome, involving the thumb/index/middle fingers and thenar atrophy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The atrophy seen in this case (hypothenar and interosseous) is <strong>not</strong> consistent with median nerve involvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">To differentiate between common compressive neuropathies of the upper extremity by correlating specific symptoms (insidious onset, worsening with elbow flexion) and key motor atrophy patterns (hypothenar eminence and first dorsal interosseous muscle) with the correct anatomical nerve distribution (Ulnar Nerve Neuropathy).</span></li><li><span style=\"font-size:14.0pt;\">This skill is essential for diagnosing the correct site of nerve entrapment (most commonly the cubital tunnel at the elbow) and initiating appropriate treatment.</span></li></ul>",
      "correct_choice_id": 390475,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98108/INI-NEET_-_GT__27th_Nov_2025_Orthopedics_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98108/INI-NEET_-_GT__27th_Nov_2025_Orthopedics_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98275,
      "choices": [
        {
          "id": 391132,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased prostaglandin F₂α production</span></p>"
        },
        {
          "id": 391133,
          "text": "<p><span style=\"font-size:14.0pt;\">Inadequate luteal phase progesterone production</span></p>"
        },
        {
          "id": 391134,
          "text": "<p><span style=\"font-size:14.0pt;\">Unopposed estrogen stimulation with anovulation</span></p>"
        },
        {
          "id": 391135,
          "text": "<p><span style=\"font-size:14.0pt;\">Excessive progesterone secretion from persistent corpus luteum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman presents with heavy vaginal bleeding following 3–4 months of amenorrhea. On examination, the uterus is symmetrically enlarged, soft, and boggy, consistent with an endometrial disorder. Endometrial biopsy reveals cystic glandular hyperplasia with a “Swiss cheese” appearance. Which of the following best describes the underlying pathophysiology?</span></p>",
      "unique_key": "Q9498665",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Unopposed estrogen stimulation with anovulation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has <strong>endometrial hyperplasia</strong>, which typically presents as <strong>prolonged amenorrhea followed by heavy uterine bleeding</strong> (termed “breakthrough bleeding”).</span></li><li><span style=\"font-size:14.0pt;\">The <strong>Swiss cheese pattern</strong> on biopsy is classic for <strong>cystic glandular hyperplasia</strong>, an early manifestation of <strong>unopposed estrogen effect</strong> on the endometrium.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In women around <strong>perimenopause</strong>, <strong>anovulatory cycles</strong> become common due to irregular <strong>gonadotropin secretion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Without ovulation, <strong>no corpus luteum forms</strong>, leading to <strong>absence of progesterone</strong> production.</span></li><li><span style=\"font-size:14.0pt;\">As a result, the <strong>endometrium is exposed to continuous estrogen stimulation</strong>, causing <strong>proliferation of glands without secretory maturation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Eventually, the unstable endometrium outgrows its blood supply, resulting in <strong>irregular heavy bleeding</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Histopathology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cystically dilated glands</strong> with irregular outlines (“Swiss cheese” pattern).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Proliferative stroma</strong> without cytologic atypia.</span></li><li><span style=\"font-size:14.0pt;\"><strong>No secretory changes</strong>, confirming <strong>anovulatory cycles</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Increased prostaglandin F₂α production:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Incorrect. PGF₂α causes <strong>uterine contractions and dysmenorrhea</strong>, not endometrial hyperplasia.</span></li><li><span style=\"font-size:14.0pt;\">It does not explain the <strong>amenorrhea followed by heavy bleeding</strong> pattern or the histologic findings.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Inadequate luteal phase progesterone production:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Incorrect. Seen in <strong>luteal phase defects</strong>, where <strong>insufficient progesterone</strong> leads to <strong>shortened cycles</strong>, not prolonged amenorrhea.</span></li><li><span style=\"font-size:14.0pt;\">Endometrial histology would show <strong>poorly developed secretory changes</strong>, not cystic glandular hyperplasia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Excessive progesterone secretion from persistent corpus luteum:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Incorrect. Progesterone dominance causes <strong>secretory endometrium</strong> and <strong>scant bleeding</strong>, not hyperplasia.</span></li><li><span style=\"font-size:14.0pt;\">The biopsy would show <strong>secretory glands</strong>, not the proliferative “Swiss cheese” pattern.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Endometrial hyperplasia with cystic glandular proliferation</strong> results from <strong>unopposed estrogen stimulation</strong> due to <strong>anovulatory cycles</strong>, commonly seen in <strong>perimenopausal women</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The absence of progesterone leads to continuous endometrial proliferation, creating the characteristic <strong>“Swiss cheese”</strong> histologic pattern and causing <strong>irregular heavy bleeding</strong>.</span></li></ul>",
      "correct_choice_id": 391134,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98275/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98275/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98287,
      "choices": [
        {
          "id": 391180,
          "text": "<p><span style=\"font-size:14.0pt;\">Weekly progesterone injections starting at 16 weeks</span></p>"
        },
        {
          "id": 391181,
          "text": "<p><span style=\"font-size:14.0pt;\">Prophylactic cerclage at 12–14 weeks</span></p>"
        },
        {
          "id": 391182,
          "text": "<p><span style=\"font-size:14.0pt;\">Bed rest from 14 weeks onwards</span></p>"
        },
        {
          "id": 391183,
          "text": "<p><span style=\"font-size:14.0pt;\">Serial cervical length measurements starting at 16 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman (G4P0) with a history of three painless second-trimester pregnancy losses at 16, 18, and 20 weeks presents for preconception counseling. Each loss was preceded by spontaneous rupture of membranes without contractions. In her last pregnancy, a transvaginal ultrasound at 14 weeks showed a cervical length of 22 mm with funneling. What is the most appropriate management in her next pregnancy?</span></p>",
      "unique_key": "Q5481293",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Prophylactic cerclage at 12–14 weeks</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This woman’s history and imaging findings are consistent with <strong>cervical insufficiency (incompetent cervix)</strong> — a condition characterized by <strong>painless cervical dilation leading to recurrent, mid-trimester pregnancy losses or preterm births</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Key Diagnostic Clues:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Recurrent painless second-trimester losses</strong> (16–20 weeks)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Spontaneous rupture of membranes</strong> without labor</span></li><li><span style=\"font-size:14.0pt;\"><strong>Short cervix with funneling</strong> on ultrasound (≤25 mm before 24 weeks)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>best preventive measure</strong> in such cases is <strong>prophylactic (history-indicated) cervical cerclage</strong>, typically performed at <strong>12–14 weeks gestation</strong>, after confirming a <strong>viable intrauterine pregnancy</strong> and <strong>absence of infection or bleeding</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Procedure:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The most common approach is the <strong>McDonald cerclage</strong> (purse-string suture at the cervico-vaginal junction).</span></li><li><span style=\"font-size:14.0pt;\">The suture is usually removed at <strong>36–37 weeks</strong> or earlier if labor begins.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Adjunctive care:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Progesterone supplementation may also be considered, but <strong>cerclage</strong> remains the mainstay for classical cervical insufficiency.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Weekly progesterone injections starting at 16 weeks:&nbsp;</strong>Incorrect. Progesterone is used for <strong>prevention of preterm labor</strong> due to <strong>spontaneous preterm birth</strong>, not for classic <strong>cervical incompetence</strong> with recurrent mid-trimester losses.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Bed rest from 14 weeks onwards:&nbsp;</strong>Incorrect. Bed rest alone <strong>does not prevent pregnancy loss</strong> and is not recommended as a substitute for cerclage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Serial cervical length measurements starting at 16 weeks:&nbsp;</strong>Incorrect. Useful for surveillance in women <strong>without a strong history</strong>, but not adequate in those with <strong>recurrent losses</strong> and proven cervical shortening — they require <strong>prophylactic cerclage</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In women with a <strong>history of recurrent, painless second-trimester pregnancy losses</strong> and <strong>short cervix on ultrasound</strong>, the <strong>most effective preventive measure</strong> is <strong>prophylactic cervical cerclage</strong>, ideally performed at <strong>12–14 weeks of gestation</strong> in the next pregnancy.</span></p>",
      "correct_choice_id": 391181,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98287/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98287/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98116,
      "choices": [
        {
          "id": 390504,
          "text": "<p><span style=\"font-size:14.0pt;\">One district judge and one social worker</span></p>"
        },
        {
          "id": 390505,
          "text": "<p><span style=\"font-size:14.0pt;\">One first-class judicial magistrate and two social workers, one of whom must be a woman</span></p>"
        },
        {
          "id": 390506,
          "text": "<p><span style=\"font-size:14.0pt;\">Two first-class judicial magistrates and one social worker</span></p>"
        },
        {
          "id": 390507,
          "text": "<p><span style=\"font-size:14.0pt;\">Three social workers, including at least two with legal experience</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A Juvenile Justice Board is reviewing a case involving a 15-year-old offender. What is the required composition of the board to ensure the case is reviewed appropriately according to the Juvenile Justice Act?</span></p>",
      "unique_key": "Q7852692",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) One first-class judicial magistrate and two social workers, one of whom must be a woman</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Juvenile Justice Board is designed to include one first-class judicial magistrate and two social workers, where at least one of the social workers must be a woman.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This composition ensures a balanced approach, combining legal oversight with insights from experienced individuals in health, education, law, psychology, or psychiatry, which are critical for addressing the needs of juvenile offenders.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_hCDSSid.png\" width=\"665\" height=\"571\"></p>",
      "correct_choice_id": 390505,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98116/INI-NEET_-_GT__27th_Nov_2025_FMT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98116/INI-NEET_-_GT__27th_Nov_2025_FMT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98493,
      "choices": [
        {
          "id": 392000,
          "text": "<p><span style=\"font-size:14.0pt;\">Fructose-1-phosphate</span></p>"
        },
        {
          "id": 392001,
          "text": "<p><span style=\"font-size:14.0pt;\">Glyceraldehyde-3-phosphate</span></p>"
        },
        {
          "id": 392002,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucose</span></p>"
        },
        {
          "id": 392003,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucose-6-phosphate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 2-year-old boy is brought to the emergency department with vomiting, lethargy, and sweating after drinking fruit juice. His parents report similar symptoms after he consumes sweets. Laboratory tests show hypoglycemia and hepatic dysfunction. A metabolic disorder involving the inability to cleave fructose metabolites is suspected. The defective enzyme, which functions as a lyase, normally acts on which of the following substrates?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4061865",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Fructose-1-phosphate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Aldolase, particularly <strong>aldolase B</strong>, acts as a lyase enzyme for <strong>fructose-1-phosphate</strong> during fructose metabolism. It catalyzes the cleavage of fructose 1 phosphate into two products:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Dihydroxyacetone phosphate (DHAP)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Glyceraldehyde</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">This reaction is essential in the liver for the proper metabolism of dietary fructose.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The enzyme performs its function without the addition of water or the involvement of oxidation-reduction reactions, which is characteristic of lyase activity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Deficiency of aldolase B leads to <strong>hereditary fructose intolerance</strong>, a metabolic condition characterized by the accumulation of fructose-1-phosphate, causing hypoglycemia, vomiting, and liver dysfunction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Glyceraldehyde-3-phosphate:</strong> This compound is an intermediate in glycolysis and the Calvin cycle, but aldolase does not act on it. Instead, enzymes like glyceraldehyde-3-phosphate dehydrogenase process this substrate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Glucose:&nbsp;</strong>Aldolase does not cleave glucose. Glucose is phosphorylated by hexokinase or glucokinase in glycolysis and follows a separate pathway.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Glucose-6-phosphate:</strong> This substrate is involved in glycolysis and the pentose phosphate pathway but is not acted upon by aldolase. Glucose-6-phosphate is processed by enzymes like glucose-6-phosphatase or glucose-6-phosphate dehydrogenase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Aldolase B acts as a lyase for fructose-1-phosphate, cleaving it into DHAP and glyceraldehyde during fructose metabolism.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This reaction is critical for energy production from dietary fructose, and defects in aldolase B result in hereditary fructose intolerance.</span></li></ul>",
      "correct_choice_id": 392000,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98493/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98493/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98118,
      "choices": [
        {
          "id": 390512,
          "text": "<p><span style=\"font-size:14.0pt;\">A person with borderline personality disorder who exhibits emotional dysregulation but can still reason through a decision is not compos mentis.</span></p>"
        },
        {
          "id": 390513,
          "text": "<p><span style=\"font-size:14.0pt;\">A person with OCD who compulsively checks locks but understands the broader implications of their actions is compos mentis.</span></p>"
        },
        {
          "id": 390514,
          "text": "<p><span style=\"font-size:14.0pt;\">A person diagnosed with dissociative identity disorder can never be considered compos mentis because they have multiple, distinct identities.</span></p><p>&nbsp;</p>"
        },
        {
          "id": 390515,
          "text": "<p><span style=\"font-size:14.0pt;\">Both B and C.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following best describes the concept of compos mentis in the context of mental health?</span></p>",
      "unique_key": "Q3892810",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) A person with OCD who compulsively checks locks but understands the broader implications of their actions is compos mentis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A person with OCD might engage in compulsive behaviours, but if they understand the broader implications of their actions (such as knowing the behaviour is irrational), they can still be considered&nbsp;<strong>compos mentis</strong>, meaning they are mentally competent to make decisions, even if their actions are influenced by compulsions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>A person with borderline personality disorder who exhibits emotional dysregulation but can still reason through a decision is not compos mentis:</strong>&nbsp;Emotional dysregulation alone (as in borderline personality disorder) does not necessarily impair a person’s decision-making capacity. Many such individuals can still think rationally and are legally considered compos mentis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>A person diagnosed with dissociative identity disorder can never be considered compos mentis because they have multiple, distinct identities:</strong> Dissociative identity disorder (DID) involves the presence of distinct identities, but it does not mean a person with DID cannot be&nbsp;<strong>compos mentis</strong>. In many cases, individuals with DID may still demonstrate decision-making capacity, depending on which identity is dominant at the time.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Compos mentis</strong> is not about the presence or absence of a mental illness but rather about <strong>cognitive clarity and decision-making capacity</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Many individuals with psychiatric conditions like OCD or even borderline personality disorder can still be considered mentally competent in legal and clinical settings.</span></li></ul>",
      "correct_choice_id": 390513,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98118/INI-NEET_-_GT__27th_Nov_2025_FMT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98118/INI-NEET_-_GT__27th_Nov_2025_FMT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 86990,
      "choices": [
        {
          "id": 346444,
          "text": "<p><span style=\"font-size:14.0pt;\">Congenital diaphragmatic hernia&nbsp;</span></p>"
        },
        {
          "id": 346445,
          "text": "<p><span style=\"font-size:14.0pt;\">Tetralogy of Fallot&nbsp;</span></p>"
        },
        {
          "id": 346446,
          "text": "<p><span style=\"font-size:14.0pt;\">Transposition of great vessels&nbsp;</span></p>"
        },
        {
          "id": 346447,
          "text": "<p><span style=\"font-size:14.0pt;\">Tracheoesophageal fistula&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Respiratory distress is noticed in a newborn. On examination, the neonate appears cyanotic with increased work of breathing. Auscultation reveals bowel sounds in the left hemithorax. Chest x-ray showed multiple air fluid levels. Which of the following congenital anomalies is most likely responsible for these findings?</span></p>",
      "unique_key": "Q7052007",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Congenital diaphragmatic hernia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical picture of a cyanotic newborn with respiratory distress and auscultation revealing bowel sounds in the left hemithorax, combined with chest X-ray showing multiple air-fluid levels, is suggestive of a congenital anomaly that allows abdominal contents into the thoracic cavity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">CDH is a defect in the diaphragm that allows abdominal organs to herniate into the thoracic cavity, impairing lung development and causing respiratory distress and cyanosis after birth.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of bowel sounds in the thorax and air-fluid levels on X-ray are indicative of this condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Tetralogy of Fallot:</strong> This is a congenital heart defect that includes four abnormalities: ventricular septal defect, pulmonary stenosis, right ventricular hypertrophy, and an overriding aorta. It leads to cyanotic congenital heart disease but does not cause bowel sounds in the thorax or air-fluid levels on X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Transposition of the great vessels:</strong> This is another congenital heart defect where the major vessels (the aorta and the pulmonary artery) are switched. It results in cyanosis but would not cause bowel sounds in the chest or air-fluid levels on X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Tracheoesophageal fistula:</strong> This condition involves an abnormal connection between the trachea and esophagus, which can lead to respiratory distress due to aspiration, but it would not cause bowel sounds in the thorax or the radiographic appearance of air-fluid levels as seen with CDH.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Congenital diaphragmatic hernia is most likely responsible for the clinical findings of cyanosis, respiratory distress, and bowel sounds in the chest of a newborn, along with air-fluid levels on chest X-ray.</span></p>",
      "correct_choice_id": 346444,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86990/FMGE_SURGERY_MOCK_2_Q_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86990/FMGE_SURGERY_MOCK_2_Q_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98111,
      "choices": [
        {
          "id": 390484,
          "text": "<p><span style=\"font-size:14.0pt;\">Rigidity, hyperthermia, and increased CPK levels</span></p>"
        },
        {
          "id": 390485,
          "text": "<p><span style=\"font-size:14.0pt;\">Rigidity, restlessness, and increased CPK levels</span></p>"
        },
        {
          "id": 390486,
          "text": "<p><span style=\"font-size:14.0pt;\">Fever, restlessness, and myoglobinuria</span></p>"
        },
        {
          "id": 390487,
          "text": "<p><span style=\"font-size:14.0pt;\">Tremors, restlessness, and increased CPK levels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The following symptoms are classically seen in patients with Neuroleptic Malignant Syndrome (NMS):</span></p>",
      "unique_key": "Q3224364",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Rigidity, hyperthermia, and increased CPK levels</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Neuroleptic Malignant Syndrome (NMS)</strong> is a rare but potentially fatal reaction to antipsychotic medications, particularly <strong>dopamine-blocking agents</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is characterized by the classic tetrad of:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Severe muscle rigidity</strong> (lead-pipe type)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hyperthermia (high fever)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Autonomic instability</strong> (fluctuating BP, tachycardia, diaphoresis)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Altered mental status</strong></span></li></ol></li><li><span style=\"font-size:14.0pt;\">Laboratory findings include <strong>elevated creatine phosphokinase (CPK)</strong> due to muscle breakdown and <strong>myoglobinuria</strong>, which may lead to renal failure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Rigidity, restlessness, and increased CPK levels:</strong> Incorrect. Restlessness suggests <strong>akathisia</strong>, not NMS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Fever, restlessness, and myoglobinuria:</strong> Incorrect. Myoglobinuria may occur, but <strong>restlessness</strong> is not a defining feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Tremors, restlessness, and increased CPK levels:</strong> Incorrect. Tremors may occur in drug-induced parkinsonism, but NMS shows <strong>rigidity</strong>, not tremor or restlessness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Neuroleptic Malignant Syndrome</strong> presents with <strong>rigidity, hyperthermia, autonomic instability, altered mental status, and elevated CPK levels</strong> following dopamine blockade—requiring prompt recognition and management with <strong>drug withdrawal, supportive care, and dantrolene or bromocriptine</strong>.</span></p>",
      "correct_choice_id": 390484,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98111/New_GT_Psychiatry_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98111/New_GT_Psychiatry_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98576,
      "choices": [
        {
          "id": 392328,
          "text": "<p><span style=\"font-size:14.0pt;\">It commonly occurs in adults and is associated with Auer rods</span></p>"
        },
        {
          "id": 392329,
          "text": "<p><span style=\"font-size:14.0pt;\">It arises from myeloid progenitor cells</span></p>"
        },
        {
          "id": 392330,
          "text": "<p><span style=\"font-size:14.0pt;\">It has a better prognosis in children and is associated with B-cell lineage</span></p>"
        },
        {
          "id": 392331,
          "text": "<p><span style=\"font-size:14.0pt;\">It shows TRAP-positive cells with cytoplasmic projections</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-year-old boy presents with fever, fatigue, and bone pain. Examination shows pallor and generalized lymphadenopathy. Peripheral smear shows atypical cells. Bone marrow biopsy reveals PAS-positive, TdT-positive blasts. Cytogenetic analysis demonstrates t(12;21) translocation. Which of the following statements about this condition is true?</span></p>",
      "unique_key": "Q9537287",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) It has a good prognosis in children and is associated with B-cell lineage</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The described case is <strong>Acute Lymphoblastic Leukemia (ALL)</strong> — specifically <strong>B-cell ALL</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Diagnostic Features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Age group:</strong> Commonly affects <strong>children (2–10 years)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Symptoms:</strong> Fever, fatigue, bone pain, lymphadenopathy, hepatosplenomegaly, and pallor.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Peripheral smear and bone marrow:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>PAS-positive</strong> (Periodic Acid–Schiff stain) — indicates lymphoid lineage.</span></li><li><span style=\"font-size:14.0pt;\"><strong>TdT-positive (Terminal deoxynucleotidyl transferase)</strong> — marker of <strong>immature lymphoid cells</strong> (pre-B or pre-T cells).</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Cytogenetic finding:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>t(12;21)</strong> translocation is characteristic of <strong>B-cell ALL</strong> and is associated with a <strong>favorable prognosis</strong> in children.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Prognostic factors:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Good prognosis:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Age 1–10 years</span></li><li><span style=\"font-size:14.0pt;\">Low WBC count (&lt;50,000/μL)</span></li><li><span style=\"font-size:14.0pt;\"><strong>B-cell phenotype</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>t(12;21) translocation</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Poor prognosis:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">&lt;1 year or &gt;10 years</span></li><li><span style=\"font-size:14.0pt;\">T-cell phenotype</span></li><li><span style=\"font-size:14.0pt;\">High leukocyte count</span></li><li><span style=\"font-size:14.0pt;\"><strong>t(9;22)</strong> (Philadelphia chromosome)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It commonly occurs in adults and is associated with Auer rods:&nbsp;</strong>Incorrect. This describes <strong>Acute Myeloid Leukemia (AML)</strong>, not ALL. <strong>Auer rods</strong> are seen in <strong>myeloblasts</strong>, not lymphoblasts.AML is more common in <strong>adults</strong>, whereas ALL is more common in <strong>children</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. It arises from myeloid progenitor cells:&nbsp;</strong>Incorrect. ALL arises from <strong>lymphoid progenitor cells</strong>, not myeloid. <strong>Myeloid progenitors</strong> give rise to AML, which is <strong>TdT-negative</strong> and <strong>MPO-positive</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It shows TRAP-positive cells with cytoplasmic projections:&nbsp;</strong>Incorrect. This finding is characteristic of <strong>Hairy Cell Leukemia</strong>, not ALL.<strong>TRAP</strong> stands for <strong>Tartrate-Resistant Acid Phosphatase</strong>, which stains positive in hairy cells (a mature B-cell neoplasm).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Acute Lymphoblastic Leukemia (ALL)</strong> is a <strong>TdT-positive, PAS-positive malignancy of lymphoid progenitor cells</strong>, most often seen in <strong>children</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>t(12;21) translocation</strong> is associated with <strong>B-cell ALL</strong> and confers a <strong>favorable prognosis</strong>.</span></li></ul>",
      "correct_choice_id": 392330,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98576/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98576/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98789,
      "choices": [
        {
          "id": 393168,
          "text": "<p><span style=\"font-size:14.0pt;\">Quinidine</span></p>"
        },
        {
          "id": 393169,
          "text": "<p><span style=\"font-size:14.0pt;\">Ibutilide</span></p>"
        },
        {
          "id": 393170,
          "text": "<p><span style=\"font-size:14.0pt;\">Procainamide</span></p>"
        },
        {
          "id": 393171,
          "text": "<p><span style=\"font-size:14.0pt;\">Lidocaine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old patient presents with episodes of palpitations, dizziness, and light-headedness. The ECG report is shown below. Which of the following drug is least likely to be associated with the development of this condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ql72VXr.png\" width=\"452\" height=\"408\"></span></p>",
      "unique_key": "Q3280392",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Lidocaine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Lidocaine, a class IB antiarrhythmic agent (K<sup>+</sup> channel opener and sodium channel blocker), is primarily used for the treatment of ventricular arrhythmias, particularly in the setting of ischemia.&nbsp;&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It works by blocking sodium channels in their inactivated state and shortening the action potential duration.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Unlike class IA agents, it does not prolong the QT interval or predispose to torsades de pointes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Quinidine:&nbsp;</strong>Quinidine is a class IA antiarrhythmic that blocks sodium and potassium channels. It prolongs the QT interval, increasing the risk of torsades de pointes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ibutilide:&nbsp;</strong>This class III agent also prolongs the QT interval and is associated with the risk of torsades de pointes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Procainamide:&nbsp;</strong>Another class IA antiarrhythmic, procainamide can prolong the QT interval, increasing the likelihood of torsades de pointes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Class IB agents, such as lidocaine, do not prolong the QT interval and are less likely to cause arrhythmias like torsades de pointes compared to class IA agents.</span></p>",
      "correct_choice_id": 393171,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98789/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98789/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98586,
      "choices": [
        {
          "id": 392368,
          "text": "<p><span style=\"font-size:14.0pt;\">Autoantibodies are directed against platelet membrane glycoproteins GpIIb/IIIa or GpIb</span></p>"
        },
        {
          "id": 392369,
          "text": "<p><span style=\"font-size:14.0pt;\">Splenic macrophages play a key role in platelet destruction</span></p>"
        },
        {
          "id": 392370,
          "text": "<p><span style=\"font-size:14.0pt;\">Platelet transfusion is the mainstay of long-term treatment</span></p>"
        },
        {
          "id": 392371,
          "text": "<p><span style=\"font-size:14.0pt;\">Corticosteroids and IV immunoglobulin are effective initial therapies</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman presents with recurrent episodes of easy bruising, petechiae over both lower limbs, and gum bleeding for the past 3 months. She had a mild viral upper respiratory infection 2 weeks before the first episode. There is no history of joint pain, splenomegaly, or use of any new drugs. On examination, she is afebrile and has no lymphadenopathy or hepatosplenomegaly. Laboratory findings: Hemoglobin: 12.4 g/dL, WBC count: 6,800 /mm³ Platelet count: 18,000 /mm³ (↓) Bleeding time: prolonged with normal PT and normal aPTT. Bone marrow aspiration: increased megakaryocytes. Which of the following statements regarding her condition is not true?</span></p>",
      "unique_key": "Q7920712",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Platelet transfusion is the mainstay of long-term treatment</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">All features (isolated thrombocytopenia, increased marrow megakaryocytes, normal coagulation profile, no splenomegaly) are consistent with Immune Thrombocytopenic Purpura (ITP).</span></li><li><span style=\"font-size:14.0pt;\">Platelet transfusion is the mainstay of long-term treatment Transfused platelets are rapidly destroyed by circulating antibodies — so platelet transfusion is not useful except in life-threatening bleeding.</span></li><li><span style=\"font-size:14.0pt;\">Mainstay therapy:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Corticosteroids (prednisolone)</span></li><li><span style=\"font-size:14.0pt;\">IVIg (blocks Fc receptors on macrophages)</span></li><li><span style=\"font-size:14.0pt;\">Rituximab or splenectomy for chronic/refractory cases.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Autoantibodies are directed against platelet membrane glycoproteins GpIIb/IIIa or GpIb:&nbsp; </strong>ITP is an autoimmune disorder where IgG antibodies are formed against platelet surface glycoproteins (GpIIb/IIIa, GpIb). These antibody-coated platelets are destroyed in the spleen by macrophages. Autoantibodies may also impair megakaryocyte platelet production.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Splenic macrophages play a key role in platelet destruction:&nbsp; </strong>The spleen is central to ITP pathogenesis. Site of antibody production (B cells). Site of platelet destruction (macrophages). Hence splenectomy is beneficial in chronic cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Corticosteroids and IV immunoglobulin are effective initial therapies:&nbsp;</strong>Corticosteroids ↓ autoantibody production and macrophage activity. IVIg competes for Fc receptors on splenic macrophages, temporarily increasing platelet count. Response typically within days.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4SLfFm5.png\" width=\"761\" height=\"469\"></strong></span></p>",
      "correct_choice_id": 392370,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98586/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98586/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98608,
      "choices": [
        {
          "id": 392452,
          "text": "<p><span style=\"font-size:14.0pt;\">Acquired syphilis - Argyll Robertson pupil</span></p>"
        },
        {
          "id": 392453,
          "text": "<p><span style=\"font-size:14.0pt;\">Early congenital syphilis - Snuffles</span></p>"
        },
        {
          "id": 392454,
          "text": "<p><span style=\"font-size:14.0pt;\">Late congenital syphilis - Hutchinson's triad</span></p>"
        },
        {
          "id": 392455,
          "text": "<p><span style=\"font-size:14.0pt;\">Congenital rubella - Gregg's triad</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old child presented in ENT OPD with complaints of hearing loss. This mother complains that the child's dentition is not appropriate according to his age. Examination revealed the following findings. What is the most likely diagnosis and its associated triad?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6BcESoX.png\" width=\"617\" height=\"238\"></span></p>",
      "unique_key": "Q6346259",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Late congenital syphilis - Hutchinson's triad</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The presentation in this case represents the classic Hutchinson's triad seen in late congenital syphilis, which includes:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Interstitial keratitis</strong> - inflammation of the corneal stroma without involvement of the epithelium or endothelium</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hutchinson's teeth</strong> - notched upper central incisors (screwdriver-shaped incisors)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Sensorineural hearing loss</strong> (VIII nerve deafness)</span></li></ol></li><li><span style=\"font-size:14.0pt;\">Additional include frontal bossing and saddle nose deformity, which are characteristic skeletal manifestations of late congenital syphilis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Late congenital syphilis typically manifests after 2 years of age and represents the chronic sequelae of untreated maternal syphilis transmitted to the fetus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acquired syphilis - Argyll Robertson pupil:&nbsp;</strong>This is a feature of acquired neurosyphilis in adults, not congenital syphilis. The Argyll Robertson pupil is characterized by small pupils that accommodate but do not react to light (light-near dissociation). This finding would not be expected in a 10-year-old with congenital infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Early congenital syphilis - Snuffles:</strong> Early congenital syphilis presents in infancy (typically under 2 years of age) with manifestations like \"snuffles\" (syphilitic rhinitis with mucopurulent discharge), maculopapular rash, and hepatosplenomegaly. This is inconsistent with the age and presentation of this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Congenital rubella - Gregg's triad:</strong> Gregg's triad consists of cataracts, congenital heart defects (particularly patent ductus arteriosus and pulmonary stenosis), and sensorineural deafness. The absence of ocular and cardiac findings, along with the presence of notched teeth and skeletal deformities, makes congenital rubella unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hutchinson's triad (interstitial keratitis, notched incisors, and sensorineural hearing loss) is pathognomonic for late congenital syphilis, which typically manifests after 2 years of age.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Recognition of this classic triad is crucial for proper diagnosis and management of this preventable infectious disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KEn60Dg.png\" width=\"761\" height=\"599\"></span></p>",
      "correct_choice_id": 392454,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98608/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98608/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98268,
      "choices": [
        {
          "id": 391104,
          "text": "<p><span style=\"font-size:14.0pt;\">Stimulation of central medullary chemoreceptors by hypoxemia</span></p>"
        },
        {
          "id": 391105,
          "text": "<p><span style=\"font-size:14.0pt;\">Activation of peripheral chemoreceptors in the carotid and aortic bodies by decreased PaO₂</span></p>"
        },
        {
          "id": 391106,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased activity of J receptors in response to elevated PaCO₂</span></p>"
        },
        {
          "id": 391107,
          "text": "<p><span style=\"font-size:14.0pt;\">Direct excitation of the phrenic nerve by elevated H⁺ concentration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 56-year-old man with a history of severe chronic obstructive pulmonary disease (COPD) presents with progressive shortness of breath. Arterial blood gas analysis reveals PaO₂ = 55 mm Hg, PaCO₂ = 60 mm Hg, and pH = 7.32. Which of the following best describes the mechanism responsible for the increased respiratory drive in this patient?</span></p>",
      "unique_key": "Q2354568",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Activation of peripheral chemoreceptors in the carotid and aortic bodies by decreased PaO₂</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hypoxemia</strong> stimulates ventilation <strong>via the peripheral chemoreceptors</strong> located in the <strong>carotid bodies (mainly)</strong> and <strong>aortic bodies</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These receptors respond directly to <strong>decreases in arterial oxygen tension (PaO₂)</strong>, typically when it falls below <strong>60 mm Hg</strong>.</span></li><li><span style=\"font-size:14.0pt;\">When activated, they send excitatory signals to the <strong>respiratory centers in the medulla</strong>, increasing the rate and depth of breathing.</span></li><li><span style=\"font-size:14.0pt;\">In contrast, the <strong>central (medullary) chemoreceptors</strong> are primarily sensitive to <strong>changes in arterial CO₂</strong> (and the corresponding H⁺ concentration in cerebrospinal fluid).</span></li><li><span style=\"font-size:14.0pt;\">In chronic hypercapnia (as in COPD), these central chemoreceptors become desensitized, making <strong>hypoxemia the dominant respiratory drive</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Stimulation of central medullary chemoreceptors by hypoxemia:&nbsp;</strong>Central chemoreceptors respond to <strong>CO₂ or H⁺</strong>, <strong>not low O₂</strong>. They are located near the ventral surface of the medulla and detect changes in <strong>CSF pH</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Increased activity of J receptors in response to elevated PaCO₂: J (juxtacapillary) receptors</strong> respond to <strong>pulmonary interstitial edema</strong> or <strong>increased capillary pressure</strong>, not to CO₂ levels. They contribute to rapid, shallow breathing seen in pulmonary congestion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Direct excitation of the phrenic nerve by elevated H⁺ concentration:&nbsp;</strong>The <strong>phrenic nerve</strong> is an efferent motor nerve supplying the <strong>diaphragm</strong>; it does not act as a chemoreceptor or sensory detector of H⁺. Its activity is controlled by the <strong>medullary respiratory centers</strong>, not by direct chemical stimuli.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Peripheral chemoreceptors (carotid and aortic bodies)</strong> detect <strong>hypoxemia (↓PaO₂)</strong> → stimulate ventilation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Central chemoreceptors (medulla)</strong> detect <strong>↑PaCO₂ or ↑H⁺</strong> → stimulate ventilation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>J receptors</strong> respond to <strong>pulmonary congestion</strong>, not gases.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stretch receptors</strong> inhibit overinflation (Hering–Breuer reflex).</span></li><li><span style=\"font-size:14.0pt;\">The <strong>phrenic nerve</strong> executes diaphragmatic movement under <strong>brainstem control</strong>.</span></li></ul>",
      "correct_choice_id": 391105,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98268/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98268/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98276,
      "choices": [
        {
          "id": 391136,
          "text": "<p><span style=\"font-size:14.0pt;\">McDonald suture</span></p>"
        },
        {
          "id": 391137,
          "text": "<p><span style=\"font-size:14.0pt;\">Transobturator tape (TOT)</span></p>"
        },
        {
          "id": 391138,
          "text": "<p><span style=\"font-size:14.0pt;\">Tension-free vaginal tape (TVT)</span></p>"
        },
        {
          "id": 391139,
          "text": "<p><span style=\"font-size:14.0pt;\">Shirodkar sling</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the surgical device shown in the image below.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6bzN3jr.png\" width=\"446\" height=\"325\"></span></p>",
      "unique_key": "Q7635882",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Transobturator tape (TOT)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The image shows a <strong>U-shaped polypropylene mesh tape with curved introducers</strong>, which is characteristic of a <strong>Transobturator Tape (TOT)</strong> used for the surgical management of <strong>stress urinary incontinence (SUI)</strong> in women.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Mechanism &amp; Purpose:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">TOT is a <strong>mid-urethral sling procedure</strong> designed to provide <strong>support to the urethra</strong> and prevent leakage during increased intra-abdominal pressure (e.g., coughing, sneezing).</span></li><li><span style=\"font-size:14.0pt;\">The tape passes <strong>through the obturator foramen</strong> (either from outside-in or inside-out) and lies <strong>beneath the mid-urethra</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It creates a <strong>\"hammock-like\" support</strong>, restoring the normal urethral closure mechanism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:14.0pt;\"><strong>Option A. McDonald suture:</strong> Used for <strong>cervical cerclage</strong> in cases of <strong>cervical incompetence</strong>, not for urinary incontinence.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tension-free vaginal tape (TVT):</strong> Similar material, but passed <strong>retropubically</strong>, not through the obturator foramen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Shirodkar sling:</strong> Another <strong>cerclage technique</strong> used to reinforce the cervix, unrelated to urinary incontinence surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Transobturator Tape (TOT)</strong> is a <strong>mid-urethral sling procedure</strong> for treating <strong>stress urinary incontinence (SUI)</strong> in women, offering effective urethral support with fewer complications than retropubic TVT.</span></p>",
      "correct_choice_id": 391137,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98276/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98276/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98792,
      "choices": [
        {
          "id": 393180,
          "text": "<p><span style=\"font-size:14.0pt;\">12.5 mg/L</span></p>"
        },
        {
          "id": 393181,
          "text": "<p><span style=\"font-size:14.0pt;\">1250 mg/L</span></p>"
        },
        {
          "id": 393182,
          "text": "<p><span style=\"font-size:14.0pt;\">50 mg/L</span></p>"
        },
        {
          "id": 393183,
          "text": "<p><span style=\"font-size:14.0pt;\">125 mg/L</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient is receiving a continuous intravenous infusion of a medication at a rate of 250 mg/hour. The drug’s clearance (CL) is known to be 5 L/hour. What is the expected steady-state plasma concentration (Css) for this patient?</span></p>",
      "unique_key": "Q2892873",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 50 mg/L</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">To calculate the <strong>steady-state plasma concentration (Css)</strong> during continuous IV infusion, use the formula:</span></li><li><span style=\"font-size:14.0pt;\">Maintenance Dosing rate (infusion rate) = Clearance x Target plasma concentration (Steady state plasma concentration; Css)</span></li><li><span style=\"font-size:14.0pt;\">So, Css = Infusion rate/Clearance</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Here:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Infusion rate = 200 mg/hour</span></li><li><span style=\"font-size:14.0pt;\">Clearance = 5 L/hour</span></li></ul><p><span style=\"font-size:14.0pt;\"><strong>So,&nbsp;</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Css = 250/5 = 50 mg/L</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">During <strong>constant IV infusion</strong>, the <strong>steady-state plasma concentration</strong> is directly proportional to the <strong>infusion rate</strong> and inversely proportional to the <strong>drug’s clearance</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_LqujmWL.png\" width=\"370\" height=\"89\"></span></p>",
      "correct_choice_id": 393182,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98792/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98792/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98556,
      "choices": [
        {
          "id": 392252,
          "text": "<p><span style=\"font-size:14.0pt;\">Arteriovenous malformation</span></p>"
        },
        {
          "id": 392253,
          "text": "<p><span style=\"font-size:14.0pt;\">Glioblastoma multiforme</span></p>"
        },
        {
          "id": 392254,
          "text": "<p><span style=\"font-size:14.0pt;\">Pituitary adenoma</span></p>"
        },
        {
          "id": 392255,
          "text": "<p><span style=\"font-size:14.0pt;\">Trigeminal neuralgia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following conditions is least likely to be treated using Gamma knife stereotactic radiosurgery?</span></p>",
      "unique_key": "Q2326773",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Glioblastoma multiforme</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Glioblastoma multiforme is a diffuse, infiltrative tumor requiring broader radiotherapy techniques and systemic treatment.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Gamma knife is designed for highly localized lesions, such as AVMs, pituitary adenomas, and trigeminal neuralgia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Arteriovenous malformation:</strong> AVMs are one of the primary indications for Gamma knife radiosurgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pituitary adenoma:</strong> These localized tumors are effectively treated with Gamma knife.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Trigeminal neuralgia:</strong> Gamma knife is widely used for this condition to target the nerve root without damaging adjacent structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Gamma knife radiosurgery is most effective for localized lesions and conditions such as AVMs, pituitary adenomas, and trigeminal neuralgia, but is not suitable for diffuse tumors like glioblastoma.</span></p>",
      "correct_choice_id": 392253,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98556/INI-NEET_-_GT__27th_Nov_2025_Radiology_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98556/INI-NEET_-_GT__27th_Nov_2025_Radiology_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98296,
      "choices": [
        {
          "id": 391216,
          "text": "<p><span style=\"font-size:14.0pt;\">Entonox</span></p>"
        },
        {
          "id": 391217,
          "text": "<p><span style=\"font-size:14.0pt;\">Nitrous Oxide</span></p>"
        },
        {
          "id": 391218,
          "text": "<p><span style=\"font-size:14.0pt;\">Chloroform</span></p>"
        },
        {
          "id": 391219,
          "text": "<p><span style=\"font-size:14.0pt;\">Cyclopropane</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Pin index of 7 is of which gas?</span></p>",
      "unique_key": "Q4320245",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Entonox</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Entonox, also known as <strong>gas and air</strong>, is a <strong>premixed gas</strong> consisting of <strong>50% Oxygen and 50% Nitrous Oxide</strong>. It's often used for <strong>analgesia</strong>, such as in <strong>labor</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>pin index</strong> of Entonox is <strong>7</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Entonox is a mixture of Nitrous Oxide and Oxygen in the ratio of 50: 50.</strong></span></li><li><span style=\"font-size:14.0pt;\">The pin index system is a <strong>safety system</strong> used on <strong>medical gas cylinders</strong> and their <strong>corresponding yokes</strong>, which are the <strong>connectors</strong> that attach to <strong>anesthesia machines</strong> or other <strong>medical gas delivery systems</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Each gas</strong> has a <strong>unique pin index number&nbsp;</strong>to <strong>prevent accidental misconnection</strong> of <strong>gas cylinders</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The pin index system ensures the <strong>safe and correct connection</strong> of <strong>medical gas cylinders</strong> to their <strong>corresponding equipment</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Each medical gas has a <strong>unique pin index</strong> to <strong>prevent</strong> the <strong>accidental administration</strong> of the <strong>wrong gas</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Entonox, a 50:50 mixture of nitrous oxide and oxygen, has a pin index number of 7.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_jRdnrO6.png\" width=\"481\" height=\"358\"></span></p>",
      "correct_choice_id": 391216,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98296/INI-NEET_-_GT__27th_Nov_2025_Anesthesia_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98296/INI-NEET_-_GT__27th_Nov_2025_Anesthesia_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98605,
      "choices": [
        {
          "id": 392440,
          "text": "<p><span style=\"font-size:14.0pt;\">Pneumonia</span></p>"
        },
        {
          "id": 392441,
          "text": "<p><span style=\"font-size:14.0pt;\">Severe pneumonia</span></p>"
        },
        {
          "id": 392442,
          "text": "<p><span style=\"font-size:14.0pt;\">No pneumonia, only cough and cold</span></p>"
        },
        {
          "id": 392443,
          "text": "<p><span style=\"font-size:14.0pt;\">Very severe pneumonia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 9-month-old infant is brought to the primary health center with a cough and fast breathing for 2 days. On examination, the respiratory rate is 58 breaths/minute, there is no chest indrawing, and the infant is feeding well. Temperature is 38.5°C. The child appears alert and there are no other signs of distress. According to IMNCI (Integrated Management of Neonatal and Childhood Illness) guidelines, how would you classify this child's condition?</span></p>",
      "unique_key": "Q1221777",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>&nbsp;Ans.</strong> <strong>A) Pneumonia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Integrated Management of Neonatal and Childhood Illness (IMNCI) provides standardized guidelines for classifying and managing common childhood illnesses.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">For respiratory infections, classification is based primarily on <strong>age-specific respiratory rate thresholds</strong>, presence of <strong>chest indrawing</strong>, and <strong>danger signs</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>In this case:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The child is 9 months old, so falls in the <strong>3-12 month age category</strong> where <strong>fast breathing is defined as RR &gt; 50/min</strong></span></li><li><span style=\"font-size:14.0pt;\">This child has <strong>RR 58/min</strong> (above the cutoff)</span></li><li><span style=\"font-size:14.0pt;\">There is <strong>no chest indrawing</strong> reported</span></li><li><span style=\"font-size:14.0pt;\">There are <strong>no danger signs</strong> mentioned (the child is feeding well and has no reported lethargy, unconsciousness, convulsions, inability to drink, or persistent vomiting)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Based on these findings, this child meets the criteria for \"Pneumonia\" according to the IMNCI classification.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This represents a significant but not severe respiratory infection requiring appropriate antibiotic therapy (typically oral amoxicillin for 5 days) along with supportive care and home management.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>IMNCI Classification of Respiratory Illness:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_S78bMur.png\" width=\"749\" height=\"291\"></strong></span></p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_oiqxaCO.png\" width=\"828\" height=\"720\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Severe pneumonia:</strong> This classification requires danger signs, which is not present in this child.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>C. No pneumonia, only cough and cold:</strong> The child has a respiratory rate of 58/min, which exceeds the threshold of 50/min for the 3-12 month age group, making this classification incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D. Very severe pneumonia</strong>: This term is not used currently.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Age-specific respiratory rate cut offs are crucial in IMNCI classification:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">0-2 months: &gt;60/min</span></li><li><span style=\"font-size:14.0pt;\">2-12 months: &gt;50/min</span></li><li><span style=\"font-size:14.0pt;\">1-5 years: &gt;40/min</span></li></ul>",
      "correct_choice_id": 392440,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98605/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98605/INI-NEET_-_GT__27th_Nov_2025_Pediatrics_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98579,
      "choices": [
        {
          "id": 392340,
          "text": "<p><span style=\"font-size:14.0pt;\">The p53 gene normally arrests the cell cycle at the G1/S checkpoint to allow DNA repair.</span></p>"
        },
        {
          "id": 392341,
          "text": "<p><span style=\"font-size:14.0pt;\">Loss of heterozygosity at 17p leads to loss of normal p53 function.</span></p>"
        },
        {
          "id": 392342,
          "text": "<p><span style=\"font-size:14.0pt;\">Overexpression of mutated p53 protein leads to increased degradation of abnormal cells.</span></p>"
        },
        {
          "id": 392343,
          "text": "<p><span style=\"font-size:14.0pt;\">HPV infection can lead to p53 degradation via E6 protein-mediated ubiquitination.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old male smoker presents with a non-healing ulcer on the lateral border of the tongue for 6 months. The lesion is indurated with rolled margins. A biopsy reveals squamous cell carcinoma, and immunohistochemistry shows overexpression of p53 protein. Further workup reveals multiple metastases to cervical lymph nodes. Which of the following statements regarding the molecular mechanisms of this neoplasm is false?</span></p>",
      "unique_key": "Q9763760",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Overexpression of mutated p53 protein leads to increased degradation of abnormal cells.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mutated p53 overexpression increases degradation - Mutated (nonfunctional) p53 protein often accumulates in cells because it is not degraded properly, and hence IHC shows overexpression.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, this does not lead to degradation of abnormal cells - instead, it fails to arrest the cell cycle or induce apoptosis, promoting tumorigenesis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;The p53 gene normally arrests the cell cycle at the G1/S checkpoint to allow DNA repair:&nbsp;</strong>p53 acts as a tumor suppressor. When DNA damage occurs, it halts the cycle at G1/S via p21 activation, allowing DNA repair. If repair fails, it induces apoptosis through BAX upregulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Loss of heterozygosity at 17p leads to loss of normal p53 function</strong>: The p53 gene is located on chromosome 17p13.1. Loss of heterozygosity (second hit) results in loss of the functional tumor suppressor, allowing uncontrolled proliferation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;HPV infection can lead to p53 degradation via E6 protein-mediated ubiquitination:</strong> In HPV-related squamous cell carcinomas, viral E6 protein binds to p53 and promotes its ubiquitin-mediated degradation, effectively mimicking p53 loss. This is a classic viral oncogenic mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">E6 protein → binds p53 → ubiquitin-mediated degradation.</span></li><li><span style=\"font-size:14.0pt;\">E7 protein → binds Rb → releases E2F → uncontrolled S-phase entry.</span></li></ul>",
      "correct_choice_id": 392342,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98579/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98579/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98531,
      "choices": [
        {
          "id": 392152,
          "text": "<p><span style=\"font-size:14.0pt;\">Wuchereria bancrofti</span></p>"
        },
        {
          "id": 392153,
          "text": "<p><span style=\"font-size:14.0pt;\">Trichuris trichiura</span></p>"
        },
        {
          "id": 392154,
          "text": "<p><span style=\"font-size:14.0pt;\">Dracunculus medinensis</span></p>"
        },
        {
          "id": 392155,
          "text": "<p><span style=\"font-size:14.0pt;\">Echinococcus granulosus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following parasites is not known to cause arthritis as a clinical manifestation?</span></p>",
      "unique_key": "Q2526140",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Trichuris trichiura</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Trichuris trichiura (whipworm) primarily inhabits the <strong>large intestine (cecum and colon)</strong>, where it causes <strong>localized mucosal inflammation</strong>, <strong>tenesmus</strong>, and <strong>rectal prolapse</strong> in heavy infections.</span></li><li><span style=\"font-size:14.0pt;\">It <strong>does not invade extraintestinal tissues</strong> and hence has <strong>no association with joint involvement or arthritis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The infection is confined to the gastrointestinal tract and is not linked to systemic immunologic or migratory manifestations that could affect joints.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Wuchereria bancrofti:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>filarial worms</strong> can occasionally induce <strong>immune complex–mediated arthritis or synovitis</strong>, especially after treatment or due to antigen release from dying microfilariae.</span></li><li><span style=\"font-size:14.0pt;\">Such immune responses can trigger <strong>periarticular inflammation</strong> and pain.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Dracunculus medinensis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The adult worm often migrates through <strong>subcutaneous tissues</strong> and may localize near joints, causing <strong>painful arthritis-like swelling</strong>, particularly in the <strong>knee or ankle region</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This is due to <strong>inflammatory reaction</strong> and <strong>secondary bacterial infection</strong> around the emerging worm.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Echinococcus granulosus:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>hydatid cysts</strong> of Echinococcus may involve <strong>bone and joint structures</strong>, leading to <strong>secondary arthritis</strong> due to <strong>pressure effects</strong> and <strong>erosion of adjacent bone</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Although rare, joint involvement can occur, particularly in <strong>hip and knee regions</strong> when bone cysts expand.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Among parasitic infections, <strong>arthritis</strong> can occur due to <strong>immune complex deposition</strong>, <strong>local tissue migration</strong>, or <strong>compression from cystic lesions</strong>.</span></li><li><span style=\"font-size:14.0pt;\">However, <strong>Trichuris trichiura</strong> infection remains confined to the <strong>intestinal lumen</strong> and <strong>does not cause arthritis</strong> or any extraintestinal manifestations.</span></li></ul>",
      "correct_choice_id": 392153,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98531/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98531/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98395,
      "choices": [
        {
          "id": 391612,
          "text": "<p><span style=\"font-size:14.0pt;\">Sensitivity represents the ability of a test to correctly identify diseased individuals</span></p>"
        },
        {
          "id": 391613,
          "text": "<p><span style=\"font-size:14.0pt;\">Specificity represents the ability of a test to correctly identify non-diseased individuals</span></p>"
        },
        {
          "id": 391614,
          "text": "<p><span style=\"font-size:14.0pt;\">Positive predictive value increases as disease prevalence increases in the population</span></p>"
        },
        {
          "id": 391615,
          "text": "<p><span style=\"font-size:14.0pt;\">Likelihood ratio positive is calculated as sensitivity divided by (specificity-1)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During an outbreak investigation, a rapid diagnostic test is being evaluated for disease screening. All of the following statements about test performance characteristics are true except:</span></p>",
      "unique_key": "Q2457616",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Likelihood ratio positive is calculated as sensitivity divided by (specificity-1)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The likelihood ratio positive (LR+) is calculated as sensitivity divided by (1-specificity), and not (specificity-1).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-25%20130756.jpg\" width=\"834\" height=\"797\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Sensitivity represents the ability of a test to correctly identify diseased individuals:&nbsp;</strong>This correctly defines sensitivity (true positive rate).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Specificity represents the ability of a test to correctly identify non-diseased individuals:</strong> This correctly defines specificity (true negative rate).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Positive predictive value increases as disease prevalence increases in the population:&nbsp;</strong>This correctly states that PPV increases with increasing disease prevalence.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sensitivity and specificity are intrinsic test characteristics that remain constant regardless of disease prevalence</span></li><li><span style=\"font-size:14.0pt;\">Predictive values (PPV and NPV) vary with disease prevalence in the population</span></li><li><span style=\"font-size:14.0pt;\">Likelihood ratios help interpret test results and incorporate both sensitivity and specificity</span></li></ul>",
      "correct_choice_id": 391615,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98395/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98395/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98495,
      "choices": [
        {
          "id": 392008,
          "text": "<p><span style=\"font-size:14.0pt;\">RNA primer removal during lagging-strand synthesis</span></p>"
        },
        {
          "id": 392009,
          "text": "<p><span style=\"font-size:14.0pt;\">3' → 5' proofreading activity</span></p>"
        },
        {
          "id": 392010,
          "text": "<p><span style=\"font-size:14.0pt;\">Ability to extend DNA from a 3'-OH end</span></p>"
        },
        {
          "id": 392011,
          "text": "<p><span style=\"font-size:14.0pt;\">Template-dependent DNA synthesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A researcher is studying DNA repair mechanisms in E. coli. During an experiment, she treats DNA polymerase I with a specific protease that removes its N-terminal portion, producing a fragment commonly used in molecular biology for synthesizing complementary DNA strands in vitro. This modified enzyme, known as the Klenow fragment lacks which of the following activities?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6165748",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) RNA primer removal during lagging-strand synthesis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Klenow fragment</strong> is generated by proteolytic cleavage of E. coli DNA polymerase I.</span></li><li><span style=\"font-size:14.0pt;\">It <strong>retains</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>5' → 3' DNA polymerase activity</strong> (extends DNA)</span></li><li><span style=\"font-size:14.0pt;\"><strong>3' → 5' exonuclease activity</strong> (proofreading)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">It <strong>lacks</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>5' → 3' exonuclease activity</strong>, which is normally responsible for <strong>RNA primer removal</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. 3' → 5' proofreading activity:&nbsp;</strong>Incorrect. Klenow fragment retains proofreading, which allows it to correct mismatched bases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ability to extend DNA from a 3'-OH end:&nbsp;</strong>Incorrect. It keeps the 5' → 3' polymerase activity, so it can extend the DNA strand.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Template-dependent DNA synthesis:&nbsp;</strong>Incorrect. Klenow fragment still synthesizes DNA using a template. This function remains intact.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>Klenow fragment</strong> of E. Coli&nbsp;<strong>DNA polymerase I</strong> retains <strong>polymerase (5′ → 3′)</strong> and <strong>proofreading (3′ → 5′ exonuclease)</strong> activities but <strong>lacks the 5′ → 3′ exonuclease activity</strong> responsible for <strong>RNA primer removal</strong>.</span></p>",
      "correct_choice_id": 392008,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98495/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98495/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98298,
      "choices": [
        {
          "id": 391224,
          "text": "<p><span style=\"font-size:14.0pt;\">Adrenaline</span></p>"
        },
        {
          "id": 391225,
          "text": "<p><span style=\"font-size:14.0pt;\">Fentanyl</span></p>"
        },
        {
          "id": 391226,
          "text": "<p><span style=\"font-size:14.0pt;\">Sodium Carbonate</span></p>"
        },
        {
          "id": 391227,
          "text": "<p><span style=\"font-size:14.0pt;\">Sodium Bicarbonate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">You want to give a brachial plexus block for open reduction internal fixation of fracture of distal end radius. In order to improve the speed of onset and depth of blockade, which of these additives should be added to the local anesthetic solution?</span></p>",
      "unique_key": "Q3841531",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Sodium Bicarbonate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sodium bicarbonate is <strong>added</strong> to <strong>local anesthetic solutions</strong> to <strong>increase the pH</strong> of the <strong>solution</strong>, making it <strong>more alkaline</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Alkalization of the solution</strong> enhances the <strong>fraction of lipid-soluble local anesthetic</strong> that is available, <strong>aiding</strong> in the <strong>diffusion of the drug</strong> across the <strong>lipid membranes of the nerves</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This results in a <strong>faster onset of anesthesia</strong> and a <strong>deeper level of blockade</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It also <strong>reduces</strong> the <strong>required dosage of local anesthetic</strong>, <strong>lowering the risk of systemic toxicity</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A</strong>. <strong>Adrenaline:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Adrenaline (<strong>epinephrine</strong>) is often <strong>added to local anesthetic solutions&nbsp;</strong>to <strong>prolong the duration</strong> of the <strong>block by vasoconstriction</strong>, which <strong>reduces the systemic absorption</strong> of the local anesthetic.</span></li><li><span style=\"font-size:14.0pt;\">While adrenaline is <strong>valuable for prolonging the block</strong>, it <strong>does not enhance</strong> the <strong>speed of onset or depth of blockade</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Fentanyl:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fentanyl is an <strong>opioid analgesic</strong> and is <strong>not typically</strong> added to <strong>local anesthetic solutions</strong> for <strong>regional blocks</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It can <strong>provide pain relief</strong> but <strong>does not affect</strong> the <strong>onset or depth of the block</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong>. <strong>Sodium Carbonate</strong>: Sodium carbonate is <strong>not commonly</strong> used as an <strong>additive to local anesthetic solutions</strong> for <strong>regional blocks</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The addition of sodium bicarbonate to a local anesthetic solution for a <strong>brachial plexus block</strong> is a <strong>valuable technique</strong> to <strong>improve</strong> the <strong>speed of onset</strong> and <strong>depth of blockade</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Alkalizing</strong> the <strong>solution</strong> enhances the <strong>availability</strong> of <strong>lipid-soluble local anesthetic</strong>, <strong>facilitating</strong> its <strong>diffusion across nerve membranes</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This <strong>not only results</strong> in a <strong>more effective blockade&nbsp;</strong>but also <strong>reduces</strong> the <strong>required dose of local anesthetic</strong>, <strong>decreasing the risk of systemic toxicity</strong>.</span></li></ul>",
      "correct_choice_id": 391227,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98298/INI-NEET_-_GT__27th_Nov_2025_Anesthesia_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98298/INI-NEET_-_GT__27th_Nov_2025_Anesthesia_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98374,
      "choices": [
        {
          "id": 391528,
          "text": "<p><span style=\"font-size:14.0pt;\">Direct maternal death, to be included in maternal mortality ratio calculation</span></p>"
        },
        {
          "id": 391529,
          "text": "<p><span style=\"font-size:14.0pt;\">Indirect maternal death, to be included in maternal mortality ratio calculation</span></p>"
        },
        {
          "id": 391530,
          "text": "<p><span style=\"font-size:14.0pt;\">Late maternal death, to be excluded from maternal mortality ratio calculation</span></p>"
        },
        {
          "id": 391531,
          "text": "<p><span style=\"font-size:14.0pt;\">Pregnancy-related death to be reported separately from maternal mortality ratio</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman dies after 6 weeks following a cesarean delivery due to pulmonary embolism that developed 35 days postpartum. According to WHO's definition of maternal death, how should this death be classified for maternal mortality statistics?</span></p>",
      "unique_key": "Q9258366",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Late maternal death, to be excluded from maternal mortality ratio calculation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Maternal death is death of mother anytime in pregnancy, labour or during delivery&nbsp;or within 42 days (6 weeks) of termination of pregnancy, irrespective of duration or site of pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes. Deaths occurring between 42 days and 1 year after termination of pregnancy are classified as \"late maternal deaths\" and are excluded from the maternal mortality ratio (MMR) calculation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The MMR only includes deaths within 42 days of termination of pregnancy.</span></li><li><span style=\"font-size:14.0pt;\">Although this death was pregnancy-related (pulmonary embolism is a known complication of pregnancy and cesarean delivery), it occurred after 6 weeks (42 days) postpartum, making it a late maternal death.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Direct maternal death, to be included in maternal mortality ratio calculation</strong>: Incorrect because deaths after 42 days postpartum are not included in direct maternal death statistics for MMR calculation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Indirect maternal death, to be included in maternal mortality ratio calculation:&nbsp;</strong>Incorrect because deaths after 42 days postpartum are not included in indirect maternal death statistics for MMR calculation. This is a distractor option, if you miss the term “after 6 weeks”, you are likely to choose this option since the other duration “35 days” postpartum might seem that the death occurred within the period defined for maternal mortality.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pregnancy-related death to be reported separately from maternal mortality ratio:&nbsp;</strong>Incorrect terminology; \"pregnancy-related death\" is not the official WHO classification for deaths occurring after 42 days postpartum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Maternal mortality ratio includes only deaths within 42 days of termination of pregnancy</span></li><li><span style=\"font-size:14.0pt;\">Deaths between 42 days to 1 year are classified as late maternal deaths and reported separately</span></li></ul>",
      "correct_choice_id": 391530,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98374/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98374/Ini-Neet_-_Gt__27Th_Nov_2025_Psm_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98497,
      "choices": [
        {
          "id": 392016,
          "text": "<p><span style=\"font-size:14.0pt;\">Mutases</span></p>"
        },
        {
          "id": 392017,
          "text": "<p><span style=\"font-size:14.0pt;\">Ligases</span></p>"
        },
        {
          "id": 392018,
          "text": "<p><span style=\"font-size:14.0pt;\">Hydrolases</span></p>"
        },
        {
          "id": 392019,
          "text": "<p><span style=\"font-size:14.0pt;\">Lyases</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which class of enzymes catalyzes structural or geometric rearrangements within a molecule, without adding or removing atoms?</span></p>",
      "unique_key": "Q3766645",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Mutases</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mutases are a subclass of <strong>isomerases</strong> that catalyze <strong>intramolecular rearrangements</strong>.</span></li><li><span style=\"font-size:14.0pt;\">They change the position of functional groups within the same molecule without altering its molecular formula.</span></li><li><span style=\"font-size:14.0pt;\">Examples:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Phosphoglycerate mutase</strong> (glycolysis)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Methylmalonyl-CoA mutase</strong> (propionate metabolism)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, they are the enzymes responsible for <strong>geometric/structural changes</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ligases:&nbsp;</strong>Incorrect. Ligases <strong>join two molecules together</strong> using ATP (e.g., DNA ligase).They do not rearrange structures internally.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hydrolases:&nbsp;</strong>Incorrect. Hydrolases <strong>break bonds by adding water</strong> (e.g., proteases, lipases).These reactions change the molecule rather than rearranging it.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lyases:&nbsp;</strong>Incorrect. Lyases <strong>add or remove groups</strong> to form double bonds (e.g., aldolase).They do not simply rearrange the molecule internally.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Isomerases (including mutases)&nbsp;</strong>catalyze <strong>structural or geometric rearrangements within a molecule</strong> without adding or removing atoms, allowing the molecule to be converted into one of its isomers.</span></p>",
      "correct_choice_id": 392016,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98497/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98497/INI-NEET_-_GT__27th_Nov_2025_Biochemistry_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98580,
      "choices": [
        {
          "id": 392344,
          "text": "<p><span style=\"font-size:14.0pt;\">The underlying mutation involves the APC tumor suppressor gene.</span></p>"
        },
        {
          "id": 392345,
          "text": "<p><span style=\"font-size:14.0pt;\">Patients have nearly a 100% lifetime risk of colorectal carcinoma if untreated.</span></p>"
        },
        {
          "id": 392346,
          "text": "<p><span style=\"font-size:14.0pt;\">The “second hit” in the remaining allele occurs through loss of heterozygosity.</span></p>"
        },
        {
          "id": 392347,
          "text": "<p><span style=\"font-size:14.0pt;\">The same gene maybe involved in hereditary nonpolyposis colorectal cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 22-year-old man presents with intermittent rectal bleeding and a family history of colectomy at a young age. Colonoscopy and microscopic picture are shown below. Genetic testing reveals a germline mutation on chromosome 5q21. All of the following statements regarding this condition are true, except:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_M9AMmJZ.png\" width=\"692\" height=\"224\"></span></p>",
      "unique_key": "Q2769422",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) The same gene maybe involved in hereditary nonpolyposis colorectal cancer&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient is a <strong>22-year-old man</strong> with <strong>intermittent rectal bleeding</strong> and a <strong>family history of colectomy at a young age</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The colonoscopy and microscopic picture show numerous polyps consistent with <strong>familial adenomatous polyposis (FAP)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The stem states a <strong>germline mutation on chromosome 5q21</strong>, which is the location of the <strong>APC tumor suppressor gene</strong>.</span></li><li><span style=\"font-size:14.0pt;\">FAP follows the <strong>two-hit hypothesis</strong>, meaning the inherited APC mutation requires a <strong>“second hit”</strong> via <strong>loss of heterozygosity</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If untreated, patients have <strong>nearly a 100% lifetime risk of colorectal carcinoma</strong>, explaining the family history of colectomy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Is false because hereditary nonpolyposis colorectal cancer (<strong>HNPCC</strong>) does not involve the same gene. HNPCC is due to <strong>DNA mismatch repair gene</strong> mutations, not APC.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;The underlying mutation involves the APC tumor suppressor gene:&nbsp;</strong>Familial Adenomatous Polyposis (FAP) is caused by germline mutations in the APC (Adenomatous Polyposis Coli) gene on chromosome 5q21. APC is a tumor suppressor that regulates β-catenin degradation and WNT signaling. Loss of APC → accumulation of β-catenin → increased transcription of growth-promoting genes (MYC, cyclin D1).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Patients have nearly a 100% lifetime risk of colorectal carcinoma if untreated:&nbsp;</strong>Virtually all patients with untreated FAP will develop colorectal carcinoma by age 40 due to the adenoma–carcinoma sequence (accumulation of APC → KRAS → p53 mutations). Thus, prophylactic colectomy is strongly recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;The “second hit” in the remaining allele occurs through loss of heterozygosity:</strong> According to Knudson’s two-hit hypothesis, patients inherit one mutant APC allele (germline) and lose the other allele (somatic loss of heterozygosity) during life, leading to complete functional loss and adenoma formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Turcot syndrome: FAP + medulloblastoma (sometimes glioblastoma).</span></li><li><span style=\"font-size:14.0pt;\">Attenuated FAP: &lt;100 polyps, later onset of cancer.</span></li><li><span style=\"font-size:14.0pt;\">Congenital hypertrophy of retinal pigment epithelium (CHRPE) → characteristic ocular finding.</span></li></ul>",
      "correct_choice_id": 392347,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98580/Ini-Neet_-_Gt__27Th_Nov_2025_Pathology_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98580/Ini-Neet_-_Gt__27Th_Nov_2025_Pathology_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98274,
      "choices": [
        {
          "id": 391128,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 391129,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 391130,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3</span></p>"
        },
        {
          "id": 391131,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding skeletal muscle excitation–contraction (EC) coupling are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Skeletal muscle contraction does not require extracellular calcium influx.</span></li><li><span style=\"font-size:14.0pt;\">The primary source of calcium during contraction is the sarcoplasmic reticulum.</span></li><li><span style=\"font-size:14.0pt;\">Dihydropyridine (L-type) Ca²⁺ channels in the T-tubules function mainly as voltage sensors rather than as calcium conduits.</span></li><li><span style=\"font-size:14.0pt;\">Mitochondrial calcium release plays a dominant role in triggering skeletal muscle contraction.</span></li></ol>",
      "unique_key": "Q1301770",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Skeletal muscle contraction does not require extracellular calcium influx:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Skeletal muscle fibers rely on calcium stored in the <strong>sarcoplasmic reticulum</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Unlike cardiac myocytes, skeletal muscle contraction is not dependent on extracellular calcium entering through L-type calcium channels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. The primary source of calcium during contraction is the sarcoplasmic reticulum:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>sarcoplasmic reticulum (SR)</strong> is the <strong>primary source of calcium</strong> during skeletal muscle contraction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The depolarization of the muscle membrane triggers SR calcium release via ryanodine receptors (RyR1).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.&nbsp;Dihydropyridine (L-type) Ca²⁺ channels in the T-tubules function mainly as voltage sensors rather than as calcium conduits:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In skeletal muscle, dihydropyridine receptors (DHPRs) in the T-tubule membrane detect depolarization.</span></li><li><span style=\"font-size:14.0pt;\">They are mechanically coupled to ryanodine receptors (RyR1) on the sarcoplasmic reticulum, triggering calcium release without the need for calcium influx.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Mitochondrial calcium release plays a dominant role in triggering skeletal muscle contraction:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is incorrect. Mitochondria can buffer calcium but do <strong>not</strong> release calcium to initiate contraction.</span></li><li><span style=\"font-size:14.0pt;\">The dominant source of calcium in skeletal muscle contraction is the sarcoplasmic reticulum, not mitochondria.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In skeletal muscle, extracellular calcium influx is not required for contraction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Dihydropyridine receptors act as voltage sensors that mechanically open ryanodine receptors on the sarcoplasmic reticulum, releasing calcium to initiate contraction.</span></li></ul>",
      "correct_choice_id": 391128,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98274/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98274/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98551,
      "choices": [
        {
          "id": 392232,
          "text": "<p><span style=\"font-size:14.0pt;\">Fuchs heterochromic iridocyclitis</span></p>"
        },
        {
          "id": 392233,
          "text": "<p><span style=\"font-size:14.0pt;\">Posner-Schlossman syndrome</span></p>"
        },
        {
          "id": 392234,
          "text": "<p><span style=\"font-size:14.0pt;\">Sympathetic ophthalmia</span></p>"
        },
        {
          "id": 392235,
          "text": "<p><span style=\"font-size:14.0pt;\">Sarcoidosis-associated uveitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old male presents with recurrent episodes of unilateral uveitis, headache, and episodic increased intraocular pressure (IOP) without signs of significant inflammation. Slit-lamp examination shows few aqueous cells, corneal epithelial edema, and open angles on gonioscopy. His symptoms resolve within a few days with topical steroids and intraocular pressure-lowering agents. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q2734719",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Posner-Schlossman syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Posner-Schlossman syndrome, also known as <strong>glaucomatocyclitic crisis</strong>, is a rare form of <strong>hypertensive uveitis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is characterized by <strong>recurrent episodes of mild anterior uveitis with transient intraocular pressure (IOP) elevation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Clinical Features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Unilateral attacks</strong> of mild anterior uveitis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Transient but significant IOP spikes</strong> that can reach <strong>40-60 mmHg</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mild inflammation:</strong> Few aqueous cells are seen, but <strong>keratic precipitates</strong> may be present.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Corneal epithelial edema</strong> due to elevated IOP.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Open angles on gonioscopy</strong>, differentiating it from angle-closure glaucoma.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Symptoms include</strong> mild discomfort, blurred vision, and seeing halos around lights.</span></li><li><span style=\"font-size:14.0pt;\">Attacks <strong>last for hours to days</strong> and can recur over time.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Between attacks, the eye appears normal.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-26%20105820.jpg\" width=\"484\" height=\"384\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The exact cause is unknown, but <strong>inflammatory cytokines and viral infections (e.g., CMV, HSV) are implicated</strong>.</span></li><li><span style=\"font-size:14.0pt;\">There is <strong>episodic trabeculitis</strong>, leading to poor aqueous humor drainage and acute IOP spikes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Topical steroids</strong> (to reduce inflammation).</span></li><li><span style=\"font-size:14.0pt;\"><strong>IOP-lowering agents</strong> (beta-blockers, carbonic anhydrase inhibitors, alpha agonists).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Avoid prostaglandin analogs</strong> (they may worsen inflammation).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Antiviral therapy</strong> if CMV is suspected.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fuchs Heterochromic Iridocyclitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Presents with <strong>chronic low-grade anterior uveitis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Unilateral iris heterochromia</strong> (affected eye is lighter in color).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fine stellate keratic precipitates (KPs)</strong> across the entire cornea.</span></li><li><span style=\"font-size:14.0pt;\"><strong>PSC cataracts</strong> are common.</span></li><li><span style=\"font-size:14.0pt;\"><strong>No posterior synechiae formation</strong>, unlike other types of uveitis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Increased IOP but less episodic compared to Posner-Schlossman syndrome</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Sympathetic Ophthalmia:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Bilateral granulomatous panuveitis</strong> occurring <strong>after penetrating ocular trauma</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>\"exciting eye\"</strong> (injured eye) triggers an autoimmune reaction that affects the <strong>\"sympathizing eye\"</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mutton-fat KPs, Dalen-Fuchs nodules</strong>, and serous retinal detachment.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Not associated with episodic IOP spikes</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Sarcoidosis-Associated Uveitis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Granulomatous uveitis</strong> with <strong>mutton-fat keratic precipitates</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Multiple systemic features:</strong> bilateral hilar lymphadenopathy, hypercalcemia, and skin nodules.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Periphlebitis (\"candle wax drippings\")</strong> seen in fundoscopic exam.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chronic course</strong>, not self-limited episodes like in Posner-Schlossman syndrome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Posner-Schlossman syndrome (glaucomatocyclitic crisis) is a rare, recurrent hypertensive uveitis that presents with mild inflammation and episodic IOP spikes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is crucial to differentiate it from chronic conditions like Fuchs heterochromic iridocyclitis, granulomatous uveitis (sarcoidosis), and post-traumatic causes like sympathetic ophthalmia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Management focuses on controlling IOP and inflammation while ruling out infectious triggers like CMV or HSV.</span></li></ul>",
      "correct_choice_id": 392233,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98551/INI-NEET_-_GT__27th_Nov_2025_Ophthalmology_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98551/INI-NEET_-_GT__27th_Nov_2025_Ophthalmology_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98119,
      "choices": [
        {
          "id": 390516,
          "text": "<p><span style=\"font-size:14.0pt;\">Zinc</span></p>"
        },
        {
          "id": 390517,
          "text": "<p><span style=\"font-size:14.0pt;\">Lead</span></p>"
        },
        {
          "id": 390518,
          "text": "<p><span style=\"font-size:14.0pt;\">Mercury</span></p>"
        },
        {
          "id": 390519,
          "text": "<p><span style=\"font-size:14.0pt;\">Silver</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old welder presents to the emergency department with fever, headache, chills, cough, and myalgia. He reports these symptoms began 6 hours after working in a poorly ventilated brass foundry. His symptoms resolve within 36 hours, only to return each Monday after resuming work. Which of the following metals is most likely responsible for his condition?</span></p>",
      "unique_key": "Q4923124",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Zinc</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Brass is combination of copper and zinc</span></li><li><span style=\"font-size:14.0pt;\">Metal fume fever (MFF) is a self-limiting febrile illness caused by inhalation of metal oxide fumes, primarily <strong>zinc oxide</strong>, leading to flu-like symptoms within 4–8 hours of exposure.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The symptoms improve within 24–36 hours but recur on repeated exposure, such as after a weekend break (Monday morning fever).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Lead: </strong>Toxicity presents with chronic neurological and hematological manifestations rather than an acute flu-like illness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Mercury: </strong>Exposure leads to neurotoxicity, renal dysfunction, and tremors but not MFF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Silver: </strong>Exposure (argyria) causes bluish-gray skin discoloration but does not cause flu-like symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Metal fume fever</strong> is also known as <strong>brass shakes</strong>, <strong>zinc shakes</strong>, <strong>metal dust fever</strong>, or <strong>Monday morning fever</strong>,</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;It is an illness primarily caused by exposure to chemicals such as <strong>zinc</strong> (most common), <strong>aluminum</strong>, or <strong>magnesium</strong> which are produced as byproducts in the fumes that result when certain metals are heated.</span></li><li><span style=\"font-size:14.0pt;\">Welders are commonly exposed to the substances that cause metal fume fever from the base metal, plating, or filler.</span></li><li><span style=\"font-size:14.0pt;\">The signs and symptoms are generally <strong>flu-like or malaria like.&nbsp;</strong>They include fever, chills, headache, fatigue, muscle aches, joint pains, shortness of breath, pneumonia, chest pain etc. Flu-like symptoms normally disappear within 24 to 48 hours.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Mnemonic: ZAM causes metal fume fever (Z for Zinc, A for aluminium, M for magnesium)</strong></span></p>",
      "correct_choice_id": 390516,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98119/INI-NEET_-_GT__27th_Nov_2025_FMT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98119/INI-NEET_-_GT__27th_Nov_2025_FMT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98107,
      "choices": [
        {
          "id": 390468,
          "text": "<p><span style=\"font-size:14.0pt;\">Septic Arthritis</span></p>"
        },
        {
          "id": 390469,
          "text": "<p><span style=\"font-size:14.0pt;\">Herpetic Whitlow</span></p>"
        },
        {
          "id": 390470,
          "text": "<p><span style=\"font-size:14.0pt;\">Pyogenic Flexor Tenosynovitis</span></p>"
        },
        {
          "id": 390471,
          "text": "<p><span style=\"font-size:14.0pt;\">Cellulitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old carpenter presents to the clinic after 48 hours sustaining a small puncture wound from a wood splinter to the palmar aspect of his right index finger. The patient reports escalating, throbbing pain in the finger. On examination, the right index finger exhibits:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fusiform swelling</span></li><li><span style=\"font-size:14.0pt;\">Slight flexion</span></li><li><span style=\"font-size:14.0pt;\">Tenderness along tendon sheath</span></li><li><span style=\"font-size:14.0pt;\">Pain on extension</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Based on these four physical exam findings, which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "Q8716163",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Pyogenic Flexor Tenosynovitis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PFT is an emergent infection caused by bacteria (usually Staphylococcus aureus) introduced into the closed space of the flexor tendon sheath.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The infection causes rapid inflammation, pus accumulation, and increased pressure, which can impede blood flow to the tendon, leading to necrosis (tendon death) and permanent loss of function if not treated immediately.</span></li><li><span style=\"font-size:14.0pt;\">The four Kanavel's Signs are:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Fusiform swelling of the affected digit (uniform, sausage-like swelling).</span></li><li><span style=\"font-size:14.0pt;\">The digit is held in slight flexion.</span></li><li><span style=\"font-size:14.0pt;\">Tenderness along the course of the flexor tendon sheath.</span></li><li><span style=\"font-size:14.0pt;\">Disproportionate pain with passive extension of the finger.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Septic Arthritis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Infection within the joint space (usually the proximal or distal interphalangeal joint).</span></li><li><span style=\"font-size:14.0pt;\">Pain and tenderness are primarily localized over the joint lines, and pain is elicited with any movement of the joint (both flexion and extension), not specifically along the tendon sheath.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The swelling is generally centered on the joint, not fusiform along the whole digit.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Herpetic Whitlow:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A viral infection of the fingertip, caused by the Herpes Simplex Virus (HSV).</span></li><li><span style=\"font-size:14.0pt;\">While painful, it is characterized by the presence of clear, clustered vesicles (blisters) on an erythematous (red) base, usually confined to the fingertip.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It does not present with Kanavel's signs and is not primarily an infection of the tendon sheath.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cellulitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A superficial soft tissue bacterial infection of the dermis and subcutaneous tissues.</span></li><li><span style=\"font-size:14.0pt;\">Presents with diffuse erythema, warmth, and tenderness, but lacks the four specific Kanavel's signs.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The infection is not confined to the tendon sheath, so passive extension does not cause the severe, specific pain characteristic of PFT.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">To recognize Pyogenic Flexor Tenosynovitis (PFT) as a surgical emergency of the hand based on the presence of the classic Kanavel's Signs (fusiform swelling, slight flexion, tenderness along the tendon sheath, and pain on passive extension).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This differentiation is critical because PFT requires urgent surgical incision and drainage to prevent irreversible tendon ischemia and permanent disability.</span></li></ul>",
      "correct_choice_id": 390470,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98107/INI-NEET_-_GT__27th_Nov_2025_Orthopedics_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98107/INI-NEET_-_GT__27th_Nov_2025_Orthopedics_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98524,
      "choices": [
        {
          "id": 392124,
          "text": "<p><span style=\"font-size:14.0pt;\">Guillain–Barré syndrome</span></p>"
        },
        {
          "id": 392125,
          "text": "<p><span style=\"font-size:14.0pt;\">Hemolytic uremic syndrome</span></p>"
        },
        {
          "id": 392126,
          "text": "<p><span style=\"font-size:14.0pt;\">Reactive arthritis</span></p>"
        },
        {
          "id": 392127,
          "text": "<p><span style=\"font-size:14.0pt;\">Toxic megacolon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Following a wedding feast, several people develop bloody diarrhea without fever. Lab findings show E. coli that does not ferment sorbitol. Which serious complication may occur in affected children?</span></p>",
      "unique_key": "Q9452012",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hemolytic uremic syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The scenario describes an outbreak due to <strong>Enterohemorrhagic Escherichia coli (EHEC)</strong> infection, commonly associated with <strong>serotype O157:H7</strong>.</span></li><li><span style=\"font-size:14.0pt;\">EHEC produces <strong>verocytotoxin (Shiga-like toxin)</strong>, which:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Inhibits <strong>protein synthesis</strong> by targeting the <strong>60S ribosomal subunit</strong> of host cells.</span></li><li><span style=\"font-size:14.0pt;\">Damages <strong>vascular endothelium</strong>, especially in the <strong>renal glomeruli</strong> and <strong>cerebral microvasculature</strong>, causing <strong>capillary microangiopathy</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This leads to <strong>Hemolytic Uremic Syndrome (HUS)</strong> — a triad of:</span><ol><li><span style=\"font-size:14.0pt;\"><strong>Microangiopathic hemolytic anemia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Thrombocytopenia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Acute renal failure</strong></span></li></ol></li><li><span style=\"font-size:14.0pt;\">Children are particularly susceptible.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The infection often follows ingestion of <strong>undercooked beef or contaminated food</strong> during community events or feasts.</span></li><li><span style=\"font-size:14.0pt;\">On <strong>Sorbitol MacConkey agar</strong>, E. coli O157:H7 colonies are <strong>colorless (non-sorbitol fermenting)</strong> — a key differentiating feature.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Guillain–Barré syndrome:&nbsp;</strong>Associated with Campylobacter jejuni infection, not E. coli. It results from molecular mimicry between bacterial lipooligosaccharides and peripheral nerve gangliosides.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Reactive arthritis:&nbsp;</strong>May follow Shigella, Salmonella, Yersinia or Campylobacter infection. Not typically linked to EHEC infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Toxic megacolon:&nbsp;</strong>A severe complication of Clostridioides difficile colitis or ulcerative colitis, not of E. coli O157:H7 infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Enterohemorrhagic E. coli (O157:H7)</strong> infection causes <strong>bloody diarrhea without fever</strong> and may progress to <strong>Hemolytic Uremic Syndrome (HUS)</strong> due to <strong>Shiga-like toxin–induced endothelial injury</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Non-sorbitol-fermenting colonies on MacConkey agar are diagnostic clues.</span></li></ul>",
      "correct_choice_id": 392125,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98524/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98524/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98578,
      "choices": [
        {
          "id": 392336,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 3 and 4 are correct</span></p>"
        },
        {
          "id": 392337,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 2, 3 and 5 are correct</span></p>"
        },
        {
          "id": 392338,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 2, 3 and 5 are correct</span></p>"
        },
        {
          "id": 392339,
          "text": "<p><span style=\"font-size:14.0pt;\">All five statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding microangiopathic hemolytic anemia&nbsp;are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">MAHA is characterized by fragmentation of RBCs due to mechanical injury within the microcirculation, producing schistocytes on peripheral smear.</span></li><li><span style=\"font-size:14.0pt;\">Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are classic causes of MAHA.</span></li><li><span style=\"font-size:14.0pt;\">Low haptoglobin levels, elevated LDH, and indirect hyperbilirubinemia are typical laboratory findings.</span></li><li><span style=\"font-size:14.0pt;\">MAHA commonly presents with isolated hemolysis without thrombocytopenia.</span></li><li><span style=\"font-size:14.0pt;\">DIC can produce MAHA due to widespread fibrin deposition in small vessels.</span></li></ol>",
      "unique_key": "Q4487132",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Only 1, 2, 3 and 5 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>MAHA is characterized by fragmentation of RBCs due to mechanical injury within the microcirculation, producing schistocytes on peripheral smear:</strong> MAHA occurs due to <strong>mechanical fragmentation of RBCs</strong> in small vessels, resulting in <strong>schistocytes (helmet cells)</strong> on peripheral smear.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are classic causes of MAHA: TTP</strong> and <strong>HUS</strong> are <strong>classic causes</strong> of MAHA, both involving <strong>microvascular thrombosis</strong> leading to RBC destruction and <strong>thrombocytopenia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Low haptoglobin levels, elevated LDH, and indirect hyperbilirubinemia are typical laboratory findings:</strong> Hemolysis in MAHA causes <strong>low haptoglobin</strong>, <strong>high LDH</strong>, and <strong>indirect hyperbilirubinemia</strong> due to intravascular RBC destruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>DIC can produce MAHA due to widespread fibrin deposition in small vessels: DIC</strong> can produce MAHA because <strong>fibrin deposition in small vessels</strong> leads to RBC shearing, <strong>schistocytes</strong>, and <strong>consumptive thrombocytopenia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>MAHA commonly presents with isolated hemolysis without thrombocytopenia:&nbsp;</strong>Incorrect. MAHA does not present with isolated hemolysis — it is always associated with thrombocytopenia due to platelet consumption in the microthrombi.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Microangiopathic Hemolytic Anemia (MAHA)</strong> is characterized by <strong>RBC fragmentation and schistocyte formation</strong> due to <strong>microvascular injury</strong>, seen in conditions like <strong>TTP, HUS, and DIC</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It presents with <strong>hemolysis and thrombocytopenia</strong>, along with <strong>low haptoglobin and elevated LDH</strong>.</span></li></ul>",
      "correct_choice_id": 392338,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98578/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98578/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98592,
      "choices": [
        {
          "id": 392388,
          "text": "<p><span style=\"font-size:14.0pt;\">Gastrointestinal stromal tumor (GIST)</span></p>"
        },
        {
          "id": 392389,
          "text": "<p><span style=\"font-size:14.0pt;\">MALT lymphoma</span></p>"
        },
        {
          "id": 392390,
          "text": "<p><span style=\"font-size:14.0pt;\">Menetrier’s disease</span></p>"
        },
        {
          "id": 392391,
          "text": "<p><span style=\"font-size:14.0pt;\">Carcinoid tumor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man presents with long-standing epigastric pain and occasional hematemesis. The pain typically occurs a few hours after meals and is relieved by food or antacids. He has a history of chronic Helicobacter pylori infection. Endoscopy reveals a single round ulcer with a clean base on the lesser curvature of the antrum. Biopsy from the ulcer edge shows active chronic gastritis with neutrophils infiltrating glandular epithelium, presence of spiral-shaped bacteria, and intestinal metaplasia in adjacent mucosa. Which of the following complications is this patient most at risk for if the condition persists?</span></p>",
      "unique_key": "Q2773540",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) MALT lymphoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a case of chronic H. pylori-associated gastritis, most likely chronic antral gastritis, which can lead to several complications.</span></li><li><span style=\"font-size:14.0pt;\">Chronic stimulation of mucosal lymphoid tissue by H. pylori infection can result in the development of extranodal marginal zone B-cell lymphoma (MALT lymphoma).</span></li><li><span style=\"font-size:14.0pt;\">H. pylori infection induces chronic inflammation → formation of mucosa-associated lymphoid tissue (MALT) → polyclonal B-cell proliferation → may evolve into monoclonal neoplastic proliferation (lymphoma).</span></li><li><span style=\"font-size:14.0pt;\">Early MALT lymphomas can regress after H. pylori eradication with antibiotics.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Gastrointestinal stromal tumor (GIST):&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mesenchymal tumor of interstitial cells of Cajal, usually seen in stomach or small intestine.</span></li><li><span style=\"font-size:14.0pt;\">Associated with c-KIT (CD117) mutation, not H. pylori.</span></li><li><span style=\"font-size:14.0pt;\">Presents as submucosal mass, not ulceration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Menetrier’s disease:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Characterized by massive foveolar hyperplasia of gastric mucosa → giant rugal folds, protein loss, and hypoproteinemia.</span></li><li><span style=\"font-size:14.0pt;\">Caused by TGF-α overexpression, not infection.</span></li><li><span style=\"font-size:14.0pt;\">Not associated with H. pylori or ulcers.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Carcinoid tumor:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Arises from enterochromaffin-like (ECL) cells in chronic autoimmune gastritis (Type A), where there is achlorhydria and hypergastrinemia, not H. pylori.</span></li><li><span style=\"font-size:14.0pt;\">Usually seen in the body/fundus, not the antrum.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>H. pylori related conditions:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_NlM08Dr.png\" width=\"759\" height=\"460\"></strong></span></p>",
      "correct_choice_id": 392389,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98592/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_14_qvHu2cw.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98592/INI-NEET_-_GT__27th_Nov_2025_Pathology_Question_14_qvHu2cw.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98110,
      "choices": [
        {
          "id": 390480,
          "text": "<p><span style=\"font-size:14.0pt;\">Open Reduction Internal Fixation (ORIF) with plating</span></p>"
        },
        {
          "id": 390481,
          "text": "<p><span style=\"font-size:14.0pt;\">Hemiarthroplasty</span></p>"
        },
        {
          "id": 390482,
          "text": "<p><span style=\"font-size:14.0pt;\">Closed Reduction Internal Fixation with a Proximal Femoral Nail</span></p>"
        },
        {
          "id": 390483,
          "text": "<p><span style=\"font-size:14.0pt;\">Non-operative management with traction and bed rest</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old female with a history of osteoporosis slips on a rug at home and presents to the emergency with severe right hip pain and inability to bear weight. X-ray is shown below. Which of the following is the most appropriate surgical intervention for this specific fracture pattern?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4VFgvkP.png\" width=\"350\" height=\"413\"></span></p>",
      "unique_key": "Q1934661",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Closed Reduction Internal Fixation with a Proximal Femoral Nail</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient's age, history of osteoporosis, mechanism of injury, and clinical findings (severe hip pain, inability to bear weight, shortened and externally rotated leg) are all classic for a Proximal Femur Fracture.</span></li><li><span style=\"font-size:14.0pt;\">Given the context of common geriatric fractures, the X-ray is highly likely to show an Intertrochanteric Fracture.</span></li><li><span style=\"font-size:14.0pt;\">Intertrochanteric fractures (ITFs) are extracapsular fractures that heal well with fixation because the blood supply to the femoral head is usually preserved.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They do not typically require joint replacement.</span></li><li><span style=\"font-size:14.0pt;\">The Proximal Femoral Nail (PFN), or another intramedullary nail system (like the Gamma Nail or Trochanteric Fixation Nail - TFN), is the preferred device, especially for unstable or comminuted ITFs and subtrochanteric fractures.</span></li><li><span style=\"font-size:14.0pt;\">The nail acts as a load-sharing implant, placed in the central axis of the femur.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This provides a biomechanically superior construct compared to plates, offering excellent stability against bending and rotational forces.</span></li><li><span style=\"font-size:14.0pt;\">Closed reduction (manipulating the fragments without a large surgical incision) minimizes soft tissue damage, reducing blood loss and infection risk.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Open Reduction Internal Fixation (ORIF) with plating:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While a Dynamic Hip Screw (DHS) is an alternative for stable ITFs, plates (like the DHS) are load-bearing implants placed on the lateral side of the femur, making them prone to mechanical failure in unstable fractures or poor quality (osteoporotic) bone.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Modern intramedullary nailing is generally superior for unstable patterns.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hemiarthroplasty:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is the treatment of choice for a displaced Femoral Neck Fracture (intracapsular fracture) in an elderly patient, as the blood supply to the femoral head is often compromised, leading to a high risk of avascular necrosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Since the fracture is most likely intertrochanteric (extracapsular), fixation is preferred over replacement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Non-operative management with traction and bed rest:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is almost never appropriate for geriatric hip fractures due to the high risk of severe complications, including pneumonia, deep vein thrombosis, pressure ulcers, and rapid functional decline.</span></li><li><span style=\"font-size:14.0pt;\">Early surgical fixation and mobilization are the standards of care.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">To identify that the Proximal Femoral Nail (PFN) is the standard of care for stabilizing intertrochanteric fractures in the elderly, particularly those with unstable or comminuted patterns and underlying osteoporosis, due to its load-sharing biomechanical advantage and minimally invasive surgical technique.</span></p>",
      "correct_choice_id": 390482,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98110/INI-NEET_-_GT__27th_Nov_2025_Orthopedics_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98110/INI-NEET_-_GT__27th_Nov_2025_Orthopedics_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98280,
      "choices": [
        {
          "id": 391152,
          "text": "<p><span style=\"font-size:14.0pt;\">Lowest FSH receptor density, highest androgen: estrogen ratio, largest antral volume</span></p>"
        },
        {
          "id": 391153,
          "text": "<p><span style=\"font-size:14.0pt;\">Highest antral estrogen concentration, lowest androgen: estrogen ratio, maximum FSH receptors</span></p>"
        },
        {
          "id": 391154,
          "text": "<p><span style=\"font-size:14.0pt;\">Highest progesterone production, moderate FSH receptors, smallest follicular fluid volume</span></p>"
        },
        {
          "id": 391155,
          "text": "<p><span style=\"font-size:14.0pt;\">Maximum LH receptors, highest androgen production, intermediate estrogen levels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which combination of factors most accurately characterizes the dominant follicle selected around days 5–7 of the menstrual cycle?</span></p>",
      "unique_key": "Q7840299",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Highest antral estrogen concentration, lowest androgen: estrogen ratio, maximum FSH receptors</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During the <strong>early to mid-follicular phase</strong> (days 1–7), multiple follicles begin to grow under the influence of <strong>follicle-stimulating hormone (FSH)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, by <strong>days 5–7</strong>, <strong>only one follicle</strong> — the <strong>dominant follicle</strong> — continues to mature, while the others undergo <strong>atresia</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Key Characteristics of the Dominant Follicle:</strong></span><ol><li><span style=\"font-size:14.0pt;\"><strong>Highest FSH receptor expression:</strong> The dominant follicle has the <strong>greatest sensitivity to FSH</strong>, allowing it to continue growing even as FSH levels begin to decline due to negative feedback from rising estrogen.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Highest intrafollicular estrogen concentration:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Granulosa cells in the dominant follicle express <strong>aromatase</strong>, converting androgens from theca cells into <strong>estradiol</strong>.</span></li><li><span style=\"font-size:14.0pt;\">High estrogen levels promote granulosa cell proliferation and further increase FSH receptor expression.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Lowest androgen: estrogen ratio:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Efficient conversion of androgens to estrogens results in a <strong>low androgen: estrogen ratio</strong>, which favors dominance and maturation.</span></li><li><span style=\"font-size:14.0pt;\">Non-dominant follicles have relatively <strong>higher androgen levels</strong>, leading to atresia.</span></li></ul></li><li><p><span style=\"font-size:14.0pt;\"><strong>Autocrine and paracrine advantage:</strong> Elevated estradiol and FSH receptor expression maintain follicular growth despite decreasing circulating FSH levels.</span></p><p>&nbsp;</p></li></ol></li></ul><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lowest FSH receptor density, highest androgen: estrogen ratio, largest antral volume:&nbsp;</strong>Incorrect. The dominant follicle has <strong>high FSH receptor density</strong> and <strong>low androgen: estrogen ratio</strong>; this option describes <strong>atretic follicles</strong> instead.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Highest progesterone production, moderate FSH receptors, smallest follicular fluid volume:&nbsp;</strong>Incorrect. Significant <strong>progesterone production</strong> occurs <strong>after ovulation</strong> in the <strong>luteal phase</strong>, not in the follicular phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Maximum LH receptors, highest androgen production, intermediate estrogen levels:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>LH receptor acquisition</strong> on granulosa cells occurs <strong>later (pre-ovulatory phase)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Dominant follicle has <strong>high estrogen, not androgen</strong>, levels at this stage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>dominant follicle</strong> is characterized by <strong>maximum FSH receptor density</strong>, <strong>highest estrogen levels</strong>, and a <strong>low androgen: estrogen ratio</strong>, enabling it to continue growth and prepare for ovulation despite falling FSH levels.</span></p>",
      "correct_choice_id": 391153,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98280/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98280/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98779,
      "choices": [
        {
          "id": 393128,
          "text": "<p><span style=\"font-size:14.0pt;\">Hemodialysis immediately after the procedure</span></p>"
        },
        {
          "id": 393129,
          "text": "<p><span style=\"font-size:14.0pt;\">IV N-acetylcysteine</span></p>"
        },
        {
          "id": 393130,
          "text": "<p><span style=\"font-size:14.0pt;\">IV normal saline</span></p>"
        },
        {
          "id": 393131,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral fluids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old woman with hypertension, diabetes, and stage 4 CKD is admitted with chest pain. After initially normal ECGs, subsequent tracings reveal ischemic ST changes suggestive of an evolving MI. Cardiac catheterization is planned. Medications include lisinopril, torsemide, aspirin, carvedilol, and insulin. BP is 110/66 mmHg, pulse is 60/min, no edema is noted, and lungs are clear. What is the best intervention to reduce the risk of contrast-associated acute kidney injury in this patient?</span></p>",
      "unique_key": "Q3487644",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) IV normal saline</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The most effective preventive measure for contrast-induced AKI in high-risk patients (such as those with CKD) is IV hydration with isotonic saline, which preserves renal perfusion and limits renal tubular exposure to contrast media.</span></li><li><span style=\"font-size:14.0pt;\">IV fluids started before the procedure and continued for a short time after significantly lower AKI risk compared to oral fluids, which are inadequate for high-risk patients.</span></li><li><span style=\"font-size:14.0pt;\">N-acetylcysteine has not been shown to offer clear benefit for AKI prevention in large studies.</span></li><li><span style=\"font-size:14.0pt;\">Hemodialysis is not indicated for prophylaxis; it is reserved only if severe AKI develops unresponsive to conservative therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Hemodialysis immediately after the procedure:</strong> Hemodialysis after the procedure is unnecessary and offers no proven preventive benefit for contrast nephropathy.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. IV N-acetylcysteine:</strong> IV N-acetylcysteine is not supported by consistent evidence for AKI prevention.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D. Oral fluids:</strong> Oral fluids alone are insufficient for AKI prophylaxis in high-risk patients like this one.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">IV isotonic saline hydration, administered before and after contrast exposure, is the preferred strategy to minimize the risk of contrast-associated AKI in patients with CKD or other risk factors.</span></p>",
      "correct_choice_id": 393130,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98779/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98779/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98533,
      "choices": [
        {
          "id": 392160,
          "text": "<p><span style=\"font-size:14.0pt;\">Color of colony and vesicle shape</span></p>"
        },
        {
          "id": 392161,
          "text": "<p><span style=\"font-size:14.0pt;\">Presence of conidiophores</span></p>"
        },
        {
          "id": 392162,
          "text": "<p><span style=\"font-size:14.0pt;\">Arrangement of hyphae</span></p>"
        },
        {
          "id": 392163,
          "text": "<p><span style=\"font-size:14.0pt;\">Presence of septate hyphae</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which combination of features differentiates Aspergillus fumigatus from Aspergillus flavus?</span></p>",
      "unique_key": "Q3201789",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Color of colony and vesicle shape</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Aspergillus fumigatus and Aspergillus flavus are both common pathogenic species of Aspergillus, but they can be <strong>differentiated by their macroscopic colony color and microscopic vesicle morphology</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Color of colony:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">A. fumigatus produces <strong>smoky green, velvety colonies</strong> with a <strong>white reverse</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A. flavus shows <strong>yellow-green, velvety colonies</strong>, also with a white reverse.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Vesicle shape:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">In A. fumigatus, the <strong>vesicle is conical</strong>, and the <strong>phialides are arranged in a single row (uniseriate)</strong> arising from the <strong>upper one-third</strong> of the vesicle.</span></li><li><span style=\"font-size:14.0pt;\">In A. flavus, the <strong>vesicle is globular</strong>, and <strong>phialides occur in one or two rows</strong>, covering the <strong>entire vesicle</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These two key differences—<strong>colony pigmentation</strong> and <strong>vesicle architecture</strong>—are the classical distinguishing features between these species on culture and LPCB (Lactophenol Cotton Blue) mount.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ASS5grs.png\" width=\"776\" height=\"721\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Presence of conidiophores:&nbsp;</strong>Both A. fumigatus and A. flavus do not possess <strong>conidiophores</strong>, so this does not differentiate them.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Arrangement of hyphae:&nbsp;</strong>Both species exhibit <strong>septate, hyaline hyphae</strong> with <strong>acute-angle branching</strong> (45°), so their hyphal arrangement is identical.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Presence of septate hyphae:&nbsp;</strong>Again, both species are <strong>septate molds</strong>; the septation is not species-specific and therefore not a differentiating feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The most reliable laboratory distinction between Aspergillus fumigatus and Aspergillus flavus lies in their <strong>colony color</strong> and <strong>microscopic vesicle morphology</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A. fumigatus → <strong>Smoky green colony, conical vesicle, uniseriate phialides</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A. flavus → <strong>Yellow-green colony, globular vesicle, uniseriate or biseriate phialides</strong>.</span></li></ul>",
      "correct_choice_id": 392160,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98533/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98533/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98278,
      "choices": [
        {
          "id": 391144,
          "text": "<p><span style=\"font-size:14.0pt;\">High-dose corticosteroids for 3 months</span></p>"
        },
        {
          "id": 391145,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-tubercular therapy for 6–9 months with DOTS</span></p>"
        },
        {
          "id": 391146,
          "text": "<p><span style=\"font-size:14.0pt;\">Bilateral salpingectomy followed by IVF</span></p>"
        },
        {
          "id": 391147,
          "text": "<p><span style=\"font-size:14.0pt;\">In vitro fertilization immediately</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman with 5 years of primary infertility undergoes diagnostic laparoscopy. Findings show bilateral cornual tubal block, beaded fallopian tubes with alternating constrictions and dilatations, and perihepatic adhesions (violin-string adhesions). Endometrial biopsy demonstrates caseating granulomas with Langerhans giant cells. What is the most appropriate initial management?</span></p>",
      "unique_key": "Q2114476",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Anti-tubercular therapy for 6–9 months with DOTS</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has <strong>genital tuberculosis (GTB)</strong>, a well-recognized cause of <strong>tubal infertility</strong> in developing countries such as India.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Diagnostic features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Laparoscopic findings:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Beaded tubes with alternating constrictions and dilatations (representing fibrosis and scarring).</span></li><li><span style=\"font-size:14.0pt;\">Bilateral cornual block due to endosalpingitis.</span></li><li><span style=\"font-size:14.0pt;\">Perihepatic adhesions (violin-string appearance) — seen in Fitz-Hugh–Curtis syndrome.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Histopathology:</strong> Caseating granulomas with Langerhans giant cells — pathognomonic of tuberculous endometritis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The infection commonly spreads hematogenously from a pulmonary focus.</span></li><li><span style=\"font-size:14.0pt;\">It primarily affects the <strong>fallopian tubes</strong>, leading to <strong>fibrosis, obstruction, and hydrosalpinx</strong>, causing <strong>infertility</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>endometrium</strong> may also be affected, reducing implantation potential.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Initial Management:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The first-line treatment is <strong>anti-tubercular therapy (ATT)</strong> for <strong>6–9 months</strong> under the <strong>DOTS regimen</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Intensive phase (2 months):</strong> Isoniazid, Rifampicin, Pyrazinamide, Ethambutol.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Continuation phase (4–7 months):</strong> Isoniazid, Rifampicin, Ethambutol.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Treatment aims to <strong>eradicate infection</strong>, reduce inflammation, and prevent further damage.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fertility interventions</strong> (like IVF) are considered <strong>only after completion of ATT</strong> and <strong>disease quiescence</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. High-dose corticosteroids for 3 months:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Steroids have no role in treating genital TB.</span></li><li><span style=\"font-size:14.0pt;\">They may worsen infection by suppressing immunity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Bilateral salpingectomy followed by IVF:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Surgery and IVF are <strong>secondary measures</strong> after completion of ATT if tubal damage is irreversible.</span></li><li><span style=\"font-size:14.0pt;\">Immediate surgery is not appropriate before treating the infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. In vitro fertilization immediately: </strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">IVF before ATT risks <strong>disease flare-up</strong> and <strong>poor endometrial receptivity</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Fertility treatment should begin only <strong>after infection control</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>genital tuberculosis</strong>, the <strong>initial management</strong> is <strong>anti-tubercular therapy (ATT) for 6–9 months under DOTS</strong>, aimed at eradicating infection and preventing further tubal and endometrial damage.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Fertility interventions such as IVF are considered <strong>only after completion of ATT</strong> and <strong>confirmation of disease inactivity</strong>.</span></li></ul>",
      "correct_choice_id": 391145,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98278/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98278/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98360,
      "choices": [
        {
          "id": 391472,
          "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-c, 3-a</span></p>"
        },
        {
          "id": 391473,
          "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-d, 3-a</span></p>"
        },
        {
          "id": 391474,
          "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-c, 3-b</span></p>"
        },
        {
          "id": 391475,
          "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-c, 3-a</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A public health officer is distributing STI treatment kits under the National STD Control Programme. Match the sexually transmitted disease with the correct color-coded STI treatment kit.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_t4hNFxD.png\" width=\"475\" height=\"127\"></span></p>",
      "unique_key": "Q3022484",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong>&nbsp;<strong>A) 1-b, 2-c, 3-a</strong></span></p><p><br><span style=\"font-size:14.0pt;\">The National STD Control Programme (India) uses color-coded kits for the syndromic management of STIs.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1-b.</strong> <strong>Urethritis — Grey kit:</strong> contains antibiotics covering gonococcal and chlamydial causes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2-c.</strong> <strong>Non-herpetic genital ulcers — White/Blue kit:</strong> provides treatment for chancroid and syphilis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3-a.</strong> <strong>Vaginal discharge — Green kit:</strong> covers bacterial vaginosis, trichomoniasis, and candidiasis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Color-coded STI kits ensure easy and rapid syndromic management of sexually transmitted infections under the National STD Control Programme, enabling primary healthcare providers to deliver standardized treatment.</span></p>",
      "correct_choice_id": 391472,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98360/INI-NEET_-_GT__27th_Nov_2025_Derma_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98360/INI-NEET_-_GT__27th_Nov_2025_Derma_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98284,
      "choices": [
        {
          "id": 391168,
          "text": "<p><span style=\"font-size:14.0pt;\">Laparoscopic hysterectomy</span></p>"
        },
        {
          "id": 391169,
          "text": "<p><span style=\"font-size:14.0pt;\">Endometrial ablation</span></p>"
        },
        {
          "id": 391170,
          "text": "<p><span style=\"font-size:14.0pt;\">Open myomectomy</span></p>"
        },
        {
          "id": 391171,
          "text": "<p><span style=\"font-size:14.0pt;\">Cervical biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What procedure is this instrument most commonly used for?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-26%20101729.jpg\" width=\"429\" height=\"343\"></p>",
      "unique_key": "Q1340151",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Open myomectomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The instrument shown in the image is a <strong>Bonney’s myomectomy clamp</strong>, which is primarily used in <strong>open myomectomy</strong> procedures.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This clamp is designed to provide hemostasis by occluding blood vessels in the uterine tissue during the removal of fibroids (myomas).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Myomectomy is a surgical procedure used to excise uterine fibroids while preserving the uterus, often performed in women who desire future fertility or want to avoid hysterectomy.</span></li><li><span style=\"font-size:14.0pt;\">The Bonney clamp allows the surgeon to control bleeding during the excision of fibroids, which is critical due to the high vascularity of the uterus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Laparoscopic hysterectomy:</strong> While laparoscopic instruments are used in hysterectomy, the Bonney’s myomectomy clamp is specifically designed for <strong>open procedures</strong>, not for use in laparoscopic surgeries.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Endometrial ablation:</strong> Endometrial ablation is a minimally invasive procedure used to remove or destroy the lining of the uterus to treat heavy menstrual bleeding. This procedure does not involve the use of a Bonney’s clamp, as it focuses on the endometrium rather than uterine fibroids.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cervical biopsy:</strong> Cervical biopsies are small tissue samples taken from the cervix, typically during a colposcopy. A Bonney’s clamp is not needed for this procedure, which involves much smaller instruments.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>Bonney’s myomectomy clamp</strong> is commonly used during an <strong>open myomectomy</strong> to control bleeding while removing uterine fibroids.</span></p>",
      "correct_choice_id": 391170,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98284/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98284/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98295,
      "choices": [
        {
          "id": 391212,
          "text": "<p><span style=\"font-size:14.0pt;\">Unconsciousness</span></p>"
        },
        {
          "id": 391213,
          "text": "<p><span style=\"font-size:14.0pt;\">Pain Relief</span></p>"
        },
        {
          "id": 391214,
          "text": "<p><span style=\"font-size:14.0pt;\">Loss of Reflexes</span></p>"
        },
        {
          "id": 391215,
          "text": "<p><span style=\"font-size:14.0pt;\">Muscle Relaxation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of these is not a property of volatile anaesthetic agents?</span></p>",
      "unique_key": "Q7273483",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Pain Relief&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is generally <strong>not considered</strong> a <strong>primary property</strong> of <strong>volatile anaesthetic agents</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While they can <strong>contribute</strong> to <strong>overall anesthesia</strong>, they <strong>do not provide</strong> significant <strong>analgesia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The main analgesic inhalational agents are <strong>nitrous oxide&nbsp;</strong>and<strong> xenon</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Properties of volatile anaesthetic agents:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Amnesia</span></li><li><span style=\"font-size:14.0pt;\">Muscle relaxation</span></li><li><span style=\"font-size:14.0pt;\">Loss of reflexes&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A</strong>. <strong>Unconsciousness</strong>: <strong>Volatile anaesthetic agents</strong> are known to induce a <strong>reversible loss of consciousness</strong>, making them <strong>essential for general anesthesia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong>. <strong>Loss of Reflexes</strong>: <strong>Volatile anaesthetics</strong> can <strong>diminish or abolish reflexes</strong>, which is <strong>important</strong> during <strong>surgical procedures</strong> to <strong>prevent spontaneous movements</strong> and <strong>potential injury</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D</strong>. <strong>Muscle Relaxation</strong>: These agents also contribute to <strong>muscle relaxation</strong>, which is necessary for some types of <strong>surgical procedures</strong>, though often, <strong>additional muscle relaxants</strong> are used to <strong>achieve adequate relaxation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Volatile anaesthetic agents are used in general anesthesia for their <strong>ability to induce unconsciousness</strong>, <strong>muscle relaxation</strong>, and <strong>suppression of reflexes</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They <strong>do not provide</strong> significant <strong>pain relief</strong>, which is why additional analgesic agents, such as <strong>opioids</strong>, <strong>are often administered concurrently</strong> during surgery.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nitrous oxide</strong> and <strong>xenon</strong> are unique among inhalational agents in that they also have analgesic properties.</span></li></ul>",
      "correct_choice_id": 391213,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98295/INI-NEET_-_GT__27th_Nov_2025_Anesthesia_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98295/INI-NEET_-_GT__27th_Nov_2025_Anesthesia_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98547,
      "choices": [
        {
          "id": 392216,
          "text": "<p><span style=\"font-size:14.0pt;\">Measurement of angle of deviation and sensory status</span></p>"
        },
        {
          "id": 392217,
          "text": "<p><span style=\"font-size:14.0pt;\">Detection of amblyopia severity</span></p>"
        },
        {
          "id": 392218,
          "text": "<p><span style=\"font-size:14.0pt;\">Evaluation of intraocular pressure differences</span></p>"
        },
        {
          "id": 392219,
          "text": "<p><span style=\"font-size:14.0pt;\">Measurement of accommodation-convergence ratio</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 7-year-old child with a history of intermittent esotropia is undergoing orthoptic evaluation. The ophthalmologist uses the slides shown in the image below in an instrument for assessment. What is the primary purpose of this device in strabismus management?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6Iq484j.png\" width=\"448\" height=\"448\"></span></p>",
      "unique_key": "Q3445232",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Measurement of angle of deviation and sensory status</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Synoptophore slides</strong> seen in the image are used for <strong>diagnosing and treating binocular vision anomalies</strong>, particularly in strabismus.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This device is used to measure:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Objective and subjective angle of deviation</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Binocular sensory functions</strong> (simultaneous perception, fusion, stereopsis)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Treatment of suppression and anomalous retinal correspondence (ARC)</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-26%20104949.jpg\" width=\"1070\" height=\"704\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Detection of amblyopia severity:</strong> Amblyopia is evaluated using <strong>visual acuity charts</strong> and contrast sensitivity tests.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Evaluation of intraocular pressure differences:</strong> This is assessed using <strong>tonometry</strong>, not the Synoptophore.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Measurement of accommodation-convergence ratio:</strong> Determined by <strong>heterophoria testing</strong>, not the Synoptophore.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The Synoptophore is used in strabismus evaluation to measure ocular deviation, assess binocular vision, and provide orthoptic treatment for fusion and suppression anomalies.</span></p>",
      "correct_choice_id": 392216,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98547/Ini-Neet_-_Gt__27Th_Nov_2025_Ophthalmology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98547/Ini-Neet_-_Gt__27Th_Nov_2025_Ophthalmology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98273,
      "choices": [
        {
          "id": 391124,
          "text": "<p><span style=\"font-size:14.0pt;\">0.38 L/min</span></p>"
        },
        {
          "id": 391125,
          "text": "<p><span style=\"font-size:14.0pt;\">0.066 L/min</span></p>"
        },
        {
          "id": 391126,
          "text": "<p><span style=\"font-size:14.0pt;\">6.16 L/min</span></p>"
        },
        {
          "id": 391127,
          "text": "<p><span style=\"font-size:14.0pt;\">5.4 L/min</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man comes for evaluation of persistent fatigue and mild shortness of breath. His pulmonary examination and chest X-ray are unremarkable. ABG analysis reveals a PaCO₂ of 45 mm Hg, and his expired air sample shows PECO₂ of 35 mm Hg. His tidal volume (VT) is measured as 0.5 L, and his respiratory rate is 14 breaths per minute. Which of the following represents his alveolar ventilation (VA)?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6377130",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 5.4 L/min</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ITTQ8Vd.png\" width=\"1017\" height=\"435\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Alveolar ventilation can be calculated from <strong>minute ventilation and the ratio of expired to arterial CO₂ pressures</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It provides a direct measure of effective ventilation in the alveoli where gas exchange occurs.</span></li></ul>",
      "correct_choice_id": 391127,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98273/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98273/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98267,
      "choices": [
        {
          "id": 391100,
          "text": "<p><span style=\"font-size:14.0pt;\">Activation of Golgi tendon organs via group Ib afferent fibers leading to muscle relaxation</span></p>"
        },
        {
          "id": 391101,
          "text": "<p><span style=\"font-size:14.0pt;\">Activation of group Ia afferent fibers from muscle spindles leading to α-motor neuron stimulation of the same muscle</span></p>"
        },
        {
          "id": 391102,
          "text": "<p><span style=\"font-size:14.0pt;\">Activation of cutaneous mechanoreceptors via Aβ fibers leading to contraction of the antagonist muscle</span></p>"
        },
        {
          "id": 391103,
          "text": "<p><span style=\"font-size:14.0pt;\">Activation of γ-motor neurons increasing tension in extrafusal fibers and inhibiting reflex contraction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old construction worker is struck on the patellar tendon by a falling object. The impact rapidly stretches the quadriceps muscle, triggering an immediate contraction that prevents his knee from buckling. Which of the following neural pathways is primarily responsible for this rapid compensatory response?</span></p>",
      "unique_key": "Q5316854",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Activation of group Ia afferent fibers from muscle spindles leading to α-motor neuron stimulation of the same muscle</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>muscle spindle</strong> is a <strong>stretch receptor</strong> embedded within skeletal muscle.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It detects <strong>changes in muscle length</strong> and mediates the <strong>myotatic (stretch) reflex</strong>, which resists excessive stretch to maintain posture and tone.</span></li><li><span style=\"font-size:14.0pt;\"><strong>When the muscle is stretched</strong>, the <strong>intrafusal fibers</strong> of the spindle also stretch.</span></li><li><span style=\"font-size:14.0pt;\">This activates <strong>group Ia afferent fibers</strong>, which send signals to the <strong>spinal cord</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In the spinal cord, these Ia afferents <strong>directly synapse with α-motor neurons</strong> that innervate the same (homonymous) muscle, causing <strong>reflex contraction</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Simultaneously, <strong>inhibitory interneurons</strong> suppress the α-motor neurons of the <strong>antagonistic muscle</strong> — a process known as <strong>reciprocal inhibition</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This allows the stretched muscle to <strong>return to its resting length</strong>, stabilizing body position — as seen in the <strong>patellar reflex</strong> (L2–L4).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Activation of Golgi tendon organs via group Ib afferent fibers leading to muscle relaxation:&nbsp;</strong>Golgi tendon organs monitor <strong>tension</strong>, not length. Group Ib fibers cause <strong>autogenic inhibition</strong>, leading to <strong>relaxation</strong>, not contraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Activation of cutaneous mechanoreceptors via Aβ fibers leading to contraction of the antagonist muscle: </strong>Aβ fibers mediate <strong>touch and pressure</strong>, not muscle stretch. They are <strong>not part of the stretch reflex</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Activation of γ-motor neurons increasing tension in extrafusal fibers and inhibiting reflex contraction:&nbsp;</strong>γ-motor neurons adjust the <strong>sensitivity of intrafusal fibers</strong>, not extrafusal contraction directly. Their activation <strong>enhances</strong>, not inhibits, reflex sensitivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Group Ia afferent fibers</strong> from <strong>muscle spindles</strong> detect <strong>muscle stretch</strong>.</span></li><li><span style=\"font-size:14.0pt;\">They <strong>activate α-motor neurons</strong>, causing <strong>reflex contraction</strong> of the same muscle and <strong>relaxation of the antagonist</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This <strong>stretch reflex</strong> helps maintain <strong>muscle tone and posture</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key concept:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Stretch → Muscle spindle → Group Ia afferents → α-motor neurons → Reflex contraction (stretch reflex)</span></p>",
      "correct_choice_id": 391101,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98267/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98267/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98784,
      "choices": [
        {
          "id": 393148,
          "text": "<p><span style=\"font-size:14.0pt;\">Observation with repeat labs and clinical examination every 3 months</span></p>"
        },
        {
          "id": 393149,
          "text": "<p><span style=\"font-size:14.0pt;\">Start bendamustine + rituximab</span></p>"
        },
        {
          "id": 393150,
          "text": "<p><span style=\"font-size:14.0pt;\">Start bortezomib + dexamethasone + lenalidomide</span></p>"
        },
        {
          "id": 393151,
          "text": "<p><span style=\"font-size:14.0pt;\">Stem cell collection in preparation for autologous stem cell transplant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 75-year-old man with CAD presents with anemia, fatigue, neuropathic pain in the feet, and mobility issues. Lab studies show an IgM monoclonal spike (7 g/dL), thrombocytopenia, and a bone marrow biopsy with 65% involvement by monoclonal plasmacytoid lymphocytes. What is the next best step in management?</span></p>",
      "unique_key": "Q5374351",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Start bendamustine + rituximab</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>The patient meets diagnostic criteria for Waldenström macroglobulinemia:</strong> symptomatic anemia, neuropathy, high serum IgM, monoclonal spike, and bone marrow involvement by lymphoplasmacytic cells.</span></li><li><span style=\"font-size:14.0pt;\">Symptomatic cases require therapy; the preferred first-line regimen is a combination of bendamustine (an alkylating agent) and rituximab (anti-CD20 monoclonal antibody), which is highly effective for initial treatment and symptom improvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Observation with repeat labs and clinical examination every 3 months:&nbsp;</strong>Observation is reserved for asymptomatic or smoldering WM, not those with severe neuropathy and fatigue.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C. Start bortezomib + dexamethasone + lenalidomide:</strong> Bortezomib-based regimens are standard for multiple myeloma, not for first-line treatment of WM.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D. Stem cell collection in preparation for autologous stem cell transplant:</strong> Stem cell transplant is not first-line for WM and is reserved for relapsed or refractory cases after initial chemotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For symptomatic Waldenström macroglobulinemia, immediate initiation of chemotherapy with bendamustine plus rituximab is standard.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Observation is reserved for asymptomatic patients, and transplant approaches are used in refractory or relapsed cases.</span></li></ul>",
      "correct_choice_id": 393149,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98784/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98784/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98288,
      "choices": [
        {
          "id": 391184,
          "text": "<p><span style=\"font-size:14.0pt;\">Score 6; repeat test in 4-6 hours</span></p>"
        },
        {
          "id": 391185,
          "text": "<p><span style=\"font-size:14.0pt;\">Score 8; repeat testing at weekly interval</span></p>"
        },
        {
          "id": 391186,
          "text": "<p><span style=\"font-size:14.0pt;\">Score 4; deliver regardless of gestational age</span></p>"
        },
        {
          "id": 391187,
          "text": "<p><span style=\"font-size:14.0pt;\">Score 10; routine prenatal care</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old G3P2 at 38 weeks presents with decreased fetal movements. Biophysical profile (BPP) is performed showing: reactive NST, one episode of fetal breathing &gt;30 seconds, two discrete body movements, good fetal tone, and AFI of 4 cm. What is the BPP score and recommended management?</span></p>",
      "unique_key": "Q9143000",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Score 6; repeat test in 4–6 hours</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 1: Biophysical Profile (BPP) Parameters</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">BPP assesses <strong>five parameters</strong>, each given <strong>2 points if normal</strong>, and <strong>0 if abnormal/absent</strong>, for a <strong>maximum total of 10 points</strong>:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>NST (Non-stress test)</strong> – 2 points if reactive</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fetal breathing movements</strong> – 2 points if ≥1 episode lasting &gt;30 seconds</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fetal body movements</strong> – 2 points if ≥3 discrete body/limb movements</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fetal tone</strong> – 2 points if ≥1 episode of extension with return to flexion</span></li><li><span style=\"font-size:14.0pt;\"><strong>Amniotic fluid index (AFI)</strong> – 2 points if ≥5 cm (normal); 0 if ≤5 cm (oligohydramnios)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 2: Scoring in this Case</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-22%20095326.jpg\" width=\"907\" height=\"423\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 3: Interpretation of BPP</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-22%20095338.jpg\" width=\"1198\" height=\"311\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, this patient has a <strong>BPP score of 6</strong>, which is <strong>equivocal</strong>, so the test should be <strong>repeated in 4–6 hours</strong> to reassess fetal well-being.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Here, as the patient is 38 weeks gestation, so best is to plan for the delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>biophysical profile (BPP)</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>score of 6/10</strong> is <strong>equivocal</strong> and warrants <strong>retesting in 4–6 hours</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>AFI &lt;5 cm</strong> indicates <strong>oligohydramnios</strong>, a sign of <strong>placental insufficiency</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Persistent <strong>low BPP</strong> requires <strong>delivery</strong> to prevent <strong>fetal hypoxia and stillbirth</strong>.</span></li></ul>",
      "correct_choice_id": 391184,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98288/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98288/INI-NEET_-_GT__27th_Nov_2025_OBG_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98584,
      "choices": [
        {
          "id": 392360,
          "text": "<p><span style=\"font-size:14.0pt;\">Hepatic adenoma</span></p>"
        },
        {
          "id": 392361,
          "text": "<p><span style=\"font-size:14.0pt;\">Dysplastic nodule in cirrhotic liver</span></p>"
        },
        {
          "id": 392362,
          "text": "<p><span style=\"font-size:14.0pt;\">Focal nodular hyperplasia</span></p>"
        },
        {
          "id": 392363,
          "text": "<p><span style=\"font-size:14.0pt;\">Cavernous hemangioma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old man with a history of chronic hepatitis B infection presents with right upper&nbsp;quadrant discomfort, early satiety, and unintentional weight loss over 3 months. On examination, there is hepatomegaly with a firm, nodular liver edge. Laboratory investigations show: Serum bilirubin: 1.5 mg/dL, ALT: 80 U/L AST: 90 U/L Serum α-fetoprotein (AFP): 2200 ng/mL (↑), Hepatitis B surface antigen (HBsAg): positive and Ultrasound abdomen: single mass lesion in the right lobe of liver. CT scan: arterial phase enhancement with rapid washout in venous phase. A liver biopsy is performed. Histology shows trabecular arrangement of polygonal cells with eosinophilic cytoplasm, hyperchromatic nuclei, and bile pigment within tumor cells. Reticulin stain shows loss of normal hepatic plate architecture. Which of the following is the most likely precursor lesion for this malignancy?</span></p>",
      "unique_key": "Q8973406",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Dysplastic nodule in cirrhotic liver</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Elevated AFP, chronic HBV infection, arterial enhancement with venous washout, and bile-containing tumor cells → Hepatocellular Carcinoma (HCC).</span></li><li><span style=\"font-size:14.0pt;\">Dysplastic nodule in cirrhotic liver: Dysplastic nodules (especially high-grade) are the direct precursors to HCC in cirrhosis.</span></li><li><span style=\"font-size:14.0pt;\">Occur in the background of chronic HBV/HCV, alcohol, or NAFLD.</span></li><li><span style=\"font-size:14.0pt;\">Show atypical hepatocytes with loss of reticulin framework, increased nuclear-cytoplasmic ratio, and unpaired arteries. → Stepwise progression: Regenerative nodule → Low-grade dysplastic nodule → High-grade dysplastic nodule → HCC.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hepatic adenoma:&nbsp;</strong>Benign tumor of hepatocytes, seen in young women on oral contraceptives. May rupture and bleed but rarely transforms into HCC (only β-catenin mutated subtype has risk). Histologically lacks bile production and portal tracts. → Not the usual precursor for HCC in a cirrhotic HBV liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Focal nodular hyperplasia</strong>: Benign, non-neoplastic lesion caused by localized vascular abnormality. Has central stellate scar and normal hepatocytes. No risk of malignant transformation. → Not related to HBV or HCC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cavernous hemangioma:&nbsp;</strong>Most common benign liver tumor, composed of blood-filled vascular channels. Usually incidental, never undergoes malignant change. → No link with HCC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_x5E6OT4.png\" width=\"757\" height=\"562\"></strong></span></p>",
      "correct_choice_id": 392361,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98584/Ini-Neet_-_Gt__27Th_Nov_2025_Pathology_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98584/Ini-Neet_-_Gt__27Th_Nov_2025_Pathology_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 86977,
      "choices": [
        {
          "id": 346392,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated PTH levels</span></p>"
        },
        {
          "id": 346393,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated urinary VMA</span></p>"
        },
        {
          "id": 346394,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated Serum Gastrin</span></p>"
        },
        {
          "id": 346395,
          "text": "<p><span style=\"font-size:14.0pt;\">Pituitary prolactinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following manifestations is not typically associated with multiple endocrine neoplasia type 1 (MEN 1) syndrome?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8424520",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Elevated urinary VMA</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pheochromocytoma is not typically associated with MEN 1 syndrome.</span></li><li><span style=\"font-size:14.0pt;\">Instead, it is commonly seen in multiple endocrine neoplasia type 2 (MEN 2).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">MEN 1 primarily involves tumors in the parathyroid glands, pancreas, and pituitary gland, but pheochromocytomas are not a feature of this syndrome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Elevated PTH levels:</strong> Parathyroid hyperplasia is one of the primary manifestations of MEN 1. Most patients with MEN 1 will develop parathyroid gland hyperplasia or adenomas, leading to primary hyperparathyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Elevated Serum Gastrin:&nbsp;</strong>Pancreatic endocrine tumors, such as gastrinomas and insulinomas, are commonly seen in MEN 1 and are a defining feature of this syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pituitary prolactinoma:</strong> Pituitary tumors, especially prolactinomas, are another common feature of MEN 1. Pituitary tumors in MEN 1 can secrete various hormones, with prolactin being one of the most common.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">MEN 1 syndrome is characterized by a combination of tumors in the parathyroid glands, pancreatic endocrine glands, and pituitary gland.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Pheochromocytoma, however, is not associated with MEN 1 and is instead a feature of MEN 2.&nbsp;</span></li></ul>",
      "correct_choice_id": 346393,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86977/FMGE_SURGERY_MOCK_2_Q_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/86977/FMGE_SURGERY_MOCK_2_Q_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98312,
      "choices": [
        {
          "id": 391280,
          "text": "<p><span style=\"font-size:14.0pt;\">Promontory</span></p>"
        },
        {
          "id": 391281,
          "text": "<p><span style=\"font-size:14.0pt;\">Oval window</span></p>"
        },
        {
          "id": 391282,
          "text": "<p><span style=\"font-size:14.0pt;\">Prussak space</span></p>"
        },
        {
          "id": 391283,
          "text": "<p><span style=\"font-size:14.0pt;\">Facial recess</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man presents with a history of recurrent ear infections and hearing loss. Otoscopic examination reveals a retraction pocket in the pars flaccida. Which of the following anatomical areas is most likely involved in the formation of a cholesteatoma in this patient?</span></p>",
      "unique_key": "Q1543409",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Prussak space</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>cholesteatoma</strong> is an abnormal growth of keratinizing squamous epithelium in the middle ear, typically arising from retraction pockets in the pars flaccida of the tympanic membrane.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>Prussak space</strong>, located between the pars flaccida and the neck of the malleus, is the most common site for the initiation of cholesteatomas.</span></li><li><span style=\"font-size:14.0pt;\">Retraction pockets in the pars flaccida extend into the Prussak space, allowing for accumulation of keratin debris and subsequent infection, leading to the formation of a cholesteatoma.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-25%20140106.jpg\" width=\"834\" height=\"532\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Promontory:&nbsp;</strong>The promontory is part of the medial wall of the middle ear and houses the cochlear basal turn. While it is an important anatomical landmark, it is not involved in the formation of cholesteatomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Oval window:&nbsp;</strong>The oval window is an opening in the medial wall of the middle ear that connects to the stapes footplate and the inner ear. It plays a role in sound conduction but is not involved in the early formation of cholesteatomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Facial recess:&nbsp;</strong>The facial recess is a surgical landmark located lateral to the facial nerve and medial to the chorda tympani in the posterior tympanum. It is not related to cholesteatoma formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Prussak space</strong> is the primary site involved in the formation of cholesteatomas, particularly those arising from retraction pockets in the pars flaccida of the tympanic membrane.</span></p>",
      "correct_choice_id": 391282,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98312/INI-NEET_-_GT__27th_Nov_2025_NET_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98312/INI-NEET_-_GT__27th_Nov_2025_NET_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98798,
      "choices": [
        {
          "id": 393204,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreases glomerular filtration rate (GFR) by renal vasoconstriction</span></p>"
        },
        {
          "id": 393205,
          "text": "<p><span style=\"font-size:14.0pt;\">Promotes sodium and water retention via aldosterone release</span></p>"
        },
        {
          "id": 393206,
          "text": "<p><span style=\"font-size:14.0pt;\">Increases renal perfusion and natriuresis via selective D1 activation</span></p>"
        },
        {
          "id": 393207,
          "text": "<p><span style=\"font-size:14.0pt;\">Causes nephrotoxicity with prolonged infusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is a unique renal effect of fenoldopam that distinguishes it from other intravenous antihypertensives?</span></p>",
      "unique_key": "Q2735931",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Increases renal perfusion and natriuresis via selective D1 activation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Fenoldopam</strong> is a <strong>selective dopamine-1 (D1) receptor agonist</strong> used intravenously for short-term management of <strong>hypertensive emergencies</strong>, especially in patients with <strong>renal dysfunction</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Its mechanism involves:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>D1 receptor stimulation</strong> → <strong>vasodilation of renal arterioles</strong>, especially the afferent arteriole</span></li><li><span style=\"font-size:14.0pt;\">This increases <strong>renal blood flow</strong>, <strong>glomerular filtration rate (GFR)</strong>, and promotes <strong>natriuresis and diuresis</strong></span></li><li><span style=\"font-size:14.0pt;\">Unlike other vasodilators (e.g., nitroprusside), fenoldopam <strong>preserves or improves renal function</strong>, making it useful in patients with concurrent <strong>acute kidney injury (AKI)</strong> or <strong>at risk for renal ischemia</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">This <strong>renoprotective</strong> profile makes fenoldopam unique among IV antihypertensives.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Decreases glomerular filtration rate (GFR) by renal vasoconstriction</strong>: Incorrect. Fenoldopam causes <strong>renal vasodilation</strong>, not constriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Promotes sodium and water retention via aldosterone release:&nbsp;</strong>Incorrect. Fenoldopam <strong>inhibits sodium reabsorption</strong> by increasing renal perfusion and natriuresis. It has no direct mineralocorticoid effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Causes nephrotoxicity with prolonged infusion:&nbsp;</strong>Incorrect. Fenoldopam is <strong>not nephrotoxic</strong>. In contrast, <strong>sodium nitroprusside</strong> may be harmful in renal failure due to <strong>cyanide accumulation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Fenoldopam, a selective <strong>dopamine-1 receptor agonist</strong>, is a unique IV antihypertensive that <strong>increases renal perfusion, GFR, and natriuresis</strong>, making it especially beneficial in hypertensive emergencies with <strong>renal impairment</strong>.</span></p>",
      "correct_choice_id": 393206,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98798/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98798/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98783,
      "choices": [
        {
          "id": 393144,
          "text": "<p><span style=\"font-size:14.0pt;\">2 U fresh frozen plasma and 10 mg IV vitamin K</span></p>"
        },
        {
          "id": 393145,
          "text": "<p><span style=\"font-size:14.0pt;\">2 U fresh frozen plasma and platelet transfusion</span></p>"
        },
        {
          "id": 393146,
          "text": "<p><span style=\"font-size:14.0pt;\">No blood products necessary. Proceed with surgery</span></p>"
        },
        {
          "id": 393147,
          "text": "<p><span style=\"font-size:14.0pt;\">Platelet transfusion alone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 54-year-old woman with hepatitis C and compensated cirrhosis needs urgent surgery for a femoral fracture after a car accident. She has a stable platelet count of 40,000/µL and stable hemoglobin, INR 1.3, and normal differential. What blood products should she receive before surgery?</span></p>",
      "unique_key": "Q5895856",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Platelet transfusion alone</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Platelet transfusion is necessary before surgery in patients with thrombocytopenia to increase the platelet count above 50,000/µL, which is the generally accepted minimum for most surgical procedures.</span></li><li><span style=\"font-size:14.0pt;\">This patient’s mild INR elevation is chronic and related to liver dysfunction, reflecting reduced synthesis of both procoagulant and anticoagulant factors, and does not constitute a true bleeding risk requiring FFP or vitamin K unless the INR is &gt; 1.5 or active bleeding is present.</span></li><li><span style=\"font-size:14.0pt;\">FFP and vitamin K are reserved for cases of significant coagulopathy or vitamin K deficiency, neither of which is supported by this patient’s labs or clinical context.</span></li><li><span style=\"font-size:14.0pt;\">Proceeding without platelet transfusion would place the patient at high risk for perioperative bleeding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. 2 U fresh frozen plasma and 10 mg IV vitamin K:</strong> FFP and vitamin K are not necessary for mild INR elevation due to chronic liver disease.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. 2 U fresh frozen plasma and platelet transfusion:</strong> FFP is only used if there is a significant, clinically relevant coagulopathy.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C. No blood products necessary. Proceed with surgery:</strong> Surgery should not proceed without increasing the platelet count, as her baseline is too low for a safe procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Platelet transfusion is required to raise the platelet count above 50,000/µL in surgical patients with thrombocytopenia due to liver disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Fresh frozen plasma and vitamin K are not indicated unless there is a major coagulopathy.</span></li></ul>",
      "correct_choice_id": 393147,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98783/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98783/INI-NEET_-_GT__27th_Nov_2025_Medicine_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98269,
      "choices": [
        {
          "id": 391108,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased leptin sensitivity</span></p>"
        },
        {
          "id": 391109,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased food intake via stimulation of the anorexigenic pathway</span></p>"
        },
        {
          "id": 391110,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of melanocortin receptors, leading to increased appetite</span></p>"
        },
        {
          "id": 391111,
          "text": "<p><span style=\"font-size:14.0pt;\">Activation of the satiety center in the hypothalamus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman with recent weight gain and increased appetite is found to have elevated Agouti-related peptide (AgRP) levels in the hypothalamus. Which of the following best explains the physiological effect of increased AgRP activity?</span></p>",
      "unique_key": "Q6794530",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Inhibition of melanocortin receptors, leading to increased appetite</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Agouti-related peptide (AgRP)</strong> is produced in the <strong>arcuate nucleus of the hypothalamus</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is an <strong>orexigenic neuropeptide</strong> → it promotes <strong>food intake</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">AgRP acts as an <strong>antagonist at melanocortin-4 receptors (MC4R)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Normally, <strong>α-MSH (from POMC neurons)</strong> activates MC4R, stimulating the <strong>anorexigenic pathway</strong> (↓ appetite).</span></li><li><span style=\"font-size:14.0pt;\">AgRP <strong>blocks this receptor</strong>, thereby reducing satiety signals and increasing appetite.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Elevated AgRP → <strong>hyperphagia, weight gain</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Increased leptin sensitivity:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Incorrect. Leptin reduces appetite by inhibiting AgRP/NPY neurons and stimulating POMC neurons.</span></li><li><span style=\"font-size:14.0pt;\">AgRP activity increases with <strong>leptin resistance</strong>, not increased leptin sensitivity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Decreased food intake via stimulation of the anorexigenic pathway:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Incorrect. The anorexigenic pathway involves <strong>POMC neurons releasing α-MSH</strong>, which activates MC4R.</span></li><li><span style=\"font-size:14.0pt;\">AgRP does the opposite by blocking MC4R.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Activation of the satiety center in the hypothalamus:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Incorrect. The <strong>ventromedial hypothalamus (satiety center)</strong> decreases food intake when activated.</span></li><li><span style=\"font-size:14.0pt;\">AgRP stimulates appetite rather than activating satiety pathways.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Agouti-related peptide (AgRP) is an orexigenic neuropeptide from the arcuate nucleus that increases appetite by inhibiting melanocortin-4 receptors, antagonizing the satiety effect of α-MSH.</span></p>",
      "correct_choice_id": 391110,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98269/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98269/INI-NEET_-_GT__27th_Nov_2025_Physiology_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98525,
      "choices": [
        {
          "id": 392128,
          "text": "<p><span style=\"font-size:14.0pt;\">Blood agar</span></p>"
        },
        {
          "id": 392129,
          "text": "<p><span style=\"font-size:14.0pt;\">Nutrient agar</span></p>"
        },
        {
          "id": 392130,
          "text": "<p><span style=\"font-size:14.0pt;\">MacConkey agar</span></p>"
        },
        {
          "id": 392131,
          "text": "<p><span style=\"font-size:14.0pt;\">Chocolate agar</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following culture media is most suitable to suppress the swarming motility seen in the image below, allowing isolation of discrete colonies?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ggn1KoG.png\" width=\"253\" height=\"253\"></span></p>",
      "unique_key": "Q4152274",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) MacConkey agar</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image depicts the <strong>swarming motility of Proteus species</strong> on <strong>blood agar</strong>, characterized by <strong>concentric waves of spreading growth</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This occurs due to <strong>flagella-mediated motility</strong>, making it difficult to isolate single colonies on routine solid media.</span></li><li><span style=\"font-size:14.0pt;\">To inhibit this motility and obtain <strong>pure colonies</strong>, culture is done on:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>MacConkey agar</strong> or</span></li><li><span style=\"font-size:14.0pt;\"><strong>CLED (Cystine-Lactose-Electrolyte-Deficient) agar</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">These media contain <strong>bile salts and a higher agar concentration</strong>, which <strong>suppress swarming behavior</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Blood agar:</strong> Allows active swarming (as shown in the image).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Nutrient agar:</strong> Also supports extensive swarming due to smooth surface moisture.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chocolate agar:</strong> Supports growth but does not inhibit motility; not preferred for isolation of Proteus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>MacConkey agar</strong> inhibits the <strong>swarming motility</strong> of Proteus species through bile salts and higher agar content, allowing the formation of <strong>discrete, non-lactose fermenting colonies</strong> for accurate identification.</span></p>",
      "correct_choice_id": 392130,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98525/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98525/INI-NEET_-_GT__27th_Nov_2025_Microbiology_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98614,
      "choices": [
        {
          "id": 392476,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased dopamine in the nigrostriatal pathway; administer lorazepam</span></p>"
        },
        {
          "id": 392477,
          "text": "<p><span style=\"font-size:14.0pt;\">Overstimulation of GABAergic pathways; administer propranolol</span></p>"
        },
        {
          "id": 392478,
          "text": "<p><span style=\"font-size:14.0pt;\">Dopamine receptor blockade in the nigrostriatal pathway; decrease dose of haloperidol</span></p>"
        },
        {
          "id": 392479,
          "text": "<p><span style=\"font-size:14.0pt;\">Acetylcholine receptor overactivation in the basal ganglia; administer benztropine or diphenhydramine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old woman with schizophrenia is started on haloperidol for acute psychosis. The following day, she returns to the emergency department with the condition, as shown in the image. She also exhibits agitation and discomfort. Which of the following pathophysiological mechanisms is most likely responsible for her presentation, and what is the best immediate treatment?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_3eRIUuc.png\" width=\"252\" height=\"297\"></span></p>",
      "unique_key": "Q7603572",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Acetylcholine receptor overactivation in the basal ganglia; administer benztropine or diphenhydramine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient is experiencing <strong>acute dystonia</strong>, a severe extrapyramidal side effect caused by <strong>dopamine receptor blockade</strong> in the nigrostriatal pathway, leading to relative overactivity of cholinergic neurons.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This imbalance between dopamine and acetylcholine causes painful, sustained muscle contractions, such as retrocollis, trismus, and oculogyric crisis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The condition is commonly seen within hours to days of starting high-potency antipsychotics such as haloperidol.</span></li><li><span style=\"font-size:14.0pt;\">The most effective immediate treatment is the administration of <strong>anticholinergic agents</strong> like <strong>benztropine</strong> or <strong>antihistamines</strong> like <strong>diphenhydramine</strong>, which restore the balance between dopamine and acetylcholine in the basal ganglia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Decreased dopamine in the nigrostriatal pathway; administer lorazepam:&nbsp;</strong>Incorrect.&nbsp;The mechanism is indeed dopamine blockade in the nigrostriatal tract, but lorazepam is&nbsp;not&nbsp;the treatment for acute dystonia. Benzodiazepines are second-line if anticholinergics fail.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Overstimulation of GABAergic pathways; administer propranolol:&nbsp;</strong>Incorrect. This describes neither the mechanism of dystonia nor the treatment. Propranolol is used for&nbsp;<strong>akathisia</strong>, not dystonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Dopamine receptor blockade in the nigrostriatal pathway; decrease dose of haloperidol:&nbsp;</strong>Partially correct mechanism, incorrect treatment.&nbsp;The underlying cause is dopamine D₂ blockade, but simply reducing the dose does not acutely relieve dystonia. You must treat emergently with anticholinergics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Acute dystonia is a painful and distressing extrapyramidal side effect caused by dopamine receptor blockade in the nigrostriatal pathway, leading to cholinergic overactivity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The first-line treatment is <strong>anticholinergic agents</strong> (e.g., benztropine) or <strong>antihistamines</strong> (e.g., diphenhydramine).</span></li></ul>",
      "correct_choice_id": 392479,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98614/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98614/INI-NEET_-_GT__27th_Nov_2025_Pharmacology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98767,
      "choices": [
        {
          "id": 393084,
          "text": "<p><span style=\"font-size:14.0pt;\">Abdominal MRI with adrenal protocol</span></p>"
        },
        {
          "id": 393085,
          "text": "<p><span style=\"font-size:14.0pt;\">No further evaluation required given the benign nature</span></p>"
        },
        {
          "id": 393086,
          "text": "<p><span style=\"font-size:14.0pt;\">24hr urine fractionated metanephrines, ODST and ARR</span></p>"
        },
        {
          "id": 393087,
          "text": "<p><span style=\"font-size:14.0pt;\">24hr urine fractionated metanephrines and ARR</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 53-year-old man with hypertension and obesity is found to have a 4.2 × 3.5 cm left adrenal mass with smooth borders on CT abdomen. He presented with dizziness, nausea, vomiting, and his blood pressure is elevated. What is the next best step in management? (Key – ODST: Overnight Dexamethasone Suppression Test, ARR: Aldosterone Renin Ratio)<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9393355",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) 24hr urine fractionated metanephrines, ODST and ARR</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient is diagnosed to have adrenal incidentaloma.</span></li><li><span style=\"font-size:14.0pt;\">All patients with an incidental adrenal mass require biochemical evaluation for hormone excess, regardless of imaging features or size.​</span></li><li><span style=\"font-size:14.0pt;\"><strong>The recommended tests are:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Screening for pheochromocytoma (24-hour urine or plasma fractionated metanephrines) – it is a must</span></li><li><span style=\"font-size:14.0pt;\">Assessment of cortisol excess (overnight dexamethasone suppression test, ODST) – must be done in obese patients</span></li><li><span style=\"font-size:14.0pt;\">Evaluation for primary aldosteronism (aldosterone-renin ratio, ARR) in hypertensive patients and/or patients with hypokalemia</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This comprehensive workup is essential because functional adrenal tumors (pheochromocytoma, cortisol excess, or aldosterone-secreting tumors) may be clinically silent.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Appropriate further imaging or intervention depends on the results.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Features of a benign tumour:</strong> Size &lt; 4cm, Density &lt; 10HU, contrast washout &gt; 50% @ 10mins and rounded/homogenous with smooth borders.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Features of a malignant tumour:</strong> Size ≥ 4cm, Density &gt; 20HU, contrast washout &lt; 50% @ 10mins and lobulated/in-homogenous with irregular borders.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Abdominal MRI with adrenal protocol:</strong> MRI with adrenal protocol is not initially needed if the lesion appears benign and smooth on CT; biochemical workup takes precedence.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. No further evaluation required given the benign nature:</strong> No further evaluation is incorrect since all adrenal masses &gt;1 cm require at least a biochemical evaluation for hormone secretion.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. 24hr urine fractionated metanephrines and ARR:</strong> 24hr urine fractionated metanephrines and ARR omits ODST, which is necessary screen for mild autonomous cortisol secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">All adrenal masses ≥1 cm should be evaluated for hormonal hyperfunction—including pheochromocytoma, subclinical Cushing's syndrome, and primary aldosteronism—to guide further management and avoid missing potentially curable but serious endocrine diseases.</span></p>",
      "correct_choice_id": 393086,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98767/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98767/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98112,
      "choices": [
        {
          "id": 390488,
          "text": "<p><span style=\"font-size:14.0pt;\">Clozapine</span></p>"
        },
        {
          "id": 390489,
          "text": "<p><span style=\"font-size:14.0pt;\">Olanzapine</span></p>"
        },
        {
          "id": 390490,
          "text": "<p><span style=\"font-size:14.0pt;\">Risperidone</span></p>"
        },
        {
          "id": 390491,
          "text": "<p><span style=\"font-size:14.0pt;\">Quetiapine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following antipsychotics is classically associated with the side effect of agranulocytosis?</span></p>",
      "unique_key": "Q4068144",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Clozapine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Clozapine</strong> is the <strong>atypical antipsychotic most classically associated with agranulocytosis</strong>, a potentially fatal reduction in neutrophil count.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Because of this, strict <strong>blood monitoring protocols</strong> are mandatory—weekly during the first 6 months, every 2 weeks for the next 6 months, and monthly thereafter.</span></li><li><span style=\"font-size:14.0pt;\">Other key adverse effects include <strong>weight gain, hypersalivation (sialorrhea), sedation (MC side effect), constipation, seizures (dose-dependent), and myocarditis.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Olanzapine:</strong> Commonly causes <strong>weight gain and metabolic syndrome</strong>, but not agranulocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Risperidone:</strong> Can cause <strong>hyperprolactinemia</strong> and <strong>extrapyramidal symptoms</strong> at higher doses.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Quetiapine:</strong> Known for <strong>sedation and metabolic effects</strong>, not agranulocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clozapine</strong> is uniquely associated with <strong>agranulocytosis</strong>, requiring routine blood monitoring and reserved for <strong>treatment-resistant schizophrenia</strong> or patients with <strong>high suicide risk.</strong></span></p>",
      "correct_choice_id": 390488,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98112/New_GT_Psychiatry_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98112/New_GT_Psychiatry_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98238,
      "choices": [
        {
          "id": 390984,
          "text": "<p><span style=\"font-size:14.0pt;\">L1 level, with the second part of duodenum anterior</span></p>"
        },
        {
          "id": 390985,
          "text": "<p><span style=\"font-size:14.0pt;\">L2 level, with the neck of pancreas anterior</span></p>"
        },
        {
          "id": 390986,
          "text": "<p><span style=\"font-size:14.0pt;\">L3 level, with the body of pancreas anterior</span></p>"
        },
        {
          "id": 390987,
          "text": "<p><span style=\"font-size:14.0pt;\">T12 level, with the head of pancreas anterior</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">At which vertebral level does the portal vein form, and which anatomical structure lies immediately anterior to its site of formation?</span></p>",
      "unique_key": "Q7792352",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) L2 level, with the neck of pancreas anterior</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>portal vein</strong> is formed by the union of the <strong>superior mesenteric vein (SMV)</strong> and the <strong>splenic vein</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Site of Formation:&nbsp;</strong>The confluence occurs <strong>behind the neck of the pancreas</strong>, at approximately the <strong>level of the L2 vertebra</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anatomical Relations:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Anterior to the formation: Neck of pancreas</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Posterior to the formation: Inferior vena cava (IVC)</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">From this point, the portal vein ascends <strong>posterior to the first part of the duodenum</strong> and then enters the <strong>lesser omentum</strong>, running toward the <strong>porta hepatis of the liver</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-18%20111312.jpg\" width=\"828\" height=\"482\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. L1 level, second part of duodenum anterior:&nbsp;</strong>Incorrect. The <strong>second part of the duodenum</strong> lies <strong>lateral</strong> (to the right), not anterior, to the portal vein formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. L3 level, body of pancreas anterior: </strong>Incorrect. The <strong>body of the pancreas</strong> lies <strong>above</strong> this level; the <strong>neck</strong> (not body) overlies the portal vein confluence.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. T12 level, head of pancreas anterior:&nbsp;</strong>Incorrect. The <strong>head of the pancreas</strong> lies below T12, and the portal vein does <strong>not</strong> form at this level.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>portal vein forms behind the neck of the pancreas at the level of L2</strong> by the union of the <strong>splenic vein</strong> and <strong>superior mesenteric vein</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Understanding this relation is crucial in <strong>pancreatic surgery</strong> and <strong>portal hypertension</strong> management, as injury to this region can lead to <strong>massive hemorrhage</strong>.</span></li></ul>",
      "correct_choice_id": 390985,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98238/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98238/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98106,
      "choices": [
        {
          "id": 390464,
          "text": "<p><span style=\"font-size:14.0pt;\">Acromioclavicular Joint Separation</span></p>"
        },
        {
          "id": 390465,
          "text": "<p><span style=\"font-size:14.0pt;\">Glenohumeral Dislocation</span></p>"
        },
        {
          "id": 390466,
          "text": "<p><span style=\"font-size:14.0pt;\">Rotator Cuff Tear</span></p>"
        },
        {
          "id": 390467,
          "text": "<p><span style=\"font-size:14.0pt;\">Clavicle Fracture</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 22-year-old male presents to the emergency after falling directly onto his left shoulder while playing football. He reports a sudden, sharp pain and says he heard a crackling sound at the time of injury.He is holding his left arm adducted and supported by his right hand. X-ray is shown below. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_bT9AI4P.png\" width=\"386\" height=\"334\"></span></p>",
      "unique_key": "Q9152727",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Clavicle Fracture</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient fell directly onto his shoulder while playing football.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is the most common mechanism for fracturing the clavicle, often by transmitting force from the fall up the arm to the collarbone.</span></li><li><span style=\"font-size:14.0pt;\">Reporting a sudden, sharp pain and hearing a \"crackling sound\" (crepitus) are classic signs that indicate a break in the bone's continuity.</span></li><li><span style=\"font-size:14.0pt;\">The patient is holding his arm adducted (close to the body) and supported by the uninjured hand.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This posturing, often called the \"sling sign,\" is a protective mechanism to reduce movement and tension on the fracture fragments.</span></li><li><span style=\"font-size:14.0pt;\">The X-ray would typically show a fracture line, most commonly in the middle third (midshaft) of the clavicle, often with displacement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acromioclavicular Joint Separation: </strong>While caused by a similar mechanism, it presents with a localized prominence and tenderness over the lateral end of the clavicle (the AC joint), and the clavicle bone itself is usually intact.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Glenohumeral Dislocation:&nbsp;</strong>Presents with the arm held in slight abduction and external rotation (often anterior dislocation) and a noticeable \"squared off\" appearance of the shoulder, not typically a deformity over the clavicle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Rotator Cuff Tear:&nbsp;</strong>Usually presents with weakness and difficulty initiating or sustaining arm movement (active range of motion), often without the immediate history of a \"crackling sound\" or the clear fracture mechanism seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">To recognize the classic presentation of a clavicle fracture, including the high-energy direct-impact mechanism, the reported crepitus (\"crackling sound\"), and the characteristic protective posturing (sling sign or supporting the arm adducted), allowing for prompt and accurate diagnosis in the emergency setting.</span></p>",
      "correct_choice_id": 390467,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98106/INI-NEET_-_GT__27th_Nov_2025_Orthopedics_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98106/INI-NEET_-_GT__27th_Nov_2025_Orthopedics_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98232,
      "choices": [
        {
          "id": 390960,
          "text": "<p><span style=\"font-size:14.0pt;\">3 → 2 → 1 → 4</span></p>"
        },
        {
          "id": 390961,
          "text": "<p><span style=\"font-size:14.0pt;\">1 → 3 → 2 → 4</span></p>"
        },
        {
          "id": 390962,
          "text": "<p><span style=\"font-size:14.0pt;\">3 → 1 → 2 → 4</span></p>"
        },
        {
          "id": 390963,
          "text": "<p><span style=\"font-size:14.0pt;\">1 → 2 → 3 → 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Arrange the following structures in their correct sequence from anterior to posterior as they attach to the intercondylar area of the upper surface of tibia:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Anterior cruciate ligament</span></li><li><span style=\"font-size:14.0pt;\">Posterior horn of medial meniscus</span></li><li><span style=\"font-size:14.0pt;\">Anterior horn of medial meniscus</span></li><li><span style=\"font-size:14.0pt;\">Posterior cruciate ligament</span></li></ol>",
      "unique_key": "Q2008979",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 3 → 1 → 2 → 4</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The intercondylar area of the upper surface of tibia has a specific sequence of attachments from anterior to posterior.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The anterior horn of the medial meniscus (3) attaches just in front of the medial articular surface.</span></li><li><span style=\"font-size:14.0pt;\">Immediately behind this, the anterior cruciate ligament (1) attaches to a smooth area.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;Moving posteriorly, the anterior horn of the lateral meniscus attaches to the front of the intercondylar eminence.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The posterior horn of the medial meniscus (2) then attaches to the depression behind the base of the medial intercondylar tubercle.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Finally, at the posteriormost position, the posterior cruciate ligament (4) attaches to the posterior smooth area.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This anatomical arrangement is crucial for knee joint stability and function.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-18%20111236.jpg\" width=\"1034\" height=\"592\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">On the intercondylar area of the upper tibia, structures attach from anterior to posterior in this sequence: anterior horn of medial meniscus → anterior cruciate ligament → posterior horn of medial meniscus → posterior cruciate ligament.</span></p>",
      "correct_choice_id": 390962,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98232/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98232/INI-NEET_-_GT__27th_Nov_2025_Anatomy_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98781,
      "choices": [
        {
          "id": 393136,
          "text": "<p><span style=\"font-size:14.0pt;\">Glomerular proteinuria</span></p>"
        },
        {
          "id": 393137,
          "text": "<p><span style=\"font-size:14.0pt;\">Tubulointerstitial proteinuria</span></p>"
        },
        {
          "id": 393138,
          "text": "<p><span style=\"font-size:14.0pt;\">Overflow proteinuria</span></p>"
        },
        {
          "id": 393139,
          "text": "<p><span style=\"font-size:14.0pt;\">Isolated proteinuria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old man with known IgG kappa light chain multiple myeloma presents with an acute rise in creatinine (3.5 mg/dL from baseline 1.3 mg/dL). His urinalysis is bland, urine protein/creatinine ratio is 5.6 g/g, and urine albumin/creatinine ratio is 0.8 g/g. What is the most likely etiology of his proteinuria?</span></p>",
      "unique_key": "Q8514284",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Overflow proteinuria</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient with multiple myeloma likely has overflow proteinuria from excessive monoclonal light chains (Bence Jones proteins) overwhelming the proximal tubule’s reabsorption capacity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In these cases, urine protein is primarily composed of non-albumin proteins (light chains), so total protein/creatinine is much higher than the albumin/creatinine ratio, and urinalysis is often bland.</span></li><li><span style=\"font-size:14.0pt;\">Overflow proteinuria occurs when abnormal low-molecular-weight proteins (such as immunoglobulin light chains in multiple myeloma) surpass the kidneys’ ability to reabsorb them, resulting in large amounts of non-albumin protein excretion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Glomerular proteinuria:</strong> Predominantly presents with high albumin excretion and would result in a urine albumin/creatinine ratio closer to the protein/creatinine ratio.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Tubulointerstitial proteinuria:</strong> Seen with tubular injury, but rarely produces excessive proteinuria and is not typical in multiple myeloma.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Isolated proteinuria:</strong> Refers to proteinuria without other clinical findings and does not fit the pattern of high non-albumin protein seen here due to light chain disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Overflow proteinuria in multiple myeloma is due to excessive filtered monoclonal light chains, which exceed tubular handling capacity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This produces high total proteinuria with a disproportionately low albumin fraction and a bland urine sediment.</span></li></ul>",
      "correct_choice_id": 393138,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98781/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/98781/Ini-Neet_-_Gt__27Th_Nov_2025_Medicine_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    }
  ]
}